data_2n2s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n2s _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.718 ' SG ' HG22 ' A' ' 24' ' ' ILE . 61.7 m . . . . . 0 C--O 1.241 0.623 0 CA-C-O 120.839 0.352 . . . . 62.009999999999998 110.052 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.9 -6.86 86.11 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-O 118.691 -1.061 . . . . 74.120000000000005 114.874 -170.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m 66.63 13.58 9.39 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.488 1.115 . . . . 71.430000000000007 110.839 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -94.16 -24.55 17.48 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.208 1.003 . . . . 73.030000000000001 110.015 -172.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 52.5 m -97.6 39.73 1.19 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.894 0.878 . . . . 41.329999999999998 110.655 170.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.551 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -99.23 -16.22 0.19 Allowed Pre-proline 0 CA--C 1.58 2.112 0 N-CA-C 115.468 1.655 . . . . 71.450000000000003 115.468 168.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 12.6 Cg_exo -69.35 -38.88 8.05 Favored 'Trans proline' 0 C--N 1.406 3.554 0 CA-C-N 123.198 2.178 . . . . 74.349999999999994 112.964 -166.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -67.59 150.75 97.69 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.362 -1.29 . . . . 73.420000000000002 112.353 -166.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.11 -29.65 87.68 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.479 2.119 . . . . 75.540000000000006 110.698 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -119.34 78.34 1.29 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.784 -1.191 . . . . 74.409999999999997 107.784 170.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.454 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 20.7 p -60.19 -27.67 67.34 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.031 -0.986 . . . . 74.400000000000006 110.954 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -45.66 -38.25 6.56 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 125.452 1.501 . . . . 73.230000000000004 111.593 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.94 43.67 3.25 Favored Glycine 0 N--CA 1.474 1.206 0 CA-C-N 114.755 -1.111 . . . . 74.5 112.531 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.446 ' O ' HG13 ' A' ' 18' ' ' VAL . 13.2 t -167.23 -46.07 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.991 1.316 . . . . 64.150000000000006 108.323 -176.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.1 t -79.47 -42.79 24.52 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.671 -1.604 . . . . 71.209999999999994 112.03 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.5 mt -63.13 -9.72 11.92 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.959 1.466 . . . . 74.219999999999999 114.959 -175.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 15' ' ' CYS . 10.2 p -83.17 -19.84 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 118.894 0.77 . . . . 74.230000000000004 110.625 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -138.87 -1.66 1.78 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.051 0.94 . . . . 71.530000000000001 111.648 -169.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.476 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 59.8 m -146.16 167.0 24.52 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.599 0.76 . . . . 60.329999999999998 110.301 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.95 155.65 52.59 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 115.206 -0.906 . . . . 75.299999999999997 110.448 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -45.52 -30.95 6.44 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.729 2.952 . . . . 74.030000000000001 114.652 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -58.87 -41.26 86.65 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.086 0.554 . . . . 73.010000000000005 111.521 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.718 HG22 ' SG ' ' A' ' 2' ' ' CYS . 47.9 mm -73.11 -51.33 26.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 C-N-CA 123.567 0.747 . . . . 75.230000000000004 110.162 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.0 m -65.37 -31.92 73.29 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.055 -0.975 . . . . 73.219999999999999 111.339 -175.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.38 -28.44 68.21 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.397 0.679 . . . . 73.040000000000006 111.522 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.12 -22.62 47.94 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.702 0.627 . . . . 53.350000000000001 112.273 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . 15.8 m95 -93.43 -36.77 12.31 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.222 0.609 . . . . 74.340000000000003 112.132 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 42.4 m -71.58 -73.14 0.19 Allowed 'General case' 0 CA--C 1.547 0.844 0 O-C-N 123.196 0.31 . . . . 63.32 110.519 176.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.074 0 CA-C-O 121.055 0.253 . . . . 72.140000000000001 112.508 -178.093 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.779 ' HB2' HG21 ' A' ' 24' ' ' ILE . 11.1 t . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.365 -0.606 . . . . 65.150000000000006 109.365 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.04 -25.09 76.39 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 111.389 -0.684 . . . . 64.349999999999994 111.389 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.1 m 66.3 5.12 3.5 Favored 'General case' 0 C--N 1.369 1.447 0 C-N-CA 124.562 1.145 . . . . 60.350000000000001 112.086 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.45 -15.84 16.36 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.039 0.935 . . . . 72.230000000000004 108.761 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 56.2 m -93.21 44.45 1.14 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.535 1.134 . . . . 64.530000000000001 110.822 170.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.491 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -117.31 5.26 0.08 OUTLIER Pre-proline 0 CA--C 1.58 2.134 0 N-CA-C 116.034 1.864 . . . . 34.259999999999998 116.034 173.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 39.9 Cg_exo -59.32 -54.08 2.92 Favored 'Trans proline' 0 C--N 1.408 3.691 0 CA-C-N 123.509 2.289 . . . . 65.430000000000007 112.867 -173.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -85.27 155.71 60.09 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 114.395 -1.275 . . . . 75.239999999999995 111.411 -171.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.9 -14.93 45.6 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.689 2.259 . . . . 71.319999999999993 111.532 165.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -108.05 56.41 0.63 Allowed 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 123.018 1.39 . . . . 72.530000000000001 108.344 170.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.531 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 22.0 p -67.85 -16.26 64.01 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.24 -1.345 . . . . 72.140000000000001 111.852 175.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -47.42 -36.47 9.9 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 126.01 1.724 . . . . 74.340000000000003 112.436 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.11 35.2 3.86 Favored Glycine 0 N--CA 1.47 0.932 0 CA-C-N 115.091 -0.959 . . . . 65.209999999999994 112.801 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 8.3 t -154.94 -46.54 0.08 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.403 1.097 . . . . 71.239999999999995 108.955 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 15.4 t -80.65 -44.19 19.24 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 113.333 -1.758 . . . . 73.439999999999998 111.562 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.442 HD21 ' SG ' ' A' ' 25' ' ' CYS . 74.9 mt -62.59 -18.56 62.41 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 114.68 1.363 . . . . 44.119999999999997 114.68 -172.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.65 -19.41 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 122.837 0.455 . . . . 71.439999999999998 111.636 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.518 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 16.0 pt20 -142.11 -34.01 0.47 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.112 0.965 . . . . 74.530000000000001 110.371 -168.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.518 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 3.7 m -104.69 158.11 16.73 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.614 1.166 . . . . 73.150000000000006 109.228 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.5 159.38 61.52 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.248 0.619 . . . . 61.109999999999999 110.962 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.69 -33.48 31.99 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.13 2.553 . . . . 51.210000000000001 112.674 164.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.0 t -57.12 -22.66 41.48 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.733 1.213 . . . . 73.549999999999997 112.401 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.779 HG21 ' HB2' ' A' ' 2' ' ' CYS . 31.8 mm -101.47 -51.55 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.681 0.792 . . . . 73.340000000000003 110.474 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.442 ' SG ' HD21 ' A' ' 17' ' ' LEU . 21.9 m -64.92 -22.14 66.94 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.089 0.956 . . . . 63.210000000000001 112.357 -172.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.61 76.0 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.616 0.766 . . . . 72.430000000000007 111.343 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.1 -19.22 63.25 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.739 -0.664 . . . . 64.120000000000005 112.722 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -89.28 -40.32 12.89 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.108 0.563 . . . . 71.340000000000003 110.877 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 21.1 m -74.55 -60.73 2.14 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.362 -0.836 . . . . 63.530000000000001 111.301 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.312 0 CA-C-N 116.015 -0.539 . . . . 35.520000000000003 112.554 -173.334 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.454 ' HB2' HG22 ' A' ' 24' ' ' ILE . 99.2 m . . . . . 0 CA--C 1.547 0.854 0 CA-C-O 121.047 0.451 . . . . 71.310000000000002 110.114 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.12 -56.76 1.05 Allowed Glycine 0 C--N 1.336 0.55 0 CA-C-N 115.98 -0.554 . . . . 74.219999999999999 112.382 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.7 p 149.97 -6.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 126.372 1.869 . . . . 72.140000000000001 108.791 -159.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -25.65 60.74 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.836 0.854 . . . . 71.540000000000006 110.698 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -100.74 53.16 0.86 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.507 1.123 . . . . 74.430000000000007 109.75 173.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.481 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -133.37 15.21 0.05 OUTLIER Pre-proline 0 CA--C 1.576 1.945 0 CA-C-N 113.724 -1.58 . . . . 72.109999999999999 114.802 169.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 31.8 Cg_exo -62.53 -51.53 3.21 Favored 'Trans proline' 0 C--N 1.407 3.657 0 CA-C-N 123.242 2.194 . . . . 72.019999999999996 111.549 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -84.68 159.66 57.64 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 113.735 -1.575 . . . . 73.140000000000001 110.793 -172.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.06 -23.92 28.89 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.475 2.117 . . . . 75.400000000000006 110.776 163.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -104.33 48.92 0.83 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.956 1.302 . . . . 74.129999999999995 109.137 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 19.9 p -61.06 -14.53 24.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.921 1.289 . . . . 74.25 113.822 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.549 ' HE3' HD12 ' A' ' 17' ' ' LEU . 61.8 m95 -47.07 -40.78 15.77 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.416 1.487 . . . . 75.540000000000006 112.298 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.33 -25.29 75.87 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-N 114.946 -1.025 . . . . 50.43 112.745 -173.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.45 ' O ' HG13 ' A' ' 18' ' ' VAL . 34.3 t -86.77 -45.63 10.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.109 0.957 . . . . 74.239999999999995 110.216 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 t -76.98 -53.76 7.42 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.619 -1.628 . . . . 53.109999999999999 112.578 -170.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.676 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -61.91 -7.81 4.24 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.854 1.798 . . . . 74.239999999999995 115.854 -175.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 15' ' ' CYS . 10.3 p -76.77 -23.73 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-N 119.278 0.945 . . . . 62.119999999999997 110.366 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -132.18 -24.19 2.11 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.253 1.021 . . . . 73.519999999999996 111.289 -169.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 2' ' ' CYS . 77.9 m -123.98 175.37 6.99 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.43 1.092 . . . . 72.129999999999995 110.472 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.52 157.4 58.46 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.915 0.886 . . . . 73.340000000000003 110.479 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HB3' HD21 ' A' ' 17' ' ' LEU . 19.9 Cg_endo -61.33 -12.43 23.75 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 123.152 2.568 . . . . 71.040000000000006 112.769 171.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.0 t -62.49 -44.05 97.32 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.445 0.698 . . . . 62.420000000000002 110.689 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.454 HG22 ' HB2' ' A' ' 2' ' ' CYS . 36.9 mm -69.99 -50.13 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 115.705 -0.679 . . . . 74.140000000000001 109.3 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.676 ' SG ' ' HG ' ' A' ' 17' ' ' LEU . 10.2 m -60.37 -36.18 77.44 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.303 -1.317 . . . . 71.010000000000005 111.733 -174.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.14 89.98 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.082 0.553 . . . . 51.43 110.687 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.07 -33.07 69.42 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.846 0.716 . . . . 54.020000000000003 113.429 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -92.37 -38.23 12.14 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.801 0.44 . . . . 73.349999999999994 111.585 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 34.5 m -69.09 -57.97 4.7 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.605 0.362 . . . . 62.439999999999998 111.676 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.777 0 CA-C-N 116.192 -0.458 . . . . 63.130000000000003 112.47 -172.92 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.667 ' SG ' HG22 ' A' ' 24' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 108.437 -0.949 . . . . 62.200000000000003 108.437 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.31 -48.7 84.71 Favored Glycine 0 C--N 1.341 0.824 0 O-C-N 124.096 0.873 . . . . 64.120000000000005 114.858 -172.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.3 p 131.25 3.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 127.505 2.322 . . . . 63.409999999999997 107.916 -159.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.33 -26.85 63.94 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.005 0.922 . . . . 73.239999999999995 109.806 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.1 m -100.72 60.75 0.98 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.957 -1.019 . . . . 72.150000000000006 110.039 167.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.635 ' HB1' ' HB3' ' A' ' 28' ' ' TRP . . . -142.92 31.77 0.13 Allowed Pre-proline 0 CA--C 1.579 2.078 0 CA-C-N 113.797 -1.547 . . . . 74.450000000000003 113.403 163.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 51.3 Cg_exo -61.26 -50.24 6.29 Favored 'Trans proline' 0 C--N 1.405 3.51 0 CA-C-N 122.08 1.779 . . . . 74.019999999999996 111.974 170.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -84.14 161.36 55.2 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 113.781 -1.554 . . . . 70.109999999999999 111.36 -171.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.71 -33.91 75.33 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.259 1.973 . . . . 74.349999999999994 110.452 161.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -94.82 78.53 3.67 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.966 -1.016 . . . . 72.120000000000005 108.97 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.466 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 18.3 p -70.44 -18.01 63.0 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.86 -0.609 . . . . 51.039999999999999 110.592 171.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.475 ' HE3' HD12 ' A' ' 17' ' ' LEU . 64.9 m95 -49.23 -35.93 18.72 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 125.284 1.434 . . . . 73.349999999999994 111.774 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -93.6 49.06 2.32 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 114.909 -1.041 . . . . 41.299999999999997 112.161 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.459 ' O ' HG13 ' A' ' 18' ' ' VAL . 16.6 t -166.2 -45.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.812 1.245 . . . . 73.049999999999997 108.709 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 12.4 t -80.8 -45.8 16.38 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 113.493 -1.685 . . . . 74.310000000000002 111.936 -169.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.475 HD12 ' HE3' ' A' ' 13' ' ' TRP . 5.4 mp -72.11 -0.18 11.16 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 114.849 1.426 . . . . 64.409999999999997 114.849 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 15' ' ' CYS . 13.6 p -82.18 -18.36 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.849 0.749 . . . . 74.230000000000004 110.096 171.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.555 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 11.5 pt20 -138.04 -6.45 1.63 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.637 0.775 . . . . 74.530000000000001 111.777 -168.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.555 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 48.7 m -143.76 172.4 12.89 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.668 0.787 . . . . 75.010000000000005 110.357 -174.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 154.74 50.14 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.209 1.004 . . . . 73.420000000000002 109.785 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.4 -18.74 40.13 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.328 2.686 . . . . 64.319999999999993 112.771 172.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 t -61.05 -39.17 88.82 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.814 0.846 . . . . 53.210000000000001 110.694 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.667 HG22 ' SG ' ' A' ' 2' ' ' CYS . 45.1 mm -77.82 -48.42 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.419 0.688 . . . . 74.019999999999996 109.709 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.6 m -64.99 -30.41 71.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.639 -1.164 . . . . 54.229999999999997 112.082 -172.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.81 -29.01 70.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.059 0.544 . . . . 70.019999999999996 111.412 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.58 -27.75 37.96 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.536 0.522 . . . . 72.219999999999999 112.409 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.635 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 26.4 m95 -92.49 -32.78 14.75 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.259 0.624 . . . . 74.340000000000003 111.395 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.2 m -73.96 -74.83 0.17 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.247 0.546 . . . . 65.109999999999999 110.637 173.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.861 0 CA-C-N 114.783 -1.099 . . . . 61.100000000000001 110.67 -169.746 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.626 ' HB2' HG22 ' A' ' 24' ' ' ILE . 36.1 t . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.079 -0.711 . . . . 75.310000000000002 109.079 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.17 -16.86 79.1 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.705 -0.497 . . . . 55.539999999999999 111.862 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.7 p 61.49 8.5 2.25 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 125.79 1.636 . . . . 52.130000000000003 112.836 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -116.06 7.1 14.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.534 0.734 . . . . 63.509999999999998 109.07 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 88.3 m -106.51 34.96 3.14 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 124.058 0.943 . . . . 73.099999999999994 110.734 170.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.517 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -96.39 -19.26 0.22 Allowed Pre-proline 0 CA--C 1.586 2.339 0 N-CA-C 115.188 1.551 . . . . 71.120000000000005 115.188 167.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 25.1 Cg_exo -63.47 -53.66 1.32 Allowed 'Trans proline' 0 C--N 1.412 3.875 0 CA-C-N 123.329 2.225 . . . . 62.149999999999999 114.072 -163.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.36 159.64 84.0 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 114.904 -1.044 . . . . 74.420000000000002 111.685 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.79 -26.35 32.51 Favored 'Trans proline' 0 CA--C 1.554 1.511 0 C-N-CA 122.193 1.929 . . . . 64.109999999999999 111.044 162.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -98.87 31.98 2.78 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 124.44 1.096 . . . . 74.409999999999997 109.612 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.6 p -61.05 -20.8 62.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.405 1.082 . . . . 74.030000000000001 112.767 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -54.76 -38.27 67.01 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.176 0.99 . . . . 75.049999999999997 110.693 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -23.89 74.82 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 115.06 -0.973 . . . . 74.219999999999999 112.781 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.457 ' O ' HG13 ' A' ' 18' ' ' VAL . 34.6 t -89.24 -43.47 10.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.492 1.117 . . . . 75.230000000000004 109.968 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 42.2 t -71.79 -52.02 19.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.151 -1.386 . . . . 64.019999999999996 111.455 -171.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.487 HD23 ' HB3' ' A' ' 22' ' ' PRO . 4.4 mp -73.0 9.89 1.06 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 115.583 1.697 . . . . 74.299999999999997 115.583 -173.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 15' ' ' CYS . 13.9 p -91.14 -12.56 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 118.875 0.761 . . . . 64.540000000000006 109.442 170.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.513 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 27.6 pt20 -152.86 2.4 0.31 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.344 0.657 . . . . 71.439999999999998 112.028 -167.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.513 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 1.4 m -147.03 156.66 43.2 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.607 0.763 . . . . 72.230000000000004 109.354 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.95 149.9 77.49 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.241 0.616 . . . . 73.140000000000001 110.819 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.487 ' HB3' HD23 ' A' ' 17' ' ' LEU . 13.2 Cg_endo -55.94 -23.2 41.81 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.525 2.817 . . . . 74.140000000000001 113.713 174.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -65.24 -38.71 91.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.955 0.502 . . . . 61.32 110.388 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.626 HG22 ' HB2' ' A' ' 2' ' ' CYS . 23.4 mm -75.1 -43.75 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.226 -0.657 . . . . 72.530000000000001 109.226 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.5 m -66.96 -28.41 68.25 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.158 0.983 . . . . 72.150000000000006 111.055 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.86 -28.3 68.86 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.563 0.745 . . . . 71.349999999999994 111.231 170.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.95 -35.71 38.34 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 116.221 -0.445 . . . . 75.140000000000001 112.133 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -82.52 -69.34 0.63 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.98 0.512 . . . . 73.519999999999996 110.296 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.5 m -64.68 -49.45 70.9 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.142 0.977 . . . . 74.010000000000005 112.096 -175.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.182 0 CA-C-N 115.52 -0.764 . . . . 39.890000000000001 112.968 -178.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.654 ' HB2' HG22 ' A' ' 24' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.71 -0.478 . . . . 61.299999999999997 109.71 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.0 -5.46 73.4 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.527 -0.596 . . . . 75.120000000000005 112.306 166.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.3 m 64.88 18.54 11.52 Favored 'General case' 0 C--N 1.372 1.545 0 C-N-CA 124.721 1.208 . . . . 64.140000000000001 109.853 -171.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -102.82 -38.49 7.4 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.449 -1.315 . . . . 73.129999999999995 107.449 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.1 m -86.67 44.86 1.19 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.212 1.005 . . . . 73.230000000000004 111.707 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.412 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -122.6 33.11 0.22 Allowed Pre-proline 0 CA--C 1.576 1.973 0 N-CA-C 114.728 1.381 . . . . 64.5 114.728 165.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 35.3 Cg_exo -64.79 -61.05 0.11 Allowed 'Trans proline' 0 C--N 1.397 3.119 0 CA-C-N 122.675 1.991 . . . . 74.400000000000006 111.072 169.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -82.67 151.54 64.95 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-N 114.239 -1.346 . . . . 74.439999999999998 111.37 -170.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.5 -32.64 96.62 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.937 2.424 . . . . 65.200000000000003 110.67 162.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -94.61 70.0 3.53 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 122.44 1.114 . . . . 73.299999999999997 108.532 171.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.527 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 22.1 p -77.8 -15.26 59.22 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.366 -1.288 . . . . 73.010000000000005 112.803 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -48.5 -38.78 21.09 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.381 1.473 . . . . 64.519999999999996 112.885 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.83 -16.97 80.31 Favored Glycine 0 N--CA 1.476 1.315 0 CA-C-N 115.553 -0.749 . . . . 74.109999999999999 113.339 -172.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 11.4 t -96.13 -51.75 4.29 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.166 0.984 . . . . 55.25 109.677 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 t -73.82 -45.3 52.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.685 -1.598 . . . . 70.010000000000005 112.715 -166.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.467 HD23 ' SG ' ' A' ' 25' ' ' CYS . 76.3 mt -59.15 -22.24 60.6 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.061 1.504 . . . . 73.25 115.061 -172.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 15' ' ' CYS . 7.6 p -78.52 -22.75 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 118.666 0.666 . . . . 65.129999999999995 111.184 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -133.85 1.0 3.27 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.03 0.932 . . . . 70.319999999999993 111.282 -170.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.1 m -149.09 167.65 25.31 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.479 1.112 . . . . 61.240000000000002 109.55 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.53 154.68 62.43 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.649 0.78 . . . . 73.439999999999998 110.492 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.32 -25.05 45.52 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.26 2.64 . . . . 74.510000000000005 112.856 167.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -57.37 -37.53 72.76 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.981 0.912 . . . . 75.049999999999997 111.137 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.654 HG22 ' HB2' ' A' ' 2' ' ' CYS . 43.3 mm -82.83 -49.41 16.93 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 C-N-CA 123.189 0.596 . . . . 70.120000000000005 110.341 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.467 ' SG ' HD23 ' A' ' 17' ' ' LEU . 11.4 m -64.26 -26.84 68.68 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.076 -0.966 . . . . 55.409999999999997 111.867 -171.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.78 -33.57 71.88 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.491 0.717 . . . . 64.430000000000007 111.76 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.51 -42.45 11.61 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 116.447 -0.342 . . . . 73.329999999999998 112.808 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -73.94 -34.23 64.23 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.868 0.467 . . . . 73.219999999999999 110.974 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 21.9 m -77.92 -78.76 0.13 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.249 0.62 . . . . 44.329999999999998 110.794 175.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.559 0 O-C-N 123.245 0.341 . . . . 44.020000000000003 112.911 -170.619 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.732 ' HB2' HG22 ' A' ' 24' ' ' ILE . 9.3 t . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 107.8 -1.185 . . . . 75.120000000000005 107.8 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.23 -11.41 67.05 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.363 -0.687 . . . . 53.229999999999997 112.958 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.4 m 68.94 6.23 5.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.998 1.319 . . . . 62.350000000000001 110.708 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -88.23 -45.47 10.05 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.291 1.037 . . . . 62.109999999999999 108.694 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 92.3 m -89.39 50.1 1.87 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.618 -1.174 . . . . 73.230000000000004 111.516 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.545 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -104.35 -15.27 0.16 Allowed Pre-proline 0 CA--C 1.577 2.011 0 N-CA-C 116.306 1.965 . . . . 62.439999999999998 116.306 167.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 14.0 Cg_exo -64.15 -49.47 3.71 Favored 'Trans proline' 0 C--N 1.407 3.644 0 CA-C-N 122.98 2.1 . . . . 71.209999999999994 113.342 -160.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -77.95 154.62 80.41 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 113.514 -1.676 . . . . 64.019999999999996 111.431 -166.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.17 -38.6 75.54 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.185 1.923 . . . . 62.149999999999999 110.425 174.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -100.56 82.42 2.45 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 107.358 -1.349 . . . . 61.229999999999997 107.358 167.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.533 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 23.6 p -73.48 -18.14 61.15 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.867 0.867 . . . . 62.149999999999999 111.778 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -48.5 -40.32 26.28 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 125.262 1.425 . . . . 73.530000000000001 112.354 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.3 -27.5 73.59 Favored Glycine 0 N--CA 1.478 1.441 0 CA-C-N 115.334 -0.848 . . . . 63.229999999999997 112.87 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 12.7 t -90.66 -45.78 8.67 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.294 1.045 . . . . 75.329999999999998 110.107 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 11.4 t -74.75 -44.48 49.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.28 -1.782 . . . . 74.230000000000004 112.122 -166.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.26 -15.99 58.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 115.019 1.488 . . . . 65.209999999999994 115.019 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 15' ' ' CYS . 14.6 p -81.06 -10.81 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 118.706 0.684 . . . . 73.120000000000005 110.884 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -147.32 -3.81 0.55 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.377 0.671 . . . . 75.140000000000001 111.663 -169.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 8.2 m -145.61 162.87 36.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.115 0.966 . . . . 54.030000000000001 109.037 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.85 157.13 67.07 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.73 0.812 . . . . 64.010000000000005 111.399 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.84 -23.72 68.61 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.485 2.79 . . . . 54.32 113.066 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.4 p -65.17 -32.63 74.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.109 0.564 . . . . 75.109999999999999 110.643 173.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.732 HG22 ' HB2' ' A' ' 2' ' ' CYS . 14.6 mm -84.81 -49.04 16.18 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 121.175 0.512 . . . . 73.340000000000003 110.242 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.1 m -62.87 -28.1 69.8 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.837 -1.074 . . . . 73.299999999999997 111.235 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.25 -45.29 72.33 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.963 0.505 . . . . 73.430000000000007 111.004 169.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.13 -32.53 60.33 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.102 -0.954 . . . . 75.230000000000004 113.64 -175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.424 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . 80.5 m95 -86.17 -28.7 23.76 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.896 0.478 . . . . 72.25 111.885 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.3 m -78.98 -70.07 0.53 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.615 0.366 . . . . 73.319999999999993 111.273 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.215 0 C-N-CA 121.743 -0.265 . . . . 52.240000000000002 113.552 -169.429 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.458 ' SG ' HG22 ' A' ' 24' ' ' ILE . 31.2 m . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 109.887 -0.412 . . . . 60.399999999999999 109.887 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.04 12.2 58.52 Favored Glycine 0 N--CA 1.473 1.145 0 N-CA-C 116.81 1.484 . . . . 63.530000000000001 116.81 -161.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.2 p 58.1 15.43 3.24 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.105 1.362 . . . . 75.329999999999998 112.29 -172.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.63 -29.41 56.44 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 108.771 -0.826 . . . . 73.310000000000002 108.771 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.5 m -96.39 51.08 1.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.286 -0.87 . . . . 52.140000000000001 110.511 168.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.415 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -122.92 21.73 0.1 OUTLIER Pre-proline 0 CA--C 1.59 2.498 0 N-CA-C 115.071 1.508 . . . . 61.219999999999999 115.071 163.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 52.6 Cg_exo -58.32 -58.26 0.82 Allowed 'Trans proline' 0 C--N 1.409 3.751 0 CA-C-N 123.239 2.192 . . . . 74.409999999999997 113.115 174.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -80.1 154.65 75.0 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 114.845 -1.07 . . . . 64.439999999999998 111.193 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.26 -35.46 91.62 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.937 2.425 . . . . 75.439999999999998 110.655 168.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.44 75.41 5.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.003 -1.11 . . . . 63.43 108.003 167.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.547 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 20.7 p -68.22 -18.21 64.51 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.732 -1.122 . . . . 75.219999999999999 110.992 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -48.88 -36.69 17.67 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 125.411 1.484 . . . . 75.510000000000005 111.419 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.37 25.27 6.42 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-N 114.987 -1.006 . . . . 73.329999999999998 113.579 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.412 ' O ' HG13 ' A' ' 18' ' ' VAL . 20.0 t -143.5 -46.52 0.29 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.777 1.231 . . . . 73.329999999999998 108.649 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.2 t -78.02 -44.62 26.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.005 -1.907 . . . . 72.239999999999995 111.763 -170.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.2 mt -62.12 -12.59 20.33 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.974 1.472 . . . . 75.430000000000007 114.974 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 15' ' ' CYS . 11.4 p -82.22 -19.75 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 119.087 0.858 . . . . 74.099999999999994 110.584 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -142.08 5.26 1.69 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.046 0.938 . . . . 74.430000000000007 111.475 -169.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.498 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 48.4 m -146.49 172.05 14.13 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.751 1.22 . . . . 73.150000000000006 109.068 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.43 161.54 24.91 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 123.555 0.742 . . . . 52.009999999999998 110.871 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.04 -31.52 8.63 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 123.631 2.888 . . . . 51.119999999999997 114.61 169.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 m -56.42 -40.48 74.76 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.278 0.631 . . . . 62.439999999999998 111.505 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.458 HG22 ' SG ' ' A' ' 2' ' ' CYS . 47.6 mm -78.3 -55.73 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.603 -0.726 . . . . 72.040000000000006 110.089 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 m -63.88 -31.29 72.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.992 -1.003 . . . . 64.540000000000006 112.131 -170.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.82 -31.12 69.42 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.969 0.508 . . . . 74.430000000000007 112.012 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.45 -26.05 48.62 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.8 0.688 . . . . 51.450000000000003 112.561 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -91.2 -31.36 16.21 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.432 0.693 . . . . 71.530000000000001 111.015 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 18.6 m -80.82 -70.02 0.56 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.012 0.925 . . . . 73.519999999999996 111.935 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.504 0 CA-C-N 115.001 -1.0 . . . . 53.219999999999999 111.685 -167.102 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.698 ' SG ' HG22 ' A' ' 24' ' ' ILE . 95.7 m . . . . . 0 CA--C 1.555 1.159 0 N-CA-C 112.248 0.462 . . . . 72.510000000000005 112.248 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.4 -6.51 77.67 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.266 -0.741 . . . . 61.43 113.966 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.0 p 60.0 15.98 5.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.475 1.51 . . . . 73.219999999999999 112.576 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -34.57 44.68 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.471 -0.786 . . . . 72.340000000000003 109.287 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 93.0 m -101.56 43.49 1.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.559 1.144 . . . . 70.340000000000003 110.727 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HA ' ' HB3' ' A' ' 28' ' ' TRP . . . -95.89 -26.09 0.25 Allowed Pre-proline 0 CA--C 1.578 2.054 0 N-CA-C 115.826 1.787 . . . . 73.040000000000006 115.826 171.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 11.8 Cg_exo -65.8 -44.47 7.91 Favored 'Trans proline' 0 C--N 1.398 3.171 0 C-N-CA 122.161 1.907 . . . . 75.319999999999993 114.005 -157.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -83.34 157.0 65.83 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 114.109 -1.405 . . . . 72.120000000000005 111.983 -160.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.28 -27.61 63.81 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.214 1.943 . . . . 75.219999999999999 111.255 162.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -104.8 38.87 1.81 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.344 1.058 . . . . 72.129999999999995 109.224 174.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.5 p -64.92 -21.64 66.86 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.55 -0.719 . . . . 71.140000000000001 111.27 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -48.62 -38.78 21.85 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 125.242 1.417 . . . . 72.430000000000007 111.79 171.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.73 -14.47 79.86 Favored Glycine 0 N--CA 1.473 1.105 0 CA-C-N 115.04 -0.982 . . . . 72.349999999999994 113.104 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 20.5 t -99.43 -41.26 7.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.121 1.368 . . . . 74.540000000000006 110.151 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 9.9 t -81.03 -45.5 16.46 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 113.174 -1.83 . . . . 73.519999999999996 112.553 -168.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.6 -0.47 1.4 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.245 1.572 . . . . 73.120000000000005 115.245 -175.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -88.35 -23.46 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-N 119.176 0.898 . . . . 74.439999999999998 110.436 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -133.79 -3.42 2.9 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.161 0.985 . . . . 74.099999999999994 111.235 -169.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.507 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 63.2 m -144.14 170.18 16.45 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.643 0.777 . . . . 61.350000000000001 110.592 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.41 159.93 34.15 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.186 0.995 . . . . 71.340000000000003 110.795 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -48.12 -30.29 14.11 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 123.686 2.924 . . . . 51.509999999999998 114.161 168.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.2 m -60.91 -39.4 89.2 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.991 0.917 . . . . 62.240000000000002 111.395 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.698 HG22 ' SG ' ' A' ' 2' ' ' CYS . 51.1 mm -77.36 -53.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 123.533 0.733 . . . . 73.299999999999997 109.82 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.7 m -62.76 -31.22 72.13 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.75 -1.114 . . . . 53.0 112.014 -173.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.6 -39.98 84.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.717 0.407 . . . . 65.150000000000006 110.572 172.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.64 -24.32 75.36 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.88 -0.6 . . . . 60.310000000000002 112.977 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.573 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . 81.7 m95 -97.14 -43.79 7.23 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.413 0.685 . . . . 74.329999999999998 111.665 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.5 m -71.4 -73.06 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.31 0.576 . . . . 52.109999999999999 110.864 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.823 0 CA-C-N 114.998 -1.001 . . . . 62.210000000000001 111.315 -170.644 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 50.1 m . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 121.022 0.439 . . . . 65.230000000000004 110.071 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.63 19.13 16.69 Favored Glycine 0 N--CA 1.47 0.905 0 CA-C-N 115.605 -0.725 . . . . 65.209999999999994 112.912 -174.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t 64.44 14.93 9.21 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.833 1.253 . . . . 74.209999999999994 110.791 -166.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -80.29 -33.14 37.93 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.372 -0.973 . . . . 72.209999999999994 108.372 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.403 ' SG ' ' NE2' ' A' ' 19' ' ' GLN . 91.3 m -99.6 46.93 0.96 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.626 -1.17 . . . . 70.329999999999998 110.964 173.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.526 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -112.74 -6.89 0.1 Allowed Pre-proline 0 CA--C 1.577 1.999 0 CA-C-O 116.409 -1.758 . . . . 38.700000000000003 115.565 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 39.1 Cg_exo -62.01 -50.69 4.63 Favored 'Trans proline' 0 C--N 1.408 3.692 0 CA-C-N 123.416 2.256 . . . . 73.409999999999997 113.176 -169.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -77.68 153.91 81.03 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 114.594 -1.185 . . . . 74.5 111.539 -170.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.47 -25.32 41.62 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.216 1.944 . . . . 63.229999999999997 110.658 164.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -104.26 45.84 0.94 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.014 1.326 . . . . 75.439999999999998 108.92 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 20.6 p -56.02 -19.79 14.13 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.499 1.12 . . . . 74.430000000000007 112.455 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -42.74 -39.51 2.47 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.096 1.758 . . . . 74.510000000000005 112.378 171.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.31 -22.09 76.12 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 115.413 -0.812 . . . . 72.409999999999997 113.616 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.438 ' O ' HG13 ' A' ' 18' ' ' VAL . 25.0 t -96.31 -46.21 6.51 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.25 1.024 . . . . 75.540000000000006 109.987 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -76.99 -47.35 21.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 113.424 -1.717 . . . . 72.319999999999993 112.734 -166.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.429 HD23 ' SG ' ' A' ' 25' ' ' CYS . 47.1 mt -61.46 -14.26 27.18 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.076 1.51 . . . . 62.409999999999997 115.076 -173.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 15' ' ' CYS . 14.0 p -74.93 -23.58 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 118.909 0.777 . . . . 74.129999999999995 110.952 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.403 ' NE2' ' SG ' ' A' ' 6' ' ' CYS . 21.4 pt20 -134.43 -18.54 1.96 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.139 0.976 . . . . 73.129999999999995 111.426 -167.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.8 m -128.55 170.9 12.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.243 1.017 . . . . 72.420000000000002 110.396 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.18 154.9 57.72 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.192 0.997 . . . . 74.230000000000004 110.8 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.48 -26.54 12.4 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.683 2.922 . . . . 74.319999999999993 114.304 168.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 m -61.98 -41.42 98.0 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.134 0.574 . . . . 60.229999999999997 111.174 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.04 -52.87 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 122.956 0.502 . . . . 54.030000000000001 110.28 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.429 ' SG ' HD23 ' A' ' 17' ' ' LEU . 4.0 m -62.0 -33.35 74.17 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.866 -1.061 . . . . 72.340000000000003 111.092 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.8 -36.77 77.43 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.603 0.761 . . . . 74.430000000000007 111.565 174.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.04 -41.53 22.13 Favored Glycine 0 C--N 1.351 1.364 0 O-C-N 123.91 0.756 . . . . 42.020000000000003 112.423 -174.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -77.93 -40.67 38.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.124 0.569 . . . . 72.219999999999999 111.863 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.8 m -67.35 -63.67 1.01 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.34 0.59 . . . . 72.329999999999998 110.542 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.654 0 CA-C-N 114.793 -1.094 . . . . 38.700000000000003 111.446 -167.942 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.753 ' HB2' HG21 ' A' ' 24' ' ' ILE . 6.2 t . . . . . 0 C--O 1.243 0.722 0 N-CA-C 108.931 -0.766 . . . . 65.439999999999998 108.931 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.46 -18.71 65.77 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.796 -0.446 . . . . 73.329999999999998 112.567 173.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.8 m 69.54 8.6 6.84 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 124.777 1.231 . . . . 71.120000000000005 112.272 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -117.55 6.64 12.53 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.494 1.117 . . . . 73.140000000000001 110.437 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 65.5 m -113.66 31.88 6.2 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.131 0.972 . . . . 65.400000000000006 110.984 176.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.569 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -95.02 -20.88 0.23 Allowed Pre-proline 0 CA--C 1.58 2.103 0 N-CA-C 115.318 1.599 . . . . 75.140000000000001 115.318 166.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 9.6 Cg_exo -70.35 -47.27 0.78 Allowed 'Trans proline' 0 C--N 1.4 3.262 0 C-N-CA 122.448 2.098 . . . . 65.450000000000003 113.849 -162.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -70.62 159.64 84.39 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.591 -1.186 . . . . 74.319999999999993 112.164 -164.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.51 -29.62 44.43 Favored 'Trans proline' 0 C--N 1.368 1.572 0 C-N-CA 122.159 1.906 . . . . 61.229999999999997 111.352 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -109.22 31.77 5.47 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.644 1.178 . . . . 73.420000000000002 109.894 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.0 p -53.54 -21.39 6.36 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.189 1.396 . . . . 74.230000000000004 114.067 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.459 ' HE3' HD12 ' A' ' 17' ' ' LEU . 81.4 m95 -55.42 -38.31 68.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.439 1.096 . . . . 74.129999999999995 111.16 175.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.92 -21.08 78.14 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 114.984 -1.007 . . . . 54.450000000000003 112.542 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.471 ' O ' HG13 ' A' ' 18' ' ' VAL . 15.1 t -83.74 -45.06 13.78 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.112 0.965 . . . . 72.510000000000005 109.645 177.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.4 t -78.52 -55.72 4.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.98 -1.464 . . . . 74.420000000000002 111.776 -168.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.459 HD12 ' HE3' ' A' ' 13' ' ' TRP . 2.2 mp -62.0 -9.19 6.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.113 1.523 . . . . 74.209999999999994 115.113 -175.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 15' ' ' CYS . 11.1 p -80.28 -15.56 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 119.255 0.934 . . . . 64.439999999999998 109.919 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.604 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 26.5 pt20 -144.23 -4.8 0.79 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.875 0.87 . . . . 65.439999999999998 111.703 -170.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.604 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 3.9 m -139.77 170.32 16.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.666 0.787 . . . . 62.0 109.197 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.08 149.91 70.65 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 122.983 0.513 . . . . 73.209999999999994 111.236 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.438 ' HB3' HD23 ' A' ' 17' ' ' LEU . 9.3 Cg_endo -54.07 -27.25 44.99 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 123.364 2.709 . . . . 54.32 112.844 165.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.3 m -62.77 -39.62 94.76 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.599 0.76 . . . . 64.219999999999999 110.473 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.753 HG21 ' HB2' ' A' ' 2' ' ' CYS . 44.9 mm -73.29 -48.33 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 123.773 0.829 . . . . 70.450000000000003 110.0 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.4 m -64.05 -31.94 73.32 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.401 1.08 . . . . 74.409999999999997 111.54 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.58 -31.43 70.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.547 -0.751 . . . . 75.540000000000006 111.865 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.64 -32.87 26.29 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 116.381 -0.372 . . . . 37.100000000000001 112.937 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -80.73 -54.55 5.52 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.938 0.495 . . . . 75.219999999999999 111.338 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -79.19 -69.99 0.54 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.25 0.62 . . . . 62.200000000000003 112.527 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.182 0 N-CA-C 112.02 -0.432 . . . . 63.140000000000001 112.02 -166.941 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.697 ' HB2' HG22 ' A' ' 24' ' ' ILE . 2.0 t . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 108.287 -1.005 . . . . 73.450000000000003 108.287 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.55 -17.64 79.75 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.392 -0.671 . . . . 52.0 112.457 170.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.1 t 71.07 29.68 2.87 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 124.808 1.243 . . . . 74.430000000000007 108.289 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -111.28 -31.27 7.12 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.278 -1.328 . . . . 72.150000000000006 109.94 -174.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 96.8 m -103.25 44.42 1.02 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.397 1.079 . . . . 73.230000000000004 112.435 -175.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.534 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -105.26 -10.47 0.12 Allowed Pre-proline 0 CA--C 1.589 2.445 0 N-CA-C 116.233 1.938 . . . . 72.030000000000001 116.233 167.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 16.3 Cg_exo -67.09 -50.67 0.97 Allowed 'Trans proline' 0 C--N 1.401 3.321 0 CA-C-N 123.752 2.376 . . . . 73.340000000000003 114.023 -167.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -80.72 162.33 60.68 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.627 -1.169 . . . . 75.239999999999995 112.602 -162.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.95 -17.09 28.95 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.534 2.156 . . . . 71.129999999999995 111.439 166.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -114.3 27.6 9.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.741 1.216 . . . . 75.420000000000002 110.249 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.9 p -62.48 -16.24 54.35 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.301 1.04 . . . . 75.310000000000002 112.779 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.417 ' HE3' HD12 ' A' ' 17' ' ' LEU . 89.2 m95 -53.76 -39.05 65.02 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.698 0.799 . . . . 75.420000000000002 110.818 173.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.36 -28.41 73.28 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 115.749 -0.66 . . . . 73.129999999999995 112.127 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.509 ' O ' HG13 ' A' ' 18' ' ' VAL . 34.3 t -80.94 -43.77 19.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.356 1.062 . . . . 75.219999999999999 109.742 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -70.32 -54.39 12.78 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.525 -1.216 . . . . 70.230000000000004 111.092 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 22' ' ' PRO . 2.1 mp -69.13 -2.64 10.77 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 115.17 1.544 . . . . 73.420000000000002 115.17 -174.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 15' ' ' CYS . 13.3 p -84.56 -16.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 119.408 1.003 . . . . 62.130000000000003 109.715 176.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -145.15 -3.07 0.77 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.55 0.74 . . . . 54.340000000000003 111.965 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.2 m -144.14 164.45 30.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.856 0.862 . . . . 70.109999999999999 109.531 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.63 154.7 73.7 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-N 115.894 -0.594 . . . . 65.519999999999996 110.515 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.505 ' HB3' HD23 ' A' ' 17' ' ' LEU . 18.3 Cg_endo -59.83 -19.53 54.83 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.957 2.438 . . . . 63.229999999999997 112.234 169.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -58.4 -38.59 77.67 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.905 0.882 . . . . 71.299999999999997 110.872 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.697 HG22 ' HB2' ' A' ' 2' ' ' CYS . 23.9 mm -84.59 -43.06 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.821 -0.627 . . . . 63.310000000000002 110.112 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 m -64.97 -30.5 71.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.238 1.015 . . . . 64.439999999999998 112.07 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.42 -24.4 65.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.991 0.516 . . . . 72.340000000000003 111.541 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.23 -45.49 8.82 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.133 -0.485 . . . . 71.439999999999998 112.138 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -77.48 -67.11 0.75 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.903 0.481 . . . . 73.409999999999997 110.906 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.1 m -69.66 -32.19 70.69 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.363 -0.835 . . . . 55.200000000000003 112.536 -173.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.837 0 CA-C-N 115.997 -0.547 . . . . 61.409999999999997 113.026 -177.656 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.406 ' HB2' HG22 ' A' ' 24' ' ' ILE . 72.2 m . . . . . 0 CA--C 1.549 0.917 0 CA-C-O 121.198 0.523 . . . . 71.439999999999998 111.086 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.81 19.78 32.6 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.282 -0.872 . . . . 39.140000000000001 113.866 -171.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.2 m 67.89 14.19 9.34 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.604 1.162 . . . . 64.230000000000004 111.193 -173.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.94 -20.37 20.07 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.409 1.083 . . . . 74.329999999999998 109.292 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 77.2 m -100.43 45.86 0.97 Allowed 'General case' 0 C--N 1.347 0.489 0 C-N-CA 124.382 1.073 . . . . 63.520000000000003 111.07 172.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.531 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -120.45 5.79 0.07 OUTLIER Pre-proline 0 CA--C 1.582 2.18 0 N-CA-C 115.657 1.725 . . . . 73.099999999999994 115.657 168.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 23.9 Cg_exo -65.55 -51.08 1.52 Allowed 'Trans proline' 0 C--N 1.406 3.589 0 CA-C-N 123.648 2.339 . . . . 72.030000000000001 112.415 -175.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -83.28 156.08 66.35 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 113.672 -1.604 . . . . 64.329999999999998 111.529 -167.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -60.9 -39.96 57.15 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.331 2.021 . . . . 72.319999999999993 110.252 166.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -92.76 75.33 4.94 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 108.411 -0.959 . . . . 72.239999999999995 108.411 170.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 15.9 p -73.24 -21.5 60.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.176 -0.92 . . . . 74.230000000000004 110.343 174.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -48.75 -37.86 20.09 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 125.351 1.46 . . . . 72.109999999999999 111.253 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.67 -36.52 92.47 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.0 -1.0 . . . . 61.399999999999999 112.006 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.9 t -80.87 -44.75 17.9 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.391 1.091 . . . . 61.130000000000003 110.439 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.1 t -82.73 -54.11 5.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.282 -1.781 . . . . 74.510000000000005 112.029 -166.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.99 -19.11 11.22 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.119 1.525 . . . . 75.510000000000005 115.119 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.52 -25.7 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 118.407 0.548 . . . . 74.430000000000007 111.324 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 16' ' ' CYS . 2.9 pp0? -134.98 -0.72 2.75 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.75 0.82 . . . . 70.409999999999997 112.227 -175.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.426 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 74.2 m -136.47 175.88 9.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.265 1.026 . . . . 73.219999999999999 110.634 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.27 160.8 27.33 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.495 1.118 . . . . 62.340000000000003 110.188 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.6 -18.44 40.15 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 122.997 2.465 . . . . 65.519999999999996 113.504 173.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.9 p -60.79 -40.02 91.06 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.148 0.579 . . . . 65.340000000000003 110.635 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.406 HG22 ' HB2' ' A' ' 2' ' ' CYS . 30.7 mm -75.68 -56.03 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 123.307 0.643 . . . . 75.049999999999997 110.1 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -61.01 -29.07 69.49 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.74 -1.118 . . . . 64.5 112.573 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.37 -36.15 79.44 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.895 0.478 . . . . 43.530000000000001 111.659 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.13 -20.59 69.63 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.974 -0.557 . . . . 74.329999999999998 112.873 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -97.39 -35.21 10.76 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.311 0.644 . . . . 71.019999999999996 111.564 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.8 m -76.77 -69.89 0.49 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.137 0.575 . . . . 60.43 111.277 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.74 0 N-CA-C 111.094 -0.803 . . . . 74.099999999999994 111.094 -173.195 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.449 ' HB2' HG22 ' A' ' 24' ' ' ILE . 4.0 t . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.242 0.544 . . . . 62.340000000000003 110.592 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.57 -0.72 75.44 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.712 -0.677 . . . . 73.329999999999998 112.884 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 m 64.05 18.63 11.34 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 124.296 1.038 . . . . 73.420000000000002 108.884 -161.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -74.32 -50.2 19.79 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 114.572 -1.195 . . . . 73.010000000000005 108.811 -165.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 64.4 m -106.2 50.33 0.78 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 113.795 -1.548 . . . . 73.310000000000002 110.858 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.517 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -89.62 -27.12 0.32 Allowed Pre-proline 0 CA--C 1.582 2.21 0 N-CA-C 115.199 1.555 . . . . 73.019999999999996 115.199 166.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 21.1 Cg_exo -64.37 -50.66 2.51 Favored 'Trans proline' 0 C--N 1.407 3.637 0 C-N-CA 122.862 2.374 . . . . 55.520000000000003 114.272 -161.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -72.45 158.81 86.82 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.765 0.826 . . . . 72.109999999999999 112.043 -167.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.41 -32.86 59.9 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.434 2.089 . . . . 62.039999999999999 110.616 163.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -95.68 32.7 1.78 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.96 1.304 . . . . 62.530000000000001 110.394 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -49.91 -32.49 14.79 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.417 1.487 . . . . 53.0 112.041 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -52.04 -40.66 61.45 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 124.719 1.207 . . . . 74.209999999999994 111.952 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.02 47.77 3.4 Favored Glycine 0 N--CA 1.478 1.434 0 CA-C-N 114.757 -1.11 . . . . 62.43 111.055 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 6.7 t -170.42 -46.44 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.055 1.342 . . . . 71.150000000000006 108.249 -169.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 41.2 t -79.56 -46.55 17.1 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 114.065 -1.425 . . . . 73.140000000000001 111.536 -170.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -76.3 15.44 0.59 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.491 1.293 . . . . 75.030000000000001 114.491 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 15' ' ' CYS . 8.1 p -97.13 -12.31 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-O 121.633 0.73 . . . . 64.329999999999998 109.725 168.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.611 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 25.9 pt20 -145.95 -3.68 0.67 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.695 0.798 . . . . 73.420000000000002 111.774 -170.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.611 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 0.8 OUTLIER -144.95 158.02 43.95 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 123.69 0.796 . . . . 72.329999999999998 108.96 -178.417 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.518 ' HB3' HG12 ' A' ' 24' ' ' ILE . . . -78.94 151.42 76.23 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.034 0.534 . . . . 73.219999999999999 110.722 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.16 -30.28 49.8 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.876 3.051 . . . . 44.329999999999998 113.281 172.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 m -63.57 -36.73 84.78 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.905 0.482 . . . . 74.420000000000002 110.776 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.518 HG12 ' HB3' ' A' ' 21' ' ' ALA . 12.1 mm -78.71 -48.35 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 109.212 -0.662 . . . . 74.329999999999998 109.212 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 m -61.69 -35.79 79.03 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.426 1.09 . . . . 75.510000000000005 111.326 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.72 -30.26 70.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.984 0.514 . . . . 64.329999999999998 111.574 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.75 -38.92 49.39 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.704 0.628 . . . . 74.129999999999995 112.071 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.475 ' HE1' HG21 ' A' ' 24' ' ' ILE . 60.0 m95 -75.96 -49.52 17.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.171 0.588 . . . . 75.140000000000001 110.831 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.08 -61.89 1.6 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.5 -0.773 . . . . 73.5 111.719 -175.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.246 0 N-CA-C 114.264 0.466 . . . . 63.32 114.264 -170.471 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.631 ' SG ' HG23 ' A' ' 24' ' ' ILE . 55.8 m . . . . . 0 CA--C 1.547 0.85 0 CA-C-O 121.135 0.493 . . . . 73.310000000000002 111.136 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.49 -7.83 87.1 Favored Glycine 0 N--CA 1.468 0.809 0 CA-C-O 119.188 -0.785 . . . . 73.310000000000002 115.023 -165.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 m 70.34 6.09 5.63 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.016 1.327 . . . . 62.399999999999999 111.002 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.41 -34.2 63.2 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.219 1.008 . . . . 63.439999999999998 109.401 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.4 m -90.14 41.41 1.05 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.246 1.019 . . . . 73.439999999999998 111.277 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.464 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -126.53 26.72 0.13 Allowed Pre-proline 0 CA--C 1.58 2.103 0 N-CA-C 115.482 1.66 . . . . 72.319999999999993 115.482 172.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 13.0 Cg_exo -68.8 -54.47 0.27 Allowed 'Trans proline' 0 C--N 1.398 3.134 0 CA-C-N 122.746 2.016 . . . . 62.43 111.267 172.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -83.86 165.13 41.1 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 113.105 -1.861 . . . . 64.530000000000001 111.471 -164.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.33 -25.38 36.26 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.209 1.94 . . . . 74.239999999999995 110.494 160.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.95 45.09 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.445 1.498 . . . . 74.439999999999998 109.593 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 13.2 p -65.3 -23.7 67.09 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.041 0.536 . . . . 74.0 111.484 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -49.85 -35.86 24.76 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 124.955 1.302 . . . . 74.409999999999997 110.981 173.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.54 41.62 3.06 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 114.65 -1.159 . . . . 40.420000000000002 112.5 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.469 ' O ' HG13 ' A' ' 18' ' ' VAL . 13.3 t -162.56 -51.15 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 125.117 1.367 . . . . 75.25 108.097 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.7 t -75.93 -44.64 39.18 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 113.624 -1.625 . . . . 64.409999999999997 111.578 -172.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 40.4 mt -61.83 -17.9 58.03 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.668 1.359 . . . . 71.310000000000002 114.668 -175.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 15' ' ' CYS . 11.9 p -79.89 -21.03 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.938 0.79 . . . . 73.129999999999995 110.447 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -140.34 8.73 2.24 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.792 0.837 . . . . 74.25 111.616 -170.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -150.86 173.47 14.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.3 1.04 . . . . 45.539999999999999 109.59 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.31 158.44 37.1 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.011 0.925 . . . . 63.030000000000001 109.959 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.73 -22.71 54.3 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.918 2.412 . . . . 73.409999999999997 112.947 171.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.5 m -63.81 -22.73 67.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.454 0.701 . . . . 74.099999999999994 111.826 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.631 HG23 ' SG ' ' A' ' 2' ' ' CYS . 43.9 mm -91.42 -53.05 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.155 0.582 . . . . 74.140000000000001 109.437 173.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.2 m -64.43 -28.36 69.62 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.789 -1.096 . . . . 52.009999999999998 113.156 -169.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.12 -32.85 72.53 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.27 0.628 . . . . 72.430000000000007 111.637 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.88 -0.94 74.03 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.885 -0.598 . . . . 62.140000000000001 112.62 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -105.67 -34.45 7.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.79 0.836 . . . . 73.430000000000007 110.562 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.0 m -77.21 -76.77 0.16 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.392 0.677 . . . . 72.409999999999997 111.029 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.106 0 CA-C-N 116.148 -0.478 . . . . 63.229999999999997 112.526 -169.213 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.606 ' SG ' HG23 ' A' ' 24' ' ' ILE . 17.7 m . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.95 0.405 . . . . 71.319999999999993 110.637 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.96 5.66 66.35 Favored Glycine 0 N--CA 1.472 1.074 0 CA-C-O 118.953 -0.915 . . . . 71.109999999999999 114.905 -168.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.6 p 54.68 20.7 3.07 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.103 1.361 . . . . 72.329999999999998 111.274 -169.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.12 -36.25 40.87 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.846 -1.07 . . . . 72.340000000000003 108.192 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 42.3 m -93.38 45.52 1.17 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.211 1.005 . . . . 72.340000000000003 111.476 171.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.532 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -116.94 7.38 0.08 OUTLIER Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 115.675 1.731 . . . . 71.239999999999995 115.675 167.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 24.5 Cg_exo -63.13 -48.96 5.43 Favored 'Trans proline' 0 C--N 1.409 3.744 0 CA-C-N 123.612 2.326 . . . . 65.209999999999994 112.261 -173.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -73.61 155.95 88.91 Favored Pre-proline 0 N--CA 1.439 -0.999 0 CA-C-N 113.187 -1.824 . . . . 44.329999999999998 111.927 -168.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.36 -37.79 79.4 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.199 1.933 . . . . 72.140000000000001 110.399 163.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -99.82 76.48 1.97 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.925 0.89 . . . . 75.450000000000003 108.79 170.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.503 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 19.7 p -69.34 -19.89 63.86 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.35 -0.841 . . . . 62.240000000000002 111.082 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -48.87 -37.18 18.85 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 125.38 1.472 . . . . 73.010000000000005 111.174 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.77 39.41 3.09 Favored Glycine 0 N--CA 1.474 1.167 0 CA-C-N 114.965 -1.016 . . . . 70.040000000000006 113.395 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 12.7 t -159.99 -48.65 0.05 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.958 1.303 . . . . 70.219999999999999 108.33 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 10.8 t -77.19 -42.01 39.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 112.952 -1.931 . . . . 74.219999999999999 112.041 -171.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.453 HD23 ' SG ' ' A' ' 25' ' ' CYS . 47.4 mt -64.34 -11.09 28.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.069 1.507 . . . . 73.430000000000007 115.069 -173.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.04 -26.3 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.857 0.753 . . . . 74.040000000000006 110.414 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -132.57 0.9 3.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.148 0.979 . . . . 74.209999999999994 111.598 -168.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 39.5 m -144.9 164.76 30.13 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.668 0.787 . . . . 73.219999999999999 109.889 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.7 155.41 65.25 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.581 0.752 . . . . 53.43 110.562 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.44 -23.85 15.14 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.271 2.648 . . . . 64.230000000000004 114.212 169.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 t -64.23 -44.62 91.28 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.079 0.552 . . . . 71.120000000000005 110.64 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.606 HG23 ' SG ' ' A' ' 2' ' ' CYS . 42.0 mm -68.04 -50.51 58.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 CA-C-O 121.283 0.564 . . . . 75.0 109.725 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.453 ' SG ' HD23 ' A' ' 17' ' ' LEU . 8.4 m -67.31 -27.54 67.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.95 -1.023 . . . . 61.030000000000001 111.657 -174.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.29 -25.27 67.56 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.717 0.407 . . . . 74.400000000000006 112.024 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.08 -19.68 56.93 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 112.259 -0.336 . . . . 52.439999999999998 112.259 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -99.83 -25.43 14.36 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.682 0.793 . . . . 75.209999999999994 111.361 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.6 m -94.14 -72.31 0.62 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.6 0.76 . . . . 73.530000000000001 110.455 175.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.865 0 CA-C-N 114.361 -1.29 . . . . 71.140000000000001 111.658 -170.15 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.731 ' HB2' HG21 ' A' ' 24' ' ' ILE . 18.5 t . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 108.901 -0.777 . . . . 71.519999999999996 108.901 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.26 -11.52 51.82 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 119.155 -0.803 . . . . 64.450000000000003 113.325 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.6 p 51.67 22.63 1.68 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 125.334 1.453 . . . . 73.450000000000003 111.801 -171.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -94.76 -44.46 7.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.236 1.414 . . . . 75.439999999999998 108.469 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 67.4 m -94.5 47.95 1.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.166 -1.379 . . . . 75.25 111.475 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.534 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -109.07 7.18 0.08 OUTLIER Pre-proline 0 CA--C 1.584 2.259 0 N-CA-C 115.843 1.794 . . . . 74.420000000000002 115.843 166.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 16.9 Cg_exo -68.4 -57.02 0.16 Allowed 'Trans proline' 0 C--N 1.406 3.602 0 CA-C-N 123.904 2.43 . . . . 71.310000000000002 113.121 -174.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.06 164.28 62.35 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 114.455 -1.248 . . . . 71.409999999999997 111.968 -166.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.17 -29.18 27.11 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.251 1.967 . . . . 64.310000000000002 111.06 164.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.52 31.72 5.01 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.466 1.107 . . . . 43.409999999999997 110.098 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 p -60.31 -9.55 3.61 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.475 1.11 . . . . 72.219999999999999 113.544 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.463 ' HE3' HD12 ' A' ' 17' ' ' LEU . 83.4 m95 -49.33 -38.31 27.49 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.937 1.295 . . . . 72.239999999999995 111.595 169.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.38 48.41 3.77 Favored Glycine 0 N--CA 1.476 1.346 0 CA-C-N 115.213 -0.903 . . . . 72.409999999999997 111.679 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 7.3 t -168.76 -46.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.924 1.289 . . . . 64.510000000000005 108.556 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' HA ' ' NE2' ' A' ' 19' ' ' GLN . 41.2 t -73.12 -48.13 38.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.74 -1.573 . . . . 72.129999999999995 112.07 -173.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.463 HD12 ' HE3' ' A' ' 13' ' ' TRP . 5.7 mp -70.34 2.3 3.98 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.143 1.905 . . . . 63.130000000000003 116.143 -171.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.465 HG12 ' HG3' ' A' ' 19' ' ' GLN . 7.6 p -83.71 -29.48 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 118.667 0.667 . . . . 75.540000000000006 109.955 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.465 ' HG3' HG12 ' A' ' 18' ' ' VAL . 2.6 pp0? -132.69 6.01 4.0 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.07 0.948 . . . . 73.409999999999997 112.182 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 17' ' ' LEU . 2.6 m -142.78 161.8 37.15 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.04 -1.096 . . . . 71.010000000000005 108.04 172.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.24 157.79 53.11 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 122.97 0.508 . . . . 52.439999999999998 110.165 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HB3' HD22 ' A' ' 17' ' ' LEU . 19.2 Cg_endo -59.44 -22.53 66.45 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.05 2.5 . . . . 62.020000000000003 113.089 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.4 p -62.15 -38.89 90.71 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.429 0.692 . . . . 64.049999999999997 110.524 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.731 HG21 ' HB2' ' A' ' 2' ' ' CYS . 10.9 mm -81.83 -46.5 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.31 -0.859 . . . . 74.209999999999994 109.855 -177.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.4 m -64.96 -24.36 67.5 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.448 1.099 . . . . 75.450000000000003 111.233 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -31.76 73.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.106 0.562 . . . . 60.020000000000003 111.59 171.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.63 -45.68 21.76 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 116.401 -0.363 . . . . 62.140000000000001 112.241 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -73.17 -58.86 3.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.273 0.629 . . . . 74.019999999999996 111.158 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.3 m -74.18 -62.45 1.51 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.591 0.756 . . . . 52.109999999999999 112.42 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.243 0 CA-C-O 120.247 -0.196 . . . . 61.409999999999997 113.012 -170.48 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.737 ' SG ' HG21 ' A' ' 24' ' ' ILE . 58.4 m . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 120.431 0.158 . . . . 74.400000000000006 110.821 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.63 3.67 47.93 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 116.771 1.468 . . . . 53.130000000000003 116.771 -164.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m 68.63 1.36 2.98 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.464 1.106 . . . . 63.020000000000003 111.539 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.49 -18.38 45.33 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 123.522 0.729 . . . . 72.299999999999997 109.653 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 83.2 m -103.96 42.95 1.13 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.09 0.956 . . . . 72.150000000000006 110.945 172.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.52 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -110.7 -5.99 0.11 Allowed Pre-proline 0 CA--C 1.586 2.35 0 N-CA-C 115.597 1.702 . . . . 60.149999999999999 115.597 168.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 25.3 Cg_exo -63.82 -58.43 0.27 Allowed 'Trans proline' 0 C--N 1.405 3.531 0 CA-C-N 123.642 2.336 . . . . 74.519999999999996 113.634 -172.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -77.52 162.92 66.83 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 114.84 -1.073 . . . . 72.319999999999993 111.851 -170.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.38 -25.22 30.58 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.57 2.18 . . . . 72.319999999999993 110.411 160.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -93.25 23.54 4.37 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 125.312 1.445 . . . . 72.409999999999997 110.181 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 p -62.03 -17.74 58.32 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.719 1.207 . . . . 62.310000000000002 113.451 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -57.97 -33.37 68.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.094 0.957 . . . . 74.319999999999993 111.106 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.85 -34.02 88.78 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 115.6 -0.727 . . . . 74.450000000000003 112.105 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.46 ' O ' HG13 ' A' ' 18' ' ' VAL . 17.9 t -78.34 -47.65 17.27 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.641 1.176 . . . . 55.409999999999997 110.225 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.9 t -80.3 -45.26 18.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.855 -1.52 . . . . 74.329999999999998 112.033 -167.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.6 mt -65.66 -5.75 9.33 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.498 1.296 . . . . 71.510000000000005 114.498 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 15' ' ' CYS . 9.1 p -87.67 -19.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.026 0.83 . . . . 74.219999999999999 110.571 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.409 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 27.0 pt20 -134.56 -2.66 2.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.076 0.951 . . . . 72.420000000000002 111.098 -170.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.409 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 37.4 m -143.27 171.11 14.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.574 0.75 . . . . 73.420000000000002 110.403 -175.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.82 155.33 41.75 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.736 0.815 . . . . 62.439999999999998 109.549 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.32 -16.41 28.41 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.826 2.351 . . . . 74.129999999999995 113.693 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 m -64.21 -36.76 85.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.617 0.367 . . . . 72.109999999999999 110.974 171.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.737 HG21 ' SG ' ' A' ' 2' ' ' CYS . 50.6 mm -75.98 -52.74 17.13 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 N-CA-C 109.051 -0.722 . . . . 74.519999999999996 109.051 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.1 m -65.17 -26.28 68.09 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.559 -1.201 . . . . 73.409999999999997 112.505 -170.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.2 -31.58 72.49 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.385 0.274 . . . . 62.329999999999998 111.171 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.91 -32.15 50.67 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 116.07 -0.514 . . . . 72.329999999999998 112.212 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -88.41 -37.47 15.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.199 0.6 . . . . 73.340000000000003 111.132 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.5 m -90.76 -80.26 0.34 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.29 0.636 . . . . 60.399999999999999 111.736 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.477 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 112.778 -167.231 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.795 ' SG ' HG22 ' A' ' 24' ' ' ILE . 23.5 m . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 110.416 -0.216 . . . . 74.129999999999995 110.416 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.83 -10.34 84.26 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-O 119.359 -0.69 . . . . 42.210000000000001 113.841 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.1 m 77.11 -12.77 1.02 Allowed 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.163 1.385 . . . . 62.409999999999997 112.176 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -94.89 19.16 10.61 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.956 0.884 . . . . 73.329999999999998 109.498 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -106.19 28.78 7.36 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.241 1.016 . . . . 73.140000000000001 110.25 166.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.524 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -103.78 -9.33 0.12 Allowed Pre-proline 0 CA--C 1.581 2.138 0 N-CA-C 116.337 1.977 . . . . 65.5 116.337 167.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 14.1 Cg_exo -67.58 -54.74 0.33 Allowed 'Trans proline' 0 C--N 1.405 3.54 0 CA-C-N 123.658 2.342 . . . . 72.540000000000006 112.926 -168.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -73.04 159.81 84.38 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 113.797 -1.547 . . . . 71.010000000000005 112.103 -166.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.77 -26.3 32.68 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.252 1.968 . . . . 70.129999999999995 110.633 162.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -99.17 27.67 4.96 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.436 1.495 . . . . 74.140000000000001 109.759 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.3 p -62.94 -17.79 62.31 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.411 1.084 . . . . 74.129999999999995 113.608 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -54.47 -38.24 66.18 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.889 0.875 . . . . 75.209999999999994 110.339 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.06 -35.42 90.55 Favored Glycine 0 N--CA 1.469 0.848 0 CA-C-N 115.24 -0.891 . . . . 72.420000000000002 112.182 -176.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.46 ' O ' HG12 ' A' ' 18' ' ' VAL . 35.2 t -67.38 -51.82 47.45 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.016 0.912 . . . . 71.120000000000005 110.583 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 t -71.48 -54.5 10.39 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.792 -1.549 . . . . 72.439999999999998 111.629 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.405 HD23 ' SG ' ' A' ' 25' ' ' CYS . 68.6 mt -51.83 -27.22 11.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.373 1.62 . . . . 72.530000000000001 115.373 -175.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 15' ' ' CYS . 14.6 p -74.43 -14.09 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.395 0.617 . . . . 43.119999999999997 111.333 -174.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -146.96 3.68 0.82 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.574 0.75 . . . . 74.329999999999998 111.178 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.8 m -148.31 169.63 19.7 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.03 0.932 . . . . 52.229999999999997 109.863 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.28 157.84 50.02 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.528 0.731 . . . . 73.230000000000004 110.658 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.28 -22.56 5.85 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.424 2.75 . . . . 75.25 113.923 165.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 m -59.22 -44.87 92.28 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.579 0.752 . . . . 70.040000000000006 111.443 172.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.795 HG22 ' SG ' ' A' ' 2' ' ' CYS . 49.2 mm -74.61 -45.47 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.473 0.709 . . . . 74.219999999999999 110.018 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.405 ' SG ' HD23 ' A' ' 17' ' ' LEU . 11.1 m -64.85 -33.25 75.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.74 0.816 . . . . 54.310000000000002 111.163 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.55 -24.85 64.68 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.962 0.505 . . . . 64.319999999999993 110.945 173.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.56 -41.35 24.95 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.951 -0.46 . . . . 71.239999999999995 111.951 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -84.71 -59.91 2.22 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.052 0.541 . . . . 74.310000000000002 111.046 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.4 m -68.89 -51.17 42.91 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.001 0.52 . . . . 60.049999999999997 111.181 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.889 0 CA-C-N 115.708 -0.678 . . . . 73.109999999999999 112.731 -176.546 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.485 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 34.9 m . . . . . 0 C--O 1.241 0.644 0 N-CA-C 109.837 -0.431 . . . . 71.120000000000005 109.837 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.74 -63.28 2.77 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 116.274 -0.421 . . . . 71.519999999999996 112.274 173.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.1 p 160.44 -12.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.157 1.783 . . . . 74.019999999999996 109.275 -167.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.64 -20.5 62.72 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.787 0.835 . . . . 43.329999999999998 110.605 -177.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.8 m -91.42 52.04 2.01 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.734 0.778 . . . . 74.329999999999998 110.815 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.513 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -130.01 13.25 0.05 OUTLIER Pre-proline 0 CA--C 1.575 1.909 0 N-CA-C 115.231 1.567 . . . . 53.0 115.231 169.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 11.8 Cg_exo -68.05 -51.0 0.67 Allowed 'Trans proline' 0 C--N 1.407 3.635 0 CA-C-N 123.436 2.263 . . . . 73.340000000000003 111.275 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -81.82 151.05 67.04 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 113.508 -1.678 . . . . 74.430000000000007 110.74 -168.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.3 -32.09 81.83 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 121.914 1.743 . . . . 74.200000000000003 111.48 171.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -105.46 57.64 0.68 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.771 1.229 . . . . 72.430000000000007 108.932 175.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.559 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 18.7 p -58.94 -14.01 8.0 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.879 1.272 . . . . 72.530000000000001 113.345 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 61.3 m95 -48.8 -35.62 14.84 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.23 1.412 . . . . 70.409999999999997 111.65 173.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.13 -32.28 79.94 Favored Glycine 0 N--CA 1.475 1.244 0 CA-C-N 115.663 -0.699 . . . . 41.140000000000001 113.055 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.7 t -82.53 -44.51 15.82 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 122.397 1.094 . . . . 60.399999999999999 110.12 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.3 t -82.7 -60.23 2.25 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 112.948 -1.933 . . . . 72.010000000000005 111.758 -169.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 13' ' ' TRP . 27.5 mt -52.34 -25.85 10.75 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.991 1.478 . . . . 74.319999999999993 114.991 -175.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.47 -22.4 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 CA-C-O 121.074 0.464 . . . . 74.209999999999994 111.1 -176.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -140.63 -5.32 1.2 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.563 0.745 . . . . 71.340000000000003 112.683 -176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 2' ' ' CYS . 80.2 m -127.79 174.32 9.23 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.158 0.983 . . . . 61.149999999999999 110.295 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.44 157.7 46.9 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 124.832 1.253 . . . . 62.310000000000002 110.111 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.44 -17.56 41.46 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 123.366 2.711 . . . . 51.530000000000001 113.389 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.5 t -56.77 -42.68 79.83 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.329 0.651 . . . . 63.350000000000001 110.811 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mm -76.84 -48.53 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 115.937 -0.574 . . . . 74.209999999999994 110.036 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.2 m -64.73 -34.85 79.3 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.746 -1.115 . . . . 75.019999999999996 111.55 -174.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.44 -20.65 64.65 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.052 0.541 . . . . 71.530000000000001 111.425 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.48 -36.06 24.39 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.841 -0.504 . . . . 35.75 111.841 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -91.12 -41.85 10.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.355 0.662 . . . . 73.219999999999999 111.739 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.559 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.6 m -69.25 -71.84 0.21 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.43 0.633 . . . . 75.239999999999995 111.344 178.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.804 0 CA-C-N 114.697 -1.138 . . . . 61.32 110.713 -169.554 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.239 0.551 0 N-CA-C 109.272 -0.64 . . . . 74.019999999999996 109.272 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.718 ' SG ' HG22 ' A' ' 24' ' ' ILE . 61.7 m -147.77 170.51 17.43 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.593 0.757 . . . . 62.009999999999998 110.052 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.9 -6.86 86.11 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-O 118.691 -1.061 . . . . 74.120000000000005 114.874 -170.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m 66.63 13.58 9.39 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.488 1.115 . . . . 71.430000000000007 110.839 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -94.16 -24.55 17.48 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.208 1.003 . . . . 73.030000000000001 110.015 -172.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 52.5 m -97.6 39.73 1.19 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.894 0.878 . . . . 41.329999999999998 110.655 170.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.551 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -99.23 -16.22 0.19 Allowed Pre-proline 0 CA--C 1.58 2.112 0 N-CA-C 115.468 1.655 . . . . 71.450000000000003 115.468 168.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 12.6 Cg_exo -69.35 -38.88 8.05 Favored 'Trans proline' 0 C--N 1.406 3.554 0 CA-C-N 123.198 2.178 . . . . 74.349999999999994 112.964 -166.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -67.59 150.75 97.69 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.362 -1.29 . . . . 73.420000000000002 112.353 -166.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.11 -29.65 87.68 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.479 2.119 . . . . 75.540000000000006 110.698 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -119.34 78.34 1.29 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.784 -1.191 . . . . 74.409999999999997 107.784 170.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.454 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 20.7 p -60.19 -27.67 67.34 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.031 -0.986 . . . . 74.400000000000006 110.954 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -45.66 -38.25 6.56 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 125.452 1.501 . . . . 73.230000000000004 111.593 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.94 43.67 3.25 Favored Glycine 0 N--CA 1.474 1.206 0 CA-C-N 114.755 -1.111 . . . . 74.5 112.531 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.446 ' O ' HG13 ' A' ' 18' ' ' VAL . 13.2 t -167.23 -46.07 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.991 1.316 . . . . 64.150000000000006 108.323 -176.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.1 t -79.47 -42.79 24.52 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.671 -1.604 . . . . 71.209999999999994 112.03 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.5 mt -63.13 -9.72 11.92 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.959 1.466 . . . . 74.219999999999999 114.959 -175.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 15' ' ' CYS . 10.2 p -83.17 -19.84 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 118.894 0.77 . . . . 74.230000000000004 110.625 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -138.87 -1.66 1.78 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.051 0.94 . . . . 71.530000000000001 111.648 -169.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.476 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 59.8 m -146.16 167.0 24.52 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.599 0.76 . . . . 60.329999999999998 110.301 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.95 155.65 52.59 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 115.206 -0.906 . . . . 75.299999999999997 110.448 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -45.52 -30.95 6.44 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.729 2.952 . . . . 74.030000000000001 114.652 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -58.87 -41.26 86.65 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.086 0.554 . . . . 73.010000000000005 111.521 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.718 HG22 ' SG ' ' A' ' 2' ' ' CYS . 47.9 mm -73.11 -51.33 26.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 C-N-CA 123.567 0.747 . . . . 75.230000000000004 110.162 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.0 m -65.37 -31.92 73.29 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.055 -0.975 . . . . 73.219999999999999 111.339 -175.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.38 -28.44 68.21 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.397 0.679 . . . . 73.040000000000006 111.522 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.12 -22.62 47.94 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.702 0.627 . . . . 53.350000000000001 112.273 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . 15.8 m95 -93.43 -36.77 12.31 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.222 0.609 . . . . 74.340000000000003 112.132 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 42.4 m -71.58 -73.14 0.19 Allowed 'General case' 0 CA--C 1.547 0.844 0 O-C-N 123.196 0.31 . . . . 63.32 110.519 176.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.61 -52.65 1.52 Allowed Glycine 0 C--N 1.345 1.074 0 CA-C-O 121.055 0.253 . . . . 72.140000000000001 112.508 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.68 73.07 0.53 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.481 -1.048 . . . . 74.430000000000007 110.481 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 CA--C 1.557 1.215 0 C-N-CA 124.318 1.047 . . . . 72.400000000000006 109.81 -175.867 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.3 p . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.324 -0.25 . . . . 61.210000000000001 110.324 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.779 ' HB2' HG21 ' A' ' 24' ' ' ILE . 11.1 t -80.18 176.73 9.49 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.365 -0.606 . . . . 65.150000000000006 109.365 171.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.04 -25.09 76.39 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 111.389 -0.684 . . . . 64.349999999999994 111.389 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.1 m 66.3 5.12 3.5 Favored 'General case' 0 C--N 1.369 1.447 0 C-N-CA 124.562 1.145 . . . . 60.350000000000001 112.086 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.45 -15.84 16.36 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.039 0.935 . . . . 72.230000000000004 108.761 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 56.2 m -93.21 44.45 1.14 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.535 1.134 . . . . 64.530000000000001 110.822 170.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.491 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -117.31 5.26 0.08 OUTLIER Pre-proline 0 CA--C 1.58 2.134 0 N-CA-C 116.034 1.864 . . . . 34.259999999999998 116.034 173.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 39.9 Cg_exo -59.32 -54.08 2.92 Favored 'Trans proline' 0 C--N 1.408 3.691 0 CA-C-N 123.509 2.289 . . . . 65.430000000000007 112.867 -173.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -85.27 155.71 60.09 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 114.395 -1.275 . . . . 75.239999999999995 111.411 -171.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.9 -14.93 45.6 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.689 2.259 . . . . 71.319999999999993 111.532 165.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -108.05 56.41 0.63 Allowed 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 123.018 1.39 . . . . 72.530000000000001 108.344 170.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.531 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 22.0 p -67.85 -16.26 64.01 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.24 -1.345 . . . . 72.140000000000001 111.852 175.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -47.42 -36.47 9.9 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 126.01 1.724 . . . . 74.340000000000003 112.436 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.11 35.2 3.86 Favored Glycine 0 N--CA 1.47 0.932 0 CA-C-N 115.091 -0.959 . . . . 65.209999999999994 112.801 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 8.3 t -154.94 -46.54 0.08 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.403 1.097 . . . . 71.239999999999995 108.955 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 15.4 t -80.65 -44.19 19.24 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 113.333 -1.758 . . . . 73.439999999999998 111.562 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.442 HD21 ' SG ' ' A' ' 25' ' ' CYS . 74.9 mt -62.59 -18.56 62.41 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 114.68 1.363 . . . . 44.119999999999997 114.68 -172.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.65 -19.41 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 122.837 0.455 . . . . 71.439999999999998 111.636 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.518 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 16.0 pt20 -142.11 -34.01 0.47 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.112 0.965 . . . . 74.530000000000001 110.371 -168.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.518 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 3.7 m -104.69 158.11 16.73 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.614 1.166 . . . . 73.150000000000006 109.228 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.5 159.38 61.52 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.248 0.619 . . . . 61.109999999999999 110.962 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.69 -33.48 31.99 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.13 2.553 . . . . 51.210000000000001 112.674 164.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.0 t -57.12 -22.66 41.48 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.733 1.213 . . . . 73.549999999999997 112.401 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.779 HG21 ' HB2' ' A' ' 2' ' ' CYS . 31.8 mm -101.47 -51.55 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.681 0.792 . . . . 73.340000000000003 110.474 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.442 ' SG ' HD21 ' A' ' 17' ' ' LEU . 21.9 m -64.92 -22.14 66.94 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.089 0.956 . . . . 63.210000000000001 112.357 -172.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.61 76.0 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.616 0.766 . . . . 72.430000000000007 111.343 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.1 -19.22 63.25 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.739 -0.664 . . . . 64.120000000000005 112.722 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -89.28 -40.32 12.89 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.108 0.563 . . . . 71.340000000000003 110.877 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 21.1 m -74.55 -60.73 2.14 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.362 -0.836 . . . . 63.530000000000001 111.301 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.22 43.13 1.48 Allowed Glycine 0 C--N 1.35 1.312 0 CA-C-N 116.015 -0.539 . . . . 35.520000000000003 112.554 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.64 156.59 27.03 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 112.355 -0.298 . . . . 71.129999999999995 112.355 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 C--O 1.249 1.033 0 C-N-CA 123.356 0.663 . . . . 62.25 109.733 178.773 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.295 -0.261 . . . . 63.240000000000002 110.295 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.454 ' HB2' HG22 ' A' ' 24' ' ' ILE . 99.2 m -78.17 -176.7 4.74 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.033 0.533 . . . . 71.310000000000002 110.114 173.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.12 -56.76 1.05 Allowed Glycine 0 C--N 1.336 0.55 0 CA-C-N 115.98 -0.554 . . . . 74.219999999999999 112.382 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.7 p 149.97 -6.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 126.372 1.869 . . . . 72.140000000000001 108.791 -159.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -25.65 60.74 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.836 0.854 . . . . 71.540000000000006 110.698 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -100.74 53.16 0.86 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.507 1.123 . . . . 74.430000000000007 109.75 173.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.481 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -133.37 15.21 0.05 OUTLIER Pre-proline 0 CA--C 1.576 1.945 0 CA-C-N 113.724 -1.58 . . . . 72.109999999999999 114.802 169.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 31.8 Cg_exo -62.53 -51.53 3.21 Favored 'Trans proline' 0 C--N 1.407 3.657 0 CA-C-N 123.242 2.194 . . . . 72.019999999999996 111.549 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -84.68 159.66 57.64 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 113.735 -1.575 . . . . 73.140000000000001 110.793 -172.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.06 -23.92 28.89 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.475 2.117 . . . . 75.400000000000006 110.776 163.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -104.33 48.92 0.83 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.956 1.302 . . . . 74.129999999999995 109.137 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 19.9 p -61.06 -14.53 24.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.921 1.289 . . . . 74.25 113.822 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.549 ' HE3' HD12 ' A' ' 17' ' ' LEU . 61.8 m95 -47.07 -40.78 15.77 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.416 1.487 . . . . 75.540000000000006 112.298 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.33 -25.29 75.87 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-N 114.946 -1.025 . . . . 50.43 112.745 -173.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.45 ' O ' HG13 ' A' ' 18' ' ' VAL . 34.3 t -86.77 -45.63 10.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.109 0.957 . . . . 74.239999999999995 110.216 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 t -76.98 -53.76 7.42 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.619 -1.628 . . . . 53.109999999999999 112.578 -170.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.676 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -61.91 -7.81 4.24 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.854 1.798 . . . . 74.239999999999995 115.854 -175.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 15' ' ' CYS . 10.3 p -76.77 -23.73 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-N 119.278 0.945 . . . . 62.119999999999997 110.366 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -132.18 -24.19 2.11 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.253 1.021 . . . . 73.519999999999996 111.289 -169.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 2' ' ' CYS . 77.9 m -123.98 175.37 6.99 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.43 1.092 . . . . 72.129999999999995 110.472 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.52 157.4 58.46 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.915 0.886 . . . . 73.340000000000003 110.479 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HB3' HD21 ' A' ' 17' ' ' LEU . 19.9 Cg_endo -61.33 -12.43 23.75 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 123.152 2.568 . . . . 71.040000000000006 112.769 171.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.0 t -62.49 -44.05 97.32 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.445 0.698 . . . . 62.420000000000002 110.689 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.454 HG22 ' HB2' ' A' ' 2' ' ' CYS . 36.9 mm -69.99 -50.13 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 115.705 -0.679 . . . . 74.140000000000001 109.3 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.676 ' SG ' ' HG ' ' A' ' 17' ' ' LEU . 10.2 m -60.37 -36.18 77.44 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.303 -1.317 . . . . 71.010000000000005 111.733 -174.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.14 89.98 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.082 0.553 . . . . 51.43 110.687 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.07 -33.07 69.42 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.846 0.716 . . . . 54.020000000000003 113.429 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -92.37 -38.23 12.14 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.801 0.44 . . . . 73.349999999999994 111.585 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 34.5 m -69.09 -57.97 4.7 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.605 0.362 . . . . 62.439999999999998 111.676 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.67 -77.77 0.1 Allowed Glycine 0 C--N 1.34 0.777 0 CA-C-N 116.192 -0.458 . . . . 63.130000000000003 112.47 -172.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.24 9.88 85.46 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.583 -0.308 . . . . 61.210000000000001 112.571 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 CA--C 1.55 0.98 0 C-N-CA 124.449 1.1 . . . . 72.510000000000005 109.757 -170.094 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 110.157 -0.312 . . . . 73.310000000000002 110.157 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.667 ' SG ' HG22 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -102.89 118.36 36.64 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.437 -0.949 . . . . 62.200000000000003 108.437 176.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.31 -48.7 84.71 Favored Glycine 0 C--N 1.341 0.824 0 O-C-N 124.096 0.873 . . . . 64.120000000000005 114.858 -172.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.3 p 131.25 3.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 127.505 2.322 . . . . 63.409999999999997 107.916 -159.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.33 -26.85 63.94 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.005 0.922 . . . . 73.239999999999995 109.806 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.1 m -100.72 60.75 0.98 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.957 -1.019 . . . . 72.150000000000006 110.039 167.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.635 ' HB1' ' HB3' ' A' ' 28' ' ' TRP . . . -142.92 31.77 0.13 Allowed Pre-proline 0 CA--C 1.579 2.078 0 CA-C-N 113.797 -1.547 . . . . 74.450000000000003 113.403 163.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 51.3 Cg_exo -61.26 -50.24 6.29 Favored 'Trans proline' 0 C--N 1.405 3.51 0 CA-C-N 122.08 1.779 . . . . 74.019999999999996 111.974 170.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -84.14 161.36 55.2 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 113.781 -1.554 . . . . 70.109999999999999 111.36 -171.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.71 -33.91 75.33 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.259 1.973 . . . . 74.349999999999994 110.452 161.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -94.82 78.53 3.67 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.966 -1.016 . . . . 72.120000000000005 108.97 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.466 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 18.3 p -70.44 -18.01 63.0 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.86 -0.609 . . . . 51.039999999999999 110.592 171.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.475 ' HE3' HD12 ' A' ' 17' ' ' LEU . 64.9 m95 -49.23 -35.93 18.72 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 125.284 1.434 . . . . 73.349999999999994 111.774 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -93.6 49.06 2.32 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 114.909 -1.041 . . . . 41.299999999999997 112.161 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.459 ' O ' HG13 ' A' ' 18' ' ' VAL . 16.6 t -166.2 -45.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.812 1.245 . . . . 73.049999999999997 108.709 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 12.4 t -80.8 -45.8 16.38 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 113.493 -1.685 . . . . 74.310000000000002 111.936 -169.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.475 HD12 ' HE3' ' A' ' 13' ' ' TRP . 5.4 mp -72.11 -0.18 11.16 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 114.849 1.426 . . . . 64.409999999999997 114.849 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 15' ' ' CYS . 13.6 p -82.18 -18.36 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.849 0.749 . . . . 74.230000000000004 110.096 171.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.555 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 11.5 pt20 -138.04 -6.45 1.63 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.637 0.775 . . . . 74.530000000000001 111.777 -168.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.555 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 48.7 m -143.76 172.4 12.89 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.668 0.787 . . . . 75.010000000000005 110.357 -174.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 154.74 50.14 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.209 1.004 . . . . 73.420000000000002 109.785 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.4 -18.74 40.13 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.328 2.686 . . . . 64.319999999999993 112.771 172.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 t -61.05 -39.17 88.82 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.814 0.846 . . . . 53.210000000000001 110.694 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.667 HG22 ' SG ' ' A' ' 2' ' ' CYS . 45.1 mm -77.82 -48.42 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.419 0.688 . . . . 74.019999999999996 109.709 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.6 m -64.99 -30.41 71.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.639 -1.164 . . . . 54.229999999999997 112.082 -172.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.81 -29.01 70.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.059 0.544 . . . . 70.019999999999996 111.412 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.58 -27.75 37.96 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.536 0.522 . . . . 72.219999999999999 112.409 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.635 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 26.4 m95 -92.49 -32.78 14.75 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.259 0.624 . . . . 74.340000000000003 111.395 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.2 m -73.96 -74.83 0.17 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.247 0.546 . . . . 65.109999999999999 110.637 173.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.02 -64.27 0.31 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 114.783 -1.099 . . . . 61.100000000000001 110.67 -169.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.34 -150.34 13.48 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.257 -0.472 . . . . 75.439999999999998 112.139 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.6 p . . . . . 0 C--O 1.254 1.332 0 C-N-CA 124.181 0.992 . . . . 64.230000000000004 110.992 -176.571 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.775 0.321 . . . . 73.299999999999997 110.479 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.626 ' HB2' HG22 ' A' ' 24' ' ' ILE . 36.1 t -78.65 -179.67 6.6 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.079 -0.711 . . . . 75.310000000000002 109.079 170.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.17 -16.86 79.1 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.705 -0.497 . . . . 55.539999999999999 111.862 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.7 p 61.49 8.5 2.25 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 125.79 1.636 . . . . 52.130000000000003 112.836 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -116.06 7.1 14.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.534 0.734 . . . . 63.509999999999998 109.07 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 88.3 m -106.51 34.96 3.14 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 124.058 0.943 . . . . 73.099999999999994 110.734 170.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.517 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -96.39 -19.26 0.22 Allowed Pre-proline 0 CA--C 1.586 2.339 0 N-CA-C 115.188 1.551 . . . . 71.120000000000005 115.188 167.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 25.1 Cg_exo -63.47 -53.66 1.32 Allowed 'Trans proline' 0 C--N 1.412 3.875 0 CA-C-N 123.329 2.225 . . . . 62.149999999999999 114.072 -163.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.36 159.64 84.0 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 114.904 -1.044 . . . . 74.420000000000002 111.685 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.79 -26.35 32.51 Favored 'Trans proline' 0 CA--C 1.554 1.511 0 C-N-CA 122.193 1.929 . . . . 64.109999999999999 111.044 162.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -98.87 31.98 2.78 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 124.44 1.096 . . . . 74.409999999999997 109.612 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.6 p -61.05 -20.8 62.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.405 1.082 . . . . 74.030000000000001 112.767 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -54.76 -38.27 67.01 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.176 0.99 . . . . 75.049999999999997 110.693 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -23.89 74.82 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 115.06 -0.973 . . . . 74.219999999999999 112.781 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.457 ' O ' HG13 ' A' ' 18' ' ' VAL . 34.6 t -89.24 -43.47 10.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.492 1.117 . . . . 75.230000000000004 109.968 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 42.2 t -71.79 -52.02 19.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.151 -1.386 . . . . 64.019999999999996 111.455 -171.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.487 HD23 ' HB3' ' A' ' 22' ' ' PRO . 4.4 mp -73.0 9.89 1.06 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 115.583 1.697 . . . . 74.299999999999997 115.583 -173.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 15' ' ' CYS . 13.9 p -91.14 -12.56 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 118.875 0.761 . . . . 64.540000000000006 109.442 170.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.513 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 27.6 pt20 -152.86 2.4 0.31 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.344 0.657 . . . . 71.439999999999998 112.028 -167.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.513 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 1.4 m -147.03 156.66 43.2 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.607 0.763 . . . . 72.230000000000004 109.354 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.95 149.9 77.49 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.241 0.616 . . . . 73.140000000000001 110.819 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.487 ' HB3' HD23 ' A' ' 17' ' ' LEU . 13.2 Cg_endo -55.94 -23.2 41.81 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.525 2.817 . . . . 74.140000000000001 113.713 174.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -65.24 -38.71 91.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.955 0.502 . . . . 61.32 110.388 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.626 HG22 ' HB2' ' A' ' 2' ' ' CYS . 23.4 mm -75.1 -43.75 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.226 -0.657 . . . . 72.530000000000001 109.226 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.5 m -66.96 -28.41 68.25 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.158 0.983 . . . . 72.150000000000006 111.055 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.86 -28.3 68.86 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.563 0.745 . . . . 71.349999999999994 111.231 170.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.95 -35.71 38.34 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 116.221 -0.445 . . . . 75.140000000000001 112.133 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -82.52 -69.34 0.63 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.98 0.512 . . . . 73.519999999999996 110.296 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.5 m -64.68 -49.45 70.9 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.142 0.977 . . . . 74.010000000000005 112.096 -175.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.42 -12.6 83.63 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.52 -0.764 . . . . 39.890000000000001 112.968 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.1 -162.66 37.93 Favored Glycine 0 C--N 1.351 1.396 0 C-N-CA 123.117 0.389 . . . . 71.030000000000001 113.255 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 C--O 1.251 1.18 0 C-N-CA 123.586 0.755 . . . . 42.020000000000003 110.765 -176.762 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.404 ' HA ' HD11 ' A' ' 24' ' ' ILE . 29.9 t . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 108.934 -0.765 . . . . 75.019999999999996 108.934 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.654 ' HB2' HG22 ' A' ' 24' ' ' ILE . 0.5 OUTLIER 59.4 -152.5 0.4 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.865 1.266 . . . . 61.299999999999997 109.71 -174.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.0 -5.46 73.4 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.527 -0.596 . . . . 75.120000000000005 112.306 166.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.3 m 64.88 18.54 11.52 Favored 'General case' 0 C--N 1.372 1.545 0 C-N-CA 124.721 1.208 . . . . 64.140000000000001 109.853 -171.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -102.82 -38.49 7.4 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.449 -1.315 . . . . 73.129999999999995 107.449 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.1 m -86.67 44.86 1.19 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.212 1.005 . . . . 73.230000000000004 111.707 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.412 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -122.6 33.11 0.22 Allowed Pre-proline 0 CA--C 1.576 1.973 0 N-CA-C 114.728 1.381 . . . . 64.5 114.728 165.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 35.3 Cg_exo -64.79 -61.05 0.11 Allowed 'Trans proline' 0 C--N 1.397 3.119 0 CA-C-N 122.675 1.991 . . . . 74.400000000000006 111.072 169.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -82.67 151.54 64.95 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-N 114.239 -1.346 . . . . 74.439999999999998 111.37 -170.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.5 -32.64 96.62 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.937 2.424 . . . . 65.200000000000003 110.67 162.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -94.61 70.0 3.53 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 122.44 1.114 . . . . 73.299999999999997 108.532 171.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.527 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 22.1 p -77.8 -15.26 59.22 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.366 -1.288 . . . . 73.010000000000005 112.803 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -48.5 -38.78 21.09 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.381 1.473 . . . . 64.519999999999996 112.885 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.83 -16.97 80.31 Favored Glycine 0 N--CA 1.476 1.315 0 CA-C-N 115.553 -0.749 . . . . 74.109999999999999 113.339 -172.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 11.4 t -96.13 -51.75 4.29 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.166 0.984 . . . . 55.25 109.677 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 t -73.82 -45.3 52.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.685 -1.598 . . . . 70.010000000000005 112.715 -166.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.467 HD23 ' SG ' ' A' ' 25' ' ' CYS . 76.3 mt -59.15 -22.24 60.6 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.061 1.504 . . . . 73.25 115.061 -172.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 15' ' ' CYS . 7.6 p -78.52 -22.75 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 118.666 0.666 . . . . 65.129999999999995 111.184 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -133.85 1.0 3.27 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.03 0.932 . . . . 70.319999999999993 111.282 -170.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.1 m -149.09 167.65 25.31 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.479 1.112 . . . . 61.240000000000002 109.55 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.53 154.68 62.43 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.649 0.78 . . . . 73.439999999999998 110.492 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.32 -25.05 45.52 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.26 2.64 . . . . 74.510000000000005 112.856 167.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -57.37 -37.53 72.76 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.981 0.912 . . . . 75.049999999999997 111.137 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.654 HG22 ' HB2' ' A' ' 2' ' ' CYS . 43.3 mm -82.83 -49.41 16.93 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 C-N-CA 123.189 0.596 . . . . 70.120000000000005 110.341 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.467 ' SG ' HD23 ' A' ' 17' ' ' LEU . 11.4 m -64.26 -26.84 68.68 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.076 -0.966 . . . . 55.409999999999997 111.867 -171.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.78 -33.57 71.88 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.491 0.717 . . . . 64.430000000000007 111.76 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.51 -42.45 11.61 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 116.447 -0.342 . . . . 73.329999999999998 112.808 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -73.94 -34.23 64.23 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.868 0.467 . . . . 73.219999999999999 110.974 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 21.9 m -77.92 -78.76 0.13 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.249 0.62 . . . . 44.329999999999998 110.794 175.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.45 -48.44 0.06 OUTLIER Glycine 0 C--N 1.354 1.559 0 O-C-N 123.245 0.341 . . . . 44.020000000000003 112.911 -170.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.33 85.61 1.14 Allowed Glycine 0 C--N 1.341 0.85 0 C-N-CA 123.049 0.357 . . . . 60.530000000000001 113.034 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.5 m . . . . . 0 C--O 1.249 1.031 0 C-N-CA 124.336 1.054 . . . . 63.200000000000003 109.829 178.571 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.481 ' HB2' HD13 ' A' ' 24' ' ' ILE . 58.1 p . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 120.974 0.416 . . . . 74.340000000000003 110.056 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.732 ' HB2' HG22 ' A' ' 24' ' ' ILE . 9.3 t -134.93 -158.88 0.91 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 107.8 -1.185 . . . . 75.120000000000005 107.8 175.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.23 -11.41 67.05 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.363 -0.687 . . . . 53.229999999999997 112.958 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.4 m 68.94 6.23 5.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.998 1.319 . . . . 62.350000000000001 110.708 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -88.23 -45.47 10.05 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.291 1.037 . . . . 62.109999999999999 108.694 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 92.3 m -89.39 50.1 1.87 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.618 -1.174 . . . . 73.230000000000004 111.516 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.545 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -104.35 -15.27 0.16 Allowed Pre-proline 0 CA--C 1.577 2.011 0 N-CA-C 116.306 1.965 . . . . 62.439999999999998 116.306 167.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 14.0 Cg_exo -64.15 -49.47 3.71 Favored 'Trans proline' 0 C--N 1.407 3.644 0 CA-C-N 122.98 2.1 . . . . 71.209999999999994 113.342 -160.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -77.95 154.62 80.41 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 113.514 -1.676 . . . . 64.019999999999996 111.431 -166.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.17 -38.6 75.54 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.185 1.923 . . . . 62.149999999999999 110.425 174.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -100.56 82.42 2.45 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 107.358 -1.349 . . . . 61.229999999999997 107.358 167.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.533 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 23.6 p -73.48 -18.14 61.15 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.867 0.867 . . . . 62.149999999999999 111.778 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -48.5 -40.32 26.28 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 125.262 1.425 . . . . 73.530000000000001 112.354 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.3 -27.5 73.59 Favored Glycine 0 N--CA 1.478 1.441 0 CA-C-N 115.334 -0.848 . . . . 63.229999999999997 112.87 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 12.7 t -90.66 -45.78 8.67 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.294 1.045 . . . . 75.329999999999998 110.107 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 11.4 t -74.75 -44.48 49.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.28 -1.782 . . . . 74.230000000000004 112.122 -166.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.26 -15.99 58.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 115.019 1.488 . . . . 65.209999999999994 115.019 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 15' ' ' CYS . 14.6 p -81.06 -10.81 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 118.706 0.684 . . . . 73.120000000000005 110.884 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -147.32 -3.81 0.55 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.377 0.671 . . . . 75.140000000000001 111.663 -169.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 8.2 m -145.61 162.87 36.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.115 0.966 . . . . 54.030000000000001 109.037 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.85 157.13 67.07 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.73 0.812 . . . . 64.010000000000005 111.399 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.84 -23.72 68.61 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.485 2.79 . . . . 54.32 113.066 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.4 p -65.17 -32.63 74.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.109 0.564 . . . . 75.109999999999999 110.643 173.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.732 HG22 ' HB2' ' A' ' 2' ' ' CYS . 14.6 mm -84.81 -49.04 16.18 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 121.175 0.512 . . . . 73.340000000000003 110.242 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.1 m -62.87 -28.1 69.8 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.837 -1.074 . . . . 73.299999999999997 111.235 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.25 -45.29 72.33 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.963 0.505 . . . . 73.430000000000007 111.004 169.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.13 -32.53 60.33 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.102 -0.954 . . . . 75.230000000000004 113.64 -175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.424 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . 80.5 m95 -86.17 -28.7 23.76 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.896 0.478 . . . . 72.25 111.885 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.3 m -78.98 -70.07 0.53 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.615 0.366 . . . . 73.319999999999993 111.273 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.84 -53.64 0.02 OUTLIER Glycine 0 C--N 1.348 1.215 0 C-N-CA 121.743 -0.265 . . . . 52.240000000000002 113.552 -169.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.17 -66.86 1.79 Allowed Glycine 0 N--CA 1.47 0.908 0 N-CA-C 110.159 -1.176 . . . . 73.519999999999996 110.159 -169.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 CA--C 1.562 1.436 0 C-N-CA 125.736 1.614 . . . . 73.400000000000006 112.714 168.812 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.6 t . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.209 -0.293 . . . . 72.209999999999994 110.209 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.458 ' SG ' HG22 ' A' ' 24' ' ' ILE . 31.2 m -126.49 164.71 20.55 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.214 0.606 . . . . 60.399999999999999 109.887 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.04 12.2 58.52 Favored Glycine 0 N--CA 1.473 1.145 0 N-CA-C 116.81 1.484 . . . . 63.530000000000001 116.81 -161.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.2 p 58.1 15.43 3.24 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.105 1.362 . . . . 75.329999999999998 112.29 -172.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.63 -29.41 56.44 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 108.771 -0.826 . . . . 73.310000000000002 108.771 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 18.5 m -96.39 51.08 1.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.286 -0.87 . . . . 52.140000000000001 110.511 168.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.415 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -122.92 21.73 0.1 OUTLIER Pre-proline 0 CA--C 1.59 2.498 0 N-CA-C 115.071 1.508 . . . . 61.219999999999999 115.071 163.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 52.6 Cg_exo -58.32 -58.26 0.82 Allowed 'Trans proline' 0 C--N 1.409 3.751 0 CA-C-N 123.239 2.192 . . . . 74.409999999999997 113.115 174.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -80.1 154.65 75.0 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 114.845 -1.07 . . . . 64.439999999999998 111.193 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.26 -35.46 91.62 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.937 2.425 . . . . 75.439999999999998 110.655 168.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.44 75.41 5.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.003 -1.11 . . . . 63.43 108.003 167.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.547 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 20.7 p -68.22 -18.21 64.51 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.732 -1.122 . . . . 75.219999999999999 110.992 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -48.88 -36.69 17.67 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 125.411 1.484 . . . . 75.510000000000005 111.419 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.37 25.27 6.42 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-N 114.987 -1.006 . . . . 73.329999999999998 113.579 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.412 ' O ' HG13 ' A' ' 18' ' ' VAL . 20.0 t -143.5 -46.52 0.29 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.777 1.231 . . . . 73.329999999999998 108.649 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.2 t -78.02 -44.62 26.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.005 -1.907 . . . . 72.239999999999995 111.763 -170.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.2 mt -62.12 -12.59 20.33 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.974 1.472 . . . . 75.430000000000007 114.974 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 15' ' ' CYS . 11.4 p -82.22 -19.75 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 119.087 0.858 . . . . 74.099999999999994 110.584 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -142.08 5.26 1.69 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.046 0.938 . . . . 74.430000000000007 111.475 -169.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.498 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 48.4 m -146.49 172.05 14.13 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.751 1.22 . . . . 73.150000000000006 109.068 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.43 161.54 24.91 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 123.555 0.742 . . . . 52.009999999999998 110.871 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.04 -31.52 8.63 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 123.631 2.888 . . . . 51.119999999999997 114.61 169.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 m -56.42 -40.48 74.76 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.278 0.631 . . . . 62.439999999999998 111.505 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.458 HG22 ' SG ' ' A' ' 2' ' ' CYS . 47.6 mm -78.3 -55.73 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.603 -0.726 . . . . 72.040000000000006 110.089 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 m -63.88 -31.29 72.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.992 -1.003 . . . . 64.540000000000006 112.131 -170.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.82 -31.12 69.42 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.969 0.508 . . . . 74.430000000000007 112.012 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.45 -26.05 48.62 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.8 0.688 . . . . 51.450000000000003 112.561 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -91.2 -31.36 16.21 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.432 0.693 . . . . 71.530000000000001 111.015 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 18.6 m -80.82 -70.02 0.56 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.012 0.925 . . . . 73.519999999999996 111.935 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.35 34.96 0.39 Allowed Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.001 -1.0 . . . . 53.219999999999999 111.685 -167.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -92.93 -169.79 39.82 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 122.706 0.193 . . . . 75.239999999999995 112.631 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.7 p . . . . . 0 C--O 1.246 0.917 0 C-N-CA 123.801 0.84 . . . . 63.329999999999998 109.378 179.601 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.245 -0.65 . . . . 70.420000000000002 109.245 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.698 ' SG ' HG22 ' A' ' 24' ' ' ILE . 95.7 m 58.41 -157.41 0.31 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.051 0.94 . . . . 72.510000000000005 112.248 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.4 -6.51 77.67 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.266 -0.741 . . . . 61.43 113.966 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.0 p 60.0 15.98 5.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.475 1.51 . . . . 73.219999999999999 112.576 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -34.57 44.68 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.471 -0.786 . . . . 72.340000000000003 109.287 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 93.0 m -101.56 43.49 1.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.559 1.144 . . . . 70.340000000000003 110.727 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HA ' ' HB3' ' A' ' 28' ' ' TRP . . . -95.89 -26.09 0.25 Allowed Pre-proline 0 CA--C 1.578 2.054 0 N-CA-C 115.826 1.787 . . . . 73.040000000000006 115.826 171.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 11.8 Cg_exo -65.8 -44.47 7.91 Favored 'Trans proline' 0 C--N 1.398 3.171 0 C-N-CA 122.161 1.907 . . . . 75.319999999999993 114.005 -157.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -83.34 157.0 65.83 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 114.109 -1.405 . . . . 72.120000000000005 111.983 -160.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.28 -27.61 63.81 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.214 1.943 . . . . 75.219999999999999 111.255 162.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -104.8 38.87 1.81 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.344 1.058 . . . . 72.129999999999995 109.224 174.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.5 p -64.92 -21.64 66.86 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.55 -0.719 . . . . 71.140000000000001 111.27 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -48.62 -38.78 21.85 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 125.242 1.417 . . . . 72.430000000000007 111.79 171.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.73 -14.47 79.86 Favored Glycine 0 N--CA 1.473 1.105 0 CA-C-N 115.04 -0.982 . . . . 72.349999999999994 113.104 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 20.5 t -99.43 -41.26 7.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.121 1.368 . . . . 74.540000000000006 110.151 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 9.9 t -81.03 -45.5 16.46 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 113.174 -1.83 . . . . 73.519999999999996 112.553 -168.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.6 -0.47 1.4 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.245 1.572 . . . . 73.120000000000005 115.245 -175.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -88.35 -23.46 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-N 119.176 0.898 . . . . 74.439999999999998 110.436 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -133.79 -3.42 2.9 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.161 0.985 . . . . 74.099999999999994 111.235 -169.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.507 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 63.2 m -144.14 170.18 16.45 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.643 0.777 . . . . 61.350000000000001 110.592 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.41 159.93 34.15 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.186 0.995 . . . . 71.340000000000003 110.795 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -48.12 -30.29 14.11 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 123.686 2.924 . . . . 51.509999999999998 114.161 168.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.2 m -60.91 -39.4 89.2 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.991 0.917 . . . . 62.240000000000002 111.395 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.698 HG22 ' SG ' ' A' ' 2' ' ' CYS . 51.1 mm -77.36 -53.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 123.533 0.733 . . . . 73.299999999999997 109.82 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.7 m -62.76 -31.22 72.13 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.75 -1.114 . . . . 53.0 112.014 -173.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.6 -39.98 84.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.717 0.407 . . . . 65.150000000000006 110.572 172.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.64 -24.32 75.36 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.88 -0.6 . . . . 60.310000000000002 112.977 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.573 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . 81.7 m95 -97.14 -43.79 7.23 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.413 0.685 . . . . 74.329999999999998 111.665 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.5 m -71.4 -73.06 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.31 0.576 . . . . 52.109999999999999 110.864 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.06 100.69 0.15 Allowed Glycine 0 C--N 1.341 0.823 0 CA-C-N 114.998 -1.001 . . . . 62.210000000000001 111.315 -170.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.76 126.66 0.87 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.864 -0.495 . . . . 55.210000000000001 111.864 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.8 p . . . . . 0 CA--C 1.561 1.376 0 C-N-CA 124.275 1.03 . . . . 72.219999999999999 110.629 -177.134 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.421 -0.214 . . . . 75.420000000000002 110.421 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 50.1 m -82.95 161.02 21.94 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.815 0.446 . . . . 65.230000000000004 110.071 170.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.63 19.13 16.69 Favored Glycine 0 N--CA 1.47 0.905 0 CA-C-N 115.605 -0.725 . . . . 65.209999999999994 112.912 -174.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t 64.44 14.93 9.21 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.833 1.253 . . . . 74.209999999999994 110.791 -166.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -80.29 -33.14 37.93 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.372 -0.973 . . . . 72.209999999999994 108.372 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.403 ' SG ' ' NE2' ' A' ' 19' ' ' GLN . 91.3 m -99.6 46.93 0.96 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.626 -1.17 . . . . 70.329999999999998 110.964 173.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.526 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -112.74 -6.89 0.1 Allowed Pre-proline 0 CA--C 1.577 1.999 0 CA-C-O 116.409 -1.758 . . . . 38.700000000000003 115.565 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 39.1 Cg_exo -62.01 -50.69 4.63 Favored 'Trans proline' 0 C--N 1.408 3.692 0 CA-C-N 123.416 2.256 . . . . 73.409999999999997 113.176 -169.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -77.68 153.91 81.03 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 114.594 -1.185 . . . . 74.5 111.539 -170.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.47 -25.32 41.62 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.216 1.944 . . . . 63.229999999999997 110.658 164.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -104.26 45.84 0.94 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.014 1.326 . . . . 75.439999999999998 108.92 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 20.6 p -56.02 -19.79 14.13 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.499 1.12 . . . . 74.430000000000007 112.455 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.453 ' HZ2' ' HB2' ' A' ' 32' ' ' SER . 69.9 m95 -42.74 -39.51 2.47 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.096 1.758 . . . . 74.510000000000005 112.378 171.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.31 -22.09 76.12 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 115.413 -0.812 . . . . 72.409999999999997 113.616 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.438 ' O ' HG13 ' A' ' 18' ' ' VAL . 25.0 t -96.31 -46.21 6.51 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.25 1.024 . . . . 75.540000000000006 109.987 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -76.99 -47.35 21.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 113.424 -1.717 . . . . 72.319999999999993 112.734 -166.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.429 HD23 ' SG ' ' A' ' 25' ' ' CYS . 47.1 mt -61.46 -14.26 27.18 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.076 1.51 . . . . 62.409999999999997 115.076 -173.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 15' ' ' CYS . 14.0 p -74.93 -23.58 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 118.909 0.777 . . . . 74.129999999999995 110.952 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.403 ' NE2' ' SG ' ' A' ' 6' ' ' CYS . 21.4 pt20 -134.43 -18.54 1.96 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.139 0.976 . . . . 73.129999999999995 111.426 -167.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.8 m -128.55 170.9 12.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.243 1.017 . . . . 72.420000000000002 110.396 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.18 154.9 57.72 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.192 0.997 . . . . 74.230000000000004 110.8 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.48 -26.54 12.4 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.683 2.922 . . . . 74.319999999999993 114.304 168.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 m -61.98 -41.42 98.0 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.134 0.574 . . . . 60.229999999999997 111.174 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.04 -52.87 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 122.956 0.502 . . . . 54.030000000000001 110.28 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.429 ' SG ' HD23 ' A' ' 17' ' ' LEU . 4.0 m -62.0 -33.35 74.17 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.866 -1.061 . . . . 72.340000000000003 111.092 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.8 -36.77 77.43 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.603 0.761 . . . . 74.430000000000007 111.565 174.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.04 -41.53 22.13 Favored Glycine 0 C--N 1.351 1.364 0 O-C-N 123.91 0.756 . . . . 42.020000000000003 112.423 -174.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -77.93 -40.67 38.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.124 0.569 . . . . 72.219999999999999 111.863 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.8 m -67.35 -63.67 1.01 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.34 0.59 . . . . 72.329999999999998 110.542 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.08 -54.71 4.75 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 114.793 -1.094 . . . . 38.700000000000003 111.446 -167.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.51 103.73 0.46 Allowed Glycine 0 C--N 1.354 1.538 0 C-N-CA 123.562 0.601 . . . . 44.509999999999998 112.347 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.453 ' HB2' ' HZ2' ' A' ' 13' ' ' TRP . 38.7 t . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.023 -1.102 . . . . 72.530000000000001 108.023 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 110.12 -0.326 . . . . 71.019999999999996 110.12 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.753 ' HB2' HG21 ' A' ' 24' ' ' ILE . 6.2 t -154.07 -172.57 4.26 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.774 0.83 . . . . 65.439999999999998 108.931 178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.46 -18.71 65.77 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.796 -0.446 . . . . 73.329999999999998 112.567 173.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.8 m 69.54 8.6 6.84 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 124.777 1.231 . . . . 71.120000000000005 112.272 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -117.55 6.64 12.53 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.494 1.117 . . . . 73.140000000000001 110.437 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 65.5 m -113.66 31.88 6.2 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.131 0.972 . . . . 65.400000000000006 110.984 176.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.569 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -95.02 -20.88 0.23 Allowed Pre-proline 0 CA--C 1.58 2.103 0 N-CA-C 115.318 1.599 . . . . 75.140000000000001 115.318 166.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 9.6 Cg_exo -70.35 -47.27 0.78 Allowed 'Trans proline' 0 C--N 1.4 3.262 0 C-N-CA 122.448 2.098 . . . . 65.450000000000003 113.849 -162.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -70.62 159.64 84.39 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.591 -1.186 . . . . 74.319999999999993 112.164 -164.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.51 -29.62 44.43 Favored 'Trans proline' 0 C--N 1.368 1.572 0 C-N-CA 122.159 1.906 . . . . 61.229999999999997 111.352 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -109.22 31.77 5.47 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.644 1.178 . . . . 73.420000000000002 109.894 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.0 p -53.54 -21.39 6.36 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.189 1.396 . . . . 74.230000000000004 114.067 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.459 ' HE3' HD12 ' A' ' 17' ' ' LEU . 81.4 m95 -55.42 -38.31 68.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.439 1.096 . . . . 74.129999999999995 111.16 175.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.92 -21.08 78.14 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 114.984 -1.007 . . . . 54.450000000000003 112.542 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.471 ' O ' HG13 ' A' ' 18' ' ' VAL . 15.1 t -83.74 -45.06 13.78 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.112 0.965 . . . . 72.510000000000005 109.645 177.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.4 t -78.52 -55.72 4.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.98 -1.464 . . . . 74.420000000000002 111.776 -168.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.459 HD12 ' HE3' ' A' ' 13' ' ' TRP . 2.2 mp -62.0 -9.19 6.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.113 1.523 . . . . 74.209999999999994 115.113 -175.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 15' ' ' CYS . 11.1 p -80.28 -15.56 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 119.255 0.934 . . . . 64.439999999999998 109.919 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.604 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 26.5 pt20 -144.23 -4.8 0.79 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.875 0.87 . . . . 65.439999999999998 111.703 -170.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.604 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 3.9 m -139.77 170.32 16.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.666 0.787 . . . . 62.0 109.197 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.08 149.91 70.65 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 122.983 0.513 . . . . 73.209999999999994 111.236 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.438 ' HB3' HD23 ' A' ' 17' ' ' LEU . 9.3 Cg_endo -54.07 -27.25 44.99 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 123.364 2.709 . . . . 54.32 112.844 165.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.3 m -62.77 -39.62 94.76 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.599 0.76 . . . . 64.219999999999999 110.473 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.753 HG21 ' HB2' ' A' ' 2' ' ' CYS . 44.9 mm -73.29 -48.33 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 123.773 0.829 . . . . 70.450000000000003 110.0 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.4 m -64.05 -31.94 73.32 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.401 1.08 . . . . 74.409999999999997 111.54 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.58 -31.43 70.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.547 -0.751 . . . . 75.540000000000006 111.865 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.64 -32.87 26.29 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 116.381 -0.372 . . . . 37.100000000000001 112.937 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -80.73 -54.55 5.52 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.938 0.495 . . . . 75.219999999999999 111.338 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -79.19 -69.99 0.54 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.25 0.62 . . . . 62.200000000000003 112.527 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.57 102.57 0.35 Allowed Glycine 0 C--N 1.347 1.182 0 N-CA-C 112.02 -0.432 . . . . 63.140000000000001 112.02 -166.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.42 76.24 1.52 Allowed Glycine 0 C--N 1.346 1.104 0 C-N-CA 122.753 0.216 . . . . 37.100000000000001 112.592 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 C--O 1.251 1.136 0 C-N-CA 123.794 0.837 . . . . 62.420000000000002 109.244 -173.939 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.4 p . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.833 0.349 . . . . 62.340000000000003 111.148 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.697 ' HB2' HG22 ' A' ' 24' ' ' ILE . 2.0 t -94.18 -165.35 1.3 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.287 -1.005 . . . . 73.450000000000003 108.287 168.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.55 -17.64 79.75 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.392 -0.671 . . . . 52.0 112.457 170.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.1 t 71.07 29.68 2.87 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 124.808 1.243 . . . . 74.430000000000007 108.289 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -111.28 -31.27 7.12 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.278 -1.328 . . . . 72.150000000000006 109.94 -174.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 96.8 m -103.25 44.42 1.02 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.397 1.079 . . . . 73.230000000000004 112.435 -175.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.534 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -105.26 -10.47 0.12 Allowed Pre-proline 0 CA--C 1.589 2.445 0 N-CA-C 116.233 1.938 . . . . 72.030000000000001 116.233 167.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 16.3 Cg_exo -67.09 -50.67 0.97 Allowed 'Trans proline' 0 C--N 1.401 3.321 0 CA-C-N 123.752 2.376 . . . . 73.340000000000003 114.023 -167.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -80.72 162.33 60.68 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.627 -1.169 . . . . 75.239999999999995 112.602 -162.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.95 -17.09 28.95 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.534 2.156 . . . . 71.129999999999995 111.439 166.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -114.3 27.6 9.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.741 1.216 . . . . 75.420000000000002 110.249 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.9 p -62.48 -16.24 54.35 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.301 1.04 . . . . 75.310000000000002 112.779 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.417 ' HE3' HD12 ' A' ' 17' ' ' LEU . 89.2 m95 -53.76 -39.05 65.02 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.698 0.799 . . . . 75.420000000000002 110.818 173.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.36 -28.41 73.28 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 115.749 -0.66 . . . . 73.129999999999995 112.127 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.509 ' O ' HG13 ' A' ' 18' ' ' VAL . 34.3 t -80.94 -43.77 19.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.356 1.062 . . . . 75.219999999999999 109.742 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -70.32 -54.39 12.78 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.525 -1.216 . . . . 70.230000000000004 111.092 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 22' ' ' PRO . 2.1 mp -69.13 -2.64 10.77 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 115.17 1.544 . . . . 73.420000000000002 115.17 -174.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 15' ' ' CYS . 13.3 p -84.56 -16.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 119.408 1.003 . . . . 62.130000000000003 109.715 176.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -145.15 -3.07 0.77 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.55 0.74 . . . . 54.340000000000003 111.965 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.2 m -144.14 164.45 30.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.856 0.862 . . . . 70.109999999999999 109.531 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.63 154.7 73.7 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-N 115.894 -0.594 . . . . 65.519999999999996 110.515 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.505 ' HB3' HD23 ' A' ' 17' ' ' LEU . 18.3 Cg_endo -59.83 -19.53 54.83 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.957 2.438 . . . . 63.229999999999997 112.234 169.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -58.4 -38.59 77.67 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.905 0.882 . . . . 71.299999999999997 110.872 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.697 HG22 ' HB2' ' A' ' 2' ' ' CYS . 23.9 mm -84.59 -43.06 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.821 -0.627 . . . . 63.310000000000002 110.112 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 m -64.97 -30.5 71.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.238 1.015 . . . . 64.439999999999998 112.07 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.42 -24.4 65.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.991 0.516 . . . . 72.340000000000003 111.541 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.23 -45.49 8.82 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.133 -0.485 . . . . 71.439999999999998 112.138 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -77.48 -67.11 0.75 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.903 0.481 . . . . 73.409999999999997 110.906 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.1 m -69.66 -32.19 70.69 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.363 -0.835 . . . . 55.200000000000003 112.536 -173.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.18 -162.1 38.15 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 115.997 -0.547 . . . . 61.409999999999997 113.026 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.71 146.62 4.49 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.606 -0.597 . . . . 42.509999999999998 111.606 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 C--O 1.249 1.055 0 N-CA-C 108.795 -0.817 . . . . 74.019999999999996 108.795 -178.873 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.769 -0.456 . . . . 55.200000000000003 109.769 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.406 ' HB2' HG22 ' A' ' 24' ' ' ILE . 72.2 m -67.79 160.63 27.86 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.198 0.523 . . . . 71.439999999999998 111.086 177.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.81 19.78 32.6 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.282 -0.872 . . . . 39.140000000000001 113.866 -171.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.2 m 67.89 14.19 9.34 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.604 1.162 . . . . 64.230000000000004 111.193 -173.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.94 -20.37 20.07 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.409 1.083 . . . . 74.329999999999998 109.292 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 77.2 m -100.43 45.86 0.97 Allowed 'General case' 0 C--N 1.347 0.489 0 C-N-CA 124.382 1.073 . . . . 63.520000000000003 111.07 172.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.531 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -120.45 5.79 0.07 OUTLIER Pre-proline 0 CA--C 1.582 2.18 0 N-CA-C 115.657 1.725 . . . . 73.099999999999994 115.657 168.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 23.9 Cg_exo -65.55 -51.08 1.52 Allowed 'Trans proline' 0 C--N 1.406 3.589 0 CA-C-N 123.648 2.339 . . . . 72.030000000000001 112.415 -175.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -83.28 156.08 66.35 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 113.672 -1.604 . . . . 64.329999999999998 111.529 -167.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -60.9 -39.96 57.15 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.331 2.021 . . . . 72.319999999999993 110.252 166.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -92.76 75.33 4.94 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 108.411 -0.959 . . . . 72.239999999999995 108.411 170.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 15.9 p -73.24 -21.5 60.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.176 -0.92 . . . . 74.230000000000004 110.343 174.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -48.75 -37.86 20.09 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 125.351 1.46 . . . . 72.109999999999999 111.253 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.67 -36.52 92.47 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.0 -1.0 . . . . 61.399999999999999 112.006 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.9 t -80.87 -44.75 17.9 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.391 1.091 . . . . 61.130000000000003 110.439 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.1 t -82.73 -54.11 5.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.282 -1.781 . . . . 74.510000000000005 112.029 -166.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.99 -19.11 11.22 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.119 1.525 . . . . 75.510000000000005 115.119 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.52 -25.7 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 118.407 0.548 . . . . 74.430000000000007 111.324 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 16' ' ' CYS . 2.9 pp0? -134.98 -0.72 2.75 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.75 0.82 . . . . 70.409999999999997 112.227 -175.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.426 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 74.2 m -136.47 175.88 9.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.265 1.026 . . . . 73.219999999999999 110.634 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.27 160.8 27.33 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.495 1.118 . . . . 62.340000000000003 110.188 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.6 -18.44 40.15 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 122.997 2.465 . . . . 65.519999999999996 113.504 173.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.9 p -60.79 -40.02 91.06 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.148 0.579 . . . . 65.340000000000003 110.635 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.406 HG22 ' HB2' ' A' ' 2' ' ' CYS . 30.7 mm -75.68 -56.03 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 123.307 0.643 . . . . 75.049999999999997 110.1 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -61.01 -29.07 69.49 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.74 -1.118 . . . . 64.5 112.573 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.37 -36.15 79.44 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.895 0.478 . . . . 43.530000000000001 111.659 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.13 -20.59 69.63 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.974 -0.557 . . . . 74.329999999999998 112.873 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -97.39 -35.21 10.76 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.311 0.644 . . . . 71.019999999999996 111.564 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.8 m -76.77 -69.89 0.49 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.137 0.575 . . . . 60.43 111.277 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.74 -64.03 0.03 OUTLIER Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.094 -0.803 . . . . 74.099999999999994 111.094 -173.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.34 175.18 44.97 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.303 -0.719 . . . . 44.399999999999999 111.303 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.251 1.151 0 C-N-CA 123.359 0.664 . . . . 44.100000000000001 109.615 179.067 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 109.683 -0.488 . . . . 71.200000000000003 109.683 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.449 ' HB2' HG22 ' A' ' 24' ' ' ILE . 4.0 t -72.45 170.29 14.61 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.083 0.553 . . . . 62.340000000000003 110.592 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.57 -0.72 75.44 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.712 -0.677 . . . . 73.329999999999998 112.884 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 m 64.05 18.63 11.34 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 124.296 1.038 . . . . 73.420000000000002 108.884 -161.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -74.32 -50.2 19.79 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 114.572 -1.195 . . . . 73.010000000000005 108.811 -165.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 64.4 m -106.2 50.33 0.78 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 113.795 -1.548 . . . . 73.310000000000002 110.858 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.517 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -89.62 -27.12 0.32 Allowed Pre-proline 0 CA--C 1.582 2.21 0 N-CA-C 115.199 1.555 . . . . 73.019999999999996 115.199 166.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 21.1 Cg_exo -64.37 -50.66 2.51 Favored 'Trans proline' 0 C--N 1.407 3.637 0 C-N-CA 122.862 2.374 . . . . 55.520000000000003 114.272 -161.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -72.45 158.81 86.82 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.765 0.826 . . . . 72.109999999999999 112.043 -167.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.41 -32.86 59.9 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.434 2.089 . . . . 62.039999999999999 110.616 163.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -95.68 32.7 1.78 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.96 1.304 . . . . 62.530000000000001 110.394 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -49.91 -32.49 14.79 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.417 1.487 . . . . 53.0 112.041 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -52.04 -40.66 61.45 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 124.719 1.207 . . . . 74.209999999999994 111.952 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.02 47.77 3.4 Favored Glycine 0 N--CA 1.478 1.434 0 CA-C-N 114.757 -1.11 . . . . 62.43 111.055 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 6.7 t -170.42 -46.44 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.055 1.342 . . . . 71.150000000000006 108.249 -169.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 41.2 t -79.56 -46.55 17.1 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 114.065 -1.425 . . . . 73.140000000000001 111.536 -170.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -76.3 15.44 0.59 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.491 1.293 . . . . 75.030000000000001 114.491 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 15' ' ' CYS . 8.1 p -97.13 -12.31 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-O 121.633 0.73 . . . . 64.329999999999998 109.725 168.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.611 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 25.9 pt20 -145.95 -3.68 0.67 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.695 0.798 . . . . 73.420000000000002 111.774 -170.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.611 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 0.8 OUTLIER -144.95 158.02 43.95 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 123.69 0.796 . . . . 72.329999999999998 108.96 -178.417 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' HB3' HG12 ' A' ' 24' ' ' ILE . . . -78.94 151.42 76.23 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.034 0.534 . . . . 73.219999999999999 110.722 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.16 -30.28 49.8 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.876 3.051 . . . . 44.329999999999998 113.281 172.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 m -63.57 -36.73 84.78 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.905 0.482 . . . . 74.420000000000002 110.776 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.518 HG12 ' HB3' ' A' ' 21' ' ' ALA . 12.1 mm -78.71 -48.35 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 109.212 -0.662 . . . . 74.329999999999998 109.212 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 m -61.69 -35.79 79.03 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.426 1.09 . . . . 75.510000000000005 111.326 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.72 -30.26 70.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.984 0.514 . . . . 64.329999999999998 111.574 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.75 -38.92 49.39 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.704 0.628 . . . . 74.129999999999995 112.071 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.475 ' HE1' HG21 ' A' ' 24' ' ' ILE . 60.0 m95 -75.96 -49.52 17.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.171 0.588 . . . . 75.140000000000001 110.831 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.08 -61.89 1.6 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.5 -0.773 . . . . 73.5 111.719 -175.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.76 -9.8 20.19 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 114.264 0.466 . . . . 63.32 114.264 -170.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.99 -39.56 37.65 Favored Glycine 0 N--CA 1.47 0.964 0 CA-C-N 117.087 0.443 . . . . 73.430000000000007 112.998 -174.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 C--O 1.25 1.084 0 C-N-CA 123.806 0.842 . . . . 74.409999999999997 109.328 178.241 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.996 -0.372 . . . . 53.5 109.996 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.631 ' SG ' HG23 ' A' ' 24' ' ' ILE . 55.8 m -74.81 -176.62 2.94 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.206 0.603 . . . . 73.310000000000002 111.136 178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.49 -7.83 87.1 Favored Glycine 0 N--CA 1.468 0.809 0 CA-C-O 119.188 -0.785 . . . . 73.310000000000002 115.023 -165.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 m 70.34 6.09 5.63 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.016 1.327 . . . . 62.399999999999999 111.002 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.41 -34.2 63.2 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.219 1.008 . . . . 63.439999999999998 109.401 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.4 m -90.14 41.41 1.05 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.246 1.019 . . . . 73.439999999999998 111.277 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -126.53 26.72 0.13 Allowed Pre-proline 0 CA--C 1.58 2.103 0 N-CA-C 115.482 1.66 . . . . 72.319999999999993 115.482 172.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 13.0 Cg_exo -68.8 -54.47 0.27 Allowed 'Trans proline' 0 C--N 1.398 3.134 0 CA-C-N 122.746 2.016 . . . . 62.43 111.267 172.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -83.86 165.13 41.1 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 113.105 -1.861 . . . . 64.530000000000001 111.471 -164.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.33 -25.38 36.26 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.209 1.94 . . . . 74.239999999999995 110.494 160.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.95 45.09 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.445 1.498 . . . . 74.439999999999998 109.593 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 13.2 p -65.3 -23.7 67.09 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.041 0.536 . . . . 74.0 111.484 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -49.85 -35.86 24.76 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 124.955 1.302 . . . . 74.409999999999997 110.981 173.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.54 41.62 3.06 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 114.65 -1.159 . . . . 40.420000000000002 112.5 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.469 ' O ' HG13 ' A' ' 18' ' ' VAL . 13.3 t -162.56 -51.15 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 125.117 1.367 . . . . 75.25 108.097 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.7 t -75.93 -44.64 39.18 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 113.624 -1.625 . . . . 64.409999999999997 111.578 -172.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 40.4 mt -61.83 -17.9 58.03 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.668 1.359 . . . . 71.310000000000002 114.668 -175.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 15' ' ' CYS . 11.9 p -79.89 -21.03 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.938 0.79 . . . . 73.129999999999995 110.447 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -140.34 8.73 2.24 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.792 0.837 . . . . 74.25 111.616 -170.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -150.86 173.47 14.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.3 1.04 . . . . 45.539999999999999 109.59 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.31 158.44 37.1 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.011 0.925 . . . . 63.030000000000001 109.959 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.73 -22.71 54.3 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.918 2.412 . . . . 73.409999999999997 112.947 171.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.5 m -63.81 -22.73 67.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.454 0.701 . . . . 74.099999999999994 111.826 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.631 HG23 ' SG ' ' A' ' 2' ' ' CYS . 43.9 mm -91.42 -53.05 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.155 0.582 . . . . 74.140000000000001 109.437 173.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.2 m -64.43 -28.36 69.62 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.789 -1.096 . . . . 52.009999999999998 113.156 -169.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.12 -32.85 72.53 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.27 0.628 . . . . 72.430000000000007 111.637 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.88 -0.94 74.03 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.885 -0.598 . . . . 62.140000000000001 112.62 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -105.67 -34.45 7.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.79 0.836 . . . . 73.430000000000007 110.562 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.0 m -77.21 -76.77 0.16 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.392 0.677 . . . . 72.409999999999997 111.029 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -148.36 53.74 0.52 Allowed Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.148 -0.478 . . . . 63.229999999999997 112.526 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.97 -50.64 10.36 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 111.097 -0.801 . . . . 52.420000000000002 111.097 173.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 CA--C 1.557 1.228 0 C-N-CA 124.787 1.235 . . . . 74.120000000000005 108.503 176.68 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.195 -0.298 . . . . 53.5 110.195 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.606 ' SG ' HG23 ' A' ' 24' ' ' ILE . 17.7 m 70.41 165.89 0.28 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.047 1.339 . . . . 71.319999999999993 110.637 -175.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.96 5.66 66.35 Favored Glycine 0 N--CA 1.472 1.074 0 CA-C-O 118.953 -0.915 . . . . 71.109999999999999 114.905 -168.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.6 p 54.68 20.7 3.07 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.103 1.361 . . . . 72.329999999999998 111.274 -169.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.12 -36.25 40.87 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.846 -1.07 . . . . 72.340000000000003 108.192 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 42.3 m -93.38 45.52 1.17 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.211 1.005 . . . . 72.340000000000003 111.476 171.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.532 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -116.94 7.38 0.08 OUTLIER Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 115.675 1.731 . . . . 71.239999999999995 115.675 167.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 24.5 Cg_exo -63.13 -48.96 5.43 Favored 'Trans proline' 0 C--N 1.409 3.744 0 CA-C-N 123.612 2.326 . . . . 65.209999999999994 112.261 -173.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -73.61 155.95 88.91 Favored Pre-proline 0 N--CA 1.439 -0.999 0 CA-C-N 113.187 -1.824 . . . . 44.329999999999998 111.927 -168.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.36 -37.79 79.4 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.199 1.933 . . . . 72.140000000000001 110.399 163.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -99.82 76.48 1.97 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.925 0.89 . . . . 75.450000000000003 108.79 170.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.503 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 19.7 p -69.34 -19.89 63.86 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.35 -0.841 . . . . 62.240000000000002 111.082 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -48.87 -37.18 18.85 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 125.38 1.472 . . . . 73.010000000000005 111.174 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.77 39.41 3.09 Favored Glycine 0 N--CA 1.474 1.167 0 CA-C-N 114.965 -1.016 . . . . 70.040000000000006 113.395 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 12.7 t -159.99 -48.65 0.05 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.958 1.303 . . . . 70.219999999999999 108.33 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 10.8 t -77.19 -42.01 39.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 112.952 -1.931 . . . . 74.219999999999999 112.041 -171.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.453 HD23 ' SG ' ' A' ' 25' ' ' CYS . 47.4 mt -64.34 -11.09 28.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.069 1.507 . . . . 73.430000000000007 115.069 -173.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.04 -26.3 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.857 0.753 . . . . 74.040000000000006 110.414 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -132.57 0.9 3.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.148 0.979 . . . . 74.209999999999994 111.598 -168.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 39.5 m -144.9 164.76 30.13 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.668 0.787 . . . . 73.219999999999999 109.889 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.7 155.41 65.25 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.581 0.752 . . . . 53.43 110.562 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.44 -23.85 15.14 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.271 2.648 . . . . 64.230000000000004 114.212 169.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 t -64.23 -44.62 91.28 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.079 0.552 . . . . 71.120000000000005 110.64 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.606 HG23 ' SG ' ' A' ' 2' ' ' CYS . 42.0 mm -68.04 -50.51 58.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 CA-C-O 121.283 0.564 . . . . 75.0 109.725 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.453 ' SG ' HD23 ' A' ' 17' ' ' LEU . 8.4 m -67.31 -27.54 67.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.95 -1.023 . . . . 61.030000000000001 111.657 -174.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.29 -25.27 67.56 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.717 0.407 . . . . 74.400000000000006 112.024 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.08 -19.68 56.93 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 112.259 -0.336 . . . . 52.439999999999998 112.259 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -99.83 -25.43 14.36 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.682 0.793 . . . . 75.209999999999994 111.361 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.6 m -94.14 -72.31 0.62 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.6 0.76 . . . . 73.530000000000001 110.455 175.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.97 163.21 16.38 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.361 -1.29 . . . . 71.140000000000001 111.658 -170.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -151.5 47.82 0.57 Allowed Glycine 0 N--CA 1.467 0.707 0 N-CA-C 111.38 -0.688 . . . . 63.450000000000003 111.38 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.2 t . . . . . 0 C--O 1.255 1.376 0 C-N-CA 124.055 0.942 . . . . 73.430000000000007 108.758 -177.571 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 110.362 -0.236 . . . . 75.549999999999997 110.362 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.731 ' HB2' HG21 ' A' ' 24' ' ' ILE . 18.5 t -166.06 178.79 6.15 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.223 1.009 . . . . 71.519999999999996 108.901 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.26 -11.52 51.82 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 119.155 -0.803 . . . . 64.450000000000003 113.325 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.6 p 51.67 22.63 1.68 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 125.334 1.453 . . . . 73.450000000000003 111.801 -171.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -94.76 -44.46 7.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.236 1.414 . . . . 75.439999999999998 108.469 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 67.4 m -94.5 47.95 1.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.166 -1.379 . . . . 75.25 111.475 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.534 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -109.07 7.18 0.08 OUTLIER Pre-proline 0 CA--C 1.584 2.259 0 N-CA-C 115.843 1.794 . . . . 74.420000000000002 115.843 166.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 16.9 Cg_exo -68.4 -57.02 0.16 Allowed 'Trans proline' 0 C--N 1.406 3.602 0 CA-C-N 123.904 2.43 . . . . 71.310000000000002 113.121 -174.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.06 164.28 62.35 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 114.455 -1.248 . . . . 71.409999999999997 111.968 -166.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.17 -29.18 27.11 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.251 1.967 . . . . 64.310000000000002 111.06 164.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.52 31.72 5.01 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.466 1.107 . . . . 43.409999999999997 110.098 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 p -60.31 -9.55 3.61 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.475 1.11 . . . . 72.219999999999999 113.544 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.463 ' HE3' HD12 ' A' ' 17' ' ' LEU . 83.4 m95 -49.33 -38.31 27.49 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.937 1.295 . . . . 72.239999999999995 111.595 169.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.38 48.41 3.77 Favored Glycine 0 N--CA 1.476 1.346 0 CA-C-N 115.213 -0.903 . . . . 72.409999999999997 111.679 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 7.3 t -168.76 -46.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.924 1.289 . . . . 64.510000000000005 108.556 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' HA ' ' NE2' ' A' ' 19' ' ' GLN . 41.2 t -73.12 -48.13 38.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.74 -1.573 . . . . 72.129999999999995 112.07 -173.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.463 HD12 ' HE3' ' A' ' 13' ' ' TRP . 5.7 mp -70.34 2.3 3.98 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.143 1.905 . . . . 63.130000000000003 116.143 -171.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.465 HG12 ' HG3' ' A' ' 19' ' ' GLN . 7.6 p -83.71 -29.48 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 118.667 0.667 . . . . 75.540000000000006 109.955 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.465 ' HG3' HG12 ' A' ' 18' ' ' VAL . 2.6 pp0? -132.69 6.01 4.0 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.07 0.948 . . . . 73.409999999999997 112.182 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 17' ' ' LEU . 2.6 m -142.78 161.8 37.15 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.04 -1.096 . . . . 71.010000000000005 108.04 172.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.24 157.79 53.11 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 122.97 0.508 . . . . 52.439999999999998 110.165 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HB3' HD22 ' A' ' 17' ' ' LEU . 19.2 Cg_endo -59.44 -22.53 66.45 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.05 2.5 . . . . 62.020000000000003 113.089 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.4 p -62.15 -38.89 90.71 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.429 0.692 . . . . 64.049999999999997 110.524 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.731 HG21 ' HB2' ' A' ' 2' ' ' CYS . 10.9 mm -81.83 -46.5 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.31 -0.859 . . . . 74.209999999999994 109.855 -177.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.4 m -64.96 -24.36 67.5 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.448 1.099 . . . . 75.450000000000003 111.233 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -31.76 73.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.106 0.562 . . . . 60.020000000000003 111.59 171.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.63 -45.68 21.76 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 116.401 -0.363 . . . . 62.140000000000001 112.241 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -73.17 -58.86 3.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.273 0.629 . . . . 74.019999999999996 111.158 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.3 m -74.18 -62.45 1.51 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.591 0.756 . . . . 52.109999999999999 112.42 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.55 -118.52 2.82 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-O 120.247 -0.196 . . . . 61.409999999999997 113.012 -170.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 144.13 95.18 0.2 Allowed Glycine 0 C--N 1.347 1.19 0 N-CA-C 110.678 -0.969 . . . . 36.259999999999998 110.678 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 CA--C 1.554 1.11 0 C-N-CA 123.543 0.737 . . . . 52.119999999999997 109.355 -174.352 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.632 -0.507 . . . . 70.510000000000005 109.632 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.737 ' SG ' HG21 ' A' ' 24' ' ' ILE . 58.4 m -92.08 179.81 5.48 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.114 0.566 . . . . 74.400000000000006 110.821 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.63 3.67 47.93 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 116.771 1.468 . . . . 53.130000000000003 116.771 -164.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m 68.63 1.36 2.98 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.464 1.106 . . . . 63.020000000000003 111.539 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.49 -18.38 45.33 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 123.522 0.729 . . . . 72.299999999999997 109.653 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 83.2 m -103.96 42.95 1.13 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.09 0.956 . . . . 72.150000000000006 110.945 172.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.52 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -110.7 -5.99 0.11 Allowed Pre-proline 0 CA--C 1.586 2.35 0 N-CA-C 115.597 1.702 . . . . 60.149999999999999 115.597 168.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 25.3 Cg_exo -63.82 -58.43 0.27 Allowed 'Trans proline' 0 C--N 1.405 3.531 0 CA-C-N 123.642 2.336 . . . . 74.519999999999996 113.634 -172.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -77.52 162.92 66.83 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 114.84 -1.073 . . . . 72.319999999999993 111.851 -170.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.38 -25.22 30.58 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.57 2.18 . . . . 72.319999999999993 110.411 160.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -93.25 23.54 4.37 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 125.312 1.445 . . . . 72.409999999999997 110.181 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 p -62.03 -17.74 58.32 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.719 1.207 . . . . 62.310000000000002 113.451 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -57.97 -33.37 68.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.094 0.957 . . . . 74.319999999999993 111.106 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.85 -34.02 88.78 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 115.6 -0.727 . . . . 74.450000000000003 112.105 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' O ' HG13 ' A' ' 18' ' ' VAL . 17.9 t -78.34 -47.65 17.27 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.641 1.176 . . . . 55.409999999999997 110.225 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.9 t -80.3 -45.26 18.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.855 -1.52 . . . . 74.329999999999998 112.033 -167.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.6 mt -65.66 -5.75 9.33 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.498 1.296 . . . . 71.510000000000005 114.498 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 15' ' ' CYS . 9.1 p -87.67 -19.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.026 0.83 . . . . 74.219999999999999 110.571 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.409 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 27.0 pt20 -134.56 -2.66 2.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.076 0.951 . . . . 72.420000000000002 111.098 -170.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.409 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 37.4 m -143.27 171.11 14.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.574 0.75 . . . . 73.420000000000002 110.403 -175.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.82 155.33 41.75 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.736 0.815 . . . . 62.439999999999998 109.549 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.32 -16.41 28.41 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.826 2.351 . . . . 74.129999999999995 113.693 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 m -64.21 -36.76 85.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.617 0.367 . . . . 72.109999999999999 110.974 171.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.737 HG21 ' SG ' ' A' ' 2' ' ' CYS . 50.6 mm -75.98 -52.74 17.13 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 N-CA-C 109.051 -0.722 . . . . 74.519999999999996 109.051 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.1 m -65.17 -26.28 68.09 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.559 -1.201 . . . . 73.409999999999997 112.505 -170.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.2 -31.58 72.49 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.385 0.274 . . . . 62.329999999999998 111.171 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.91 -32.15 50.67 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 116.07 -0.514 . . . . 72.329999999999998 112.212 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -88.41 -37.47 15.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.199 0.6 . . . . 73.340000000000003 111.132 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.5 m -90.76 -80.26 0.34 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.29 0.636 . . . . 60.399999999999999 111.736 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.36 -84.32 0.06 OUTLIER Glycine 0 C--N 1.353 1.477 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 112.778 -167.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.98 155.99 18.48 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 112.223 -0.351 . . . . 60.420000000000002 112.223 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.7 t . . . . . 0 C--O 1.249 1.042 0 C-N-CA 123.958 0.903 . . . . 65.030000000000001 108.933 -178.667 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.646 0.26 . . . . 64.430000000000007 110.374 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.795 ' SG ' HG22 ' A' ' 24' ' ' ILE . 23.5 m -138.92 -166.86 2.1 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.266 0.626 . . . . 74.129999999999995 110.416 -173.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.83 -10.34 84.26 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-O 119.359 -0.69 . . . . 42.210000000000001 113.841 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.1 m 77.11 -12.77 1.02 Allowed 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.163 1.385 . . . . 62.409999999999997 112.176 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -94.89 19.16 10.61 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.956 0.884 . . . . 73.329999999999998 109.498 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -106.19 28.78 7.36 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.241 1.016 . . . . 73.140000000000001 110.25 166.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.524 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -103.78 -9.33 0.12 Allowed Pre-proline 0 CA--C 1.581 2.138 0 N-CA-C 116.337 1.977 . . . . 65.5 116.337 167.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 14.1 Cg_exo -67.58 -54.74 0.33 Allowed 'Trans proline' 0 C--N 1.405 3.54 0 CA-C-N 123.658 2.342 . . . . 72.540000000000006 112.926 -168.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -73.04 159.81 84.38 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 113.797 -1.547 . . . . 71.010000000000005 112.103 -166.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.77 -26.3 32.68 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.252 1.968 . . . . 70.129999999999995 110.633 162.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -99.17 27.67 4.96 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.436 1.495 . . . . 74.140000000000001 109.759 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.3 p -62.94 -17.79 62.31 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.411 1.084 . . . . 74.129999999999995 113.608 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -54.47 -38.24 66.18 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.889 0.875 . . . . 75.209999999999994 110.339 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.06 -35.42 90.55 Favored Glycine 0 N--CA 1.469 0.848 0 CA-C-N 115.24 -0.891 . . . . 72.420000000000002 112.182 -176.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' O ' HG12 ' A' ' 18' ' ' VAL . 35.2 t -67.38 -51.82 47.45 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.016 0.912 . . . . 71.120000000000005 110.583 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 t -71.48 -54.5 10.39 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.792 -1.549 . . . . 72.439999999999998 111.629 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.405 HD23 ' SG ' ' A' ' 25' ' ' CYS . 68.6 mt -51.83 -27.22 11.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.373 1.62 . . . . 72.530000000000001 115.373 -175.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 15' ' ' CYS . 14.6 p -74.43 -14.09 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.395 0.617 . . . . 43.119999999999997 111.333 -174.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -146.96 3.68 0.82 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.574 0.75 . . . . 74.329999999999998 111.178 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.8 m -148.31 169.63 19.7 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.03 0.932 . . . . 52.229999999999997 109.863 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.28 157.84 50.02 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.528 0.731 . . . . 73.230000000000004 110.658 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.28 -22.56 5.85 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.424 2.75 . . . . 75.25 113.923 165.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 m -59.22 -44.87 92.28 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.579 0.752 . . . . 70.040000000000006 111.443 172.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.795 HG22 ' SG ' ' A' ' 2' ' ' CYS . 49.2 mm -74.61 -45.47 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.473 0.709 . . . . 74.219999999999999 110.018 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.405 ' SG ' HD23 ' A' ' 17' ' ' LEU . 11.1 m -64.85 -33.25 75.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.74 0.816 . . . . 54.310000000000002 111.163 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.55 -24.85 64.68 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.962 0.505 . . . . 64.319999999999993 110.945 173.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.56 -41.35 24.95 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.951 -0.46 . . . . 71.239999999999995 111.951 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -84.71 -59.91 2.22 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.052 0.541 . . . . 74.310000000000002 111.046 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.4 m -68.89 -51.17 42.91 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.001 0.52 . . . . 60.049999999999997 111.181 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.67 -45.33 17.87 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.708 -0.678 . . . . 73.109999999999999 112.731 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.65 -156.45 53.3 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-O 119.964 -0.353 . . . . 52.130000000000003 113.103 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.9 t . . . . . 0 C--O 1.252 1.192 0 N-CA-C 108.429 -0.952 . . . . 62.310000000000002 108.429 177.135 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.6 p . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 110.093 -0.336 . . . . 64.540000000000006 110.093 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.485 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 34.9 m -74.48 164.71 26.27 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.837 -0.431 . . . . 71.120000000000005 109.837 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.74 -63.28 2.77 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 116.274 -0.421 . . . . 71.519999999999996 112.274 173.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.1 p 160.44 -12.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.157 1.783 . . . . 74.019999999999996 109.275 -167.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.64 -20.5 62.72 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.787 0.835 . . . . 43.329999999999998 110.605 -177.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.8 m -91.42 52.04 2.01 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.734 0.778 . . . . 74.329999999999998 110.815 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.513 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -130.01 13.25 0.05 OUTLIER Pre-proline 0 CA--C 1.575 1.909 0 N-CA-C 115.231 1.567 . . . . 53.0 115.231 169.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 11.8 Cg_exo -68.05 -51.0 0.67 Allowed 'Trans proline' 0 C--N 1.407 3.635 0 CA-C-N 123.436 2.263 . . . . 73.340000000000003 111.275 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -81.82 151.05 67.04 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 113.508 -1.678 . . . . 74.430000000000007 110.74 -168.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.3 -32.09 81.83 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 121.914 1.743 . . . . 74.200000000000003 111.48 171.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -105.46 57.64 0.68 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.771 1.229 . . . . 72.430000000000007 108.932 175.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.559 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 18.7 p -58.94 -14.01 8.0 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.879 1.272 . . . . 72.530000000000001 113.345 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 61.3 m95 -48.8 -35.62 14.84 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.23 1.412 . . . . 70.409999999999997 111.65 173.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.13 -32.28 79.94 Favored Glycine 0 N--CA 1.475 1.244 0 CA-C-N 115.663 -0.699 . . . . 41.140000000000001 113.055 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.7 t -82.53 -44.51 15.82 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 122.397 1.094 . . . . 60.399999999999999 110.12 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.3 t -82.7 -60.23 2.25 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 112.948 -1.933 . . . . 72.010000000000005 111.758 -169.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 13' ' ' TRP . 27.5 mt -52.34 -25.85 10.75 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.991 1.478 . . . . 74.319999999999993 114.991 -175.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.47 -22.4 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 CA-C-O 121.074 0.464 . . . . 74.209999999999994 111.1 -176.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -140.63 -5.32 1.2 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.563 0.745 . . . . 71.340000000000003 112.683 -176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 2' ' ' CYS . 80.2 m -127.79 174.32 9.23 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.158 0.983 . . . . 61.149999999999999 110.295 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.44 157.7 46.9 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 124.832 1.253 . . . . 62.310000000000002 110.111 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.44 -17.56 41.46 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 123.366 2.711 . . . . 51.530000000000001 113.389 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.5 t -56.77 -42.68 79.83 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.329 0.651 . . . . 63.350000000000001 110.811 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mm -76.84 -48.53 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 115.937 -0.574 . . . . 74.209999999999994 110.036 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.2 m -64.73 -34.85 79.3 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.746 -1.115 . . . . 75.019999999999996 111.55 -174.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.44 -20.65 64.65 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.052 0.541 . . . . 71.530000000000001 111.425 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.48 -36.06 24.39 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.841 -0.504 . . . . 35.75 111.841 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -91.12 -41.85 10.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.355 0.662 . . . . 73.219999999999999 111.739 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.559 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.6 m -69.25 -71.84 0.21 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.43 0.633 . . . . 75.239999999999995 111.344 178.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.02 123.34 0.96 Allowed Glycine 0 C--N 1.34 0.804 0 CA-C-N 114.697 -1.138 . . . . 61.32 110.713 -169.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.79 -34.14 1.98 Allowed Glycine 0 N--CA 1.463 0.442 0 N-CA-C 110.985 -0.846 . . . . 43.219999999999999 110.985 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.6 m . . . . . 0 CA--C 1.56 1.33 0 C-N-CA 125.409 1.484 . . . . 73.310000000000002 111.266 176.04 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.735 ' SG ' HG21 ' A' ' 24' ' ' ILE . 61.7 m . . . . . 0 C--O 1.241 0.623 0 CA-C-O 120.839 0.352 . . . . 62.01 110.052 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.9 -6.86 86.11 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-O 118.691 -1.061 . . . . 74.12 114.874 -170.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m 66.63 13.58 9.39 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.488 1.115 . . . . 71.12 110.839 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -94.16 -24.55 17.48 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.208 1.003 . . . . 73.03 110.015 -172.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 52.5 m -97.6 39.73 1.19 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.894 0.878 . . . . 41.33 110.655 170.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.569 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -99.23 -16.22 0.19 Allowed Pre-proline 0 CA--C 1.58 2.112 0 N-CA-C 115.468 1.655 . . . . 71.45 115.468 168.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 12.6 Cg_exo -69.35 -38.88 8.05 Favored 'Trans proline' 0 C--N 1.406 3.554 0 CA-C-N 123.198 2.178 . . . . 74.35 112.964 -166.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -67.59 150.75 97.69 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.362 -1.29 . . . . 73.42 112.353 -166.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.11 -29.65 87.68 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.479 2.119 . . . . 75.54 110.698 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -119.34 78.34 1.29 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.784 -1.191 . . . . 74.41 107.784 170.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 20.7 p -60.19 -27.67 67.34 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.031 -0.986 . . . . 74.4 110.954 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -45.66 -38.25 6.56 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 125.452 1.501 . . . . 71.2 111.593 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.94 43.67 3.25 Favored Glycine 0 N--CA 1.474 1.206 0 CA-C-N 114.755 -1.111 . . . . 74.5 112.531 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.461 ' O ' HG12 ' A' ' 18' ' ' VAL . 13.2 t -167.23 -46.07 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.991 1.316 . . . . 64.15 108.323 -176.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.1 t -79.47 -42.79 24.52 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.671 -1.604 . . . . 71.21 112.03 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.403 HD23 ' SG ' ' A' ' 25' ' ' CYS . 71.5 mt -63.13 -9.72 11.92 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.959 1.466 . . . . 74.22 114.959 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 15' ' ' CYS . 10.2 p -83.17 -19.84 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 118.894 0.77 . . . . 74.23 110.625 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -138.87 -1.66 1.78 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.051 0.94 . . . . 71.53 111.648 -169.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 59.8 m -146.16 167.0 24.52 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.599 0.76 . . . . 60.33 110.301 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.95 155.65 52.59 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 115.206 -0.906 . . . . 75.3 110.448 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -45.52 -30.95 6.44 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.729 2.952 . . . . 74.03 114.652 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -58.87 -41.26 86.65 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.086 0.554 . . . . 73.01 111.521 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.735 HG21 ' SG ' ' A' ' 2' ' ' CYS . 47.9 mm -73.11 -51.33 26.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 C-N-CA 123.567 0.747 . . . . 75.23 110.162 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.403 ' SG ' HD23 ' A' ' 17' ' ' LEU . 7.0 m -65.37 -31.92 73.29 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.055 -0.975 . . . . 73.22 111.339 -175.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.38 -28.44 68.21 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.397 0.679 . . . . 55.14 111.522 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.12 -22.62 47.94 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.702 0.627 . . . . 53.35 112.273 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . 15.8 m95 -93.43 -36.77 12.31 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.222 0.609 . . . . 72.23 112.132 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 42.4 m -71.58 -73.14 0.19 Allowed 'General case' 0 CA--C 1.547 0.844 0 O-C-N 123.196 0.31 . . . . 63.32 110.519 176.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.074 0 CA-C-O 121.055 0.253 . . . . 72.14 112.508 -178.093 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.823 ' HB2' HG21 ' A' ' 24' ' ' ILE . 11.1 t . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.365 -0.606 . . . . 65.15 109.365 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.04 -25.09 76.39 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 111.389 -0.684 . . . . 64.35 111.389 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.1 m 66.3 5.12 3.5 Favored 'General case' 0 C--N 1.369 1.447 0 C-N-CA 124.562 1.145 . . . . 60.35 112.086 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.45 -15.84 16.36 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.039 0.935 . . . . 72.23 108.761 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 56.2 m -93.21 44.45 1.14 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.535 1.134 . . . . 64.53 110.822 170.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.501 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -117.31 5.26 0.08 OUTLIER Pre-proline 0 CA--C 1.58 2.134 0 N-CA-C 116.034 1.864 . . . . 21.31 116.034 173.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 39.9 Cg_exo -59.32 -54.08 2.92 Favored 'Trans proline' 0 C--N 1.408 3.691 0 CA-C-N 123.509 2.289 . . . . 65.43 112.867 -173.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -85.27 155.71 60.09 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 114.395 -1.275 . . . . 75.24 111.411 -171.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.9 -14.93 45.6 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.689 2.259 . . . . 71.32 111.532 165.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -108.05 56.41 0.63 Allowed 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 123.018 1.39 . . . . 72.53 108.344 170.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.531 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 22.0 p -67.85 -16.26 64.01 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.24 -1.345 . . . . 72.14 111.852 175.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -47.42 -36.47 9.9 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 126.01 1.724 . . . . 73.12 112.436 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.11 35.2 3.86 Favored Glycine 0 N--CA 1.47 0.932 0 CA-C-N 115.091 -0.959 . . . . 65.21 112.801 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 8.3 t -154.94 -46.54 0.08 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.403 1.097 . . . . 41.31 108.955 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 15.4 t -80.65 -44.19 19.24 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 113.333 -1.758 . . . . 73.44 111.562 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.453 HD23 ' SG ' ' A' ' 25' ' ' CYS . 74.9 mt -62.59 -18.56 62.41 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 114.68 1.363 . . . . 44.12 114.68 -172.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.65 -19.41 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 122.837 0.455 . . . . 71.44 111.636 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.527 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 16.0 pt20 -142.11 -34.01 0.47 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.112 0.965 . . . . 74.53 110.371 -168.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.527 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 3.7 m -104.69 158.11 16.73 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.614 1.166 . . . . 62.53 109.228 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.5 159.38 61.52 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.248 0.619 . . . . 43.43 110.962 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.69 -33.48 31.99 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.13 2.553 . . . . 51.21 112.674 164.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.0 t -57.12 -22.66 41.48 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.733 1.213 . . . . 73.55 112.401 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.823 HG21 ' HB2' ' A' ' 2' ' ' CYS . 31.8 mm -101.47 -51.55 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.681 0.792 . . . . 73.34 110.474 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.453 ' SG ' HD23 ' A' ' 17' ' ' LEU . 21.9 m -64.92 -22.14 66.94 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.089 0.956 . . . . 63.21 112.357 -172.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.61 76.0 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.616 0.766 . . . . 72.43 111.343 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.1 -19.22 63.25 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.739 -0.664 . . . . 64.12 112.722 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -89.28 -40.32 12.89 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.108 0.563 . . . . 71.34 110.877 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 21.1 m -74.55 -60.73 2.14 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.362 -0.836 . . . . 63.53 111.301 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.312 0 CA-C-N 116.015 -0.539 . . . . 35.52 112.554 -173.334 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.458 ' HB2' HG21 ' A' ' 24' ' ' ILE . 99.2 m . . . . . 0 CA--C 1.547 0.854 0 CA-C-O 121.047 0.451 . . . . 71.31 110.114 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.12 -56.76 1.05 Allowed Glycine 0 C--N 1.336 0.55 0 CA-C-N 115.98 -0.554 . . . . 74.22 112.382 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.7 p 149.97 -6.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 126.372 1.869 . . . . 72.14 108.791 -159.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -25.65 60.74 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.836 0.854 . . . . 71.54 110.698 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -100.74 53.16 0.86 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.507 1.123 . . . . 74.43 109.75 173.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.503 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -133.37 15.21 0.05 OUTLIER Pre-proline 0 CA--C 1.576 1.945 0 CA-C-N 113.724 -1.58 . . . . 72.11 114.802 169.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 31.8 Cg_exo -62.53 -51.53 3.21 Favored 'Trans proline' 0 C--N 1.407 3.657 0 CA-C-N 123.242 2.194 . . . . 72.02 111.549 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -84.68 159.66 57.64 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 113.735 -1.575 . . . . 72.44 110.793 -172.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.06 -23.92 28.89 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.475 2.117 . . . . 75.4 110.776 163.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -104.33 48.92 0.83 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.956 1.302 . . . . 74.13 109.137 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 19.9 p -61.06 -14.53 24.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.921 1.289 . . . . 74.25 113.822 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.551 ' HE3' HD11 ' A' ' 17' ' ' LEU . 61.8 m95 -47.07 -40.78 15.77 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.416 1.487 . . . . 75.54 112.298 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.33 -25.29 75.87 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-N 114.946 -1.025 . . . . 50.43 112.745 -173.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.467 ' O ' HG12 ' A' ' 18' ' ' VAL . 34.3 t -86.77 -45.63 10.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.109 0.957 . . . . 74.24 110.216 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 t -76.98 -53.76 7.42 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.619 -1.628 . . . . 53.11 112.578 -170.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.677 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -61.91 -7.81 4.24 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.854 1.798 . . . . 74.24 115.854 -175.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 15' ' ' CYS . 10.3 p -76.77 -23.73 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-N 119.278 0.945 . . . . 62.12 110.366 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -132.18 -24.19 2.11 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.253 1.021 . . . . 73.52 111.289 -169.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 2' ' ' CYS . 77.9 m -123.98 175.37 6.99 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.43 1.092 . . . . 72.13 110.472 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.52 157.4 58.46 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.915 0.886 . . . . 73.34 110.479 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.426 ' HB3' HD21 ' A' ' 17' ' ' LEU . 19.9 Cg_endo -61.33 -12.43 23.75 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 123.152 2.568 . . . . 71.04 112.769 171.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.0 t -62.49 -44.05 97.32 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.445 0.698 . . . . 50.44 110.689 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 2' ' ' CYS . 36.9 mm -69.99 -50.13 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 115.705 -0.679 . . . . 74.14 109.3 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.677 ' SG ' ' HG ' ' A' ' 17' ' ' LEU . 10.2 m -60.37 -36.18 77.44 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.303 -1.317 . . . . 71.01 111.733 -174.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.14 89.98 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.082 0.553 . . . . 51.43 110.687 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.07 -33.07 69.42 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.846 0.716 . . . . 54.02 113.429 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -92.37 -38.23 12.14 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.801 0.44 . . . . 73.35 111.585 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 34.5 m -69.09 -57.97 4.7 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.605 0.362 . . . . 62.44 111.676 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.777 0 CA-C-N 116.192 -0.458 . . . . 63.13 112.47 -172.92 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.68 ' SG ' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 108.437 -0.949 . . . . 62.2 108.437 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.31 -48.7 84.71 Favored Glycine 0 C--N 1.341 0.824 0 O-C-N 124.096 0.873 . . . . 64.12 114.858 -172.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.3 p 131.25 3.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 127.505 2.322 . . . . 63.41 107.916 -159.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.33 -26.85 63.94 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.005 0.922 . . . . 73.24 109.806 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 34.1 m -100.72 60.75 0.98 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.957 -1.019 . . . . 72.15 110.039 167.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.686 ' HB2' ' HB3' ' A' ' 28' ' ' TRP . . . -142.92 31.77 0.13 Allowed Pre-proline 0 CA--C 1.579 2.078 0 CA-C-N 113.797 -1.547 . . . . 74.45 113.403 163.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 51.3 Cg_exo -61.26 -50.24 6.29 Favored 'Trans proline' 0 C--N 1.405 3.51 0 CA-C-N 122.08 1.779 . . . . 74.02 111.974 170.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -84.14 161.36 55.2 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 113.781 -1.554 . . . . 45.12 111.36 -171.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.71 -33.91 75.33 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.259 1.973 . . . . 74.35 110.452 161.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -94.82 78.53 3.67 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.966 -1.016 . . . . 72.12 108.97 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.466 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 18.3 p -70.44 -18.01 63.0 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.86 -0.609 . . . . 51.04 110.592 171.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.52 ' HE3' HD11 ' A' ' 17' ' ' LEU . 64.9 m95 -49.23 -35.93 18.72 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 125.284 1.434 . . . . 73.35 111.774 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -93.6 49.06 2.32 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 114.909 -1.041 . . . . 41.3 112.161 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.47 ' O ' HG12 ' A' ' 18' ' ' VAL . 16.6 t -166.2 -45.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.812 1.245 . . . . 73.05 108.709 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 12.4 t -80.8 -45.8 16.38 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 113.493 -1.685 . . . . 74.31 111.936 -169.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.52 HD11 ' HE3' ' A' ' 13' ' ' TRP . 5.4 mp -72.11 -0.18 11.16 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 114.849 1.426 . . . . 64.41 114.849 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 15' ' ' CYS . 13.6 p -82.18 -18.36 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.849 0.749 . . . . 74.23 110.096 171.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.563 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 11.5 pt20 -138.04 -6.45 1.63 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.637 0.775 . . . . 73.3 111.777 -168.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.563 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 48.7 m -143.76 172.4 12.89 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.668 0.787 . . . . 75.01 110.357 -174.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 154.74 50.14 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.209 1.004 . . . . 41.23 109.785 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.4 -18.74 40.13 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.328 2.686 . . . . 64.32 112.771 172.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 t -61.05 -39.17 88.82 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.814 0.846 . . . . 53.21 110.694 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.68 HG21 ' SG ' ' A' ' 2' ' ' CYS . 45.1 mm -77.82 -48.42 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.419 0.688 . . . . 74.02 109.709 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.6 m -64.99 -30.41 71.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.639 -1.164 . . . . 54.23 112.082 -172.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.81 -29.01 70.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.059 0.544 . . . . 70.02 111.412 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.58 -27.75 37.96 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.536 0.522 . . . . 72.22 112.409 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.686 ' HB3' ' HB2' ' A' ' 7' ' ' ALA . 26.4 m95 -92.49 -32.78 14.75 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.259 0.624 . . . . 74.34 111.395 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.2 m -73.96 -74.83 0.17 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.247 0.546 . . . . 65.11 110.637 173.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.861 0 CA-C-N 114.783 -1.099 . . . . 61.1 110.67 -169.746 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.666 ' HB2' HG21 ' A' ' 24' ' ' ILE . 36.1 t . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.079 -0.711 . . . . 75.31 109.079 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.17 -16.86 79.1 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.705 -0.497 . . . . 55.54 111.862 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.7 p 61.49 8.5 2.25 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 125.79 1.636 . . . . 52.13 112.836 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -116.06 7.1 14.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.534 0.734 . . . . 63.51 109.07 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 88.3 m -106.51 34.96 3.14 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 124.058 0.943 . . . . 73.1 110.734 170.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.532 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -96.39 -19.26 0.22 Allowed Pre-proline 0 CA--C 1.586 2.339 0 N-CA-C 115.188 1.551 . . . . 71.12 115.188 167.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 25.1 Cg_exo -63.47 -53.66 1.32 Allowed 'Trans proline' 0 C--N 1.412 3.875 0 CA-C-N 123.329 2.225 . . . . 51.23 114.072 -163.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.36 159.64 84.0 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 114.904 -1.044 . . . . 74.42 111.685 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.79 -26.35 32.51 Favored 'Trans proline' 0 CA--C 1.554 1.511 0 C-N-CA 122.193 1.929 . . . . 63.43 111.044 162.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -98.87 31.98 2.78 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 124.44 1.096 . . . . 74.41 109.612 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 2.6 p -61.05 -20.8 62.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.405 1.082 . . . . 74.03 112.767 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -54.76 -38.27 67.01 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.176 0.99 . . . . 74.41 110.693 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -23.89 74.82 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 115.06 -0.973 . . . . 74.22 112.781 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.476 ' O ' HG12 ' A' ' 18' ' ' VAL . 34.6 t -89.24 -43.47 10.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.492 1.117 . . . . 75.23 109.968 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 42.2 t -71.79 -52.02 19.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.151 -1.386 . . . . 64.02 111.455 -171.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.462 HD21 ' HB3' ' A' ' 22' ' ' PRO . 4.4 mp -73.0 9.89 1.06 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 115.583 1.697 . . . . 71.2 115.583 -173.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 15' ' ' CYS . 13.9 p -91.14 -12.56 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 118.875 0.761 . . . . 61.23 109.442 170.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.523 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 27.6 pt20 -152.86 2.4 0.31 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.344 0.657 . . . . 71.44 112.028 -167.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.523 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 1.4 m -147.03 156.66 43.2 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.607 0.763 . . . . 72.23 109.354 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.95 149.9 77.49 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.241 0.616 . . . . 73.14 110.819 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.462 ' HB3' HD21 ' A' ' 17' ' ' LEU . 13.2 Cg_endo -55.94 -23.2 41.81 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.525 2.817 . . . . 74.14 113.713 174.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -65.24 -38.71 91.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.955 0.502 . . . . 61.32 110.388 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.666 HG21 ' HB2' ' A' ' 2' ' ' CYS . 23.4 mm -75.1 -43.75 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.226 -0.657 . . . . 72.53 109.226 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.5 m -66.96 -28.41 68.25 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.158 0.983 . . . . 72.15 111.055 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.86 -28.3 68.86 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.563 0.745 . . . . 71.35 111.231 170.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.95 -35.71 38.34 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 116.221 -0.445 . . . . 75.14 112.133 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -82.52 -69.34 0.63 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.98 0.512 . . . . 71.04 110.296 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.5 m -64.68 -49.45 70.9 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.142 0.977 . . . . 74.01 112.096 -175.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.182 0 CA-C-N 115.52 -0.764 . . . . 23.4 112.968 -178.985 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.698 ' HB2' HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.71 -0.478 . . . . 61.3 109.71 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.0 -5.46 73.4 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.527 -0.596 . . . . 75.12 112.306 166.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.3 m 64.88 18.54 11.52 Favored 'General case' 0 C--N 1.372 1.545 0 C-N-CA 124.721 1.208 . . . . 64.14 109.853 -171.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -102.82 -38.49 7.4 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.449 -1.315 . . . . 73.13 107.449 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.1 m -86.67 44.86 1.19 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.212 1.005 . . . . 73.23 111.707 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.433 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -122.6 33.11 0.22 Allowed Pre-proline 0 CA--C 1.576 1.973 0 N-CA-C 114.728 1.381 . . . . 64.5 114.728 165.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 35.3 Cg_exo -64.79 -61.05 0.11 Allowed 'Trans proline' 0 C--N 1.397 3.119 0 CA-C-N 122.675 1.991 . . . . 73.21 111.072 169.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -82.67 151.54 64.95 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-N 114.239 -1.346 . . . . 74.44 111.37 -170.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.5 -32.64 96.62 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.937 2.424 . . . . 65.2 110.67 162.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -94.61 70.0 3.53 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 122.44 1.114 . . . . 73.3 108.532 171.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.527 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 22.1 p -77.8 -15.26 59.22 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.366 -1.288 . . . . 71.44 112.803 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -48.5 -38.78 21.09 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.381 1.473 . . . . 55.41 112.885 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.83 -16.97 80.31 Favored Glycine 0 N--CA 1.476 1.315 0 CA-C-N 115.553 -0.749 . . . . 74.11 113.339 -172.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.435 ' O ' HG12 ' A' ' 18' ' ' VAL . 11.4 t -96.13 -51.75 4.29 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.166 0.984 . . . . 55.25 109.677 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 t -73.82 -45.3 52.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.685 -1.598 . . . . 54.21 112.715 -166.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.485 HD23 ' SG ' ' A' ' 25' ' ' CYS . 76.3 mt -59.15 -22.24 60.6 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.061 1.504 . . . . 73.25 115.061 -172.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 15' ' ' CYS . 7.6 p -78.52 -22.75 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 118.666 0.666 . . . . 33.2 111.184 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -133.85 1.0 3.27 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.03 0.932 . . . . 70.32 111.282 -170.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.1 m -149.09 167.65 25.31 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.479 1.112 . . . . 61.24 109.55 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.53 154.68 62.43 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.649 0.78 . . . . 50.13 110.492 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.32 -25.05 45.52 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.26 2.64 . . . . 53.31 112.856 167.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -57.37 -37.53 72.76 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.981 0.912 . . . . 73.13 111.137 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.698 HG21 ' HB2' ' A' ' 2' ' ' CYS . 43.3 mm -82.83 -49.41 16.93 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 C-N-CA 123.189 0.596 . . . . 70.12 110.341 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.485 ' SG ' HD23 ' A' ' 17' ' ' LEU . 11.4 m -64.26 -26.84 68.68 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.076 -0.966 . . . . 54.33 111.867 -171.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.78 -33.57 71.88 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.491 0.717 . . . . 64.43 111.76 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.51 -42.45 11.61 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 116.447 -0.342 . . . . 73.33 112.808 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -73.94 -34.23 64.23 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.868 0.467 . . . . 62.22 110.974 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 21.9 m -77.92 -78.76 0.13 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.249 0.62 . . . . 44.33 110.794 175.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.559 0 O-C-N 123.245 0.341 . . . . 44.02 112.911 -170.619 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.765 ' HB2' HG21 ' A' ' 24' ' ' ILE . 9.3 t . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 107.8 -1.185 . . . . 75.12 107.8 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.23 -11.41 67.05 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.363 -0.687 . . . . 53.23 112.958 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.4 m 68.94 6.23 5.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.998 1.319 . . . . 62.35 110.708 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -88.23 -45.47 10.05 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.291 1.037 . . . . 62.11 108.694 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 92.3 m -89.39 50.1 1.87 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.618 -1.174 . . . . 73.23 111.516 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.556 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -104.35 -15.27 0.16 Allowed Pre-proline 0 CA--C 1.577 2.011 0 N-CA-C 116.306 1.965 . . . . 61.44 116.306 167.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 14.0 Cg_exo -64.15 -49.47 3.71 Favored 'Trans proline' 0 C--N 1.407 3.644 0 CA-C-N 122.98 2.1 . . . . 71.21 113.342 -160.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -77.95 154.62 80.41 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 113.514 -1.676 . . . . 64.02 111.431 -166.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.17 -38.6 75.54 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.185 1.923 . . . . 62.15 110.425 174.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -100.56 82.42 2.45 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 107.358 -1.349 . . . . 61.23 107.358 167.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.533 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 23.6 p -73.48 -18.14 61.15 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.867 0.867 . . . . 62.15 111.778 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -48.5 -40.32 26.28 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 125.262 1.425 . . . . 73.53 112.354 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.3 -27.5 73.59 Favored Glycine 0 N--CA 1.478 1.441 0 CA-C-N 115.334 -0.848 . . . . 63.23 112.87 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 12.7 t -90.66 -45.78 8.67 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.294 1.045 . . . . 75.33 110.107 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 11.4 t -74.75 -44.48 49.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.28 -1.782 . . . . 62.34 112.122 -166.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.405 HD23 ' SG ' ' A' ' 25' ' ' CYS . 72.7 mt -63.26 -15.99 58.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 115.019 1.488 . . . . 65.21 115.019 -173.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 15' ' ' CYS . 14.6 p -81.06 -10.81 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 118.706 0.684 . . . . 73.12 110.884 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -147.32 -3.81 0.55 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.377 0.671 . . . . 75.14 111.663 -169.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 8.2 m -145.61 162.87 36.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.115 0.966 . . . . 54.03 109.037 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.85 157.13 67.07 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.73 0.812 . . . . 64.01 111.399 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.84 -23.72 68.61 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.485 2.79 . . . . 54.32 113.066 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.4 p -65.17 -32.63 74.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.109 0.564 . . . . 75.11 110.643 173.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.765 HG21 ' HB2' ' A' ' 2' ' ' CYS . 14.6 mm -84.81 -49.04 16.18 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 121.175 0.512 . . . . 73.34 110.242 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.405 ' SG ' HD23 ' A' ' 17' ' ' LEU . 16.1 m -62.87 -28.1 69.8 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.837 -1.074 . . . . 73.3 111.235 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.25 -45.29 72.33 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.963 0.505 . . . . 64.11 111.004 169.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.13 -32.53 60.33 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.102 -0.954 . . . . 75.23 113.64 -175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -86.17 -28.7 23.76 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.896 0.478 . . . . 72.25 111.885 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.3 m -78.98 -70.07 0.53 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.615 0.366 . . . . 73.32 111.273 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.215 0 C-N-CA 121.743 -0.265 . . . . 52.24 113.552 -169.429 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.468 ' SG ' HG21 ' A' ' 24' ' ' ILE . 31.2 m . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 109.887 -0.412 . . . . 60.4 109.887 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.04 12.2 58.52 Favored Glycine 0 N--CA 1.473 1.145 0 N-CA-C 116.81 1.484 . . . . 63.53 116.81 -161.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.2 p 58.1 15.43 3.24 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.105 1.362 . . . . 74.04 112.29 -172.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.63 -29.41 56.44 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 108.771 -0.826 . . . . 73.31 108.771 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 18.5 m -96.39 51.08 1.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.286 -0.87 . . . . 52.14 110.511 168.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.433 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -122.92 21.73 0.1 OUTLIER Pre-proline 0 CA--C 1.59 2.498 0 N-CA-C 115.071 1.508 . . . . 61.22 115.071 163.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 52.6 Cg_exo -58.32 -58.26 0.82 Allowed 'Trans proline' 0 C--N 1.409 3.751 0 CA-C-N 123.239 2.192 . . . . 74.41 113.115 174.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -80.1 154.65 75.0 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 114.845 -1.07 . . . . 64.44 111.193 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.26 -35.46 91.62 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.937 2.425 . . . . 75.44 110.655 168.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.44 75.41 5.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.003 -1.11 . . . . 63.43 108.003 167.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.547 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 20.7 p -68.22 -18.21 64.51 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.732 -1.122 . . . . 75.22 110.992 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -48.88 -36.69 17.67 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 125.411 1.484 . . . . 75.0 111.419 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.37 25.27 6.42 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-N 114.987 -1.006 . . . . 73.33 113.579 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.428 ' O ' HG12 ' A' ' 18' ' ' VAL . 20.0 t -143.5 -46.52 0.29 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.777 1.231 . . . . 73.33 108.649 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.2 t -78.02 -44.62 26.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.005 -1.907 . . . . 72.24 111.763 -170.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.2 mt -62.12 -12.59 20.33 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.974 1.472 . . . . 75.43 114.974 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 15' ' ' CYS . 11.4 p -82.22 -19.75 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 119.087 0.858 . . . . 74.1 110.584 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -142.08 5.26 1.69 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.046 0.938 . . . . 74.43 111.475 -169.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 48.4 m -146.49 172.05 14.13 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.751 1.22 . . . . 73.15 109.068 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.43 161.54 24.91 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 123.555 0.742 . . . . 52.01 110.871 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.04 -31.52 8.63 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 123.631 2.888 . . . . 51.12 114.61 169.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 m -56.42 -40.48 74.76 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.278 0.631 . . . . 62.44 111.505 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.468 HG21 ' SG ' ' A' ' 2' ' ' CYS . 47.6 mm -78.3 -55.73 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.603 -0.726 . . . . 72.04 110.089 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 m -63.88 -31.29 72.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.992 -1.003 . . . . 64.54 112.131 -170.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.82 -31.12 69.42 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.969 0.508 . . . . 74.43 112.012 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.45 -26.05 48.62 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.8 0.688 . . . . 51.45 112.561 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -91.2 -31.36 16.21 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.432 0.693 . . . . 70.31 111.015 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 18.6 m -80.82 -70.02 0.56 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.012 0.925 . . . . 70.33 111.935 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.504 0 CA-C-N 115.001 -1.0 . . . . 53.22 111.685 -167.102 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.718 ' SG ' HG21 ' A' ' 24' ' ' ILE . 95.7 m . . . . . 0 CA--C 1.555 1.159 0 N-CA-C 112.248 0.462 . . . . 72.51 112.248 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.4 -6.51 77.67 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.266 -0.741 . . . . 61.43 113.966 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.0 p 60.0 15.98 5.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.475 1.51 . . . . 73.22 112.576 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -34.57 44.68 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.471 -0.786 . . . . 72.34 109.287 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 93.0 m -101.56 43.49 1.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.559 1.144 . . . . 70.34 110.727 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.535 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -95.89 -26.09 0.25 Allowed Pre-proline 0 CA--C 1.578 2.054 0 N-CA-C 115.826 1.787 . . . . 73.04 115.826 171.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 11.8 Cg_exo -65.8 -44.47 7.91 Favored 'Trans proline' 0 C--N 1.398 3.171 0 C-N-CA 122.161 1.907 . . . . 75.32 114.005 -157.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -83.34 157.0 65.83 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 114.109 -1.405 . . . . 72.12 111.983 -160.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.28 -27.61 63.81 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.214 1.943 . . . . 75.22 111.255 162.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -104.8 38.87 1.81 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.344 1.058 . . . . 72.13 109.224 174.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.5 p -64.92 -21.64 66.86 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.55 -0.719 . . . . 71.14 111.27 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -48.62 -38.78 21.85 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 125.242 1.417 . . . . 72.43 111.79 171.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.73 -14.47 79.86 Favored Glycine 0 N--CA 1.473 1.105 0 CA-C-N 115.04 -0.982 . . . . 72.35 113.104 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 20.5 t -99.43 -41.26 7.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.121 1.368 . . . . 74.54 110.151 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 9.9 t -81.03 -45.5 16.46 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 113.174 -1.83 . . . . 73.52 112.553 -168.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.6 -0.47 1.4 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.245 1.572 . . . . 71.13 115.245 -175.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -88.35 -23.46 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-N 119.176 0.898 . . . . 73.11 110.436 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -133.79 -3.42 2.9 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.161 0.985 . . . . 74.1 111.235 -169.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.507 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 63.2 m -144.14 170.18 16.45 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.643 0.777 . . . . 61.35 110.592 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.41 159.93 34.15 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.186 0.995 . . . . 71.34 110.795 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -48.12 -30.29 14.11 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 123.686 2.924 . . . . 51.44 114.161 168.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.2 m -60.91 -39.4 89.2 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.991 0.917 . . . . 62.24 111.395 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.718 HG21 ' SG ' ' A' ' 2' ' ' CYS . 51.1 mm -77.36 -53.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 123.533 0.733 . . . . 73.3 109.82 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.7 m -62.76 -31.22 72.13 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.75 -1.114 . . . . 33.44 112.014 -173.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.6 -39.98 84.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.717 0.407 . . . . 65.15 110.572 172.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.64 -24.32 75.36 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.88 -0.6 . . . . 60.31 112.977 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.51 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . 81.7 m95 -97.14 -43.79 7.23 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.413 0.685 . . . . 74.33 111.665 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.5 m -71.4 -73.06 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.31 0.576 . . . . 52.11 110.864 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.823 0 CA-C-N 114.998 -1.001 . . . . 62.21 111.315 -170.644 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 50.1 m . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 121.022 0.439 . . . . 65.23 110.071 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.63 19.13 16.69 Favored Glycine 0 N--CA 1.47 0.905 0 CA-C-N 115.605 -0.725 . . . . 65.21 112.912 -174.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t 64.44 14.93 9.21 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.833 1.253 . . . . 74.21 110.791 -166.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -80.29 -33.14 37.93 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.372 -0.973 . . . . 72.21 108.372 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.3 m -99.6 46.93 0.96 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.626 -1.17 . . . . 70.33 110.964 173.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.541 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -112.74 -6.89 0.1 Allowed Pre-proline 0 CA--C 1.577 1.999 0 CA-C-O 116.409 -1.758 . . . . 24.21 115.565 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 39.1 Cg_exo -62.01 -50.69 4.63 Favored 'Trans proline' 0 C--N 1.408 3.692 0 CA-C-N 123.416 2.256 . . . . 73.41 113.176 -169.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -77.68 153.91 81.03 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 114.594 -1.185 . . . . 74.5 111.539 -170.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.47 -25.32 41.62 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.216 1.944 . . . . 61.15 110.658 164.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -104.26 45.84 0.94 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.014 1.326 . . . . 70.4 108.92 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 20.6 p -56.02 -19.79 14.13 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.499 1.12 . . . . 74.43 112.455 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -42.74 -39.51 2.47 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.096 1.758 . . . . 60.02 112.378 171.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.31 -22.09 76.12 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 115.413 -0.812 . . . . 72.41 113.616 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.469 ' O ' HG12 ' A' ' 18' ' ' VAL . 25.0 t -96.31 -46.21 6.51 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.25 1.024 . . . . 75.54 109.987 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -76.99 -47.35 21.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 113.424 -1.717 . . . . 72.32 112.734 -166.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.436 HD23 ' SG ' ' A' ' 25' ' ' CYS . 47.1 mt -61.46 -14.26 27.18 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.076 1.51 . . . . 62.41 115.076 -173.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 15' ' ' CYS . 14.0 p -74.93 -23.58 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 118.909 0.777 . . . . 74.13 110.952 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -134.43 -18.54 1.96 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.139 0.976 . . . . 73.13 111.426 -167.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.8 m -128.55 170.9 12.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.243 1.017 . . . . 72.42 110.396 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.18 154.9 57.72 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.192 0.997 . . . . 74.21 110.8 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.48 -26.54 12.4 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.683 2.922 . . . . 74.32 114.304 168.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 m -61.98 -41.42 98.0 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.134 0.574 . . . . 55.25 111.174 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.04 -52.87 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 122.956 0.502 . . . . 54.03 110.28 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.436 ' SG ' HD23 ' A' ' 17' ' ' LEU . 4.0 m -62.0 -33.35 74.17 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.866 -1.061 . . . . 72.34 111.092 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.8 -36.77 77.43 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.603 0.761 . . . . 74.43 111.565 174.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.04 -41.53 22.13 Favored Glycine 0 C--N 1.351 1.364 0 O-C-N 123.91 0.756 . . . . 42.02 112.423 -174.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -77.93 -40.67 38.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.124 0.569 . . . . 63.4 111.863 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.8 m -67.35 -63.67 1.01 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.34 0.59 . . . . 72.33 110.542 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.654 0 CA-C-N 114.793 -1.094 . . . . 32.23 111.446 -167.942 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.765 ' HB2' HG21 ' A' ' 24' ' ' ILE . 6.2 t . . . . . 0 C--O 1.243 0.722 0 N-CA-C 108.931 -0.766 . . . . 25.42 108.931 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.46 -18.71 65.77 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.796 -0.446 . . . . 73.33 112.567 173.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.8 m 69.54 8.6 6.84 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 124.777 1.231 . . . . 55.31 112.272 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -117.55 6.64 12.53 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.494 1.117 . . . . 73.14 110.437 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.5 m -113.66 31.88 6.2 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.131 0.972 . . . . 65.4 110.984 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.578 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -95.02 -20.88 0.23 Allowed Pre-proline 0 CA--C 1.58 2.103 0 N-CA-C 115.318 1.599 . . . . 64.45 115.318 166.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 9.6 Cg_exo -70.35 -47.27 0.78 Allowed 'Trans proline' 0 C--N 1.4 3.262 0 C-N-CA 122.448 2.098 . . . . 65.45 113.849 -162.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -70.62 159.64 84.39 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.591 -1.186 . . . . 74.32 112.164 -164.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.51 -29.62 44.43 Favored 'Trans proline' 0 C--N 1.368 1.572 0 C-N-CA 122.159 1.906 . . . . 61.23 111.352 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -109.22 31.77 5.47 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.644 1.178 . . . . 73.42 109.894 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.0 p -53.54 -21.39 6.36 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.189 1.396 . . . . 74.23 114.067 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.465 ' HE3' HD11 ' A' ' 17' ' ' LEU . 81.4 m95 -55.42 -38.31 68.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.439 1.096 . . . . 64.23 111.16 175.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.92 -21.08 78.14 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 114.984 -1.007 . . . . 54.45 112.542 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' O ' HG12 ' A' ' 18' ' ' VAL . 15.1 t -83.74 -45.06 13.78 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.112 0.965 . . . . 72.51 109.645 177.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.4 t -78.52 -55.72 4.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.98 -1.464 . . . . 74.42 111.776 -168.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.465 HD11 ' HE3' ' A' ' 13' ' ' TRP . 2.2 mp -62.0 -9.19 6.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.113 1.523 . . . . 72.44 115.113 -175.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 15' ' ' CYS . 11.1 p -80.28 -15.56 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 119.255 0.934 . . . . 64.44 109.919 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.611 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 26.5 pt20 -144.23 -4.8 0.79 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.875 0.87 . . . . 31.41 111.703 -170.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.611 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 3.9 m -139.77 170.32 16.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.666 0.787 . . . . 62.0 109.197 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.432 ' HB3' HG12 ' A' ' 24' ' ' ILE . . . -80.08 149.91 70.65 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 122.983 0.513 . . . . 73.21 111.236 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.437 ' HB3' HD21 ' A' ' 17' ' ' LEU . 9.3 Cg_endo -54.07 -27.25 44.99 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 123.364 2.709 . . . . 54.32 112.844 165.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.3 m -62.77 -39.62 94.76 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.599 0.76 . . . . 64.22 110.473 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.765 HG21 ' HB2' ' A' ' 2' ' ' CYS . 44.9 mm -73.29 -48.33 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 123.773 0.829 . . . . 70.45 110.0 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.4 m -64.05 -31.94 73.32 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.401 1.08 . . . . 74.41 111.54 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.58 -31.43 70.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.547 -0.751 . . . . 75.54 111.865 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.64 -32.87 26.29 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 116.381 -0.372 . . . . 25.21 112.937 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -80.73 -54.55 5.52 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.938 0.495 . . . . 71.31 111.338 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -79.19 -69.99 0.54 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.25 0.62 . . . . 62.2 112.527 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.182 0 N-CA-C 112.02 -0.432 . . . . 63.14 112.02 -166.941 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.748 ' HB2' HG21 ' A' ' 24' ' ' ILE . 2.0 t . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 108.287 -1.005 . . . . 73.45 108.287 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.55 -17.64 79.75 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.392 -0.671 . . . . 52.0 112.457 170.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.1 t 71.07 29.68 2.87 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 124.808 1.243 . . . . 65.13 108.289 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -111.28 -31.27 7.12 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.278 -1.328 . . . . 72.15 109.94 -174.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 96.8 m -103.25 44.42 1.02 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.397 1.079 . . . . 73.23 112.435 -175.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.547 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -105.26 -10.47 0.12 Allowed Pre-proline 0 CA--C 1.589 2.445 0 N-CA-C 116.233 1.938 . . . . 72.03 116.233 167.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 16.3 Cg_exo -67.09 -50.67 0.97 Allowed 'Trans proline' 0 C--N 1.401 3.321 0 CA-C-N 123.752 2.376 . . . . 73.12 114.023 -167.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -80.72 162.33 60.68 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.627 -1.169 . . . . 75.24 112.602 -162.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.95 -17.09 28.95 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.534 2.156 . . . . 71.13 111.439 166.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -114.3 27.6 9.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.741 1.216 . . . . 74.3 110.249 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.9 p -62.48 -16.24 54.35 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.301 1.04 . . . . 75.31 112.779 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.43 ' HE3' HD11 ' A' ' 17' ' ' LEU . 89.2 m95 -53.76 -39.05 65.02 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.698 0.799 . . . . 72.11 110.818 173.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.36 -28.41 73.28 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 115.749 -0.66 . . . . 73.13 112.127 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.52 ' O ' HG12 ' A' ' 18' ' ' VAL . 34.3 t -80.94 -43.77 19.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.356 1.062 . . . . 75.22 109.742 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -70.32 -54.39 12.78 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.525 -1.216 . . . . 64.2 111.092 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 22' ' ' PRO . 2.1 mp -69.13 -2.64 10.77 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 115.17 1.544 . . . . 72.43 115.17 -174.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 15' ' ' CYS . 13.3 p -84.56 -16.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 119.408 1.003 . . . . 62.13 109.715 176.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -145.15 -3.07 0.77 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.55 0.74 . . . . 54.34 111.965 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.2 m -144.14 164.45 30.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.856 0.862 . . . . 70.11 109.531 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.63 154.7 73.7 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-N 115.894 -0.594 . . . . 65.52 110.515 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.479 ' HB3' HD21 ' A' ' 17' ' ' LEU . 18.3 Cg_endo -59.83 -19.53 54.83 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.957 2.438 . . . . 63.23 112.234 169.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -58.4 -38.59 77.67 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.905 0.882 . . . . 71.3 110.872 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.748 HG21 ' HB2' ' A' ' 2' ' ' CYS . 23.9 mm -84.59 -43.06 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.821 -0.627 . . . . 63.31 110.112 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 m -64.97 -30.5 71.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.238 1.015 . . . . 64.44 112.07 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.42 -24.4 65.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.991 0.516 . . . . 42.53 111.541 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.23 -45.49 8.82 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.133 -0.485 . . . . 71.44 112.138 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -77.48 -67.11 0.75 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.903 0.481 . . . . 73.41 110.906 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.1 m -69.66 -32.19 70.69 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.363 -0.835 . . . . 52.41 112.536 -173.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.837 0 CA-C-N 115.997 -0.547 . . . . 61.41 113.026 -177.656 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.2 m . . . . . 0 CA--C 1.549 0.917 0 CA-C-O 121.198 0.523 . . . . 71.44 111.086 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.81 19.78 32.6 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.282 -0.872 . . . . 33.45 113.866 -171.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.2 m 67.89 14.19 9.34 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.604 1.162 . . . . 64.23 111.193 -173.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.94 -20.37 20.07 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.409 1.083 . . . . 74.33 109.292 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 77.2 m -100.43 45.86 0.97 Allowed 'General case' 0 C--N 1.347 0.489 0 C-N-CA 124.382 1.073 . . . . 63.52 111.07 172.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.545 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -120.45 5.79 0.07 OUTLIER Pre-proline 0 CA--C 1.582 2.18 0 N-CA-C 115.657 1.725 . . . . 73.1 115.657 168.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 23.9 Cg_exo -65.55 -51.08 1.52 Allowed 'Trans proline' 0 C--N 1.406 3.589 0 CA-C-N 123.648 2.339 . . . . 72.03 112.415 -175.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -83.28 156.08 66.35 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 113.672 -1.604 . . . . 64.11 111.529 -167.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -60.9 -39.96 57.15 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.331 2.021 . . . . 72.32 110.252 166.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -92.76 75.33 4.94 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 108.411 -0.959 . . . . 70.44 108.411 170.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 15.9 p -73.24 -21.5 60.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.176 -0.92 . . . . 74.23 110.343 174.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -48.75 -37.86 20.09 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 125.351 1.46 . . . . 72.11 111.253 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.67 -36.52 92.47 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.0 -1.0 . . . . 61.4 112.006 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.9 t -80.87 -44.75 17.9 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.391 1.091 . . . . 61.13 110.439 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HA ' ' NE2' ' A' ' 19' ' ' GLN . 5.1 t -82.73 -54.11 5.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.282 -1.781 . . . . 74.51 112.029 -166.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.99 -19.11 11.22 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.119 1.525 . . . . 45.43 115.119 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.52 -25.7 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 118.407 0.548 . . . . 72.03 111.324 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.431 ' NE2' ' HA ' ' A' ' 16' ' ' CYS . 2.9 pp0? -134.98 -0.72 2.75 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.75 0.82 . . . . 70.41 112.227 -175.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 74.2 m -136.47 175.88 9.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.265 1.026 . . . . 72.02 110.634 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.27 160.8 27.33 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.495 1.118 . . . . 62.34 110.188 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.6 -18.44 40.15 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 122.997 2.465 . . . . 65.52 113.504 173.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.9 p -60.79 -40.02 91.06 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.148 0.579 . . . . 65.34 110.635 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.7 mm -75.68 -56.03 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 123.307 0.643 . . . . 70.24 110.1 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -61.01 -29.07 69.49 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.74 -1.118 . . . . 64.5 112.573 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.37 -36.15 79.44 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.895 0.478 . . . . 43.53 111.659 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.13 -20.59 69.63 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.974 -0.557 . . . . 74.33 112.873 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -97.39 -35.21 10.76 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.311 0.644 . . . . 71.02 111.564 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.8 m -76.77 -69.89 0.49 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.137 0.575 . . . . 60.43 111.277 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.74 0 N-CA-C 111.094 -0.803 . . . . 74.1 111.094 -173.195 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.491 ' HB2' HG21 ' A' ' 24' ' ' ILE . 4.0 t . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.242 0.544 . . . . 62.34 110.592 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.57 -0.72 75.44 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.712 -0.677 . . . . 73.33 112.884 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 m 64.05 18.63 11.34 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 124.296 1.038 . . . . 73.42 108.884 -161.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -74.32 -50.2 19.79 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 114.572 -1.195 . . . . 73.01 108.811 -165.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 64.4 m -106.2 50.33 0.78 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 113.795 -1.548 . . . . 73.31 110.858 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.538 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -89.62 -27.12 0.32 Allowed Pre-proline 0 CA--C 1.582 2.21 0 N-CA-C 115.199 1.555 . . . . 73.02 115.199 166.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 21.1 Cg_exo -64.37 -50.66 2.51 Favored 'Trans proline' 0 C--N 1.407 3.637 0 C-N-CA 122.862 2.374 . . . . 55.52 114.272 -161.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -72.45 158.81 86.82 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.765 0.826 . . . . 72.11 112.043 -167.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.41 -32.86 59.9 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.434 2.089 . . . . 62.04 110.616 163.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -95.68 32.7 1.78 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.96 1.304 . . . . 62.53 110.394 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -49.91 -32.49 14.79 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.417 1.487 . . . . 53.0 112.041 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -52.04 -40.66 61.45 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 124.719 1.207 . . . . 53.21 111.952 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.02 47.77 3.4 Favored Glycine 0 N--CA 1.478 1.434 0 CA-C-N 114.757 -1.11 . . . . 62.43 111.055 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 6.7 t -170.42 -46.44 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.055 1.342 . . . . 71.15 108.249 -169.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 41.2 t -79.56 -46.55 17.1 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 114.065 -1.425 . . . . 73.14 111.536 -170.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -76.3 15.44 0.59 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.491 1.293 . . . . 75.03 114.491 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 15' ' ' CYS . 8.1 p -97.13 -12.31 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-O 121.633 0.73 . . . . 64.33 109.725 168.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.62 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 25.9 pt20 -145.95 -3.68 0.67 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.695 0.798 . . . . 73.42 111.774 -170.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.62 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 0.8 OUTLIER -144.95 158.02 43.95 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 123.69 0.796 . . . . 61.11 108.96 -178.417 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.526 ' HB3' HG12 ' A' ' 24' ' ' ILE . . . -78.94 151.42 76.23 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.034 0.534 . . . . 51.21 110.722 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.16 -30.28 49.8 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.876 3.051 . . . . 44.33 113.281 172.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 m -63.57 -36.73 84.78 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.905 0.482 . . . . 74.42 110.776 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.526 HG12 ' HB3' ' A' ' 21' ' ' ALA . 12.1 mm -78.71 -48.35 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 109.212 -0.662 . . . . 74.33 109.212 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 m -61.69 -35.79 79.03 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.426 1.09 . . . . 75.51 111.326 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.72 -30.26 70.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.984 0.514 . . . . 64.33 111.574 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.75 -38.92 49.39 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.704 0.628 . . . . 74.13 112.071 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.491 ' HE1' HG22 ' A' ' 24' ' ' ILE . 60.0 m95 -75.96 -49.52 17.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.171 0.588 . . . . 75.14 110.831 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.08 -61.89 1.6 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.5 -0.773 . . . . 73.5 111.719 -175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.246 0 N-CA-C 114.264 0.466 . . . . 63.32 114.264 -170.471 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.642 ' SG ' HG21 ' A' ' 24' ' ' ILE . 55.8 m . . . . . 0 CA--C 1.547 0.85 0 CA-C-O 121.135 0.493 . . . . 73.31 111.136 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.49 -7.83 87.1 Favored Glycine 0 N--CA 1.468 0.809 0 CA-C-O 119.188 -0.785 . . . . 73.31 115.023 -165.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 m 70.34 6.09 5.63 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.016 1.327 . . . . 62.4 111.002 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.41 -34.2 63.2 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.219 1.008 . . . . 63.44 109.401 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.4 m -90.14 41.41 1.05 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.246 1.019 . . . . 73.44 111.277 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.484 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -126.53 26.72 0.13 Allowed Pre-proline 0 CA--C 1.58 2.103 0 N-CA-C 115.482 1.66 . . . . 72.32 115.482 172.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 13.0 Cg_exo -68.8 -54.47 0.27 Allowed 'Trans proline' 0 C--N 1.398 3.134 0 CA-C-N 122.746 2.016 . . . . 62.43 111.267 172.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -83.86 165.13 41.1 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 113.105 -1.861 . . . . 64.53 111.471 -164.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.33 -25.38 36.26 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.209 1.94 . . . . 74.24 110.494 160.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.95 45.09 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.445 1.498 . . . . 74.44 109.593 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 13.2 p -65.3 -23.7 67.09 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.041 0.536 . . . . 74.0 111.484 -176.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -49.85 -35.86 24.76 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 124.955 1.302 . . . . 74.41 110.981 173.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.54 41.62 3.06 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 114.65 -1.159 . . . . 40.42 112.5 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.477 ' O ' HG12 ' A' ' 18' ' ' VAL . 13.3 t -162.56 -51.15 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 125.117 1.367 . . . . 75.25 108.097 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.7 t -75.93 -44.64 39.18 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 113.624 -1.625 . . . . 64.41 111.578 -172.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 40.4 mt -61.83 -17.9 58.03 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.668 1.359 . . . . 71.31 114.668 -175.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 15' ' ' CYS . 11.9 p -79.89 -21.03 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.938 0.79 . . . . 63.52 110.447 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -140.34 8.73 2.24 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.792 0.837 . . . . 74.25 111.616 -170.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -150.86 173.47 14.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.3 1.04 . . . . 44.2 109.59 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.31 158.44 37.1 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.011 0.925 . . . . 63.03 109.959 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.73 -22.71 54.3 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.918 2.412 . . . . 73.41 112.947 171.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.5 m -63.81 -22.73 67.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.454 0.701 . . . . 71.02 111.826 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.642 HG21 ' SG ' ' A' ' 2' ' ' CYS . 43.9 mm -91.42 -53.05 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.155 0.582 . . . . 74.14 109.437 173.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.2 m -64.43 -28.36 69.62 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.789 -1.096 . . . . 52.01 113.156 -169.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.12 -32.85 72.53 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.27 0.628 . . . . 72.43 111.637 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.88 -0.94 74.03 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.885 -0.598 . . . . 62.14 112.62 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -105.67 -34.45 7.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.79 0.836 . . . . 73.43 110.562 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.0 m -77.21 -76.77 0.16 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.392 0.677 . . . . 72.41 111.029 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.106 0 CA-C-N 116.148 -0.478 . . . . 63.23 112.526 -169.213 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.613 ' SG ' HG21 ' A' ' 24' ' ' ILE . 17.7 m . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.95 0.405 . . . . 71.32 110.637 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.96 5.66 66.35 Favored Glycine 0 N--CA 1.472 1.074 0 CA-C-O 118.953 -0.915 . . . . 71.11 114.905 -168.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.6 p 54.68 20.7 3.07 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.103 1.361 . . . . 72.33 111.274 -169.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.12 -36.25 40.87 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.846 -1.07 . . . . 72.34 108.192 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.3 m -93.38 45.52 1.17 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.211 1.005 . . . . 41.42 111.476 171.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.549 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -116.94 7.38 0.08 OUTLIER Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 115.675 1.731 . . . . 71.24 115.675 167.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 24.5 Cg_exo -63.13 -48.96 5.43 Favored 'Trans proline' 0 C--N 1.409 3.744 0 CA-C-N 123.612 2.326 . . . . 65.21 112.261 -173.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -73.61 155.95 88.91 Favored Pre-proline 0 N--CA 1.439 -0.999 0 CA-C-N 113.187 -1.824 . . . . 44.33 111.927 -168.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.36 -37.79 79.4 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.199 1.933 . . . . 72.14 110.399 163.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -99.82 76.48 1.97 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.925 0.89 . . . . 75.45 108.79 170.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.503 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 19.7 p -69.34 -19.89 63.86 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.35 -0.841 . . . . 62.24 111.082 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -48.87 -37.18 18.85 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 125.38 1.472 . . . . 73.01 111.174 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.77 39.41 3.09 Favored Glycine 0 N--CA 1.474 1.167 0 CA-C-N 114.965 -1.016 . . . . 70.04 113.395 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.7 t -159.99 -48.65 0.05 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.958 1.303 . . . . 70.22 108.33 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 10.8 t -77.19 -42.01 39.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 112.952 -1.931 . . . . 62.03 112.041 -171.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.463 HD23 ' SG ' ' A' ' 25' ' ' CYS . 47.4 mt -64.34 -11.09 28.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.069 1.507 . . . . 73.4 115.069 -173.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.04 -26.3 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.857 0.753 . . . . 74.04 110.414 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -132.57 0.9 3.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.148 0.979 . . . . 74.21 111.598 -168.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 39.5 m -144.9 164.76 30.13 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.668 0.787 . . . . 73.22 109.889 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.7 155.41 65.25 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.581 0.752 . . . . 53.43 110.562 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.44 -23.85 15.14 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.271 2.648 . . . . 64.23 114.212 169.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 t -64.23 -44.62 91.28 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.079 0.552 . . . . 71.12 110.64 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.613 HG21 ' SG ' ' A' ' 2' ' ' CYS . 42.0 mm -68.04 -50.51 58.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 CA-C-O 121.283 0.564 . . . . 75.0 109.725 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.463 ' SG ' HD23 ' A' ' 17' ' ' LEU . 8.4 m -67.31 -27.54 67.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.95 -1.023 . . . . 42.12 111.657 -174.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.29 -25.27 67.56 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.717 0.407 . . . . 74.4 112.024 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.08 -19.68 56.93 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 112.259 -0.336 . . . . 52.44 112.259 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -99.83 -25.43 14.36 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.682 0.793 . . . . 75.21 111.361 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.6 m -94.14 -72.31 0.62 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.6 0.76 . . . . 73.53 110.455 175.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.865 0 CA-C-N 114.361 -1.29 . . . . 71.14 111.658 -170.15 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.779 ' HB2' HG21 ' A' ' 24' ' ' ILE . 18.5 t . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 108.901 -0.777 . . . . 53.04 108.901 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.26 -11.52 51.82 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 119.155 -0.803 . . . . 64.45 113.325 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.6 p 51.67 22.63 1.68 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 125.334 1.453 . . . . 73.45 111.801 -171.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -94.76 -44.46 7.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.236 1.414 . . . . 75.44 108.469 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 67.4 m -94.5 47.95 1.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.166 -1.379 . . . . 75.25 111.475 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.56 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -109.07 7.18 0.08 OUTLIER Pre-proline 0 CA--C 1.584 2.259 0 N-CA-C 115.843 1.794 . . . . 73.32 115.843 166.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 16.9 Cg_exo -68.4 -57.02 0.16 Allowed 'Trans proline' 0 C--N 1.406 3.602 0 CA-C-N 123.904 2.43 . . . . 71.3 113.121 -174.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.06 164.28 62.35 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 114.455 -1.248 . . . . 71.41 111.968 -166.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.17 -29.18 27.11 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.251 1.967 . . . . 64.31 111.06 164.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.52 31.72 5.01 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.466 1.107 . . . . 43.41 110.098 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 p -60.31 -9.55 3.61 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.475 1.11 . . . . 72.22 113.544 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.479 ' HE3' HD11 ' A' ' 17' ' ' LEU . 83.4 m95 -49.33 -38.31 27.49 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.937 1.295 . . . . 72.24 111.595 169.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.38 48.41 3.77 Favored Glycine 0 N--CA 1.476 1.346 0 CA-C-N 115.213 -0.903 . . . . 72.41 111.679 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 7.3 t -168.76 -46.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.924 1.289 . . . . 64.51 108.556 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.44 ' HA ' ' NE2' ' A' ' 19' ' ' GLN . 41.2 t -73.12 -48.13 38.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.74 -1.573 . . . . 72.13 112.07 -173.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.479 HD11 ' HE3' ' A' ' 13' ' ' TRP . 5.7 mp -70.34 2.3 3.98 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.143 1.905 . . . . 52.01 116.143 -171.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.509 HG13 ' HG3' ' A' ' 19' ' ' GLN . 7.6 p -83.71 -29.48 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 118.667 0.667 . . . . 75.54 109.955 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.509 ' HG3' HG13 ' A' ' 18' ' ' VAL . 2.6 pp0? -132.69 6.01 4.0 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.07 0.948 . . . . 73.41 112.182 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 17' ' ' LEU . 2.6 m -142.78 161.8 37.15 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.04 -1.096 . . . . 71.01 108.04 172.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.24 157.79 53.11 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 122.97 0.508 . . . . 52.44 110.165 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HB3' HD21 ' A' ' 17' ' ' LEU . 19.2 Cg_endo -59.44 -22.53 66.45 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.05 2.5 . . . . 62.02 113.089 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.4 p -62.15 -38.89 90.71 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.429 0.692 . . . . 64.05 110.524 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.779 HG21 ' HB2' ' A' ' 2' ' ' CYS . 10.9 mm -81.83 -46.5 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.31 -0.859 . . . . 71.42 109.855 -177.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.4 m -64.96 -24.36 67.5 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.448 1.099 . . . . 75.45 111.233 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -31.76 73.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.106 0.562 . . . . 60.02 111.59 171.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.63 -45.68 21.76 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 116.401 -0.363 . . . . 62.14 112.241 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -73.17 -58.86 3.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.273 0.629 . . . . 71.25 111.158 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.3 m -74.18 -62.45 1.51 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.591 0.756 . . . . 52.11 112.42 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.243 0 CA-C-O 120.247 -0.196 . . . . 61.41 113.012 -170.48 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.747 ' SG ' HG21 ' A' ' 24' ' ' ILE . 58.4 m . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 120.431 0.158 . . . . 74.4 110.821 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.63 3.67 47.93 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 116.771 1.468 . . . . 53.13 116.771 -164.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m 68.63 1.36 2.98 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.464 1.106 . . . . 63.02 111.539 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.49 -18.38 45.33 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 123.522 0.729 . . . . 72.3 109.653 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 83.2 m -103.96 42.95 1.13 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.09 0.956 . . . . 72.15 110.945 172.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.532 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -110.7 -5.99 0.11 Allowed Pre-proline 0 CA--C 1.586 2.35 0 N-CA-C 115.597 1.702 . . . . 60.15 115.597 168.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 25.3 Cg_exo -63.82 -58.43 0.27 Allowed 'Trans proline' 0 C--N 1.405 3.531 0 CA-C-N 123.642 2.336 . . . . 74.52 113.634 -172.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -77.52 162.92 66.83 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 114.84 -1.073 . . . . 72.32 111.851 -170.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.38 -25.22 30.58 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.57 2.18 . . . . 72.32 110.411 160.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -93.25 23.54 4.37 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 125.312 1.445 . . . . 72.41 110.181 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 p -62.03 -17.74 58.32 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.719 1.207 . . . . 62.31 113.451 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -57.97 -33.37 68.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.094 0.957 . . . . 74.32 111.106 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.85 -34.02 88.78 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 115.6 -0.727 . . . . 74.45 112.105 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.469 ' O ' HG12 ' A' ' 18' ' ' VAL . 17.9 t -78.34 -47.65 17.27 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.641 1.176 . . . . 55.41 110.225 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.9 t -80.3 -45.26 18.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.855 -1.52 . . . . 72.44 112.033 -167.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.401 HD23 ' SG ' ' A' ' 25' ' ' CYS . 78.6 mt -65.66 -5.75 9.33 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.498 1.296 . . . . 71.51 114.498 -174.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 15' ' ' CYS . 9.1 p -87.67 -19.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.026 0.83 . . . . 74.22 110.571 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.415 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 27.0 pt20 -134.56 -2.66 2.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.076 0.951 . . . . 72.42 111.098 -170.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.415 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 37.4 m -143.27 171.11 14.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.574 0.75 . . . . 63.43 110.403 -175.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.82 155.33 41.75 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.736 0.815 . . . . 62.44 109.549 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.32 -16.41 28.41 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.826 2.351 . . . . 74.13 113.693 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 m -64.21 -36.76 85.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.617 0.367 . . . . 70.13 110.974 171.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.747 HG21 ' SG ' ' A' ' 2' ' ' CYS . 50.6 mm -75.98 -52.74 17.13 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 N-CA-C 109.051 -0.722 . . . . 74.52 109.051 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.401 ' SG ' HD23 ' A' ' 17' ' ' LEU . 21.1 m -65.17 -26.28 68.09 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.559 -1.201 . . . . 73.41 112.505 -170.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.2 -31.58 72.49 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.385 0.274 . . . . 62.33 111.171 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.91 -32.15 50.67 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 116.07 -0.514 . . . . 72.33 112.212 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -88.41 -37.47 15.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.199 0.6 . . . . 64.44 111.132 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.5 m -90.76 -80.26 0.34 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.29 0.636 . . . . 60.4 111.736 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.477 0 CA-C-N 116.168 -0.469 . . . . 72.32 112.778 -167.231 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.813 ' SG ' HG21 ' A' ' 24' ' ' ILE . 23.5 m . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 110.416 -0.216 . . . . 74.13 110.416 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.83 -10.34 84.26 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-O 119.359 -0.69 . . . . 42.21 113.841 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.1 m 77.11 -12.77 1.02 Allowed 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.163 1.385 . . . . 62.41 112.176 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -94.89 19.16 10.61 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.956 0.884 . . . . 73.33 109.498 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 99.2 m -106.19 28.78 7.36 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.241 1.016 . . . . 73.14 110.25 166.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.542 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -103.78 -9.33 0.12 Allowed Pre-proline 0 CA--C 1.581 2.138 0 N-CA-C 116.337 1.977 . . . . 65.5 116.337 167.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 14.1 Cg_exo -67.58 -54.74 0.33 Allowed 'Trans proline' 0 C--N 1.405 3.54 0 CA-C-N 123.658 2.342 . . . . 72.54 112.926 -168.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -73.04 159.81 84.38 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 113.797 -1.547 . . . . 71.01 112.103 -166.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.77 -26.3 32.68 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.252 1.968 . . . . 70.13 110.633 162.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -99.17 27.67 4.96 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.436 1.495 . . . . 74.14 109.759 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 6.3 p -62.94 -17.79 62.31 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.411 1.084 . . . . 74.13 113.608 -176.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -54.47 -38.24 66.18 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.889 0.875 . . . . 75.21 110.339 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.06 -35.42 90.55 Favored Glycine 0 N--CA 1.469 0.848 0 CA-C-N 115.24 -0.891 . . . . 72.42 112.182 -176.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.47 ' O ' HG12 ' A' ' 18' ' ' VAL . 35.2 t -67.38 -51.82 47.45 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.016 0.912 . . . . 71.12 110.583 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 t -71.48 -54.5 10.39 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.792 -1.549 . . . . 43.1 111.629 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.417 HD23 ' SG ' ' A' ' 25' ' ' CYS . 68.6 mt -51.83 -27.22 11.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.373 1.62 . . . . 61.4 115.373 -175.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 15' ' ' CYS . 14.6 p -74.43 -14.09 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.395 0.617 . . . . 43.12 111.333 -174.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -146.96 3.68 0.82 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.574 0.75 . . . . 74.33 111.178 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.8 m -148.31 169.63 19.7 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.03 0.932 . . . . 52.23 109.863 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.28 157.84 50.02 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.528 0.731 . . . . 73.23 110.658 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.28 -22.56 5.85 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.424 2.75 . . . . 75.25 113.923 165.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 m -59.22 -44.87 92.28 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.579 0.752 . . . . 70.04 111.443 172.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.813 HG21 ' SG ' ' A' ' 2' ' ' CYS . 49.2 mm -74.61 -45.47 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.473 0.709 . . . . 74.22 110.018 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.417 ' SG ' HD23 ' A' ' 17' ' ' LEU . 11.1 m -64.85 -33.25 75.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.74 0.816 . . . . 54.31 111.163 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.55 -24.85 64.68 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.962 0.505 . . . . 64.32 110.945 173.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.56 -41.35 24.95 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.951 -0.46 . . . . 71.24 111.951 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -84.71 -59.91 2.22 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.052 0.541 . . . . 74.31 111.046 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.4 m -68.89 -51.17 42.91 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.001 0.52 . . . . 60.05 111.181 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.889 0 CA-C-N 115.708 -0.678 . . . . 73.11 112.731 -176.546 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.485 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 34.9 m . . . . . 0 C--O 1.241 0.644 0 N-CA-C 109.837 -0.431 . . . . 71.12 109.837 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.74 -63.28 2.77 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 116.274 -0.421 . . . . 71.52 112.274 173.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.1 p 160.44 -12.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.157 1.783 . . . . 74.02 109.275 -167.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.64 -20.5 62.72 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.787 0.835 . . . . 43.33 110.605 -177.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.8 m -91.42 52.04 2.01 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.734 0.778 . . . . 74.33 110.815 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.531 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -130.01 13.25 0.05 OUTLIER Pre-proline 0 CA--C 1.575 1.909 0 N-CA-C 115.231 1.567 . . . . 53.0 115.231 169.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 11.8 Cg_exo -68.05 -51.0 0.67 Allowed 'Trans proline' 0 C--N 1.407 3.635 0 CA-C-N 123.436 2.263 . . . . 73.34 111.275 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -81.82 151.05 67.04 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 113.508 -1.678 . . . . 74.43 110.74 -168.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.3 -32.09 81.83 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 121.914 1.743 . . . . 74.2 111.48 171.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -105.46 57.64 0.68 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.771 1.229 . . . . 72.43 108.932 175.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.559 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 18.7 p -58.94 -14.01 8.0 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.879 1.272 . . . . 72.53 113.345 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 61.3 m95 -48.8 -35.62 14.84 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.23 1.412 . . . . 63.34 111.65 173.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.13 -32.28 79.94 Favored Glycine 0 N--CA 1.475 1.244 0 CA-C-N 115.663 -0.699 . . . . 41.14 113.055 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.7 t -82.53 -44.51 15.82 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 122.397 1.094 . . . . 60.4 110.12 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.3 t -82.7 -60.23 2.25 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 112.948 -1.933 . . . . 72.01 111.758 -169.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.5 mt -52.34 -25.85 10.75 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.991 1.478 . . . . 74.32 114.991 -175.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.407 HG13 ' HG3' ' A' ' 19' ' ' GLN . 7.3 p -67.47 -22.4 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 CA-C-O 121.074 0.464 . . . . 74.21 111.1 -176.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.407 ' HG3' HG13 ' A' ' 18' ' ' VAL . 3.3 pp0? -140.63 -5.32 1.2 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.563 0.745 . . . . 71.34 112.683 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 2' ' ' CYS . 80.2 m -127.79 174.32 9.23 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.158 0.983 . . . . 61.15 110.295 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.44 157.7 46.9 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 124.832 1.253 . . . . 62.31 110.111 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.44 -17.56 41.46 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 123.366 2.711 . . . . 51.53 113.389 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.5 t -56.77 -42.68 79.83 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.329 0.651 . . . . 63.35 110.811 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mm -76.84 -48.53 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 115.937 -0.574 . . . . 74.21 110.036 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.2 m -64.73 -34.85 79.3 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.746 -1.115 . . . . 75.02 111.55 -174.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.44 -20.65 64.65 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.052 0.541 . . . . 71.53 111.425 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.48 -36.06 24.39 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.841 -0.504 . . . . 25.33 111.841 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -91.12 -41.85 10.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.355 0.662 . . . . 71.43 111.739 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.559 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.6 m -69.25 -71.84 0.21 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.43 0.633 . . . . 75.24 111.344 178.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.804 0 CA-C-N 114.697 -1.138 . . . . 61.32 110.713 -169.554 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.239 0.551 0 N-CA-C 109.272 -0.64 . . . . 74.02 109.272 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.735 ' SG ' HG21 ' A' ' 24' ' ' ILE . 61.7 m -147.77 170.51 17.43 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.593 0.757 . . . . 62.01 110.052 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.9 -6.86 86.11 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-O 118.691 -1.061 . . . . 74.12 114.874 -170.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m 66.63 13.58 9.39 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.488 1.115 . . . . 71.12 110.839 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -94.16 -24.55 17.48 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.208 1.003 . . . . 73.03 110.015 -172.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 52.5 m -97.6 39.73 1.19 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.894 0.878 . . . . 41.33 110.655 170.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.569 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -99.23 -16.22 0.19 Allowed Pre-proline 0 CA--C 1.58 2.112 0 N-CA-C 115.468 1.655 . . . . 71.45 115.468 168.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 12.6 Cg_exo -69.35 -38.88 8.05 Favored 'Trans proline' 0 C--N 1.406 3.554 0 CA-C-N 123.198 2.178 . . . . 74.35 112.964 -166.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -67.59 150.75 97.69 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.362 -1.29 . . . . 73.42 112.353 -166.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.11 -29.65 87.68 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.479 2.119 . . . . 75.54 110.698 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -119.34 78.34 1.29 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.784 -1.191 . . . . 74.41 107.784 170.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 20.7 p -60.19 -27.67 67.34 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.031 -0.986 . . . . 74.4 110.954 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -45.66 -38.25 6.56 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 125.452 1.501 . . . . 71.2 111.593 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.94 43.67 3.25 Favored Glycine 0 N--CA 1.474 1.206 0 CA-C-N 114.755 -1.111 . . . . 74.5 112.531 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.461 ' O ' HG12 ' A' ' 18' ' ' VAL . 13.2 t -167.23 -46.07 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.991 1.316 . . . . 64.15 108.323 -176.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.1 t -79.47 -42.79 24.52 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.671 -1.604 . . . . 71.21 112.03 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.403 HD23 ' SG ' ' A' ' 25' ' ' CYS . 71.5 mt -63.13 -9.72 11.92 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.959 1.466 . . . . 74.22 114.959 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 15' ' ' CYS . 10.2 p -83.17 -19.84 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 118.894 0.77 . . . . 74.23 110.625 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -138.87 -1.66 1.78 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.051 0.94 . . . . 71.53 111.648 -169.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 59.8 m -146.16 167.0 24.52 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.599 0.76 . . . . 60.33 110.301 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.95 155.65 52.59 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 115.206 -0.906 . . . . 75.3 110.448 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -45.52 -30.95 6.44 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.729 2.952 . . . . 74.03 114.652 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -58.87 -41.26 86.65 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.086 0.554 . . . . 73.01 111.521 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.735 HG21 ' SG ' ' A' ' 2' ' ' CYS . 47.9 mm -73.11 -51.33 26.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 C-N-CA 123.567 0.747 . . . . 75.23 110.162 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.403 ' SG ' HD23 ' A' ' 17' ' ' LEU . 7.0 m -65.37 -31.92 73.29 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.055 -0.975 . . . . 73.22 111.339 -175.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.38 -28.44 68.21 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.397 0.679 . . . . 55.14 111.522 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.12 -22.62 47.94 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.702 0.627 . . . . 53.35 112.273 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . 15.8 m95 -93.43 -36.77 12.31 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.222 0.609 . . . . 72.23 112.132 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 42.4 m -71.58 -73.14 0.19 Allowed 'General case' 0 CA--C 1.547 0.844 0 O-C-N 123.196 0.31 . . . . 63.32 110.519 176.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.61 -52.65 1.52 Allowed Glycine 0 C--N 1.345 1.074 0 CA-C-O 121.055 0.253 . . . . 72.14 112.508 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.68 73.07 0.53 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.481 -1.048 . . . . 74.43 110.481 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 CA--C 1.557 1.215 0 C-N-CA 124.318 1.047 . . . . 72.4 109.81 -175.867 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.3 p . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.324 -0.25 . . . . 34.22 110.324 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.823 ' HB2' HG21 ' A' ' 24' ' ' ILE . 11.1 t -80.18 176.73 9.49 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.365 -0.606 . . . . 65.15 109.365 171.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.04 -25.09 76.39 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 111.389 -0.684 . . . . 64.35 111.389 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.1 m 66.3 5.12 3.5 Favored 'General case' 0 C--N 1.369 1.447 0 C-N-CA 124.562 1.145 . . . . 60.35 112.086 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.45 -15.84 16.36 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.039 0.935 . . . . 72.23 108.761 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 56.2 m -93.21 44.45 1.14 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.535 1.134 . . . . 64.53 110.822 170.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.501 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -117.31 5.26 0.08 OUTLIER Pre-proline 0 CA--C 1.58 2.134 0 N-CA-C 116.034 1.864 . . . . 21.31 116.034 173.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 39.9 Cg_exo -59.32 -54.08 2.92 Favored 'Trans proline' 0 C--N 1.408 3.691 0 CA-C-N 123.509 2.289 . . . . 65.43 112.867 -173.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -85.27 155.71 60.09 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 114.395 -1.275 . . . . 75.24 111.411 -171.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.9 -14.93 45.6 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.689 2.259 . . . . 71.32 111.532 165.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -108.05 56.41 0.63 Allowed 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 123.018 1.39 . . . . 72.53 108.344 170.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.531 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 22.0 p -67.85 -16.26 64.01 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.24 -1.345 . . . . 72.14 111.852 175.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -47.42 -36.47 9.9 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 126.01 1.724 . . . . 73.12 112.436 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.11 35.2 3.86 Favored Glycine 0 N--CA 1.47 0.932 0 CA-C-N 115.091 -0.959 . . . . 65.21 112.801 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 8.3 t -154.94 -46.54 0.08 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.403 1.097 . . . . 41.31 108.955 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 15.4 t -80.65 -44.19 19.24 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 113.333 -1.758 . . . . 73.44 111.562 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.453 HD23 ' SG ' ' A' ' 25' ' ' CYS . 74.9 mt -62.59 -18.56 62.41 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 114.68 1.363 . . . . 44.12 114.68 -172.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.65 -19.41 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 122.837 0.455 . . . . 71.44 111.636 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.527 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 16.0 pt20 -142.11 -34.01 0.47 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.112 0.965 . . . . 74.53 110.371 -168.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.527 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 3.7 m -104.69 158.11 16.73 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.614 1.166 . . . . 62.53 109.228 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.5 159.38 61.52 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.248 0.619 . . . . 43.43 110.962 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.69 -33.48 31.99 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.13 2.553 . . . . 51.21 112.674 164.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.0 t -57.12 -22.66 41.48 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.733 1.213 . . . . 73.55 112.401 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.823 HG21 ' HB2' ' A' ' 2' ' ' CYS . 31.8 mm -101.47 -51.55 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.681 0.792 . . . . 73.34 110.474 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.453 ' SG ' HD23 ' A' ' 17' ' ' LEU . 21.9 m -64.92 -22.14 66.94 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.089 0.956 . . . . 63.21 112.357 -172.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.61 76.0 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.616 0.766 . . . . 72.43 111.343 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.1 -19.22 63.25 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.739 -0.664 . . . . 64.12 112.722 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -89.28 -40.32 12.89 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.108 0.563 . . . . 71.34 110.877 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 21.1 m -74.55 -60.73 2.14 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.362 -0.836 . . . . 63.53 111.301 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.22 43.13 1.48 Allowed Glycine 0 C--N 1.35 1.312 0 CA-C-N 116.015 -0.539 . . . . 35.52 112.554 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.64 156.59 27.03 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 112.355 -0.298 . . . . 71.13 112.355 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 C--O 1.249 1.033 0 C-N-CA 123.356 0.663 . . . . 62.25 109.733 178.773 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.295 -0.261 . . . . 63.24 110.295 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.458 ' HB2' HG21 ' A' ' 24' ' ' ILE . 99.2 m -78.17 -176.7 4.74 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.033 0.533 . . . . 71.31 110.114 173.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.12 -56.76 1.05 Allowed Glycine 0 C--N 1.336 0.55 0 CA-C-N 115.98 -0.554 . . . . 74.22 112.382 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.7 p 149.97 -6.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 126.372 1.869 . . . . 72.14 108.791 -159.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -25.65 60.74 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.836 0.854 . . . . 71.54 110.698 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -100.74 53.16 0.86 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.507 1.123 . . . . 74.43 109.75 173.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.503 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -133.37 15.21 0.05 OUTLIER Pre-proline 0 CA--C 1.576 1.945 0 CA-C-N 113.724 -1.58 . . . . 72.11 114.802 169.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 31.8 Cg_exo -62.53 -51.53 3.21 Favored 'Trans proline' 0 C--N 1.407 3.657 0 CA-C-N 123.242 2.194 . . . . 72.02 111.549 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -84.68 159.66 57.64 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 113.735 -1.575 . . . . 72.44 110.793 -172.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.06 -23.92 28.89 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.475 2.117 . . . . 75.4 110.776 163.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -104.33 48.92 0.83 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.956 1.302 . . . . 74.13 109.137 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 19.9 p -61.06 -14.53 24.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.921 1.289 . . . . 74.25 113.822 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.551 ' HE3' HD11 ' A' ' 17' ' ' LEU . 61.8 m95 -47.07 -40.78 15.77 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.416 1.487 . . . . 75.54 112.298 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.33 -25.29 75.87 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-N 114.946 -1.025 . . . . 50.43 112.745 -173.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' O ' HG12 ' A' ' 18' ' ' VAL . 34.3 t -86.77 -45.63 10.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.109 0.957 . . . . 74.24 110.216 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 t -76.98 -53.76 7.42 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.619 -1.628 . . . . 53.11 112.578 -170.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.677 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -61.91 -7.81 4.24 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.854 1.798 . . . . 74.24 115.854 -175.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 15' ' ' CYS . 10.3 p -76.77 -23.73 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-N 119.278 0.945 . . . . 62.12 110.366 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -132.18 -24.19 2.11 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.253 1.021 . . . . 73.52 111.289 -169.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 2' ' ' CYS . 77.9 m -123.98 175.37 6.99 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.43 1.092 . . . . 72.13 110.472 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.52 157.4 58.46 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.915 0.886 . . . . 73.34 110.479 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.426 ' HB3' HD21 ' A' ' 17' ' ' LEU . 19.9 Cg_endo -61.33 -12.43 23.75 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 123.152 2.568 . . . . 71.04 112.769 171.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.0 t -62.49 -44.05 97.32 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.445 0.698 . . . . 50.44 110.689 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 2' ' ' CYS . 36.9 mm -69.99 -50.13 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 115.705 -0.679 . . . . 74.14 109.3 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.677 ' SG ' ' HG ' ' A' ' 17' ' ' LEU . 10.2 m -60.37 -36.18 77.44 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.303 -1.317 . . . . 71.01 111.733 -174.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.14 89.98 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.082 0.553 . . . . 51.43 110.687 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.07 -33.07 69.42 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.846 0.716 . . . . 54.02 113.429 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -92.37 -38.23 12.14 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.801 0.44 . . . . 73.35 111.585 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 34.5 m -69.09 -57.97 4.7 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.605 0.362 . . . . 62.44 111.676 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.67 -77.77 0.1 Allowed Glycine 0 C--N 1.34 0.777 0 CA-C-N 116.192 -0.458 . . . . 63.13 112.47 -172.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.24 9.88 85.46 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.583 -0.308 . . . . 61.21 112.571 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 CA--C 1.55 0.98 0 C-N-CA 124.449 1.1 . . . . 72.51 109.757 -170.094 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 110.157 -0.312 . . . . 73.31 110.157 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.68 ' SG ' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -102.89 118.36 36.64 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.437 -0.949 . . . . 62.2 108.437 176.407 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.31 -48.7 84.71 Favored Glycine 0 C--N 1.341 0.824 0 O-C-N 124.096 0.873 . . . . 64.12 114.858 -172.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.3 p 131.25 3.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 127.505 2.322 . . . . 63.41 107.916 -159.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.33 -26.85 63.94 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.005 0.922 . . . . 73.24 109.806 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 34.1 m -100.72 60.75 0.98 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.957 -1.019 . . . . 72.15 110.039 167.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.686 ' HB2' ' HB3' ' A' ' 28' ' ' TRP . . . -142.92 31.77 0.13 Allowed Pre-proline 0 CA--C 1.579 2.078 0 CA-C-N 113.797 -1.547 . . . . 74.45 113.403 163.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 51.3 Cg_exo -61.26 -50.24 6.29 Favored 'Trans proline' 0 C--N 1.405 3.51 0 CA-C-N 122.08 1.779 . . . . 74.02 111.974 170.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -84.14 161.36 55.2 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 113.781 -1.554 . . . . 45.12 111.36 -171.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.71 -33.91 75.33 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.259 1.973 . . . . 74.35 110.452 161.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -94.82 78.53 3.67 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.966 -1.016 . . . . 72.12 108.97 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.466 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 18.3 p -70.44 -18.01 63.0 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.86 -0.609 . . . . 51.04 110.592 171.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.52 ' HE3' HD11 ' A' ' 17' ' ' LEU . 64.9 m95 -49.23 -35.93 18.72 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 125.284 1.434 . . . . 73.35 111.774 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -93.6 49.06 2.32 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 114.909 -1.041 . . . . 41.3 112.161 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.47 ' O ' HG12 ' A' ' 18' ' ' VAL . 16.6 t -166.2 -45.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.812 1.245 . . . . 73.05 108.709 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 12.4 t -80.8 -45.8 16.38 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 113.493 -1.685 . . . . 74.31 111.936 -169.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.52 HD11 ' HE3' ' A' ' 13' ' ' TRP . 5.4 mp -72.11 -0.18 11.16 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 114.849 1.426 . . . . 64.41 114.849 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 15' ' ' CYS . 13.6 p -82.18 -18.36 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.849 0.749 . . . . 74.23 110.096 171.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.563 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 11.5 pt20 -138.04 -6.45 1.63 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.637 0.775 . . . . 73.3 111.777 -168.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.563 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 48.7 m -143.76 172.4 12.89 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.668 0.787 . . . . 75.01 110.357 -174.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 154.74 50.14 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.209 1.004 . . . . 41.23 109.785 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.4 -18.74 40.13 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.328 2.686 . . . . 64.32 112.771 172.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 t -61.05 -39.17 88.82 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.814 0.846 . . . . 53.21 110.694 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.68 HG21 ' SG ' ' A' ' 2' ' ' CYS . 45.1 mm -77.82 -48.42 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.419 0.688 . . . . 74.02 109.709 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.6 m -64.99 -30.41 71.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.639 -1.164 . . . . 54.23 112.082 -172.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.81 -29.01 70.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.059 0.544 . . . . 70.02 111.412 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.58 -27.75 37.96 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.536 0.522 . . . . 72.22 112.409 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.686 ' HB3' ' HB2' ' A' ' 7' ' ' ALA . 26.4 m95 -92.49 -32.78 14.75 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.259 0.624 . . . . 74.34 111.395 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.2 m -73.96 -74.83 0.17 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.247 0.546 . . . . 65.11 110.637 173.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.02 -64.27 0.31 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 114.783 -1.099 . . . . 61.1 110.67 -169.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.34 -150.34 13.48 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.257 -0.472 . . . . 75.44 112.139 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.6 p . . . . . 0 C--O 1.254 1.332 0 C-N-CA 124.181 0.992 . . . . 42.02 110.992 -176.571 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.775 0.321 . . . . 73.3 110.479 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.666 ' HB2' HG21 ' A' ' 24' ' ' ILE . 36.1 t -78.65 -179.67 6.6 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.079 -0.711 . . . . 75.31 109.079 170.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.17 -16.86 79.1 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.705 -0.497 . . . . 55.54 111.862 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.7 p 61.49 8.5 2.25 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 125.79 1.636 . . . . 52.13 112.836 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -116.06 7.1 14.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.534 0.734 . . . . 63.51 109.07 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 88.3 m -106.51 34.96 3.14 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 124.058 0.943 . . . . 73.1 110.734 170.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.532 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -96.39 -19.26 0.22 Allowed Pre-proline 0 CA--C 1.586 2.339 0 N-CA-C 115.188 1.551 . . . . 71.12 115.188 167.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 25.1 Cg_exo -63.47 -53.66 1.32 Allowed 'Trans proline' 0 C--N 1.412 3.875 0 CA-C-N 123.329 2.225 . . . . 51.23 114.072 -163.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.36 159.64 84.0 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 114.904 -1.044 . . . . 74.42 111.685 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.79 -26.35 32.51 Favored 'Trans proline' 0 CA--C 1.554 1.511 0 C-N-CA 122.193 1.929 . . . . 63.43 111.044 162.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -98.87 31.98 2.78 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 124.44 1.096 . . . . 74.41 109.612 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 2.6 p -61.05 -20.8 62.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.405 1.082 . . . . 74.03 112.767 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -54.76 -38.27 67.01 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.176 0.99 . . . . 74.41 110.693 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -23.89 74.82 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 115.06 -0.973 . . . . 74.22 112.781 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.476 ' O ' HG12 ' A' ' 18' ' ' VAL . 34.6 t -89.24 -43.47 10.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.492 1.117 . . . . 75.23 109.968 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 42.2 t -71.79 -52.02 19.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.151 -1.386 . . . . 64.02 111.455 -171.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.462 HD21 ' HB3' ' A' ' 22' ' ' PRO . 4.4 mp -73.0 9.89 1.06 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 115.583 1.697 . . . . 71.2 115.583 -173.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 15' ' ' CYS . 13.9 p -91.14 -12.56 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 118.875 0.761 . . . . 61.23 109.442 170.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.523 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 27.6 pt20 -152.86 2.4 0.31 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.344 0.657 . . . . 71.44 112.028 -167.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.523 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 1.4 m -147.03 156.66 43.2 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.607 0.763 . . . . 72.23 109.354 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.95 149.9 77.49 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.241 0.616 . . . . 73.14 110.819 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.462 ' HB3' HD21 ' A' ' 17' ' ' LEU . 13.2 Cg_endo -55.94 -23.2 41.81 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.525 2.817 . . . . 74.14 113.713 174.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -65.24 -38.71 91.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.955 0.502 . . . . 61.32 110.388 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.666 HG21 ' HB2' ' A' ' 2' ' ' CYS . 23.4 mm -75.1 -43.75 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.226 -0.657 . . . . 72.53 109.226 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.5 m -66.96 -28.41 68.25 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.158 0.983 . . . . 72.15 111.055 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.86 -28.3 68.86 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.563 0.745 . . . . 71.35 111.231 170.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.95 -35.71 38.34 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 116.221 -0.445 . . . . 75.14 112.133 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -82.52 -69.34 0.63 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.98 0.512 . . . . 71.04 110.296 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.5 m -64.68 -49.45 70.9 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.142 0.977 . . . . 74.01 112.096 -175.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.42 -12.6 83.63 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.52 -0.764 . . . . 23.4 112.968 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.1 -162.66 37.93 Favored Glycine 0 C--N 1.351 1.396 0 C-N-CA 123.117 0.389 . . . . 71.03 113.255 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 C--O 1.251 1.18 0 C-N-CA 123.586 0.755 . . . . 42.02 110.765 -176.762 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.456 ' HA ' HD12 ' A' ' 24' ' ' ILE . 29.9 t . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 108.934 -0.765 . . . . 63.13 108.934 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.698 ' HB2' HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER 59.4 -152.5 0.4 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.865 1.266 . . . . 61.3 109.71 -174.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.0 -5.46 73.4 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.527 -0.596 . . . . 75.12 112.306 166.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.3 m 64.88 18.54 11.52 Favored 'General case' 0 C--N 1.372 1.545 0 C-N-CA 124.721 1.208 . . . . 64.14 109.853 -171.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -102.82 -38.49 7.4 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.449 -1.315 . . . . 73.13 107.449 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.1 m -86.67 44.86 1.19 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.212 1.005 . . . . 73.23 111.707 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.433 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -122.6 33.11 0.22 Allowed Pre-proline 0 CA--C 1.576 1.973 0 N-CA-C 114.728 1.381 . . . . 64.5 114.728 165.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 35.3 Cg_exo -64.79 -61.05 0.11 Allowed 'Trans proline' 0 C--N 1.397 3.119 0 CA-C-N 122.675 1.991 . . . . 73.21 111.072 169.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -82.67 151.54 64.95 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-N 114.239 -1.346 . . . . 74.44 111.37 -170.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.5 -32.64 96.62 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.937 2.424 . . . . 65.2 110.67 162.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -94.61 70.0 3.53 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 122.44 1.114 . . . . 73.3 108.532 171.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.527 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 22.1 p -77.8 -15.26 59.22 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.366 -1.288 . . . . 71.44 112.803 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -48.5 -38.78 21.09 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.381 1.473 . . . . 55.41 112.885 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.83 -16.97 80.31 Favored Glycine 0 N--CA 1.476 1.315 0 CA-C-N 115.553 -0.749 . . . . 74.11 113.339 -172.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.435 ' O ' HG12 ' A' ' 18' ' ' VAL . 11.4 t -96.13 -51.75 4.29 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.166 0.984 . . . . 55.25 109.677 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 t -73.82 -45.3 52.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.685 -1.598 . . . . 54.21 112.715 -166.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.485 HD23 ' SG ' ' A' ' 25' ' ' CYS . 76.3 mt -59.15 -22.24 60.6 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.061 1.504 . . . . 73.25 115.061 -172.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 15' ' ' CYS . 7.6 p -78.52 -22.75 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 118.666 0.666 . . . . 33.2 111.184 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -133.85 1.0 3.27 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.03 0.932 . . . . 70.32 111.282 -170.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.1 m -149.09 167.65 25.31 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.479 1.112 . . . . 61.24 109.55 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.53 154.68 62.43 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.649 0.78 . . . . 50.13 110.492 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.32 -25.05 45.52 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.26 2.64 . . . . 53.31 112.856 167.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -57.37 -37.53 72.76 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.981 0.912 . . . . 73.13 111.137 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.698 HG21 ' HB2' ' A' ' 2' ' ' CYS . 43.3 mm -82.83 -49.41 16.93 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 C-N-CA 123.189 0.596 . . . . 70.12 110.341 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.485 ' SG ' HD23 ' A' ' 17' ' ' LEU . 11.4 m -64.26 -26.84 68.68 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.076 -0.966 . . . . 54.33 111.867 -171.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.78 -33.57 71.88 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.491 0.717 . . . . 64.43 111.76 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.51 -42.45 11.61 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 116.447 -0.342 . . . . 73.33 112.808 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -73.94 -34.23 64.23 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.868 0.467 . . . . 62.22 110.974 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 21.9 m -77.92 -78.76 0.13 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.249 0.62 . . . . 44.33 110.794 175.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.45 -48.44 0.06 OUTLIER Glycine 0 C--N 1.354 1.559 0 O-C-N 123.245 0.341 . . . . 44.02 112.911 -170.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.33 85.61 1.14 Allowed Glycine 0 C--N 1.341 0.85 0 C-N-CA 123.049 0.357 . . . . 60.53 113.034 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.5 m . . . . . 0 C--O 1.249 1.031 0 C-N-CA 124.336 1.054 . . . . 63.2 109.829 178.571 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.508 ' HB2' HD12 ' A' ' 24' ' ' ILE . 58.1 p . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 120.974 0.416 . . . . 74.34 110.056 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.765 ' HB2' HG21 ' A' ' 24' ' ' ILE . 9.3 t -134.93 -158.88 0.91 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 107.8 -1.185 . . . . 75.12 107.8 175.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.23 -11.41 67.05 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.363 -0.687 . . . . 53.23 112.958 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.4 m 68.94 6.23 5.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.998 1.319 . . . . 62.35 110.708 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -88.23 -45.47 10.05 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.291 1.037 . . . . 62.11 108.694 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 92.3 m -89.39 50.1 1.87 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.618 -1.174 . . . . 73.23 111.516 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.556 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -104.35 -15.27 0.16 Allowed Pre-proline 0 CA--C 1.577 2.011 0 N-CA-C 116.306 1.965 . . . . 61.44 116.306 167.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 14.0 Cg_exo -64.15 -49.47 3.71 Favored 'Trans proline' 0 C--N 1.407 3.644 0 CA-C-N 122.98 2.1 . . . . 71.21 113.342 -160.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -77.95 154.62 80.41 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 113.514 -1.676 . . . . 64.02 111.431 -166.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.17 -38.6 75.54 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.185 1.923 . . . . 62.15 110.425 174.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -100.56 82.42 2.45 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 107.358 -1.349 . . . . 61.23 107.358 167.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.533 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 23.6 p -73.48 -18.14 61.15 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.867 0.867 . . . . 62.15 111.778 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -48.5 -40.32 26.28 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 125.262 1.425 . . . . 73.53 112.354 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.3 -27.5 73.59 Favored Glycine 0 N--CA 1.478 1.441 0 CA-C-N 115.334 -0.848 . . . . 63.23 112.87 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 12.7 t -90.66 -45.78 8.67 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.294 1.045 . . . . 75.33 110.107 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 11.4 t -74.75 -44.48 49.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.28 -1.782 . . . . 62.34 112.122 -166.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.405 HD23 ' SG ' ' A' ' 25' ' ' CYS . 72.7 mt -63.26 -15.99 58.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 115.019 1.488 . . . . 65.21 115.019 -173.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 15' ' ' CYS . 14.6 p -81.06 -10.81 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 118.706 0.684 . . . . 73.12 110.884 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -147.32 -3.81 0.55 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.377 0.671 . . . . 75.14 111.663 -169.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 8.2 m -145.61 162.87 36.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.115 0.966 . . . . 54.03 109.037 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.85 157.13 67.07 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.73 0.812 . . . . 64.01 111.399 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.84 -23.72 68.61 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.485 2.79 . . . . 54.32 113.066 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.4 p -65.17 -32.63 74.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.109 0.564 . . . . 75.11 110.643 173.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.765 HG21 ' HB2' ' A' ' 2' ' ' CYS . 14.6 mm -84.81 -49.04 16.18 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 121.175 0.512 . . . . 73.34 110.242 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.405 ' SG ' HD23 ' A' ' 17' ' ' LEU . 16.1 m -62.87 -28.1 69.8 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.837 -1.074 . . . . 73.3 111.235 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.25 -45.29 72.33 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.963 0.505 . . . . 64.11 111.004 169.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.13 -32.53 60.33 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.102 -0.954 . . . . 75.23 113.64 -175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -86.17 -28.7 23.76 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.896 0.478 . . . . 72.25 111.885 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.3 m -78.98 -70.07 0.53 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.615 0.366 . . . . 73.32 111.273 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.84 -53.64 0.02 OUTLIER Glycine 0 C--N 1.348 1.215 0 C-N-CA 121.743 -0.265 . . . . 52.24 113.552 -169.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.17 -66.86 1.79 Allowed Glycine 0 N--CA 1.47 0.908 0 N-CA-C 110.159 -1.176 . . . . 73.52 110.159 -169.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 CA--C 1.562 1.436 0 C-N-CA 125.736 1.614 . . . . 73.4 112.714 168.812 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.6 t . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.209 -0.293 . . . . 72.21 110.209 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.468 ' SG ' HG21 ' A' ' 24' ' ' ILE . 31.2 m -126.49 164.71 20.55 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.214 0.606 . . . . 60.4 109.887 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.04 12.2 58.52 Favored Glycine 0 N--CA 1.473 1.145 0 N-CA-C 116.81 1.484 . . . . 63.53 116.81 -161.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.2 p 58.1 15.43 3.24 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.105 1.362 . . . . 74.04 112.29 -172.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.63 -29.41 56.44 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 108.771 -0.826 . . . . 73.31 108.771 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 18.5 m -96.39 51.08 1.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.286 -0.87 . . . . 52.14 110.511 168.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.433 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -122.92 21.73 0.1 OUTLIER Pre-proline 0 CA--C 1.59 2.498 0 N-CA-C 115.071 1.508 . . . . 61.22 115.071 163.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 52.6 Cg_exo -58.32 -58.26 0.82 Allowed 'Trans proline' 0 C--N 1.409 3.751 0 CA-C-N 123.239 2.192 . . . . 74.41 113.115 174.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -80.1 154.65 75.0 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 114.845 -1.07 . . . . 64.44 111.193 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.26 -35.46 91.62 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.937 2.425 . . . . 75.44 110.655 168.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.44 75.41 5.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.003 -1.11 . . . . 63.43 108.003 167.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.547 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 20.7 p -68.22 -18.21 64.51 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.732 -1.122 . . . . 75.22 110.992 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -48.88 -36.69 17.67 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 125.411 1.484 . . . . 75.0 111.419 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.37 25.27 6.42 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-N 114.987 -1.006 . . . . 73.33 113.579 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.428 ' O ' HG12 ' A' ' 18' ' ' VAL . 20.0 t -143.5 -46.52 0.29 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.777 1.231 . . . . 73.33 108.649 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.2 t -78.02 -44.62 26.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.005 -1.907 . . . . 72.24 111.763 -170.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.2 mt -62.12 -12.59 20.33 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.974 1.472 . . . . 75.43 114.974 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 15' ' ' CYS . 11.4 p -82.22 -19.75 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 119.087 0.858 . . . . 74.1 110.584 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -142.08 5.26 1.69 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.046 0.938 . . . . 74.43 111.475 -169.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 48.4 m -146.49 172.05 14.13 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.751 1.22 . . . . 73.15 109.068 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.43 161.54 24.91 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 123.555 0.742 . . . . 52.01 110.871 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.04 -31.52 8.63 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 123.631 2.888 . . . . 51.12 114.61 169.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 m -56.42 -40.48 74.76 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.278 0.631 . . . . 62.44 111.505 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.468 HG21 ' SG ' ' A' ' 2' ' ' CYS . 47.6 mm -78.3 -55.73 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.603 -0.726 . . . . 72.04 110.089 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 m -63.88 -31.29 72.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.992 -1.003 . . . . 64.54 112.131 -170.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.82 -31.12 69.42 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.969 0.508 . . . . 74.43 112.012 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.45 -26.05 48.62 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.8 0.688 . . . . 51.45 112.561 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -91.2 -31.36 16.21 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.432 0.693 . . . . 70.31 111.015 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 18.6 m -80.82 -70.02 0.56 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.012 0.925 . . . . 70.33 111.935 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.35 34.96 0.39 Allowed Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.001 -1.0 . . . . 53.22 111.685 -167.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -92.93 -169.79 39.82 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 122.706 0.193 . . . . 75.24 112.631 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.7 p . . . . . 0 C--O 1.246 0.917 0 C-N-CA 123.801 0.84 . . . . 61.21 109.378 179.601 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.245 -0.65 . . . . 70.42 109.245 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.718 ' SG ' HG21 ' A' ' 24' ' ' ILE . 95.7 m 58.41 -157.41 0.31 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.051 0.94 . . . . 72.51 112.248 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.4 -6.51 77.67 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.266 -0.741 . . . . 61.43 113.966 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.0 p 60.0 15.98 5.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.475 1.51 . . . . 73.22 112.576 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -34.57 44.68 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.471 -0.786 . . . . 72.34 109.287 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 93.0 m -101.56 43.49 1.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.559 1.144 . . . . 70.34 110.727 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.535 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -95.89 -26.09 0.25 Allowed Pre-proline 0 CA--C 1.578 2.054 0 N-CA-C 115.826 1.787 . . . . 73.04 115.826 171.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 11.8 Cg_exo -65.8 -44.47 7.91 Favored 'Trans proline' 0 C--N 1.398 3.171 0 C-N-CA 122.161 1.907 . . . . 75.32 114.005 -157.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -83.34 157.0 65.83 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 114.109 -1.405 . . . . 72.12 111.983 -160.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.28 -27.61 63.81 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.214 1.943 . . . . 75.22 111.255 162.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -104.8 38.87 1.81 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.344 1.058 . . . . 72.13 109.224 174.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.5 p -64.92 -21.64 66.86 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.55 -0.719 . . . . 71.14 111.27 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -48.62 -38.78 21.85 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 125.242 1.417 . . . . 72.43 111.79 171.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.73 -14.47 79.86 Favored Glycine 0 N--CA 1.473 1.105 0 CA-C-N 115.04 -0.982 . . . . 72.35 113.104 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 20.5 t -99.43 -41.26 7.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.121 1.368 . . . . 74.54 110.151 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 9.9 t -81.03 -45.5 16.46 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 113.174 -1.83 . . . . 73.52 112.553 -168.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.6 -0.47 1.4 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.245 1.572 . . . . 71.13 115.245 -175.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -88.35 -23.46 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-N 119.176 0.898 . . . . 73.11 110.436 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -133.79 -3.42 2.9 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.161 0.985 . . . . 74.1 111.235 -169.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.507 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 63.2 m -144.14 170.18 16.45 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.643 0.777 . . . . 61.35 110.592 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.41 159.93 34.15 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.186 0.995 . . . . 71.34 110.795 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -48.12 -30.29 14.11 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 123.686 2.924 . . . . 51.44 114.161 168.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.2 m -60.91 -39.4 89.2 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.991 0.917 . . . . 62.24 111.395 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.718 HG21 ' SG ' ' A' ' 2' ' ' CYS . 51.1 mm -77.36 -53.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 123.533 0.733 . . . . 73.3 109.82 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.7 m -62.76 -31.22 72.13 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.75 -1.114 . . . . 33.44 112.014 -173.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.6 -39.98 84.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.717 0.407 . . . . 65.15 110.572 172.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.64 -24.32 75.36 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.88 -0.6 . . . . 60.31 112.977 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.51 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . 81.7 m95 -97.14 -43.79 7.23 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.413 0.685 . . . . 74.33 111.665 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.5 m -71.4 -73.06 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.31 0.576 . . . . 52.11 110.864 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.06 100.69 0.15 Allowed Glycine 0 C--N 1.341 0.823 0 CA-C-N 114.998 -1.001 . . . . 62.21 111.315 -170.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.76 126.66 0.87 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.864 -0.495 . . . . 55.21 111.864 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.8 p . . . . . 0 CA--C 1.561 1.376 0 C-N-CA 124.275 1.03 . . . . 72.22 110.629 -177.134 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.421 -0.214 . . . . 75.41 110.421 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 50.1 m -82.95 161.02 21.94 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.815 0.446 . . . . 65.23 110.071 170.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.63 19.13 16.69 Favored Glycine 0 N--CA 1.47 0.905 0 CA-C-N 115.605 -0.725 . . . . 65.21 112.912 -174.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t 64.44 14.93 9.21 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.833 1.253 . . . . 74.21 110.791 -166.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -80.29 -33.14 37.93 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.372 -0.973 . . . . 72.21 108.372 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.3 m -99.6 46.93 0.96 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.626 -1.17 . . . . 70.33 110.964 173.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.541 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -112.74 -6.89 0.1 Allowed Pre-proline 0 CA--C 1.577 1.999 0 CA-C-O 116.409 -1.758 . . . . 24.21 115.565 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 39.1 Cg_exo -62.01 -50.69 4.63 Favored 'Trans proline' 0 C--N 1.408 3.692 0 CA-C-N 123.416 2.256 . . . . 73.41 113.176 -169.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -77.68 153.91 81.03 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 114.594 -1.185 . . . . 74.5 111.539 -170.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.47 -25.32 41.62 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.216 1.944 . . . . 61.15 110.658 164.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -104.26 45.84 0.94 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.014 1.326 . . . . 70.4 108.92 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 20.6 p -56.02 -19.79 14.13 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.499 1.12 . . . . 74.43 112.455 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.45 ' HZ2' ' HB2' ' A' ' 32' ' ' SER . 69.9 m95 -42.74 -39.51 2.47 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.096 1.758 . . . . 60.02 112.378 171.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.31 -22.09 76.12 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 115.413 -0.812 . . . . 72.41 113.616 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.469 ' O ' HG12 ' A' ' 18' ' ' VAL . 25.0 t -96.31 -46.21 6.51 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.25 1.024 . . . . 75.54 109.987 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -76.99 -47.35 21.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 113.424 -1.717 . . . . 72.32 112.734 -166.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.436 HD23 ' SG ' ' A' ' 25' ' ' CYS . 47.1 mt -61.46 -14.26 27.18 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.076 1.51 . . . . 62.41 115.076 -173.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 15' ' ' CYS . 14.0 p -74.93 -23.58 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 118.909 0.777 . . . . 74.13 110.952 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -134.43 -18.54 1.96 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.139 0.976 . . . . 73.13 111.426 -167.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.8 m -128.55 170.9 12.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.243 1.017 . . . . 72.42 110.396 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.18 154.9 57.72 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.192 0.997 . . . . 74.21 110.8 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.48 -26.54 12.4 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.683 2.922 . . . . 74.32 114.304 168.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 m -61.98 -41.42 98.0 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.134 0.574 . . . . 55.25 111.174 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.04 -52.87 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 122.956 0.502 . . . . 54.03 110.28 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.436 ' SG ' HD23 ' A' ' 17' ' ' LEU . 4.0 m -62.0 -33.35 74.17 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.866 -1.061 . . . . 72.34 111.092 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.8 -36.77 77.43 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.603 0.761 . . . . 74.43 111.565 174.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.04 -41.53 22.13 Favored Glycine 0 C--N 1.351 1.364 0 O-C-N 123.91 0.756 . . . . 42.02 112.423 -174.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -77.93 -40.67 38.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.124 0.569 . . . . 63.4 111.863 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.8 m -67.35 -63.67 1.01 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.34 0.59 . . . . 72.33 110.542 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.08 -54.71 4.75 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 114.793 -1.094 . . . . 32.23 111.446 -167.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.51 103.73 0.46 Allowed Glycine 0 C--N 1.354 1.538 0 C-N-CA 123.562 0.601 . . . . 44.51 112.347 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.45 ' HB2' ' HZ2' ' A' ' 13' ' ' TRP . 38.7 t . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.023 -1.102 . . . . 72.53 108.023 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 110.12 -0.326 . . . . 71.02 110.12 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.765 ' HB2' HG21 ' A' ' 24' ' ' ILE . 6.2 t -154.07 -172.57 4.26 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.774 0.83 . . . . 25.42 108.931 178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.46 -18.71 65.77 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.796 -0.446 . . . . 73.33 112.567 173.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.8 m 69.54 8.6 6.84 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 124.777 1.231 . . . . 55.31 112.272 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -117.55 6.64 12.53 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.494 1.117 . . . . 73.14 110.437 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.5 m -113.66 31.88 6.2 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.131 0.972 . . . . 65.4 110.984 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.578 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -95.02 -20.88 0.23 Allowed Pre-proline 0 CA--C 1.58 2.103 0 N-CA-C 115.318 1.599 . . . . 64.45 115.318 166.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 9.6 Cg_exo -70.35 -47.27 0.78 Allowed 'Trans proline' 0 C--N 1.4 3.262 0 C-N-CA 122.448 2.098 . . . . 65.45 113.849 -162.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -70.62 159.64 84.39 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.591 -1.186 . . . . 74.32 112.164 -164.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.51 -29.62 44.43 Favored 'Trans proline' 0 C--N 1.368 1.572 0 C-N-CA 122.159 1.906 . . . . 61.23 111.352 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -109.22 31.77 5.47 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.644 1.178 . . . . 73.42 109.894 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.0 p -53.54 -21.39 6.36 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.189 1.396 . . . . 74.23 114.067 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.465 ' HE3' HD11 ' A' ' 17' ' ' LEU . 81.4 m95 -55.42 -38.31 68.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.439 1.096 . . . . 64.23 111.16 175.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.92 -21.08 78.14 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 114.984 -1.007 . . . . 54.45 112.542 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' O ' HG12 ' A' ' 18' ' ' VAL . 15.1 t -83.74 -45.06 13.78 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.112 0.965 . . . . 72.51 109.645 177.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.4 t -78.52 -55.72 4.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.98 -1.464 . . . . 74.42 111.776 -168.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.465 HD11 ' HE3' ' A' ' 13' ' ' TRP . 2.2 mp -62.0 -9.19 6.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.113 1.523 . . . . 72.44 115.113 -175.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 15' ' ' CYS . 11.1 p -80.28 -15.56 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 119.255 0.934 . . . . 64.44 109.919 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.611 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 26.5 pt20 -144.23 -4.8 0.79 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.875 0.87 . . . . 31.41 111.703 -170.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.611 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 3.9 m -139.77 170.32 16.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.666 0.787 . . . . 62.0 109.197 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.432 ' HB3' HG12 ' A' ' 24' ' ' ILE . . . -80.08 149.91 70.65 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 122.983 0.513 . . . . 73.21 111.236 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.437 ' HB3' HD21 ' A' ' 17' ' ' LEU . 9.3 Cg_endo -54.07 -27.25 44.99 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 123.364 2.709 . . . . 54.32 112.844 165.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.3 m -62.77 -39.62 94.76 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.599 0.76 . . . . 64.22 110.473 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.765 HG21 ' HB2' ' A' ' 2' ' ' CYS . 44.9 mm -73.29 -48.33 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 123.773 0.829 . . . . 70.45 110.0 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.4 m -64.05 -31.94 73.32 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.401 1.08 . . . . 74.41 111.54 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.58 -31.43 70.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.547 -0.751 . . . . 75.54 111.865 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.64 -32.87 26.29 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 116.381 -0.372 . . . . 25.21 112.937 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -80.73 -54.55 5.52 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.938 0.495 . . . . 71.31 111.338 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -79.19 -69.99 0.54 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.25 0.62 . . . . 62.2 112.527 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.57 102.57 0.35 Allowed Glycine 0 C--N 1.347 1.182 0 N-CA-C 112.02 -0.432 . . . . 63.14 112.02 -166.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.42 76.24 1.52 Allowed Glycine 0 C--N 1.346 1.104 0 C-N-CA 122.753 0.216 . . . . 34.44 112.592 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 C--O 1.251 1.136 0 C-N-CA 123.794 0.837 . . . . 62.42 109.244 -173.939 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.4 p . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.833 0.349 . . . . 62.34 111.148 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.748 ' HB2' HG21 ' A' ' 24' ' ' ILE . 2.0 t -94.18 -165.35 1.3 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.287 -1.005 . . . . 73.45 108.287 168.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.55 -17.64 79.75 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.392 -0.671 . . . . 52.0 112.457 170.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.1 t 71.07 29.68 2.87 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 124.808 1.243 . . . . 65.13 108.289 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -111.28 -31.27 7.12 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.278 -1.328 . . . . 72.15 109.94 -174.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 96.8 m -103.25 44.42 1.02 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.397 1.079 . . . . 73.23 112.435 -175.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.547 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -105.26 -10.47 0.12 Allowed Pre-proline 0 CA--C 1.589 2.445 0 N-CA-C 116.233 1.938 . . . . 72.03 116.233 167.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 16.3 Cg_exo -67.09 -50.67 0.97 Allowed 'Trans proline' 0 C--N 1.401 3.321 0 CA-C-N 123.752 2.376 . . . . 73.12 114.023 -167.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -80.72 162.33 60.68 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.627 -1.169 . . . . 75.24 112.602 -162.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.95 -17.09 28.95 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.534 2.156 . . . . 71.13 111.439 166.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -114.3 27.6 9.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.741 1.216 . . . . 74.3 110.249 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.9 p -62.48 -16.24 54.35 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.301 1.04 . . . . 75.31 112.779 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.43 ' HE3' HD11 ' A' ' 17' ' ' LEU . 89.2 m95 -53.76 -39.05 65.02 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.698 0.799 . . . . 72.11 110.818 173.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.36 -28.41 73.28 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 115.749 -0.66 . . . . 73.13 112.127 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.52 ' O ' HG12 ' A' ' 18' ' ' VAL . 34.3 t -80.94 -43.77 19.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.356 1.062 . . . . 75.22 109.742 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -70.32 -54.39 12.78 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.525 -1.216 . . . . 64.2 111.092 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 22' ' ' PRO . 2.1 mp -69.13 -2.64 10.77 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 115.17 1.544 . . . . 72.43 115.17 -174.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 15' ' ' CYS . 13.3 p -84.56 -16.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 119.408 1.003 . . . . 62.13 109.715 176.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -145.15 -3.07 0.77 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.55 0.74 . . . . 54.34 111.965 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.2 m -144.14 164.45 30.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.856 0.862 . . . . 70.11 109.531 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.63 154.7 73.7 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-N 115.894 -0.594 . . . . 65.52 110.515 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.479 ' HB3' HD21 ' A' ' 17' ' ' LEU . 18.3 Cg_endo -59.83 -19.53 54.83 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.957 2.438 . . . . 63.23 112.234 169.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -58.4 -38.59 77.67 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.905 0.882 . . . . 71.3 110.872 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.748 HG21 ' HB2' ' A' ' 2' ' ' CYS . 23.9 mm -84.59 -43.06 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.821 -0.627 . . . . 63.31 110.112 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 m -64.97 -30.5 71.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.238 1.015 . . . . 64.44 112.07 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.42 -24.4 65.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.991 0.516 . . . . 42.53 111.541 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.23 -45.49 8.82 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.133 -0.485 . . . . 71.44 112.138 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -77.48 -67.11 0.75 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.903 0.481 . . . . 73.41 110.906 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.1 m -69.66 -32.19 70.69 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.363 -0.835 . . . . 52.41 112.536 -173.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.18 -162.1 38.15 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 115.997 -0.547 . . . . 61.41 113.026 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.71 146.62 4.49 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.606 -0.597 . . . . 42.51 111.606 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 C--O 1.249 1.055 0 N-CA-C 108.795 -0.817 . . . . 74.02 108.795 -178.873 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.769 -0.456 . . . . 55.2 109.769 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.2 m -67.79 160.63 27.86 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.198 0.523 . . . . 71.44 111.086 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.81 19.78 32.6 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.282 -0.872 . . . . 33.45 113.866 -171.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.2 m 67.89 14.19 9.34 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.604 1.162 . . . . 64.23 111.193 -173.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.94 -20.37 20.07 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.409 1.083 . . . . 74.33 109.292 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 77.2 m -100.43 45.86 0.97 Allowed 'General case' 0 C--N 1.347 0.489 0 C-N-CA 124.382 1.073 . . . . 63.52 111.07 172.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.545 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -120.45 5.79 0.07 OUTLIER Pre-proline 0 CA--C 1.582 2.18 0 N-CA-C 115.657 1.725 . . . . 73.1 115.657 168.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 23.9 Cg_exo -65.55 -51.08 1.52 Allowed 'Trans proline' 0 C--N 1.406 3.589 0 CA-C-N 123.648 2.339 . . . . 72.03 112.415 -175.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -83.28 156.08 66.35 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 113.672 -1.604 . . . . 64.11 111.529 -167.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -60.9 -39.96 57.15 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.331 2.021 . . . . 72.32 110.252 166.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -92.76 75.33 4.94 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 108.411 -0.959 . . . . 70.44 108.411 170.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 15.9 p -73.24 -21.5 60.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.176 -0.92 . . . . 74.23 110.343 174.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -48.75 -37.86 20.09 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 125.351 1.46 . . . . 72.11 111.253 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.67 -36.52 92.47 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.0 -1.0 . . . . 61.4 112.006 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.9 t -80.87 -44.75 17.9 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.391 1.091 . . . . 61.13 110.439 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HA ' ' NE2' ' A' ' 19' ' ' GLN . 5.1 t -82.73 -54.11 5.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.282 -1.781 . . . . 74.51 112.029 -166.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.99 -19.11 11.22 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.119 1.525 . . . . 45.43 115.119 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.52 -25.7 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 118.407 0.548 . . . . 72.03 111.324 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.431 ' NE2' ' HA ' ' A' ' 16' ' ' CYS . 2.9 pp0? -134.98 -0.72 2.75 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.75 0.82 . . . . 70.41 112.227 -175.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 74.2 m -136.47 175.88 9.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.265 1.026 . . . . 72.02 110.634 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.27 160.8 27.33 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.495 1.118 . . . . 62.34 110.188 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.6 -18.44 40.15 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 122.997 2.465 . . . . 65.52 113.504 173.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.9 p -60.79 -40.02 91.06 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.148 0.579 . . . . 65.34 110.635 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.7 mm -75.68 -56.03 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 123.307 0.643 . . . . 70.24 110.1 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -61.01 -29.07 69.49 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.74 -1.118 . . . . 64.5 112.573 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.37 -36.15 79.44 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.895 0.478 . . . . 43.53 111.659 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.13 -20.59 69.63 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.974 -0.557 . . . . 74.33 112.873 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -97.39 -35.21 10.76 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.311 0.644 . . . . 71.02 111.564 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.8 m -76.77 -69.89 0.49 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.137 0.575 . . . . 60.43 111.277 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.74 -64.03 0.03 OUTLIER Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.094 -0.803 . . . . 74.1 111.094 -173.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.34 175.18 44.97 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.303 -0.719 . . . . 44.4 111.303 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.251 1.151 0 C-N-CA 123.359 0.664 . . . . 44.1 109.615 179.067 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 109.683 -0.488 . . . . 71.2 109.683 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.491 ' HB2' HG21 ' A' ' 24' ' ' ILE . 4.0 t -72.45 170.29 14.61 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.083 0.553 . . . . 62.34 110.592 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.57 -0.72 75.44 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.712 -0.677 . . . . 73.33 112.884 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 m 64.05 18.63 11.34 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 124.296 1.038 . . . . 73.42 108.884 -161.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -74.32 -50.2 19.79 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 114.572 -1.195 . . . . 73.01 108.811 -165.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 64.4 m -106.2 50.33 0.78 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 113.795 -1.548 . . . . 73.31 110.858 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.538 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -89.62 -27.12 0.32 Allowed Pre-proline 0 CA--C 1.582 2.21 0 N-CA-C 115.199 1.555 . . . . 73.02 115.199 166.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 21.1 Cg_exo -64.37 -50.66 2.51 Favored 'Trans proline' 0 C--N 1.407 3.637 0 C-N-CA 122.862 2.374 . . . . 55.52 114.272 -161.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -72.45 158.81 86.82 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.765 0.826 . . . . 72.11 112.043 -167.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.41 -32.86 59.9 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.434 2.089 . . . . 62.04 110.616 163.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -95.68 32.7 1.78 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.96 1.304 . . . . 62.53 110.394 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -49.91 -32.49 14.79 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.417 1.487 . . . . 53.0 112.041 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -52.04 -40.66 61.45 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 124.719 1.207 . . . . 53.21 111.952 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.02 47.77 3.4 Favored Glycine 0 N--CA 1.478 1.434 0 CA-C-N 114.757 -1.11 . . . . 62.43 111.055 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 6.7 t -170.42 -46.44 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.055 1.342 . . . . 71.15 108.249 -169.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 41.2 t -79.56 -46.55 17.1 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 114.065 -1.425 . . . . 73.14 111.536 -170.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -76.3 15.44 0.59 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.491 1.293 . . . . 75.03 114.491 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 15' ' ' CYS . 8.1 p -97.13 -12.31 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-O 121.633 0.73 . . . . 64.33 109.725 168.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.62 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 25.9 pt20 -145.95 -3.68 0.67 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.695 0.798 . . . . 73.42 111.774 -170.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.62 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 0.8 OUTLIER -144.95 158.02 43.95 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 123.69 0.796 . . . . 61.11 108.96 -178.417 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.526 ' HB3' HG12 ' A' ' 24' ' ' ILE . . . -78.94 151.42 76.23 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.034 0.534 . . . . 51.21 110.722 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.16 -30.28 49.8 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.876 3.051 . . . . 44.33 113.281 172.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 m -63.57 -36.73 84.78 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.905 0.482 . . . . 74.42 110.776 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.526 HG12 ' HB3' ' A' ' 21' ' ' ALA . 12.1 mm -78.71 -48.35 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 109.212 -0.662 . . . . 74.33 109.212 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 m -61.69 -35.79 79.03 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.426 1.09 . . . . 75.51 111.326 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.72 -30.26 70.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.984 0.514 . . . . 64.33 111.574 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.75 -38.92 49.39 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.704 0.628 . . . . 74.13 112.071 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.491 ' HE1' HG22 ' A' ' 24' ' ' ILE . 60.0 m95 -75.96 -49.52 17.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.171 0.588 . . . . 75.14 110.831 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.08 -61.89 1.6 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.5 -0.773 . . . . 73.5 111.719 -175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.76 -9.8 20.19 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 114.264 0.466 . . . . 63.32 114.264 -170.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.99 -39.56 37.65 Favored Glycine 0 N--CA 1.47 0.964 0 CA-C-N 117.087 0.443 . . . . 73.43 112.998 -174.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 C--O 1.25 1.084 0 C-N-CA 123.806 0.842 . . . . 74.41 109.328 178.241 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.996 -0.372 . . . . 53.5 109.996 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.642 ' SG ' HG21 ' A' ' 24' ' ' ILE . 55.8 m -74.81 -176.62 2.94 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.206 0.603 . . . . 73.31 111.136 178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.49 -7.83 87.1 Favored Glycine 0 N--CA 1.468 0.809 0 CA-C-O 119.188 -0.785 . . . . 73.31 115.023 -165.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 m 70.34 6.09 5.63 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.016 1.327 . . . . 62.4 111.002 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.41 -34.2 63.2 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.219 1.008 . . . . 63.44 109.401 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.4 m -90.14 41.41 1.05 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.246 1.019 . . . . 73.44 111.277 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.484 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -126.53 26.72 0.13 Allowed Pre-proline 0 CA--C 1.58 2.103 0 N-CA-C 115.482 1.66 . . . . 72.32 115.482 172.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 13.0 Cg_exo -68.8 -54.47 0.27 Allowed 'Trans proline' 0 C--N 1.398 3.134 0 CA-C-N 122.746 2.016 . . . . 62.43 111.267 172.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -83.86 165.13 41.1 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 113.105 -1.861 . . . . 64.53 111.471 -164.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.33 -25.38 36.26 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.209 1.94 . . . . 74.24 110.494 160.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.95 45.09 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.445 1.498 . . . . 74.44 109.593 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 13.2 p -65.3 -23.7 67.09 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.041 0.536 . . . . 74.0 111.484 -176.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -49.85 -35.86 24.76 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 124.955 1.302 . . . . 74.41 110.981 173.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.54 41.62 3.06 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 114.65 -1.159 . . . . 40.42 112.5 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' O ' HG12 ' A' ' 18' ' ' VAL . 13.3 t -162.56 -51.15 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 125.117 1.367 . . . . 75.25 108.097 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.7 t -75.93 -44.64 39.18 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 113.624 -1.625 . . . . 64.41 111.578 -172.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 40.4 mt -61.83 -17.9 58.03 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.668 1.359 . . . . 71.31 114.668 -175.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 15' ' ' CYS . 11.9 p -79.89 -21.03 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.938 0.79 . . . . 63.52 110.447 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -140.34 8.73 2.24 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.792 0.837 . . . . 74.25 111.616 -170.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -150.86 173.47 14.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.3 1.04 . . . . 44.2 109.59 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.31 158.44 37.1 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.011 0.925 . . . . 63.03 109.959 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.73 -22.71 54.3 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.918 2.412 . . . . 73.41 112.947 171.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.5 m -63.81 -22.73 67.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.454 0.701 . . . . 71.02 111.826 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.642 HG21 ' SG ' ' A' ' 2' ' ' CYS . 43.9 mm -91.42 -53.05 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.155 0.582 . . . . 74.14 109.437 173.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.2 m -64.43 -28.36 69.62 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.789 -1.096 . . . . 52.01 113.156 -169.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.12 -32.85 72.53 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.27 0.628 . . . . 72.43 111.637 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.88 -0.94 74.03 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.885 -0.598 . . . . 62.14 112.62 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -105.67 -34.45 7.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.79 0.836 . . . . 73.43 110.562 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.0 m -77.21 -76.77 0.16 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.392 0.677 . . . . 72.41 111.029 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -148.36 53.74 0.52 Allowed Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.148 -0.478 . . . . 63.23 112.526 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.97 -50.64 10.36 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 111.097 -0.801 . . . . 52.42 111.097 173.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 CA--C 1.557 1.228 0 C-N-CA 124.787 1.235 . . . . 73.41 108.503 176.68 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.195 -0.298 . . . . 43.41 110.195 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.613 ' SG ' HG21 ' A' ' 24' ' ' ILE . 17.7 m 70.41 165.89 0.28 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.047 1.339 . . . . 71.32 110.637 -175.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.96 5.66 66.35 Favored Glycine 0 N--CA 1.472 1.074 0 CA-C-O 118.953 -0.915 . . . . 71.11 114.905 -168.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.6 p 54.68 20.7 3.07 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.103 1.361 . . . . 72.33 111.274 -169.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.12 -36.25 40.87 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.846 -1.07 . . . . 72.34 108.192 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.3 m -93.38 45.52 1.17 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.211 1.005 . . . . 41.42 111.476 171.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.549 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -116.94 7.38 0.08 OUTLIER Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 115.675 1.731 . . . . 71.24 115.675 167.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 24.5 Cg_exo -63.13 -48.96 5.43 Favored 'Trans proline' 0 C--N 1.409 3.744 0 CA-C-N 123.612 2.326 . . . . 65.21 112.261 -173.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -73.61 155.95 88.91 Favored Pre-proline 0 N--CA 1.439 -0.999 0 CA-C-N 113.187 -1.824 . . . . 44.33 111.927 -168.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.36 -37.79 79.4 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.199 1.933 . . . . 72.14 110.399 163.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -99.82 76.48 1.97 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.925 0.89 . . . . 75.45 108.79 170.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.503 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 19.7 p -69.34 -19.89 63.86 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.35 -0.841 . . . . 62.24 111.082 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -48.87 -37.18 18.85 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 125.38 1.472 . . . . 73.01 111.174 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.77 39.41 3.09 Favored Glycine 0 N--CA 1.474 1.167 0 CA-C-N 114.965 -1.016 . . . . 70.04 113.395 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.7 t -159.99 -48.65 0.05 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.958 1.303 . . . . 70.22 108.33 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 10.8 t -77.19 -42.01 39.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 112.952 -1.931 . . . . 62.03 112.041 -171.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.463 HD23 ' SG ' ' A' ' 25' ' ' CYS . 47.4 mt -64.34 -11.09 28.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.069 1.507 . . . . 73.4 115.069 -173.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.04 -26.3 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.857 0.753 . . . . 74.04 110.414 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -132.57 0.9 3.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.148 0.979 . . . . 74.21 111.598 -168.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 39.5 m -144.9 164.76 30.13 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.668 0.787 . . . . 73.22 109.889 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.7 155.41 65.25 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.581 0.752 . . . . 53.43 110.562 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.44 -23.85 15.14 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.271 2.648 . . . . 64.23 114.212 169.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 t -64.23 -44.62 91.28 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.079 0.552 . . . . 71.12 110.64 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.613 HG21 ' SG ' ' A' ' 2' ' ' CYS . 42.0 mm -68.04 -50.51 58.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 CA-C-O 121.283 0.564 . . . . 75.0 109.725 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.463 ' SG ' HD23 ' A' ' 17' ' ' LEU . 8.4 m -67.31 -27.54 67.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.95 -1.023 . . . . 42.12 111.657 -174.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.29 -25.27 67.56 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.717 0.407 . . . . 74.4 112.024 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.08 -19.68 56.93 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 112.259 -0.336 . . . . 52.44 112.259 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -99.83 -25.43 14.36 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.682 0.793 . . . . 75.21 111.361 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.6 m -94.14 -72.31 0.62 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.6 0.76 . . . . 73.53 110.455 175.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.97 163.21 16.38 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.361 -1.29 . . . . 71.14 111.658 -170.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -151.5 47.82 0.57 Allowed Glycine 0 N--CA 1.467 0.707 0 N-CA-C 111.38 -0.688 . . . . 63.45 111.38 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.2 t . . . . . 0 C--O 1.255 1.376 0 C-N-CA 124.055 0.942 . . . . 73.43 108.758 -177.571 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 110.362 -0.236 . . . . 75.55 110.362 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.779 ' HB2' HG21 ' A' ' 24' ' ' ILE . 18.5 t -166.06 178.79 6.15 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.223 1.009 . . . . 53.04 108.901 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.26 -11.52 51.82 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 119.155 -0.803 . . . . 64.45 113.325 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.6 p 51.67 22.63 1.68 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 125.334 1.453 . . . . 73.45 111.801 -171.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -94.76 -44.46 7.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.236 1.414 . . . . 75.44 108.469 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 67.4 m -94.5 47.95 1.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.166 -1.379 . . . . 75.25 111.475 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.56 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -109.07 7.18 0.08 OUTLIER Pre-proline 0 CA--C 1.584 2.259 0 N-CA-C 115.843 1.794 . . . . 73.32 115.843 166.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 16.9 Cg_exo -68.4 -57.02 0.16 Allowed 'Trans proline' 0 C--N 1.406 3.602 0 CA-C-N 123.904 2.43 . . . . 71.3 113.121 -174.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.06 164.28 62.35 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 114.455 -1.248 . . . . 71.41 111.968 -166.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.17 -29.18 27.11 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.251 1.967 . . . . 64.31 111.06 164.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.52 31.72 5.01 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.466 1.107 . . . . 43.41 110.098 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 p -60.31 -9.55 3.61 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.475 1.11 . . . . 72.22 113.544 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.479 ' HE3' HD11 ' A' ' 17' ' ' LEU . 83.4 m95 -49.33 -38.31 27.49 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.937 1.295 . . . . 72.24 111.595 169.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.38 48.41 3.77 Favored Glycine 0 N--CA 1.476 1.346 0 CA-C-N 115.213 -0.903 . . . . 72.41 111.679 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 7.3 t -168.76 -46.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.924 1.289 . . . . 64.51 108.556 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.44 ' HA ' ' NE2' ' A' ' 19' ' ' GLN . 41.2 t -73.12 -48.13 38.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.74 -1.573 . . . . 72.13 112.07 -173.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.479 HD11 ' HE3' ' A' ' 13' ' ' TRP . 5.7 mp -70.34 2.3 3.98 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.143 1.905 . . . . 52.01 116.143 -171.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.509 HG13 ' HG3' ' A' ' 19' ' ' GLN . 7.6 p -83.71 -29.48 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 118.667 0.667 . . . . 75.54 109.955 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.509 ' HG3' HG13 ' A' ' 18' ' ' VAL . 2.6 pp0? -132.69 6.01 4.0 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.07 0.948 . . . . 73.41 112.182 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 17' ' ' LEU . 2.6 m -142.78 161.8 37.15 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.04 -1.096 . . . . 71.01 108.04 172.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.24 157.79 53.11 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 122.97 0.508 . . . . 52.44 110.165 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HB3' HD21 ' A' ' 17' ' ' LEU . 19.2 Cg_endo -59.44 -22.53 66.45 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.05 2.5 . . . . 62.02 113.089 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.4 p -62.15 -38.89 90.71 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.429 0.692 . . . . 64.05 110.524 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.779 HG21 ' HB2' ' A' ' 2' ' ' CYS . 10.9 mm -81.83 -46.5 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.31 -0.859 . . . . 71.42 109.855 -177.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.4 m -64.96 -24.36 67.5 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.448 1.099 . . . . 75.45 111.233 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -31.76 73.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.106 0.562 . . . . 60.02 111.59 171.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.63 -45.68 21.76 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 116.401 -0.363 . . . . 62.14 112.241 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -73.17 -58.86 3.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.273 0.629 . . . . 71.25 111.158 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.3 m -74.18 -62.45 1.51 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.591 0.756 . . . . 52.11 112.42 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.55 -118.52 2.82 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-O 120.247 -0.196 . . . . 61.41 113.012 -170.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 144.13 95.18 0.2 Allowed Glycine 0 C--N 1.347 1.19 0 N-CA-C 110.678 -0.969 . . . . 30.52 110.678 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 CA--C 1.554 1.11 0 C-N-CA 123.543 0.737 . . . . 45.21 109.355 -174.352 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.632 -0.507 . . . . 70.51 109.632 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.747 ' SG ' HG21 ' A' ' 24' ' ' ILE . 58.4 m -92.08 179.81 5.48 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.114 0.566 . . . . 74.4 110.821 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.63 3.67 47.93 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 116.771 1.468 . . . . 53.13 116.771 -164.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m 68.63 1.36 2.98 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.464 1.106 . . . . 63.02 111.539 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.49 -18.38 45.33 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 123.522 0.729 . . . . 72.3 109.653 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 83.2 m -103.96 42.95 1.13 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.09 0.956 . . . . 72.15 110.945 172.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.532 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -110.7 -5.99 0.11 Allowed Pre-proline 0 CA--C 1.586 2.35 0 N-CA-C 115.597 1.702 . . . . 60.15 115.597 168.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 25.3 Cg_exo -63.82 -58.43 0.27 Allowed 'Trans proline' 0 C--N 1.405 3.531 0 CA-C-N 123.642 2.336 . . . . 74.52 113.634 -172.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -77.52 162.92 66.83 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 114.84 -1.073 . . . . 72.32 111.851 -170.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.38 -25.22 30.58 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.57 2.18 . . . . 72.32 110.411 160.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -93.25 23.54 4.37 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 125.312 1.445 . . . . 72.41 110.181 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 p -62.03 -17.74 58.32 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.719 1.207 . . . . 62.31 113.451 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -57.97 -33.37 68.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.094 0.957 . . . . 74.32 111.106 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.85 -34.02 88.78 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 115.6 -0.727 . . . . 74.45 112.105 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.469 ' O ' HG12 ' A' ' 18' ' ' VAL . 17.9 t -78.34 -47.65 17.27 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.641 1.176 . . . . 55.41 110.225 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.9 t -80.3 -45.26 18.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.855 -1.52 . . . . 72.44 112.033 -167.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.401 HD23 ' SG ' ' A' ' 25' ' ' CYS . 78.6 mt -65.66 -5.75 9.33 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.498 1.296 . . . . 71.51 114.498 -174.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 15' ' ' CYS . 9.1 p -87.67 -19.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.026 0.83 . . . . 74.22 110.571 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.415 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 27.0 pt20 -134.56 -2.66 2.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.076 0.951 . . . . 72.42 111.098 -170.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.415 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 37.4 m -143.27 171.11 14.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.574 0.75 . . . . 63.43 110.403 -175.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.82 155.33 41.75 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.736 0.815 . . . . 62.44 109.549 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.32 -16.41 28.41 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.826 2.351 . . . . 74.13 113.693 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 m -64.21 -36.76 85.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.617 0.367 . . . . 70.13 110.974 171.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.747 HG21 ' SG ' ' A' ' 2' ' ' CYS . 50.6 mm -75.98 -52.74 17.13 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 N-CA-C 109.051 -0.722 . . . . 74.52 109.051 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.401 ' SG ' HD23 ' A' ' 17' ' ' LEU . 21.1 m -65.17 -26.28 68.09 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.559 -1.201 . . . . 73.41 112.505 -170.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.2 -31.58 72.49 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.385 0.274 . . . . 62.33 111.171 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.91 -32.15 50.67 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 116.07 -0.514 . . . . 72.33 112.212 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -88.41 -37.47 15.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.199 0.6 . . . . 64.44 111.132 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.5 m -90.76 -80.26 0.34 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.29 0.636 . . . . 60.4 111.736 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.36 -84.32 0.06 OUTLIER Glycine 0 C--N 1.353 1.477 0 CA-C-N 116.168 -0.469 . . . . 72.32 112.778 -167.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.98 155.99 18.48 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 112.223 -0.351 . . . . 60.42 112.223 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.7 t . . . . . 0 C--O 1.249 1.042 0 C-N-CA 123.958 0.903 . . . . 65.03 108.933 -178.667 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.646 0.26 . . . . 55.42 110.374 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.813 ' SG ' HG21 ' A' ' 24' ' ' ILE . 23.5 m -138.92 -166.86 2.1 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.266 0.626 . . . . 74.13 110.416 -173.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.83 -10.34 84.26 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-O 119.359 -0.69 . . . . 42.21 113.841 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.1 m 77.11 -12.77 1.02 Allowed 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.163 1.385 . . . . 62.41 112.176 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -94.89 19.16 10.61 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.956 0.884 . . . . 73.33 109.498 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 99.2 m -106.19 28.78 7.36 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.241 1.016 . . . . 73.14 110.25 166.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.542 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -103.78 -9.33 0.12 Allowed Pre-proline 0 CA--C 1.581 2.138 0 N-CA-C 116.337 1.977 . . . . 65.5 116.337 167.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 14.1 Cg_exo -67.58 -54.74 0.33 Allowed 'Trans proline' 0 C--N 1.405 3.54 0 CA-C-N 123.658 2.342 . . . . 72.54 112.926 -168.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -73.04 159.81 84.38 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 113.797 -1.547 . . . . 71.01 112.103 -166.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.77 -26.3 32.68 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.252 1.968 . . . . 70.13 110.633 162.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -99.17 27.67 4.96 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.436 1.495 . . . . 74.14 109.759 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 6.3 p -62.94 -17.79 62.31 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.411 1.084 . . . . 74.13 113.608 -176.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -54.47 -38.24 66.18 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.889 0.875 . . . . 75.21 110.339 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.06 -35.42 90.55 Favored Glycine 0 N--CA 1.469 0.848 0 CA-C-N 115.24 -0.891 . . . . 72.42 112.182 -176.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.47 ' O ' HG12 ' A' ' 18' ' ' VAL . 35.2 t -67.38 -51.82 47.45 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.016 0.912 . . . . 71.12 110.583 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 t -71.48 -54.5 10.39 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.792 -1.549 . . . . 43.1 111.629 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.417 HD23 ' SG ' ' A' ' 25' ' ' CYS . 68.6 mt -51.83 -27.22 11.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.373 1.62 . . . . 61.4 115.373 -175.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 15' ' ' CYS . 14.6 p -74.43 -14.09 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.395 0.617 . . . . 43.12 111.333 -174.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -146.96 3.68 0.82 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.574 0.75 . . . . 74.33 111.178 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.8 m -148.31 169.63 19.7 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.03 0.932 . . . . 52.23 109.863 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.28 157.84 50.02 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.528 0.731 . . . . 73.23 110.658 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.28 -22.56 5.85 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.424 2.75 . . . . 75.25 113.923 165.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 m -59.22 -44.87 92.28 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.579 0.752 . . . . 70.04 111.443 172.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.813 HG21 ' SG ' ' A' ' 2' ' ' CYS . 49.2 mm -74.61 -45.47 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.473 0.709 . . . . 74.22 110.018 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.417 ' SG ' HD23 ' A' ' 17' ' ' LEU . 11.1 m -64.85 -33.25 75.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.74 0.816 . . . . 54.31 111.163 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.55 -24.85 64.68 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.962 0.505 . . . . 64.32 110.945 173.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.56 -41.35 24.95 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.951 -0.46 . . . . 71.24 111.951 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -84.71 -59.91 2.22 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.052 0.541 . . . . 74.31 111.046 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.4 m -68.89 -51.17 42.91 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.001 0.52 . . . . 60.05 111.181 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.67 -45.33 17.87 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.708 -0.678 . . . . 73.11 112.731 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.65 -156.45 53.3 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-O 119.964 -0.353 . . . . 52.13 113.103 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.9 t . . . . . 0 C--O 1.252 1.192 0 N-CA-C 108.429 -0.952 . . . . 55.12 108.429 177.135 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.6 p . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 110.093 -0.336 . . . . 64.02 110.093 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.485 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 34.9 m -74.48 164.71 26.27 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.837 -0.431 . . . . 71.12 109.837 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.74 -63.28 2.77 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 116.274 -0.421 . . . . 71.52 112.274 173.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.1 p 160.44 -12.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.157 1.783 . . . . 74.02 109.275 -167.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.64 -20.5 62.72 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.787 0.835 . . . . 43.33 110.605 -177.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.8 m -91.42 52.04 2.01 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.734 0.778 . . . . 74.33 110.815 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.531 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -130.01 13.25 0.05 OUTLIER Pre-proline 0 CA--C 1.575 1.909 0 N-CA-C 115.231 1.567 . . . . 53.0 115.231 169.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 11.8 Cg_exo -68.05 -51.0 0.67 Allowed 'Trans proline' 0 C--N 1.407 3.635 0 CA-C-N 123.436 2.263 . . . . 73.34 111.275 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -81.82 151.05 67.04 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 113.508 -1.678 . . . . 74.43 110.74 -168.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.3 -32.09 81.83 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 121.914 1.743 . . . . 74.2 111.48 171.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -105.46 57.64 0.68 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.771 1.229 . . . . 72.43 108.932 175.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.559 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 18.7 p -58.94 -14.01 8.0 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.879 1.272 . . . . 72.53 113.345 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 61.3 m95 -48.8 -35.62 14.84 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.23 1.412 . . . . 63.34 111.65 173.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.13 -32.28 79.94 Favored Glycine 0 N--CA 1.475 1.244 0 CA-C-N 115.663 -0.699 . . . . 41.14 113.055 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.7 t -82.53 -44.51 15.82 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 122.397 1.094 . . . . 60.4 110.12 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.3 t -82.7 -60.23 2.25 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 112.948 -1.933 . . . . 72.01 111.758 -169.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.5 mt -52.34 -25.85 10.75 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.991 1.478 . . . . 74.32 114.991 -175.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.407 HG13 ' HG3' ' A' ' 19' ' ' GLN . 7.3 p -67.47 -22.4 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 CA-C-O 121.074 0.464 . . . . 74.21 111.1 -176.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.407 ' HG3' HG13 ' A' ' 18' ' ' VAL . 3.3 pp0? -140.63 -5.32 1.2 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.563 0.745 . . . . 71.34 112.683 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 2' ' ' CYS . 80.2 m -127.79 174.32 9.23 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.158 0.983 . . . . 61.15 110.295 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.44 157.7 46.9 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 124.832 1.253 . . . . 62.31 110.111 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.44 -17.56 41.46 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 123.366 2.711 . . . . 51.53 113.389 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.5 t -56.77 -42.68 79.83 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.329 0.651 . . . . 63.35 110.811 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mm -76.84 -48.53 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 115.937 -0.574 . . . . 74.21 110.036 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.2 m -64.73 -34.85 79.3 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.746 -1.115 . . . . 75.02 111.55 -174.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.44 -20.65 64.65 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.052 0.541 . . . . 71.53 111.425 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.48 -36.06 24.39 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.841 -0.504 . . . . 25.33 111.841 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -91.12 -41.85 10.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.355 0.662 . . . . 71.43 111.739 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.559 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.6 m -69.25 -71.84 0.21 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.43 0.633 . . . . 75.24 111.344 178.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.02 123.34 0.96 Allowed Glycine 0 C--N 1.34 0.804 0 CA-C-N 114.697 -1.138 . . . . 61.32 110.713 -169.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.79 -34.14 1.98 Allowed Glycine 0 N--CA 1.463 0.442 0 N-CA-C 110.985 -0.846 . . . . 43.22 110.985 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.6 m . . . . . 0 CA--C 1.56 1.33 0 C-N-CA 125.409 1.484 . . . . 73.31 111.266 176.04 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.735 ' SG ' HG21 ' A' ' 24' ' ' ILE . 61.7 m . . . . . 0 C--O 1.241 0.623 0 CA-C-O 120.839 0.352 . . . . 62.009999999999998 110.052 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.9 -6.86 86.11 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-O 118.691 -1.061 . . . . 74.120000000000005 114.874 -170.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m 66.63 13.58 9.39 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.488 1.115 . . . . 71.120000000000005 110.839 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -94.16 -24.55 17.48 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.208 1.003 . . . . 73.030000000000001 110.015 -172.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 52.5 m -97.6 39.73 1.19 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.894 0.878 . . . . 41.329999999999998 110.655 170.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.569 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -99.23 -16.22 0.19 Allowed Pre-proline 0 CA--C 1.58 2.112 0 N-CA-C 115.468 1.655 . . . . 71.450000000000003 115.468 168.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 12.6 Cg_exo -69.35 -38.88 8.05 Favored 'Trans proline' 0 C--N 1.406 3.554 0 CA-C-N 123.198 2.178 . . . . 74.349999999999994 112.964 -166.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -67.59 150.75 97.69 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.362 -1.29 . . . . 73.420000000000002 112.353 -166.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.11 -29.65 87.68 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.479 2.119 . . . . 75.540000000000006 110.698 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -119.34 78.34 1.29 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.784 -1.191 . . . . 74.409999999999997 107.784 170.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 20.7 p -60.19 -27.67 67.34 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.031 -0.986 . . . . 74.400000000000006 110.954 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -45.66 -38.25 6.56 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 125.452 1.501 . . . . 71.200000000000003 111.593 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.94 43.67 3.25 Favored Glycine 0 N--CA 1.474 1.206 0 CA-C-N 114.755 -1.111 . . . . 74.5 112.531 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.461 ' O ' HG12 ' A' ' 18' ' ' VAL . 13.2 t -167.23 -46.07 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.991 1.316 . . . . 64.150000000000006 108.323 -176.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.1 t -79.47 -42.79 24.52 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.671 -1.604 . . . . 71.209999999999994 112.03 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.403 HD23 ' SG ' ' A' ' 25' ' ' CYS . 71.5 mt -63.13 -9.72 11.92 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.959 1.466 . . . . 74.219999999999999 114.959 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 15' ' ' CYS . 10.2 p -83.17 -19.84 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 118.894 0.77 . . . . 74.230000000000004 110.625 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -138.87 -1.66 1.78 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.051 0.94 . . . . 71.530000000000001 111.648 -169.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 59.8 m -146.16 167.0 24.52 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.599 0.76 . . . . 60.329999999999998 110.301 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.95 155.65 52.59 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 115.206 -0.906 . . . . 75.299999999999997 110.448 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -45.52 -30.95 6.44 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.729 2.952 . . . . 74.030000000000001 114.652 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -58.87 -41.26 86.65 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.086 0.554 . . . . 73.010000000000005 111.521 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.735 HG21 ' SG ' ' A' ' 2' ' ' CYS . 47.9 mm -73.11 -51.33 26.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 C-N-CA 123.567 0.747 . . . . 75.230000000000004 110.162 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.403 ' SG ' HD23 ' A' ' 17' ' ' LEU . 7.0 m -65.37 -31.92 73.29 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.055 -0.975 . . . . 73.219999999999999 111.339 -175.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.38 -28.44 68.21 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.397 0.679 . . . . 55.140000000000001 111.522 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.12 -22.62 47.94 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.702 0.627 . . . . 53.350000000000001 112.273 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . 15.8 m95 -93.43 -36.77 12.31 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.222 0.609 . . . . 72.230000000000004 112.132 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 42.4 m -71.58 -73.14 0.19 Allowed 'General case' 0 CA--C 1.547 0.844 0 O-C-N 123.196 0.31 . . . . 63.32 110.519 176.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.074 0 CA-C-O 121.055 0.253 . . . . 72.140000000000001 112.508 -178.093 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.823 ' HB2' HG21 ' A' ' 24' ' ' ILE . 11.1 t . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.365 -0.606 . . . . 65.150000000000006 109.365 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.04 -25.09 76.39 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 111.389 -0.684 . . . . 64.349999999999994 111.389 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.1 m 66.3 5.12 3.5 Favored 'General case' 0 C--N 1.369 1.447 0 C-N-CA 124.562 1.145 . . . . 60.350000000000001 112.086 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.45 -15.84 16.36 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.039 0.935 . . . . 72.230000000000004 108.761 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 56.2 m -93.21 44.45 1.14 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.535 1.134 . . . . 64.530000000000001 110.822 170.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.501 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -117.31 5.26 0.08 OUTLIER Pre-proline 0 CA--C 1.58 2.134 0 N-CA-C 116.034 1.864 . . . . 21.309999999999999 116.034 173.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 39.9 Cg_exo -59.32 -54.08 2.92 Favored 'Trans proline' 0 C--N 1.408 3.691 0 CA-C-N 123.509 2.289 . . . . 65.430000000000007 112.867 -173.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -85.27 155.71 60.09 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 114.395 -1.275 . . . . 75.239999999999995 111.411 -171.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.9 -14.93 45.6 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.689 2.259 . . . . 71.319999999999993 111.532 165.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -108.05 56.41 0.63 Allowed 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 123.018 1.39 . . . . 72.530000000000001 108.344 170.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.531 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 22.0 p -67.85 -16.26 64.01 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.24 -1.345 . . . . 72.140000000000001 111.852 175.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -47.42 -36.47 9.9 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 126.01 1.724 . . . . 73.120000000000005 112.436 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.11 35.2 3.86 Favored Glycine 0 N--CA 1.47 0.932 0 CA-C-N 115.091 -0.959 . . . . 65.209999999999994 112.801 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 8.3 t -154.94 -46.54 0.08 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.403 1.097 . . . . 41.310000000000002 108.955 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 15.4 t -80.65 -44.19 19.24 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 113.333 -1.758 . . . . 73.439999999999998 111.562 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.453 HD23 ' SG ' ' A' ' 25' ' ' CYS . 74.9 mt -62.59 -18.56 62.41 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 114.68 1.363 . . . . 44.119999999999997 114.68 -172.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.65 -19.41 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 122.837 0.455 . . . . 71.439999999999998 111.636 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.527 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 16.0 pt20 -142.11 -34.01 0.47 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.112 0.965 . . . . 74.530000000000001 110.371 -168.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.527 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 3.7 m -104.69 158.11 16.73 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.614 1.166 . . . . 62.530000000000001 109.228 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.5 159.38 61.52 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.248 0.619 . . . . 43.43 110.962 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.69 -33.48 31.99 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.13 2.553 . . . . 51.210000000000001 112.674 164.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.0 t -57.12 -22.66 41.48 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.733 1.213 . . . . 73.549999999999997 112.401 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.823 HG21 ' HB2' ' A' ' 2' ' ' CYS . 31.8 mm -101.47 -51.55 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.681 0.792 . . . . 73.340000000000003 110.474 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.453 ' SG ' HD23 ' A' ' 17' ' ' LEU . 21.9 m -64.92 -22.14 66.94 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.089 0.956 . . . . 63.210000000000001 112.357 -172.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.61 76.0 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.616 0.766 . . . . 72.430000000000007 111.343 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.1 -19.22 63.25 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.739 -0.664 . . . . 64.120000000000005 112.722 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -89.28 -40.32 12.89 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.108 0.563 . . . . 71.340000000000003 110.877 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 21.1 m -74.55 -60.73 2.14 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.362 -0.836 . . . . 63.530000000000001 111.301 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.312 0 CA-C-N 116.015 -0.539 . . . . 35.520000000000003 112.554 -173.334 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.458 ' HB2' HG21 ' A' ' 24' ' ' ILE . 99.2 m . . . . . 0 CA--C 1.547 0.854 0 CA-C-O 121.047 0.451 . . . . 71.310000000000002 110.114 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.12 -56.76 1.05 Allowed Glycine 0 C--N 1.336 0.55 0 CA-C-N 115.98 -0.554 . . . . 74.219999999999999 112.382 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.7 p 149.97 -6.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 126.372 1.869 . . . . 72.140000000000001 108.791 -159.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -25.65 60.74 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.836 0.854 . . . . 71.540000000000006 110.698 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -100.74 53.16 0.86 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.507 1.123 . . . . 74.430000000000007 109.75 173.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.503 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -133.37 15.21 0.05 OUTLIER Pre-proline 0 CA--C 1.576 1.945 0 CA-C-N 113.724 -1.58 . . . . 72.109999999999999 114.802 169.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 31.8 Cg_exo -62.53 -51.53 3.21 Favored 'Trans proline' 0 C--N 1.407 3.657 0 CA-C-N 123.242 2.194 . . . . 72.019999999999996 111.549 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -84.68 159.66 57.64 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 113.735 -1.575 . . . . 72.439999999999998 110.793 -172.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.06 -23.92 28.89 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.475 2.117 . . . . 75.400000000000006 110.776 163.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -104.33 48.92 0.83 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.956 1.302 . . . . 74.129999999999995 109.137 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 19.9 p -61.06 -14.53 24.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.921 1.289 . . . . 74.25 113.822 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.551 ' HE3' HD11 ' A' ' 17' ' ' LEU . 61.8 m95 -47.07 -40.78 15.77 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.416 1.487 . . . . 75.540000000000006 112.298 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.33 -25.29 75.87 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-N 114.946 -1.025 . . . . 50.43 112.745 -173.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.467 ' O ' HG12 ' A' ' 18' ' ' VAL . 34.3 t -86.77 -45.63 10.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.109 0.957 . . . . 74.239999999999995 110.216 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 t -76.98 -53.76 7.42 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.619 -1.628 . . . . 53.109999999999999 112.578 -170.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.677 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -61.91 -7.81 4.24 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.854 1.798 . . . . 74.239999999999995 115.854 -175.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 15' ' ' CYS . 10.3 p -76.77 -23.73 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-N 119.278 0.945 . . . . 62.119999999999997 110.366 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -132.18 -24.19 2.11 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.253 1.021 . . . . 73.519999999999996 111.289 -169.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 2' ' ' CYS . 77.9 m -123.98 175.37 6.99 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.43 1.092 . . . . 72.129999999999995 110.472 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.52 157.4 58.46 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.915 0.886 . . . . 73.340000000000003 110.479 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.426 ' HB3' HD21 ' A' ' 17' ' ' LEU . 19.9 Cg_endo -61.33 -12.43 23.75 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 123.152 2.568 . . . . 71.040000000000006 112.769 171.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.0 t -62.49 -44.05 97.32 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.445 0.698 . . . . 50.439999999999998 110.689 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 2' ' ' CYS . 36.9 mm -69.99 -50.13 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 115.705 -0.679 . . . . 74.140000000000001 109.3 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.677 ' SG ' ' HG ' ' A' ' 17' ' ' LEU . 10.2 m -60.37 -36.18 77.44 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.303 -1.317 . . . . 71.010000000000005 111.733 -174.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.14 89.98 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.082 0.553 . . . . 51.43 110.687 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.07 -33.07 69.42 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.846 0.716 . . . . 54.020000000000003 113.429 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -92.37 -38.23 12.14 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.801 0.44 . . . . 73.349999999999994 111.585 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 34.5 m -69.09 -57.97 4.7 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.605 0.362 . . . . 62.439999999999998 111.676 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.777 0 CA-C-N 116.192 -0.458 . . . . 63.130000000000003 112.47 -172.92 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.68 ' SG ' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 108.437 -0.949 . . . . 62.200000000000003 108.437 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.31 -48.7 84.71 Favored Glycine 0 C--N 1.341 0.824 0 O-C-N 124.096 0.873 . . . . 64.120000000000005 114.858 -172.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.3 p 131.25 3.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 127.505 2.322 . . . . 63.409999999999997 107.916 -159.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.33 -26.85 63.94 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.005 0.922 . . . . 73.239999999999995 109.806 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 34.1 m -100.72 60.75 0.98 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.957 -1.019 . . . . 72.150000000000006 110.039 167.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.686 ' HB2' ' HB3' ' A' ' 28' ' ' TRP . . . -142.92 31.77 0.13 Allowed Pre-proline 0 CA--C 1.579 2.078 0 CA-C-N 113.797 -1.547 . . . . 74.450000000000003 113.403 163.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 51.3 Cg_exo -61.26 -50.24 6.29 Favored 'Trans proline' 0 C--N 1.405 3.51 0 CA-C-N 122.08 1.779 . . . . 74.019999999999996 111.974 170.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -84.14 161.36 55.2 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 113.781 -1.554 . . . . 45.119999999999997 111.36 -171.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.71 -33.91 75.33 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.259 1.973 . . . . 74.349999999999994 110.452 161.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -94.82 78.53 3.67 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.966 -1.016 . . . . 72.120000000000005 108.97 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.466 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 18.3 p -70.44 -18.01 63.0 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.86 -0.609 . . . . 51.039999999999999 110.592 171.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.52 ' HE3' HD11 ' A' ' 17' ' ' LEU . 64.9 m95 -49.23 -35.93 18.72 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 125.284 1.434 . . . . 73.349999999999994 111.774 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -93.6 49.06 2.32 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 114.909 -1.041 . . . . 41.299999999999997 112.161 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.47 ' O ' HG12 ' A' ' 18' ' ' VAL . 16.6 t -166.2 -45.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.812 1.245 . . . . 73.049999999999997 108.709 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 12.4 t -80.8 -45.8 16.38 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 113.493 -1.685 . . . . 74.310000000000002 111.936 -169.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.52 HD11 ' HE3' ' A' ' 13' ' ' TRP . 5.4 mp -72.11 -0.18 11.16 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 114.849 1.426 . . . . 64.409999999999997 114.849 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 15' ' ' CYS . 13.6 p -82.18 -18.36 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.849 0.749 . . . . 74.230000000000004 110.096 171.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.563 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 11.5 pt20 -138.04 -6.45 1.63 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.637 0.775 . . . . 73.299999999999997 111.777 -168.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.563 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 48.7 m -143.76 172.4 12.89 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.668 0.787 . . . . 75.010000000000005 110.357 -174.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 154.74 50.14 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.209 1.004 . . . . 41.229999999999997 109.785 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.4 -18.74 40.13 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.328 2.686 . . . . 64.319999999999993 112.771 172.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 t -61.05 -39.17 88.82 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.814 0.846 . . . . 53.210000000000001 110.694 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.68 HG21 ' SG ' ' A' ' 2' ' ' CYS . 45.1 mm -77.82 -48.42 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.419 0.688 . . . . 74.019999999999996 109.709 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.6 m -64.99 -30.41 71.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.639 -1.164 . . . . 54.229999999999997 112.082 -172.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.81 -29.01 70.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.059 0.544 . . . . 70.019999999999996 111.412 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.58 -27.75 37.96 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.536 0.522 . . . . 72.219999999999999 112.409 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.686 ' HB3' ' HB2' ' A' ' 7' ' ' ALA . 26.4 m95 -92.49 -32.78 14.75 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.259 0.624 . . . . 74.340000000000003 111.395 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.2 m -73.96 -74.83 0.17 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.247 0.546 . . . . 65.109999999999999 110.637 173.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.861 0 CA-C-N 114.783 -1.099 . . . . 61.100000000000001 110.67 -169.746 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.666 ' HB2' HG21 ' A' ' 24' ' ' ILE . 36.1 t . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.079 -0.711 . . . . 75.310000000000002 109.079 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.17 -16.86 79.1 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.705 -0.497 . . . . 55.539999999999999 111.862 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.7 p 61.49 8.5 2.25 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 125.79 1.636 . . . . 52.130000000000003 112.836 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -116.06 7.1 14.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.534 0.734 . . . . 63.509999999999998 109.07 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 88.3 m -106.51 34.96 3.14 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 124.058 0.943 . . . . 73.099999999999994 110.734 170.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.532 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -96.39 -19.26 0.22 Allowed Pre-proline 0 CA--C 1.586 2.339 0 N-CA-C 115.188 1.551 . . . . 71.120000000000005 115.188 167.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 25.1 Cg_exo -63.47 -53.66 1.32 Allowed 'Trans proline' 0 C--N 1.412 3.875 0 CA-C-N 123.329 2.225 . . . . 51.229999999999997 114.072 -163.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.36 159.64 84.0 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 114.904 -1.044 . . . . 74.420000000000002 111.685 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.79 -26.35 32.51 Favored 'Trans proline' 0 CA--C 1.554 1.511 0 C-N-CA 122.193 1.929 . . . . 63.43 111.044 162.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -98.87 31.98 2.78 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 124.44 1.096 . . . . 74.409999999999997 109.612 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 2.6 p -61.05 -20.8 62.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.405 1.082 . . . . 74.030000000000001 112.767 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -54.76 -38.27 67.01 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.176 0.99 . . . . 74.409999999999997 110.693 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -23.89 74.82 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 115.06 -0.973 . . . . 74.219999999999999 112.781 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.476 ' O ' HG12 ' A' ' 18' ' ' VAL . 34.6 t -89.24 -43.47 10.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.492 1.117 . . . . 75.230000000000004 109.968 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 42.2 t -71.79 -52.02 19.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.151 -1.386 . . . . 64.019999999999996 111.455 -171.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.462 HD21 ' HB3' ' A' ' 22' ' ' PRO . 4.4 mp -73.0 9.89 1.06 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 115.583 1.697 . . . . 71.200000000000003 115.583 -173.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 15' ' ' CYS . 13.9 p -91.14 -12.56 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 118.875 0.761 . . . . 61.229999999999997 109.442 170.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.523 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 27.6 pt20 -152.86 2.4 0.31 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.344 0.657 . . . . 71.439999999999998 112.028 -167.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.523 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 1.4 m -147.03 156.66 43.2 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.607 0.763 . . . . 72.230000000000004 109.354 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.95 149.9 77.49 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.241 0.616 . . . . 73.140000000000001 110.819 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.462 ' HB3' HD21 ' A' ' 17' ' ' LEU . 13.2 Cg_endo -55.94 -23.2 41.81 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.525 2.817 . . . . 74.140000000000001 113.713 174.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -65.24 -38.71 91.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.955 0.502 . . . . 61.32 110.388 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.666 HG21 ' HB2' ' A' ' 2' ' ' CYS . 23.4 mm -75.1 -43.75 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.226 -0.657 . . . . 72.530000000000001 109.226 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.5 m -66.96 -28.41 68.25 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.158 0.983 . . . . 72.150000000000006 111.055 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.86 -28.3 68.86 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.563 0.745 . . . . 71.349999999999994 111.231 170.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.95 -35.71 38.34 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 116.221 -0.445 . . . . 75.140000000000001 112.133 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -82.52 -69.34 0.63 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.98 0.512 . . . . 71.040000000000006 110.296 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.5 m -64.68 -49.45 70.9 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.142 0.977 . . . . 74.010000000000005 112.096 -175.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.182 0 CA-C-N 115.52 -0.764 . . . . 23.399999999999999 112.968 -178.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.698 ' HB2' HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.71 -0.478 . . . . 61.299999999999997 109.71 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.0 -5.46 73.4 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.527 -0.596 . . . . 75.120000000000005 112.306 166.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.3 m 64.88 18.54 11.52 Favored 'General case' 0 C--N 1.372 1.545 0 C-N-CA 124.721 1.208 . . . . 64.140000000000001 109.853 -171.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -102.82 -38.49 7.4 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.449 -1.315 . . . . 73.129999999999995 107.449 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.1 m -86.67 44.86 1.19 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.212 1.005 . . . . 73.230000000000004 111.707 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.433 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -122.6 33.11 0.22 Allowed Pre-proline 0 CA--C 1.576 1.973 0 N-CA-C 114.728 1.381 . . . . 64.5 114.728 165.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 35.3 Cg_exo -64.79 -61.05 0.11 Allowed 'Trans proline' 0 C--N 1.397 3.119 0 CA-C-N 122.675 1.991 . . . . 73.209999999999994 111.072 169.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -82.67 151.54 64.95 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-N 114.239 -1.346 . . . . 74.439999999999998 111.37 -170.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.5 -32.64 96.62 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.937 2.424 . . . . 65.200000000000003 110.67 162.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -94.61 70.0 3.53 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 122.44 1.114 . . . . 73.299999999999997 108.532 171.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.527 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 22.1 p -77.8 -15.26 59.22 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.366 -1.288 . . . . 71.439999999999998 112.803 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -48.5 -38.78 21.09 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.381 1.473 . . . . 55.409999999999997 112.885 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.83 -16.97 80.31 Favored Glycine 0 N--CA 1.476 1.315 0 CA-C-N 115.553 -0.749 . . . . 74.109999999999999 113.339 -172.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.435 ' O ' HG12 ' A' ' 18' ' ' VAL . 11.4 t -96.13 -51.75 4.29 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.166 0.984 . . . . 55.25 109.677 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 t -73.82 -45.3 52.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.685 -1.598 . . . . 54.210000000000001 112.715 -166.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.485 HD23 ' SG ' ' A' ' 25' ' ' CYS . 76.3 mt -59.15 -22.24 60.6 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.061 1.504 . . . . 73.25 115.061 -172.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 15' ' ' CYS . 7.6 p -78.52 -22.75 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 118.666 0.666 . . . . 33.200000000000003 111.184 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -133.85 1.0 3.27 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.03 0.932 . . . . 70.319999999999993 111.282 -170.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.1 m -149.09 167.65 25.31 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.479 1.112 . . . . 61.240000000000002 109.55 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.53 154.68 62.43 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.649 0.78 . . . . 50.130000000000003 110.492 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.32 -25.05 45.52 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.26 2.64 . . . . 53.310000000000002 112.856 167.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -57.37 -37.53 72.76 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.981 0.912 . . . . 73.129999999999995 111.137 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.698 HG21 ' HB2' ' A' ' 2' ' ' CYS . 43.3 mm -82.83 -49.41 16.93 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 C-N-CA 123.189 0.596 . . . . 70.120000000000005 110.341 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.485 ' SG ' HD23 ' A' ' 17' ' ' LEU . 11.4 m -64.26 -26.84 68.68 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.076 -0.966 . . . . 54.329999999999998 111.867 -171.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.78 -33.57 71.88 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.491 0.717 . . . . 64.430000000000007 111.76 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.51 -42.45 11.61 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 116.447 -0.342 . . . . 73.329999999999998 112.808 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -73.94 -34.23 64.23 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.868 0.467 . . . . 62.219999999999999 110.974 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 21.9 m -77.92 -78.76 0.13 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.249 0.62 . . . . 44.329999999999998 110.794 175.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.559 0 O-C-N 123.245 0.341 . . . . 44.020000000000003 112.911 -170.619 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.765 ' HB2' HG21 ' A' ' 24' ' ' ILE . 9.3 t . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 107.8 -1.185 . . . . 75.120000000000005 107.8 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.23 -11.41 67.05 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.363 -0.687 . . . . 53.229999999999997 112.958 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.4 m 68.94 6.23 5.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.998 1.319 . . . . 62.350000000000001 110.708 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -88.23 -45.47 10.05 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.291 1.037 . . . . 62.109999999999999 108.694 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 92.3 m -89.39 50.1 1.87 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.618 -1.174 . . . . 73.230000000000004 111.516 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.556 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -104.35 -15.27 0.16 Allowed Pre-proline 0 CA--C 1.577 2.011 0 N-CA-C 116.306 1.965 . . . . 61.439999999999998 116.306 167.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 14.0 Cg_exo -64.15 -49.47 3.71 Favored 'Trans proline' 0 C--N 1.407 3.644 0 CA-C-N 122.98 2.1 . . . . 71.209999999999994 113.342 -160.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -77.95 154.62 80.41 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 113.514 -1.676 . . . . 64.019999999999996 111.431 -166.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.17 -38.6 75.54 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.185 1.923 . . . . 62.149999999999999 110.425 174.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -100.56 82.42 2.45 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 107.358 -1.349 . . . . 61.229999999999997 107.358 167.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.533 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 23.6 p -73.48 -18.14 61.15 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.867 0.867 . . . . 62.149999999999999 111.778 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -48.5 -40.32 26.28 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 125.262 1.425 . . . . 73.530000000000001 112.354 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.3 -27.5 73.59 Favored Glycine 0 N--CA 1.478 1.441 0 CA-C-N 115.334 -0.848 . . . . 63.229999999999997 112.87 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 12.7 t -90.66 -45.78 8.67 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.294 1.045 . . . . 75.329999999999998 110.107 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 11.4 t -74.75 -44.48 49.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.28 -1.782 . . . . 62.340000000000003 112.122 -166.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.405 HD23 ' SG ' ' A' ' 25' ' ' CYS . 72.7 mt -63.26 -15.99 58.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 115.019 1.488 . . . . 65.209999999999994 115.019 -173.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 15' ' ' CYS . 14.6 p -81.06 -10.81 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 118.706 0.684 . . . . 73.120000000000005 110.884 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -147.32 -3.81 0.55 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.377 0.671 . . . . 75.140000000000001 111.663 -169.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 8.2 m -145.61 162.87 36.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.115 0.966 . . . . 54.030000000000001 109.037 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.85 157.13 67.07 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.73 0.812 . . . . 64.010000000000005 111.399 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.84 -23.72 68.61 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.485 2.79 . . . . 54.32 113.066 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.4 p -65.17 -32.63 74.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.109 0.564 . . . . 75.109999999999999 110.643 173.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.765 HG21 ' HB2' ' A' ' 2' ' ' CYS . 14.6 mm -84.81 -49.04 16.18 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 121.175 0.512 . . . . 73.340000000000003 110.242 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.405 ' SG ' HD23 ' A' ' 17' ' ' LEU . 16.1 m -62.87 -28.1 69.8 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.837 -1.074 . . . . 73.299999999999997 111.235 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.25 -45.29 72.33 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.963 0.505 . . . . 64.109999999999999 111.004 169.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.13 -32.53 60.33 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.102 -0.954 . . . . 75.230000000000004 113.64 -175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -86.17 -28.7 23.76 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.896 0.478 . . . . 72.25 111.885 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.3 m -78.98 -70.07 0.53 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.615 0.366 . . . . 73.319999999999993 111.273 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.215 0 C-N-CA 121.743 -0.265 . . . . 52.240000000000002 113.552 -169.429 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.468 ' SG ' HG21 ' A' ' 24' ' ' ILE . 31.2 m . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 109.887 -0.412 . . . . 60.399999999999999 109.887 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.04 12.2 58.52 Favored Glycine 0 N--CA 1.473 1.145 0 N-CA-C 116.81 1.484 . . . . 63.530000000000001 116.81 -161.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.2 p 58.1 15.43 3.24 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.105 1.362 . . . . 74.040000000000006 112.29 -172.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.63 -29.41 56.44 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 108.771 -0.826 . . . . 73.310000000000002 108.771 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 18.5 m -96.39 51.08 1.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.286 -0.87 . . . . 52.140000000000001 110.511 168.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.433 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -122.92 21.73 0.1 OUTLIER Pre-proline 0 CA--C 1.59 2.498 0 N-CA-C 115.071 1.508 . . . . 61.219999999999999 115.071 163.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 52.6 Cg_exo -58.32 -58.26 0.82 Allowed 'Trans proline' 0 C--N 1.409 3.751 0 CA-C-N 123.239 2.192 . . . . 74.409999999999997 113.115 174.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -80.1 154.65 75.0 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 114.845 -1.07 . . . . 64.439999999999998 111.193 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.26 -35.46 91.62 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.937 2.425 . . . . 75.439999999999998 110.655 168.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.44 75.41 5.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.003 -1.11 . . . . 63.43 108.003 167.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.547 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 20.7 p -68.22 -18.21 64.51 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.732 -1.122 . . . . 75.219999999999999 110.992 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -48.88 -36.69 17.67 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 125.411 1.484 . . . . 75.0 111.419 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.37 25.27 6.42 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-N 114.987 -1.006 . . . . 73.329999999999998 113.579 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.428 ' O ' HG12 ' A' ' 18' ' ' VAL . 20.0 t -143.5 -46.52 0.29 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.777 1.231 . . . . 73.329999999999998 108.649 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.2 t -78.02 -44.62 26.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.005 -1.907 . . . . 72.239999999999995 111.763 -170.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.2 mt -62.12 -12.59 20.33 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.974 1.472 . . . . 75.430000000000007 114.974 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 15' ' ' CYS . 11.4 p -82.22 -19.75 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 119.087 0.858 . . . . 74.099999999999994 110.584 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -142.08 5.26 1.69 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.046 0.938 . . . . 74.430000000000007 111.475 -169.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 48.4 m -146.49 172.05 14.13 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.751 1.22 . . . . 73.150000000000006 109.068 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.43 161.54 24.91 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 123.555 0.742 . . . . 52.009999999999998 110.871 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.04 -31.52 8.63 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 123.631 2.888 . . . . 51.119999999999997 114.61 169.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 m -56.42 -40.48 74.76 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.278 0.631 . . . . 62.439999999999998 111.505 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.468 HG21 ' SG ' ' A' ' 2' ' ' CYS . 47.6 mm -78.3 -55.73 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.603 -0.726 . . . . 72.040000000000006 110.089 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 m -63.88 -31.29 72.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.992 -1.003 . . . . 64.540000000000006 112.131 -170.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.82 -31.12 69.42 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.969 0.508 . . . . 74.430000000000007 112.012 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.45 -26.05 48.62 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.8 0.688 . . . . 51.450000000000003 112.561 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -91.2 -31.36 16.21 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.432 0.693 . . . . 70.310000000000002 111.015 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 18.6 m -80.82 -70.02 0.56 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.012 0.925 . . . . 70.329999999999998 111.935 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.504 0 CA-C-N 115.001 -1.0 . . . . 53.219999999999999 111.685 -167.102 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.718 ' SG ' HG21 ' A' ' 24' ' ' ILE . 95.7 m . . . . . 0 CA--C 1.555 1.159 0 N-CA-C 112.248 0.462 . . . . 72.510000000000005 112.248 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.4 -6.51 77.67 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.266 -0.741 . . . . 61.43 113.966 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.0 p 60.0 15.98 5.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.475 1.51 . . . . 73.219999999999999 112.576 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -34.57 44.68 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.471 -0.786 . . . . 72.340000000000003 109.287 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 93.0 m -101.56 43.49 1.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.559 1.144 . . . . 70.340000000000003 110.727 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.535 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -95.89 -26.09 0.25 Allowed Pre-proline 0 CA--C 1.578 2.054 0 N-CA-C 115.826 1.787 . . . . 73.040000000000006 115.826 171.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 11.8 Cg_exo -65.8 -44.47 7.91 Favored 'Trans proline' 0 C--N 1.398 3.171 0 C-N-CA 122.161 1.907 . . . . 75.319999999999993 114.005 -157.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -83.34 157.0 65.83 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 114.109 -1.405 . . . . 72.120000000000005 111.983 -160.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.28 -27.61 63.81 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.214 1.943 . . . . 75.219999999999999 111.255 162.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -104.8 38.87 1.81 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.344 1.058 . . . . 72.129999999999995 109.224 174.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.5 p -64.92 -21.64 66.86 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.55 -0.719 . . . . 71.140000000000001 111.27 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -48.62 -38.78 21.85 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 125.242 1.417 . . . . 72.430000000000007 111.79 171.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.73 -14.47 79.86 Favored Glycine 0 N--CA 1.473 1.105 0 CA-C-N 115.04 -0.982 . . . . 72.349999999999994 113.104 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 20.5 t -99.43 -41.26 7.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.121 1.368 . . . . 74.540000000000006 110.151 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 9.9 t -81.03 -45.5 16.46 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 113.174 -1.83 . . . . 73.519999999999996 112.553 -168.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.6 -0.47 1.4 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.245 1.572 . . . . 71.129999999999995 115.245 -175.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -88.35 -23.46 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-N 119.176 0.898 . . . . 73.109999999999999 110.436 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -133.79 -3.42 2.9 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.161 0.985 . . . . 74.099999999999994 111.235 -169.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.507 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 63.2 m -144.14 170.18 16.45 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.643 0.777 . . . . 61.350000000000001 110.592 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.41 159.93 34.15 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.186 0.995 . . . . 71.340000000000003 110.795 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -48.12 -30.29 14.11 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 123.686 2.924 . . . . 51.439999999999998 114.161 168.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.2 m -60.91 -39.4 89.2 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.991 0.917 . . . . 62.240000000000002 111.395 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.718 HG21 ' SG ' ' A' ' 2' ' ' CYS . 51.1 mm -77.36 -53.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 123.533 0.733 . . . . 73.299999999999997 109.82 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.7 m -62.76 -31.22 72.13 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.75 -1.114 . . . . 33.439999999999998 112.014 -173.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.6 -39.98 84.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.717 0.407 . . . . 65.150000000000006 110.572 172.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.64 -24.32 75.36 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.88 -0.6 . . . . 60.310000000000002 112.977 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.51 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . 81.7 m95 -97.14 -43.79 7.23 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.413 0.685 . . . . 74.329999999999998 111.665 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.5 m -71.4 -73.06 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.31 0.576 . . . . 52.109999999999999 110.864 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.823 0 CA-C-N 114.998 -1.001 . . . . 62.210000000000001 111.315 -170.644 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 50.1 m . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 121.022 0.439 . . . . 65.230000000000004 110.071 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.63 19.13 16.69 Favored Glycine 0 N--CA 1.47 0.905 0 CA-C-N 115.605 -0.725 . . . . 65.209999999999994 112.912 -174.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t 64.44 14.93 9.21 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.833 1.253 . . . . 74.209999999999994 110.791 -166.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -80.29 -33.14 37.93 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.372 -0.973 . . . . 72.209999999999994 108.372 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.403 ' SG ' ' NE2' ' A' ' 19' ' ' GLN . 91.3 m -99.6 46.93 0.96 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.626 -1.17 . . . . 70.329999999999998 110.964 173.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.541 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -112.74 -6.89 0.1 Allowed Pre-proline 0 CA--C 1.577 1.999 0 CA-C-O 116.409 -1.758 . . . . 24.210000000000001 115.565 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 39.1 Cg_exo -62.01 -50.69 4.63 Favored 'Trans proline' 0 C--N 1.408 3.692 0 CA-C-N 123.416 2.256 . . . . 73.409999999999997 113.176 -169.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -77.68 153.91 81.03 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 114.594 -1.185 . . . . 74.5 111.539 -170.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.47 -25.32 41.62 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.216 1.944 . . . . 61.149999999999999 110.658 164.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -104.26 45.84 0.94 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.014 1.326 . . . . 70.400000000000006 108.92 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 20.6 p -56.02 -19.79 14.13 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.499 1.12 . . . . 74.430000000000007 112.455 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -42.74 -39.51 2.47 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.096 1.758 . . . . 60.020000000000003 112.378 171.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.31 -22.09 76.12 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 115.413 -0.812 . . . . 72.409999999999997 113.616 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.469 ' O ' HG12 ' A' ' 18' ' ' VAL . 25.0 t -96.31 -46.21 6.51 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.25 1.024 . . . . 75.540000000000006 109.987 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -76.99 -47.35 21.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 113.424 -1.717 . . . . 72.319999999999993 112.734 -166.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.436 HD23 ' SG ' ' A' ' 25' ' ' CYS . 47.1 mt -61.46 -14.26 27.18 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.076 1.51 . . . . 62.409999999999997 115.076 -173.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 15' ' ' CYS . 14.0 p -74.93 -23.58 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 118.909 0.777 . . . . 74.129999999999995 110.952 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.403 ' NE2' ' SG ' ' A' ' 6' ' ' CYS . 21.4 pt20 -134.43 -18.54 1.96 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.139 0.976 . . . . 73.129999999999995 111.426 -167.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.8 m -128.55 170.9 12.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.243 1.017 . . . . 72.420000000000002 110.396 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.18 154.9 57.72 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.192 0.997 . . . . 74.209999999999994 110.8 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.48 -26.54 12.4 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.683 2.922 . . . . 74.319999999999993 114.304 168.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 m -61.98 -41.42 98.0 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.134 0.574 . . . . 55.25 111.174 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.04 -52.87 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 122.956 0.502 . . . . 54.030000000000001 110.28 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.436 ' SG ' HD23 ' A' ' 17' ' ' LEU . 4.0 m -62.0 -33.35 74.17 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.866 -1.061 . . . . 72.340000000000003 111.092 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.8 -36.77 77.43 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.603 0.761 . . . . 74.430000000000007 111.565 174.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.04 -41.53 22.13 Favored Glycine 0 C--N 1.351 1.364 0 O-C-N 123.91 0.756 . . . . 42.020000000000003 112.423 -174.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -77.93 -40.67 38.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.124 0.569 . . . . 63.399999999999999 111.863 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.8 m -67.35 -63.67 1.01 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.34 0.59 . . . . 72.329999999999998 110.542 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.654 0 CA-C-N 114.793 -1.094 . . . . 32.229999999999997 111.446 -167.942 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.765 ' HB2' HG21 ' A' ' 24' ' ' ILE . 6.2 t . . . . . 0 C--O 1.243 0.722 0 N-CA-C 108.931 -0.766 . . . . 25.420000000000002 108.931 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.46 -18.71 65.77 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.796 -0.446 . . . . 73.329999999999998 112.567 173.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.8 m 69.54 8.6 6.84 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 124.777 1.231 . . . . 55.310000000000002 112.272 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -117.55 6.64 12.53 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.494 1.117 . . . . 73.140000000000001 110.437 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.5 m -113.66 31.88 6.2 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.131 0.972 . . . . 65.400000000000006 110.984 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.578 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -95.02 -20.88 0.23 Allowed Pre-proline 0 CA--C 1.58 2.103 0 N-CA-C 115.318 1.599 . . . . 64.450000000000003 115.318 166.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 9.6 Cg_exo -70.35 -47.27 0.78 Allowed 'Trans proline' 0 C--N 1.4 3.262 0 C-N-CA 122.448 2.098 . . . . 65.450000000000003 113.849 -162.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -70.62 159.64 84.39 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.591 -1.186 . . . . 74.319999999999993 112.164 -164.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.51 -29.62 44.43 Favored 'Trans proline' 0 C--N 1.368 1.572 0 C-N-CA 122.159 1.906 . . . . 61.229999999999997 111.352 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -109.22 31.77 5.47 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.644 1.178 . . . . 73.420000000000002 109.894 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.0 p -53.54 -21.39 6.36 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.189 1.396 . . . . 74.230000000000004 114.067 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.465 ' HE3' HD11 ' A' ' 17' ' ' LEU . 81.4 m95 -55.42 -38.31 68.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.439 1.096 . . . . 64.230000000000004 111.16 175.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.92 -21.08 78.14 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 114.984 -1.007 . . . . 54.450000000000003 112.542 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' O ' HG12 ' A' ' 18' ' ' VAL . 15.1 t -83.74 -45.06 13.78 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.112 0.965 . . . . 72.510000000000005 109.645 177.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.4 t -78.52 -55.72 4.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.98 -1.464 . . . . 74.420000000000002 111.776 -168.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.465 HD11 ' HE3' ' A' ' 13' ' ' TRP . 2.2 mp -62.0 -9.19 6.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.113 1.523 . . . . 72.439999999999998 115.113 -175.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 15' ' ' CYS . 11.1 p -80.28 -15.56 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 119.255 0.934 . . . . 64.439999999999998 109.919 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.611 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 26.5 pt20 -144.23 -4.8 0.79 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.875 0.87 . . . . 31.41 111.703 -170.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.611 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 3.9 m -139.77 170.32 16.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.666 0.787 . . . . 62.0 109.197 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.432 ' HB3' HG12 ' A' ' 24' ' ' ILE . . . -80.08 149.91 70.65 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 122.983 0.513 . . . . 73.209999999999994 111.236 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.437 ' HB3' HD21 ' A' ' 17' ' ' LEU . 9.3 Cg_endo -54.07 -27.25 44.99 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 123.364 2.709 . . . . 54.32 112.844 165.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.3 m -62.77 -39.62 94.76 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.599 0.76 . . . . 64.219999999999999 110.473 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.765 HG21 ' HB2' ' A' ' 2' ' ' CYS . 44.9 mm -73.29 -48.33 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 123.773 0.829 . . . . 70.450000000000003 110.0 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.4 m -64.05 -31.94 73.32 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.401 1.08 . . . . 74.409999999999997 111.54 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.58 -31.43 70.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.547 -0.751 . . . . 75.540000000000006 111.865 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.64 -32.87 26.29 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 116.381 -0.372 . . . . 25.210000000000001 112.937 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -80.73 -54.55 5.52 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.938 0.495 . . . . 71.310000000000002 111.338 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -79.19 -69.99 0.54 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.25 0.62 . . . . 62.200000000000003 112.527 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.182 0 N-CA-C 112.02 -0.432 . . . . 63.140000000000001 112.02 -166.941 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.748 ' HB2' HG21 ' A' ' 24' ' ' ILE . 2.0 t . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 108.287 -1.005 . . . . 73.450000000000003 108.287 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.55 -17.64 79.75 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.392 -0.671 . . . . 52.0 112.457 170.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.1 t 71.07 29.68 2.87 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 124.808 1.243 . . . . 65.129999999999995 108.289 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -111.28 -31.27 7.12 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.278 -1.328 . . . . 72.150000000000006 109.94 -174.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 96.8 m -103.25 44.42 1.02 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.397 1.079 . . . . 73.230000000000004 112.435 -175.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.547 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -105.26 -10.47 0.12 Allowed Pre-proline 0 CA--C 1.589 2.445 0 N-CA-C 116.233 1.938 . . . . 72.030000000000001 116.233 167.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 16.3 Cg_exo -67.09 -50.67 0.97 Allowed 'Trans proline' 0 C--N 1.401 3.321 0 CA-C-N 123.752 2.376 . . . . 73.120000000000005 114.023 -167.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -80.72 162.33 60.68 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.627 -1.169 . . . . 75.239999999999995 112.602 -162.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.95 -17.09 28.95 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.534 2.156 . . . . 71.129999999999995 111.439 166.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -114.3 27.6 9.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.741 1.216 . . . . 74.299999999999997 110.249 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.9 p -62.48 -16.24 54.35 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.301 1.04 . . . . 75.310000000000002 112.779 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.43 ' HE3' HD11 ' A' ' 17' ' ' LEU . 89.2 m95 -53.76 -39.05 65.02 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.698 0.799 . . . . 72.109999999999999 110.818 173.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.36 -28.41 73.28 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 115.749 -0.66 . . . . 73.129999999999995 112.127 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.52 ' O ' HG12 ' A' ' 18' ' ' VAL . 34.3 t -80.94 -43.77 19.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.356 1.062 . . . . 75.219999999999999 109.742 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -70.32 -54.39 12.78 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.525 -1.216 . . . . 64.200000000000003 111.092 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 22' ' ' PRO . 2.1 mp -69.13 -2.64 10.77 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 115.17 1.544 . . . . 72.430000000000007 115.17 -174.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 15' ' ' CYS . 13.3 p -84.56 -16.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 119.408 1.003 . . . . 62.130000000000003 109.715 176.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -145.15 -3.07 0.77 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.55 0.74 . . . . 54.340000000000003 111.965 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.2 m -144.14 164.45 30.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.856 0.862 . . . . 70.109999999999999 109.531 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.63 154.7 73.7 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-N 115.894 -0.594 . . . . 65.519999999999996 110.515 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.479 ' HB3' HD21 ' A' ' 17' ' ' LEU . 18.3 Cg_endo -59.83 -19.53 54.83 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.957 2.438 . . . . 63.229999999999997 112.234 169.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -58.4 -38.59 77.67 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.905 0.882 . . . . 71.299999999999997 110.872 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.748 HG21 ' HB2' ' A' ' 2' ' ' CYS . 23.9 mm -84.59 -43.06 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.821 -0.627 . . . . 63.310000000000002 110.112 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 m -64.97 -30.5 71.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.238 1.015 . . . . 64.439999999999998 112.07 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.42 -24.4 65.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.991 0.516 . . . . 42.530000000000001 111.541 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.23 -45.49 8.82 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.133 -0.485 . . . . 71.439999999999998 112.138 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -77.48 -67.11 0.75 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.903 0.481 . . . . 73.409999999999997 110.906 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.1 m -69.66 -32.19 70.69 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.363 -0.835 . . . . 52.409999999999997 112.536 -173.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.837 0 CA-C-N 115.997 -0.547 . . . . 61.409999999999997 113.026 -177.656 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.2 m . . . . . 0 CA--C 1.549 0.917 0 CA-C-O 121.198 0.523 . . . . 71.439999999999998 111.086 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.81 19.78 32.6 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.282 -0.872 . . . . 33.450000000000003 113.866 -171.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.2 m 67.89 14.19 9.34 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.604 1.162 . . . . 64.230000000000004 111.193 -173.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.94 -20.37 20.07 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.409 1.083 . . . . 74.329999999999998 109.292 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 77.2 m -100.43 45.86 0.97 Allowed 'General case' 0 C--N 1.347 0.489 0 C-N-CA 124.382 1.073 . . . . 63.520000000000003 111.07 172.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.545 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -120.45 5.79 0.07 OUTLIER Pre-proline 0 CA--C 1.582 2.18 0 N-CA-C 115.657 1.725 . . . . 73.099999999999994 115.657 168.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 23.9 Cg_exo -65.55 -51.08 1.52 Allowed 'Trans proline' 0 C--N 1.406 3.589 0 CA-C-N 123.648 2.339 . . . . 72.030000000000001 112.415 -175.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -83.28 156.08 66.35 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 113.672 -1.604 . . . . 64.109999999999999 111.529 -167.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -60.9 -39.96 57.15 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.331 2.021 . . . . 72.319999999999993 110.252 166.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -92.76 75.33 4.94 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 108.411 -0.959 . . . . 70.439999999999998 108.411 170.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 15.9 p -73.24 -21.5 60.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.176 -0.92 . . . . 74.230000000000004 110.343 174.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -48.75 -37.86 20.09 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 125.351 1.46 . . . . 72.109999999999999 111.253 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.67 -36.52 92.47 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.0 -1.0 . . . . 61.399999999999999 112.006 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.9 t -80.87 -44.75 17.9 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.391 1.091 . . . . 61.130000000000003 110.439 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HA ' ' NE2' ' A' ' 19' ' ' GLN . 5.1 t -82.73 -54.11 5.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.282 -1.781 . . . . 74.510000000000005 112.029 -166.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.99 -19.11 11.22 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.119 1.525 . . . . 45.43 115.119 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.52 -25.7 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 118.407 0.548 . . . . 72.030000000000001 111.324 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.431 ' NE2' ' HA ' ' A' ' 16' ' ' CYS . 2.9 pp0? -134.98 -0.72 2.75 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.75 0.82 . . . . 70.409999999999997 112.227 -175.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 74.2 m -136.47 175.88 9.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.265 1.026 . . . . 72.019999999999996 110.634 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.27 160.8 27.33 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.495 1.118 . . . . 62.340000000000003 110.188 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.6 -18.44 40.15 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 122.997 2.465 . . . . 65.519999999999996 113.504 173.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.9 p -60.79 -40.02 91.06 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.148 0.579 . . . . 65.340000000000003 110.635 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.7 mm -75.68 -56.03 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 123.307 0.643 . . . . 70.239999999999995 110.1 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -61.01 -29.07 69.49 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.74 -1.118 . . . . 64.5 112.573 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.37 -36.15 79.44 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.895 0.478 . . . . 43.530000000000001 111.659 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.13 -20.59 69.63 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.974 -0.557 . . . . 74.329999999999998 112.873 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -97.39 -35.21 10.76 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.311 0.644 . . . . 71.019999999999996 111.564 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.8 m -76.77 -69.89 0.49 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.137 0.575 . . . . 60.43 111.277 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.74 0 N-CA-C 111.094 -0.803 . . . . 74.099999999999994 111.094 -173.195 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.491 ' HB2' HG21 ' A' ' 24' ' ' ILE . 4.0 t . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.242 0.544 . . . . 62.340000000000003 110.592 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.57 -0.72 75.44 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.712 -0.677 . . . . 73.329999999999998 112.884 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 m 64.05 18.63 11.34 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 124.296 1.038 . . . . 73.420000000000002 108.884 -161.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -74.32 -50.2 19.79 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 114.572 -1.195 . . . . 73.010000000000005 108.811 -165.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 64.4 m -106.2 50.33 0.78 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 113.795 -1.548 . . . . 73.310000000000002 110.858 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.538 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -89.62 -27.12 0.32 Allowed Pre-proline 0 CA--C 1.582 2.21 0 N-CA-C 115.199 1.555 . . . . 73.019999999999996 115.199 166.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 21.1 Cg_exo -64.37 -50.66 2.51 Favored 'Trans proline' 0 C--N 1.407 3.637 0 C-N-CA 122.862 2.374 . . . . 55.520000000000003 114.272 -161.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -72.45 158.81 86.82 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.765 0.826 . . . . 72.109999999999999 112.043 -167.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.41 -32.86 59.9 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.434 2.089 . . . . 62.039999999999999 110.616 163.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -95.68 32.7 1.78 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.96 1.304 . . . . 62.530000000000001 110.394 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -49.91 -32.49 14.79 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.417 1.487 . . . . 53.0 112.041 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -52.04 -40.66 61.45 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 124.719 1.207 . . . . 53.210000000000001 111.952 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.02 47.77 3.4 Favored Glycine 0 N--CA 1.478 1.434 0 CA-C-N 114.757 -1.11 . . . . 62.43 111.055 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 6.7 t -170.42 -46.44 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.055 1.342 . . . . 71.150000000000006 108.249 -169.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 41.2 t -79.56 -46.55 17.1 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 114.065 -1.425 . . . . 73.140000000000001 111.536 -170.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -76.3 15.44 0.59 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.491 1.293 . . . . 75.030000000000001 114.491 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 15' ' ' CYS . 8.1 p -97.13 -12.31 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-O 121.633 0.73 . . . . 64.329999999999998 109.725 168.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.62 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 25.9 pt20 -145.95 -3.68 0.67 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.695 0.798 . . . . 73.420000000000002 111.774 -170.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.62 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 0.8 OUTLIER -144.95 158.02 43.95 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 123.69 0.796 . . . . 61.109999999999999 108.96 -178.417 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.526 ' HB3' HG12 ' A' ' 24' ' ' ILE . . . -78.94 151.42 76.23 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.034 0.534 . . . . 51.210000000000001 110.722 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.16 -30.28 49.8 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.876 3.051 . . . . 44.329999999999998 113.281 172.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 m -63.57 -36.73 84.78 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.905 0.482 . . . . 74.420000000000002 110.776 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.526 HG12 ' HB3' ' A' ' 21' ' ' ALA . 12.1 mm -78.71 -48.35 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 109.212 -0.662 . . . . 74.329999999999998 109.212 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 m -61.69 -35.79 79.03 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.426 1.09 . . . . 75.510000000000005 111.326 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.72 -30.26 70.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.984 0.514 . . . . 64.329999999999998 111.574 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.75 -38.92 49.39 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.704 0.628 . . . . 74.129999999999995 112.071 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.491 ' HE1' HG22 ' A' ' 24' ' ' ILE . 60.0 m95 -75.96 -49.52 17.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.171 0.588 . . . . 75.140000000000001 110.831 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.08 -61.89 1.6 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.5 -0.773 . . . . 73.5 111.719 -175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.246 0 N-CA-C 114.264 0.466 . . . . 63.32 114.264 -170.471 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.642 ' SG ' HG21 ' A' ' 24' ' ' ILE . 55.8 m . . . . . 0 CA--C 1.547 0.85 0 CA-C-O 121.135 0.493 . . . . 73.310000000000002 111.136 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.49 -7.83 87.1 Favored Glycine 0 N--CA 1.468 0.809 0 CA-C-O 119.188 -0.785 . . . . 73.310000000000002 115.023 -165.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 m 70.34 6.09 5.63 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.016 1.327 . . . . 62.399999999999999 111.002 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.41 -34.2 63.2 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.219 1.008 . . . . 63.439999999999998 109.401 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.4 m -90.14 41.41 1.05 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.246 1.019 . . . . 73.439999999999998 111.277 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.484 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -126.53 26.72 0.13 Allowed Pre-proline 0 CA--C 1.58 2.103 0 N-CA-C 115.482 1.66 . . . . 72.319999999999993 115.482 172.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 13.0 Cg_exo -68.8 -54.47 0.27 Allowed 'Trans proline' 0 C--N 1.398 3.134 0 CA-C-N 122.746 2.016 . . . . 62.43 111.267 172.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -83.86 165.13 41.1 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 113.105 -1.861 . . . . 64.530000000000001 111.471 -164.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.33 -25.38 36.26 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.209 1.94 . . . . 74.239999999999995 110.494 160.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.95 45.09 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.445 1.498 . . . . 74.439999999999998 109.593 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 13.2 p -65.3 -23.7 67.09 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.041 0.536 . . . . 74.0 111.484 -176.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -49.85 -35.86 24.76 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 124.955 1.302 . . . . 74.409999999999997 110.981 173.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.54 41.62 3.06 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 114.65 -1.159 . . . . 40.420000000000002 112.5 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.477 ' O ' HG12 ' A' ' 18' ' ' VAL . 13.3 t -162.56 -51.15 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 125.117 1.367 . . . . 75.25 108.097 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.7 t -75.93 -44.64 39.18 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 113.624 -1.625 . . . . 64.409999999999997 111.578 -172.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 40.4 mt -61.83 -17.9 58.03 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.668 1.359 . . . . 71.310000000000002 114.668 -175.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 15' ' ' CYS . 11.9 p -79.89 -21.03 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.938 0.79 . . . . 63.520000000000003 110.447 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -140.34 8.73 2.24 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.792 0.837 . . . . 74.25 111.616 -170.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -150.86 173.47 14.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.3 1.04 . . . . 44.200000000000003 109.59 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.31 158.44 37.1 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.011 0.925 . . . . 63.030000000000001 109.959 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.73 -22.71 54.3 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.918 2.412 . . . . 73.409999999999997 112.947 171.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.5 m -63.81 -22.73 67.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.454 0.701 . . . . 71.019999999999996 111.826 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.642 HG21 ' SG ' ' A' ' 2' ' ' CYS . 43.9 mm -91.42 -53.05 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.155 0.582 . . . . 74.140000000000001 109.437 173.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.2 m -64.43 -28.36 69.62 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.789 -1.096 . . . . 52.009999999999998 113.156 -169.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.12 -32.85 72.53 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.27 0.628 . . . . 72.430000000000007 111.637 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.88 -0.94 74.03 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.885 -0.598 . . . . 62.140000000000001 112.62 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -105.67 -34.45 7.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.79 0.836 . . . . 73.430000000000007 110.562 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.0 m -77.21 -76.77 0.16 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.392 0.677 . . . . 72.409999999999997 111.029 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.106 0 CA-C-N 116.148 -0.478 . . . . 63.229999999999997 112.526 -169.213 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.613 ' SG ' HG21 ' A' ' 24' ' ' ILE . 17.7 m . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.95 0.405 . . . . 71.319999999999993 110.637 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.96 5.66 66.35 Favored Glycine 0 N--CA 1.472 1.074 0 CA-C-O 118.953 -0.915 . . . . 71.109999999999999 114.905 -168.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.6 p 54.68 20.7 3.07 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.103 1.361 . . . . 72.329999999999998 111.274 -169.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.12 -36.25 40.87 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.846 -1.07 . . . . 72.340000000000003 108.192 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.3 m -93.38 45.52 1.17 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.211 1.005 . . . . 41.420000000000002 111.476 171.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.549 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -116.94 7.38 0.08 OUTLIER Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 115.675 1.731 . . . . 71.239999999999995 115.675 167.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 24.5 Cg_exo -63.13 -48.96 5.43 Favored 'Trans proline' 0 C--N 1.409 3.744 0 CA-C-N 123.612 2.326 . . . . 65.209999999999994 112.261 -173.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -73.61 155.95 88.91 Favored Pre-proline 0 N--CA 1.439 -0.999 0 CA-C-N 113.187 -1.824 . . . . 44.329999999999998 111.927 -168.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.36 -37.79 79.4 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.199 1.933 . . . . 72.140000000000001 110.399 163.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -99.82 76.48 1.97 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.925 0.89 . . . . 75.450000000000003 108.79 170.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.503 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 19.7 p -69.34 -19.89 63.86 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.35 -0.841 . . . . 62.240000000000002 111.082 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -48.87 -37.18 18.85 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 125.38 1.472 . . . . 73.010000000000005 111.174 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.77 39.41 3.09 Favored Glycine 0 N--CA 1.474 1.167 0 CA-C-N 114.965 -1.016 . . . . 70.040000000000006 113.395 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.7 t -159.99 -48.65 0.05 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.958 1.303 . . . . 70.219999999999999 108.33 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 10.8 t -77.19 -42.01 39.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 112.952 -1.931 . . . . 62.030000000000001 112.041 -171.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.463 HD23 ' SG ' ' A' ' 25' ' ' CYS . 47.4 mt -64.34 -11.09 28.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.069 1.507 . . . . 73.400000000000006 115.069 -173.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.04 -26.3 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.857 0.753 . . . . 74.040000000000006 110.414 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -132.57 0.9 3.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.148 0.979 . . . . 74.209999999999994 111.598 -168.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 39.5 m -144.9 164.76 30.13 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.668 0.787 . . . . 73.219999999999999 109.889 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.7 155.41 65.25 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.581 0.752 . . . . 53.43 110.562 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.44 -23.85 15.14 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.271 2.648 . . . . 64.230000000000004 114.212 169.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 t -64.23 -44.62 91.28 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.079 0.552 . . . . 71.120000000000005 110.64 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.613 HG21 ' SG ' ' A' ' 2' ' ' CYS . 42.0 mm -68.04 -50.51 58.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 CA-C-O 121.283 0.564 . . . . 75.0 109.725 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.463 ' SG ' HD23 ' A' ' 17' ' ' LEU . 8.4 m -67.31 -27.54 67.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.95 -1.023 . . . . 42.119999999999997 111.657 -174.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.29 -25.27 67.56 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.717 0.407 . . . . 74.400000000000006 112.024 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.08 -19.68 56.93 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 112.259 -0.336 . . . . 52.439999999999998 112.259 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -99.83 -25.43 14.36 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.682 0.793 . . . . 75.209999999999994 111.361 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.6 m -94.14 -72.31 0.62 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.6 0.76 . . . . 73.530000000000001 110.455 175.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.865 0 CA-C-N 114.361 -1.29 . . . . 71.140000000000001 111.658 -170.15 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.779 ' HB2' HG21 ' A' ' 24' ' ' ILE . 18.5 t . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 108.901 -0.777 . . . . 53.039999999999999 108.901 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.26 -11.52 51.82 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 119.155 -0.803 . . . . 64.450000000000003 113.325 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.6 p 51.67 22.63 1.68 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 125.334 1.453 . . . . 73.450000000000003 111.801 -171.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -94.76 -44.46 7.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.236 1.414 . . . . 75.439999999999998 108.469 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 67.4 m -94.5 47.95 1.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.166 -1.379 . . . . 75.25 111.475 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.56 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -109.07 7.18 0.08 OUTLIER Pre-proline 0 CA--C 1.584 2.259 0 N-CA-C 115.843 1.794 . . . . 73.319999999999993 115.843 166.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 16.9 Cg_exo -68.4 -57.02 0.16 Allowed 'Trans proline' 0 C--N 1.406 3.602 0 CA-C-N 123.904 2.43 . . . . 71.299999999999997 113.121 -174.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.06 164.28 62.35 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 114.455 -1.248 . . . . 71.409999999999997 111.968 -166.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.17 -29.18 27.11 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.251 1.967 . . . . 64.310000000000002 111.06 164.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.52 31.72 5.01 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.466 1.107 . . . . 43.409999999999997 110.098 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 p -60.31 -9.55 3.61 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.475 1.11 . . . . 72.219999999999999 113.544 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.479 ' HE3' HD11 ' A' ' 17' ' ' LEU . 83.4 m95 -49.33 -38.31 27.49 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.937 1.295 . . . . 72.239999999999995 111.595 169.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.38 48.41 3.77 Favored Glycine 0 N--CA 1.476 1.346 0 CA-C-N 115.213 -0.903 . . . . 72.409999999999997 111.679 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 7.3 t -168.76 -46.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.924 1.289 . . . . 64.510000000000005 108.556 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.44 ' HA ' ' NE2' ' A' ' 19' ' ' GLN . 41.2 t -73.12 -48.13 38.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.74 -1.573 . . . . 72.129999999999995 112.07 -173.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.479 HD11 ' HE3' ' A' ' 13' ' ' TRP . 5.7 mp -70.34 2.3 3.98 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.143 1.905 . . . . 52.009999999999998 116.143 -171.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.509 HG13 ' HG3' ' A' ' 19' ' ' GLN . 7.6 p -83.71 -29.48 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 118.667 0.667 . . . . 75.540000000000006 109.955 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.509 ' HG3' HG13 ' A' ' 18' ' ' VAL . 2.6 pp0? -132.69 6.01 4.0 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.07 0.948 . . . . 73.409999999999997 112.182 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 17' ' ' LEU . 2.6 m -142.78 161.8 37.15 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.04 -1.096 . . . . 71.010000000000005 108.04 172.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.24 157.79 53.11 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 122.97 0.508 . . . . 52.439999999999998 110.165 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HB3' HD21 ' A' ' 17' ' ' LEU . 19.2 Cg_endo -59.44 -22.53 66.45 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.05 2.5 . . . . 62.020000000000003 113.089 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.4 p -62.15 -38.89 90.71 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.429 0.692 . . . . 64.049999999999997 110.524 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.779 HG21 ' HB2' ' A' ' 2' ' ' CYS . 10.9 mm -81.83 -46.5 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.31 -0.859 . . . . 71.420000000000002 109.855 -177.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.4 m -64.96 -24.36 67.5 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.448 1.099 . . . . 75.450000000000003 111.233 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -31.76 73.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.106 0.562 . . . . 60.020000000000003 111.59 171.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.63 -45.68 21.76 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 116.401 -0.363 . . . . 62.140000000000001 112.241 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -73.17 -58.86 3.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.273 0.629 . . . . 71.25 111.158 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.3 m -74.18 -62.45 1.51 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.591 0.756 . . . . 52.109999999999999 112.42 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.243 0 CA-C-O 120.247 -0.196 . . . . 61.409999999999997 113.012 -170.48 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.747 ' SG ' HG21 ' A' ' 24' ' ' ILE . 58.4 m . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 120.431 0.158 . . . . 74.400000000000006 110.821 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.63 3.67 47.93 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 116.771 1.468 . . . . 53.130000000000003 116.771 -164.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m 68.63 1.36 2.98 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.464 1.106 . . . . 63.020000000000003 111.539 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.49 -18.38 45.33 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 123.522 0.729 . . . . 72.299999999999997 109.653 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 83.2 m -103.96 42.95 1.13 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.09 0.956 . . . . 72.150000000000006 110.945 172.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.532 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -110.7 -5.99 0.11 Allowed Pre-proline 0 CA--C 1.586 2.35 0 N-CA-C 115.597 1.702 . . . . 60.149999999999999 115.597 168.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 25.3 Cg_exo -63.82 -58.43 0.27 Allowed 'Trans proline' 0 C--N 1.405 3.531 0 CA-C-N 123.642 2.336 . . . . 74.519999999999996 113.634 -172.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -77.52 162.92 66.83 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 114.84 -1.073 . . . . 72.319999999999993 111.851 -170.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.38 -25.22 30.58 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.57 2.18 . . . . 72.319999999999993 110.411 160.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -93.25 23.54 4.37 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 125.312 1.445 . . . . 72.409999999999997 110.181 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 p -62.03 -17.74 58.32 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.719 1.207 . . . . 62.310000000000002 113.451 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -57.97 -33.37 68.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.094 0.957 . . . . 74.319999999999993 111.106 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.85 -34.02 88.78 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 115.6 -0.727 . . . . 74.450000000000003 112.105 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.469 ' O ' HG12 ' A' ' 18' ' ' VAL . 17.9 t -78.34 -47.65 17.27 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.641 1.176 . . . . 55.409999999999997 110.225 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.9 t -80.3 -45.26 18.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.855 -1.52 . . . . 72.439999999999998 112.033 -167.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.401 HD23 ' SG ' ' A' ' 25' ' ' CYS . 78.6 mt -65.66 -5.75 9.33 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.498 1.296 . . . . 71.510000000000005 114.498 -174.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 15' ' ' CYS . 9.1 p -87.67 -19.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.026 0.83 . . . . 74.219999999999999 110.571 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.415 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 27.0 pt20 -134.56 -2.66 2.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.076 0.951 . . . . 72.420000000000002 111.098 -170.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.415 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 37.4 m -143.27 171.11 14.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.574 0.75 . . . . 63.43 110.403 -175.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.82 155.33 41.75 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.736 0.815 . . . . 62.439999999999998 109.549 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.32 -16.41 28.41 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.826 2.351 . . . . 74.129999999999995 113.693 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 m -64.21 -36.76 85.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.617 0.367 . . . . 70.129999999999995 110.974 171.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.747 HG21 ' SG ' ' A' ' 2' ' ' CYS . 50.6 mm -75.98 -52.74 17.13 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 N-CA-C 109.051 -0.722 . . . . 74.519999999999996 109.051 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.401 ' SG ' HD23 ' A' ' 17' ' ' LEU . 21.1 m -65.17 -26.28 68.09 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.559 -1.201 . . . . 73.409999999999997 112.505 -170.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.2 -31.58 72.49 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.385 0.274 . . . . 62.329999999999998 111.171 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.91 -32.15 50.67 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 116.07 -0.514 . . . . 72.329999999999998 112.212 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -88.41 -37.47 15.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.199 0.6 . . . . 64.439999999999998 111.132 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.5 m -90.76 -80.26 0.34 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.29 0.636 . . . . 60.399999999999999 111.736 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.477 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 112.778 -167.231 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.813 ' SG ' HG21 ' A' ' 24' ' ' ILE . 23.5 m . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 110.416 -0.216 . . . . 74.129999999999995 110.416 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.83 -10.34 84.26 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-O 119.359 -0.69 . . . . 42.210000000000001 113.841 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.1 m 77.11 -12.77 1.02 Allowed 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.163 1.385 . . . . 62.409999999999997 112.176 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -94.89 19.16 10.61 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.956 0.884 . . . . 73.329999999999998 109.498 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 99.2 m -106.19 28.78 7.36 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.241 1.016 . . . . 73.140000000000001 110.25 166.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.542 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -103.78 -9.33 0.12 Allowed Pre-proline 0 CA--C 1.581 2.138 0 N-CA-C 116.337 1.977 . . . . 65.5 116.337 167.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 14.1 Cg_exo -67.58 -54.74 0.33 Allowed 'Trans proline' 0 C--N 1.405 3.54 0 CA-C-N 123.658 2.342 . . . . 72.540000000000006 112.926 -168.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -73.04 159.81 84.38 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 113.797 -1.547 . . . . 71.010000000000005 112.103 -166.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.77 -26.3 32.68 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.252 1.968 . . . . 70.129999999999995 110.633 162.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -99.17 27.67 4.96 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.436 1.495 . . . . 74.140000000000001 109.759 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 6.3 p -62.94 -17.79 62.31 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.411 1.084 . . . . 74.129999999999995 113.608 -176.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -54.47 -38.24 66.18 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.889 0.875 . . . . 75.209999999999994 110.339 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.06 -35.42 90.55 Favored Glycine 0 N--CA 1.469 0.848 0 CA-C-N 115.24 -0.891 . . . . 72.420000000000002 112.182 -176.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.47 ' O ' HG12 ' A' ' 18' ' ' VAL . 35.2 t -67.38 -51.82 47.45 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.016 0.912 . . . . 71.120000000000005 110.583 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 t -71.48 -54.5 10.39 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.792 -1.549 . . . . 43.100000000000001 111.629 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.417 HD23 ' SG ' ' A' ' 25' ' ' CYS . 68.6 mt -51.83 -27.22 11.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.373 1.62 . . . . 61.399999999999999 115.373 -175.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 15' ' ' CYS . 14.6 p -74.43 -14.09 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.395 0.617 . . . . 43.119999999999997 111.333 -174.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -146.96 3.68 0.82 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.574 0.75 . . . . 74.329999999999998 111.178 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.8 m -148.31 169.63 19.7 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.03 0.932 . . . . 52.229999999999997 109.863 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.28 157.84 50.02 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.528 0.731 . . . . 73.230000000000004 110.658 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.28 -22.56 5.85 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.424 2.75 . . . . 75.25 113.923 165.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 m -59.22 -44.87 92.28 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.579 0.752 . . . . 70.040000000000006 111.443 172.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.813 HG21 ' SG ' ' A' ' 2' ' ' CYS . 49.2 mm -74.61 -45.47 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.473 0.709 . . . . 74.219999999999999 110.018 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.417 ' SG ' HD23 ' A' ' 17' ' ' LEU . 11.1 m -64.85 -33.25 75.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.74 0.816 . . . . 54.310000000000002 111.163 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.55 -24.85 64.68 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.962 0.505 . . . . 64.319999999999993 110.945 173.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.56 -41.35 24.95 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.951 -0.46 . . . . 71.239999999999995 111.951 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -84.71 -59.91 2.22 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.052 0.541 . . . . 74.310000000000002 111.046 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.4 m -68.89 -51.17 42.91 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.001 0.52 . . . . 60.049999999999997 111.181 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.889 0 CA-C-N 115.708 -0.678 . . . . 73.109999999999999 112.731 -176.546 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.485 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 34.9 m . . . . . 0 C--O 1.241 0.644 0 N-CA-C 109.837 -0.431 . . . . 71.120000000000005 109.837 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.74 -63.28 2.77 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 116.274 -0.421 . . . . 71.519999999999996 112.274 173.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.1 p 160.44 -12.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.157 1.783 . . . . 74.019999999999996 109.275 -167.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.64 -20.5 62.72 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.787 0.835 . . . . 43.329999999999998 110.605 -177.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.8 m -91.42 52.04 2.01 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.734 0.778 . . . . 74.329999999999998 110.815 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.531 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -130.01 13.25 0.05 OUTLIER Pre-proline 0 CA--C 1.575 1.909 0 N-CA-C 115.231 1.567 . . . . 53.0 115.231 169.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 11.8 Cg_exo -68.05 -51.0 0.67 Allowed 'Trans proline' 0 C--N 1.407 3.635 0 CA-C-N 123.436 2.263 . . . . 73.340000000000003 111.275 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -81.82 151.05 67.04 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 113.508 -1.678 . . . . 74.430000000000007 110.74 -168.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.3 -32.09 81.83 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 121.914 1.743 . . . . 74.200000000000003 111.48 171.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -105.46 57.64 0.68 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.771 1.229 . . . . 72.430000000000007 108.932 175.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.559 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 18.7 p -58.94 -14.01 8.0 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.879 1.272 . . . . 72.530000000000001 113.345 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 61.3 m95 -48.8 -35.62 14.84 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.23 1.412 . . . . 63.340000000000003 111.65 173.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.13 -32.28 79.94 Favored Glycine 0 N--CA 1.475 1.244 0 CA-C-N 115.663 -0.699 . . . . 41.140000000000001 113.055 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.7 t -82.53 -44.51 15.82 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 122.397 1.094 . . . . 60.399999999999999 110.12 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.3 t -82.7 -60.23 2.25 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 112.948 -1.933 . . . . 72.010000000000005 111.758 -169.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.5 mt -52.34 -25.85 10.75 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.991 1.478 . . . . 74.319999999999993 114.991 -175.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.407 HG13 ' HG3' ' A' ' 19' ' ' GLN . 7.3 p -67.47 -22.4 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 CA-C-O 121.074 0.464 . . . . 74.209999999999994 111.1 -176.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.407 ' HG3' HG13 ' A' ' 18' ' ' VAL . 3.3 pp0? -140.63 -5.32 1.2 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.563 0.745 . . . . 71.340000000000003 112.683 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 2' ' ' CYS . 80.2 m -127.79 174.32 9.23 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.158 0.983 . . . . 61.149999999999999 110.295 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.44 157.7 46.9 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 124.832 1.253 . . . . 62.310000000000002 110.111 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.44 -17.56 41.46 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 123.366 2.711 . . . . 51.530000000000001 113.389 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.5 t -56.77 -42.68 79.83 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.329 0.651 . . . . 63.350000000000001 110.811 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mm -76.84 -48.53 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 115.937 -0.574 . . . . 74.209999999999994 110.036 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.2 m -64.73 -34.85 79.3 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.746 -1.115 . . . . 75.019999999999996 111.55 -174.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.44 -20.65 64.65 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.052 0.541 . . . . 71.530000000000001 111.425 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.48 -36.06 24.39 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.841 -0.504 . . . . 25.329999999999998 111.841 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -91.12 -41.85 10.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.355 0.662 . . . . 71.430000000000007 111.739 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.559 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.6 m -69.25 -71.84 0.21 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.43 0.633 . . . . 75.239999999999995 111.344 178.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.804 0 CA-C-N 114.697 -1.138 . . . . 61.32 110.713 -169.554 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.239 0.551 0 N-CA-C 109.272 -0.64 . . . . 74.019999999999996 109.272 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.735 ' SG ' HG21 ' A' ' 24' ' ' ILE . 61.7 m -147.77 170.51 17.43 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.593 0.757 . . . . 62.009999999999998 110.052 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.9 -6.86 86.11 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-O 118.691 -1.061 . . . . 74.120000000000005 114.874 -170.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m 66.63 13.58 9.39 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.488 1.115 . . . . 71.120000000000005 110.839 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -94.16 -24.55 17.48 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.208 1.003 . . . . 73.030000000000001 110.015 -172.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 52.5 m -97.6 39.73 1.19 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.894 0.878 . . . . 41.329999999999998 110.655 170.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.569 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -99.23 -16.22 0.19 Allowed Pre-proline 0 CA--C 1.58 2.112 0 N-CA-C 115.468 1.655 . . . . 71.450000000000003 115.468 168.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 12.6 Cg_exo -69.35 -38.88 8.05 Favored 'Trans proline' 0 C--N 1.406 3.554 0 CA-C-N 123.198 2.178 . . . . 74.349999999999994 112.964 -166.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -67.59 150.75 97.69 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.362 -1.29 . . . . 73.420000000000002 112.353 -166.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.11 -29.65 87.68 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.479 2.119 . . . . 75.540000000000006 110.698 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -119.34 78.34 1.29 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.784 -1.191 . . . . 74.409999999999997 107.784 170.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 20.7 p -60.19 -27.67 67.34 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.031 -0.986 . . . . 74.400000000000006 110.954 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -45.66 -38.25 6.56 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 125.452 1.501 . . . . 71.200000000000003 111.593 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.94 43.67 3.25 Favored Glycine 0 N--CA 1.474 1.206 0 CA-C-N 114.755 -1.111 . . . . 74.5 112.531 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.461 ' O ' HG12 ' A' ' 18' ' ' VAL . 13.2 t -167.23 -46.07 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.991 1.316 . . . . 64.150000000000006 108.323 -176.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.1 t -79.47 -42.79 24.52 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.671 -1.604 . . . . 71.209999999999994 112.03 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.403 HD23 ' SG ' ' A' ' 25' ' ' CYS . 71.5 mt -63.13 -9.72 11.92 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.959 1.466 . . . . 74.219999999999999 114.959 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 15' ' ' CYS . 10.2 p -83.17 -19.84 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 118.894 0.77 . . . . 74.230000000000004 110.625 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -138.87 -1.66 1.78 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.051 0.94 . . . . 71.530000000000001 111.648 -169.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 59.8 m -146.16 167.0 24.52 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.599 0.76 . . . . 60.329999999999998 110.301 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.95 155.65 52.59 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 115.206 -0.906 . . . . 75.299999999999997 110.448 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -45.52 -30.95 6.44 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.729 2.952 . . . . 74.030000000000001 114.652 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -58.87 -41.26 86.65 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.086 0.554 . . . . 73.010000000000005 111.521 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.735 HG21 ' SG ' ' A' ' 2' ' ' CYS . 47.9 mm -73.11 -51.33 26.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 C-N-CA 123.567 0.747 . . . . 75.230000000000004 110.162 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.403 ' SG ' HD23 ' A' ' 17' ' ' LEU . 7.0 m -65.37 -31.92 73.29 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.055 -0.975 . . . . 73.219999999999999 111.339 -175.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.38 -28.44 68.21 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.397 0.679 . . . . 55.140000000000001 111.522 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.12 -22.62 47.94 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.702 0.627 . . . . 53.350000000000001 112.273 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . 15.8 m95 -93.43 -36.77 12.31 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.222 0.609 . . . . 72.230000000000004 112.132 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 42.4 m -71.58 -73.14 0.19 Allowed 'General case' 0 CA--C 1.547 0.844 0 O-C-N 123.196 0.31 . . . . 63.32 110.519 176.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.61 -52.65 1.52 Allowed Glycine 0 C--N 1.345 1.074 0 CA-C-O 121.055 0.253 . . . . 72.140000000000001 112.508 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.68 73.07 0.53 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.481 -1.048 . . . . 74.430000000000007 110.481 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 CA--C 1.557 1.215 0 C-N-CA 124.318 1.047 . . . . 72.400000000000006 109.81 -175.867 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.3 p . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.324 -0.25 . . . . 34.219999999999999 110.324 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.823 ' HB2' HG21 ' A' ' 24' ' ' ILE . 11.1 t -80.18 176.73 9.49 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.365 -0.606 . . . . 65.150000000000006 109.365 171.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.04 -25.09 76.39 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 111.389 -0.684 . . . . 64.349999999999994 111.389 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.1 m 66.3 5.12 3.5 Favored 'General case' 0 C--N 1.369 1.447 0 C-N-CA 124.562 1.145 . . . . 60.350000000000001 112.086 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -102.45 -15.84 16.36 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.039 0.935 . . . . 72.230000000000004 108.761 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 56.2 m -93.21 44.45 1.14 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.535 1.134 . . . . 64.530000000000001 110.822 170.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.501 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -117.31 5.26 0.08 OUTLIER Pre-proline 0 CA--C 1.58 2.134 0 N-CA-C 116.034 1.864 . . . . 21.309999999999999 116.034 173.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 39.9 Cg_exo -59.32 -54.08 2.92 Favored 'Trans proline' 0 C--N 1.408 3.691 0 CA-C-N 123.509 2.289 . . . . 65.430000000000007 112.867 -173.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -85.27 155.71 60.09 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 114.395 -1.275 . . . . 75.239999999999995 111.411 -171.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.9 -14.93 45.6 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.689 2.259 . . . . 71.319999999999993 111.532 165.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -108.05 56.41 0.63 Allowed 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 123.018 1.39 . . . . 72.530000000000001 108.344 170.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.531 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 22.0 p -67.85 -16.26 64.01 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.24 -1.345 . . . . 72.140000000000001 111.852 175.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -47.42 -36.47 9.9 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 126.01 1.724 . . . . 73.120000000000005 112.436 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.11 35.2 3.86 Favored Glycine 0 N--CA 1.47 0.932 0 CA-C-N 115.091 -0.959 . . . . 65.209999999999994 112.801 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 8.3 t -154.94 -46.54 0.08 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.403 1.097 . . . . 41.310000000000002 108.955 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 15.4 t -80.65 -44.19 19.24 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 113.333 -1.758 . . . . 73.439999999999998 111.562 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.453 HD23 ' SG ' ' A' ' 25' ' ' CYS . 74.9 mt -62.59 -18.56 62.41 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 114.68 1.363 . . . . 44.119999999999997 114.68 -172.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.65 -19.41 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 122.837 0.455 . . . . 71.439999999999998 111.636 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.527 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 16.0 pt20 -142.11 -34.01 0.47 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.112 0.965 . . . . 74.530000000000001 110.371 -168.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.527 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 3.7 m -104.69 158.11 16.73 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.614 1.166 . . . . 62.530000000000001 109.228 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.5 159.38 61.52 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.248 0.619 . . . . 43.43 110.962 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.69 -33.48 31.99 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.13 2.553 . . . . 51.210000000000001 112.674 164.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.0 t -57.12 -22.66 41.48 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.733 1.213 . . . . 73.549999999999997 112.401 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.823 HG21 ' HB2' ' A' ' 2' ' ' CYS . 31.8 mm -101.47 -51.55 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.681 0.792 . . . . 73.340000000000003 110.474 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.453 ' SG ' HD23 ' A' ' 17' ' ' LEU . 21.9 m -64.92 -22.14 66.94 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.089 0.956 . . . . 63.210000000000001 112.357 -172.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.61 76.0 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.616 0.766 . . . . 72.430000000000007 111.343 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.1 -19.22 63.25 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.739 -0.664 . . . . 64.120000000000005 112.722 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -89.28 -40.32 12.89 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.108 0.563 . . . . 71.340000000000003 110.877 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 21.1 m -74.55 -60.73 2.14 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.362 -0.836 . . . . 63.530000000000001 111.301 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.22 43.13 1.48 Allowed Glycine 0 C--N 1.35 1.312 0 CA-C-N 116.015 -0.539 . . . . 35.520000000000003 112.554 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.64 156.59 27.03 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 112.355 -0.298 . . . . 71.129999999999995 112.355 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 C--O 1.249 1.033 0 C-N-CA 123.356 0.663 . . . . 62.25 109.733 178.773 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.295 -0.261 . . . . 63.240000000000002 110.295 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.458 ' HB2' HG21 ' A' ' 24' ' ' ILE . 99.2 m -78.17 -176.7 4.74 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.033 0.533 . . . . 71.310000000000002 110.114 173.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.12 -56.76 1.05 Allowed Glycine 0 C--N 1.336 0.55 0 CA-C-N 115.98 -0.554 . . . . 74.219999999999999 112.382 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.7 p 149.97 -6.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 126.372 1.869 . . . . 72.140000000000001 108.791 -159.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -25.65 60.74 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.836 0.854 . . . . 71.540000000000006 110.698 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -100.74 53.16 0.86 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.507 1.123 . . . . 74.430000000000007 109.75 173.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.503 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -133.37 15.21 0.05 OUTLIER Pre-proline 0 CA--C 1.576 1.945 0 CA-C-N 113.724 -1.58 . . . . 72.109999999999999 114.802 169.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 31.8 Cg_exo -62.53 -51.53 3.21 Favored 'Trans proline' 0 C--N 1.407 3.657 0 CA-C-N 123.242 2.194 . . . . 72.019999999999996 111.549 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -84.68 159.66 57.64 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 113.735 -1.575 . . . . 72.439999999999998 110.793 -172.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.06 -23.92 28.89 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.475 2.117 . . . . 75.400000000000006 110.776 163.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -104.33 48.92 0.83 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.956 1.302 . . . . 74.129999999999995 109.137 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 19.9 p -61.06 -14.53 24.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.921 1.289 . . . . 74.25 113.822 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.551 ' HE3' HD11 ' A' ' 17' ' ' LEU . 61.8 m95 -47.07 -40.78 15.77 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.416 1.487 . . . . 75.540000000000006 112.298 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.33 -25.29 75.87 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-N 114.946 -1.025 . . . . 50.43 112.745 -173.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' O ' HG12 ' A' ' 18' ' ' VAL . 34.3 t -86.77 -45.63 10.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.109 0.957 . . . . 74.239999999999995 110.216 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 t -76.98 -53.76 7.42 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 113.619 -1.628 . . . . 53.109999999999999 112.578 -170.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.677 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -61.91 -7.81 4.24 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.854 1.798 . . . . 74.239999999999995 115.854 -175.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 15' ' ' CYS . 10.3 p -76.77 -23.73 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-N 119.278 0.945 . . . . 62.119999999999997 110.366 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -132.18 -24.19 2.11 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.253 1.021 . . . . 73.519999999999996 111.289 -169.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 2' ' ' CYS . 77.9 m -123.98 175.37 6.99 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.43 1.092 . . . . 72.129999999999995 110.472 -173.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.52 157.4 58.46 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.915 0.886 . . . . 73.340000000000003 110.479 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.426 ' HB3' HD21 ' A' ' 17' ' ' LEU . 19.9 Cg_endo -61.33 -12.43 23.75 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 123.152 2.568 . . . . 71.040000000000006 112.769 171.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.0 t -62.49 -44.05 97.32 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.445 0.698 . . . . 50.439999999999998 110.689 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 2' ' ' CYS . 36.9 mm -69.99 -50.13 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 115.705 -0.679 . . . . 74.140000000000001 109.3 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.677 ' SG ' ' HG ' ' A' ' 17' ' ' LEU . 10.2 m -60.37 -36.18 77.44 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.303 -1.317 . . . . 71.010000000000005 111.733 -174.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.14 89.98 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.082 0.553 . . . . 51.43 110.687 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.07 -33.07 69.42 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.846 0.716 . . . . 54.020000000000003 113.429 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -92.37 -38.23 12.14 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.801 0.44 . . . . 73.349999999999994 111.585 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 34.5 m -69.09 -57.97 4.7 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.605 0.362 . . . . 62.439999999999998 111.676 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.67 -77.77 0.1 Allowed Glycine 0 C--N 1.34 0.777 0 CA-C-N 116.192 -0.458 . . . . 63.130000000000003 112.47 -172.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.24 9.88 85.46 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.583 -0.308 . . . . 61.210000000000001 112.571 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 CA--C 1.55 0.98 0 C-N-CA 124.449 1.1 . . . . 72.510000000000005 109.757 -170.094 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 110.157 -0.312 . . . . 73.310000000000002 110.157 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.68 ' SG ' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -102.89 118.36 36.64 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.437 -0.949 . . . . 62.200000000000003 108.437 176.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.31 -48.7 84.71 Favored Glycine 0 C--N 1.341 0.824 0 O-C-N 124.096 0.873 . . . . 64.120000000000005 114.858 -172.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.3 p 131.25 3.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 127.505 2.322 . . . . 63.409999999999997 107.916 -159.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.33 -26.85 63.94 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.005 0.922 . . . . 73.239999999999995 109.806 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 34.1 m -100.72 60.75 0.98 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.957 -1.019 . . . . 72.150000000000006 110.039 167.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.686 ' HB2' ' HB3' ' A' ' 28' ' ' TRP . . . -142.92 31.77 0.13 Allowed Pre-proline 0 CA--C 1.579 2.078 0 CA-C-N 113.797 -1.547 . . . . 74.450000000000003 113.403 163.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 51.3 Cg_exo -61.26 -50.24 6.29 Favored 'Trans proline' 0 C--N 1.405 3.51 0 CA-C-N 122.08 1.779 . . . . 74.019999999999996 111.974 170.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -84.14 161.36 55.2 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 113.781 -1.554 . . . . 45.119999999999997 111.36 -171.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.71 -33.91 75.33 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.259 1.973 . . . . 74.349999999999994 110.452 161.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -94.82 78.53 3.67 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.966 -1.016 . . . . 72.120000000000005 108.97 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.466 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 18.3 p -70.44 -18.01 63.0 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.86 -0.609 . . . . 51.039999999999999 110.592 171.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.52 ' HE3' HD11 ' A' ' 17' ' ' LEU . 64.9 m95 -49.23 -35.93 18.72 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 125.284 1.434 . . . . 73.349999999999994 111.774 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -93.6 49.06 2.32 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 114.909 -1.041 . . . . 41.299999999999997 112.161 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.47 ' O ' HG12 ' A' ' 18' ' ' VAL . 16.6 t -166.2 -45.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.812 1.245 . . . . 73.049999999999997 108.709 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 12.4 t -80.8 -45.8 16.38 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 113.493 -1.685 . . . . 74.310000000000002 111.936 -169.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.52 HD11 ' HE3' ' A' ' 13' ' ' TRP . 5.4 mp -72.11 -0.18 11.16 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 114.849 1.426 . . . . 64.409999999999997 114.849 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 15' ' ' CYS . 13.6 p -82.18 -18.36 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.849 0.749 . . . . 74.230000000000004 110.096 171.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.563 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 11.5 pt20 -138.04 -6.45 1.63 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.637 0.775 . . . . 73.299999999999997 111.777 -168.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.563 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 48.7 m -143.76 172.4 12.89 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.668 0.787 . . . . 75.010000000000005 110.357 -174.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 154.74 50.14 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.209 1.004 . . . . 41.229999999999997 109.785 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.4 -18.74 40.13 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.328 2.686 . . . . 64.319999999999993 112.771 172.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 t -61.05 -39.17 88.82 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.814 0.846 . . . . 53.210000000000001 110.694 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.68 HG21 ' SG ' ' A' ' 2' ' ' CYS . 45.1 mm -77.82 -48.42 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.419 0.688 . . . . 74.019999999999996 109.709 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.6 m -64.99 -30.41 71.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.639 -1.164 . . . . 54.229999999999997 112.082 -172.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.81 -29.01 70.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.059 0.544 . . . . 70.019999999999996 111.412 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.58 -27.75 37.96 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.536 0.522 . . . . 72.219999999999999 112.409 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.686 ' HB3' ' HB2' ' A' ' 7' ' ' ALA . 26.4 m95 -92.49 -32.78 14.75 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.259 0.624 . . . . 74.340000000000003 111.395 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.2 m -73.96 -74.83 0.17 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.247 0.546 . . . . 65.109999999999999 110.637 173.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.02 -64.27 0.31 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 114.783 -1.099 . . . . 61.100000000000001 110.67 -169.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.34 -150.34 13.48 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.257 -0.472 . . . . 75.439999999999998 112.139 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.6 p . . . . . 0 C--O 1.254 1.332 0 C-N-CA 124.181 0.992 . . . . 42.020000000000003 110.992 -176.571 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.775 0.321 . . . . 73.299999999999997 110.479 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.666 ' HB2' HG21 ' A' ' 24' ' ' ILE . 36.1 t -78.65 -179.67 6.6 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.079 -0.711 . . . . 75.310000000000002 109.079 170.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.17 -16.86 79.1 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.705 -0.497 . . . . 55.539999999999999 111.862 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.7 p 61.49 8.5 2.25 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 125.79 1.636 . . . . 52.130000000000003 112.836 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -116.06 7.1 14.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.534 0.734 . . . . 63.509999999999998 109.07 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 88.3 m -106.51 34.96 3.14 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 124.058 0.943 . . . . 73.099999999999994 110.734 170.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.532 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -96.39 -19.26 0.22 Allowed Pre-proline 0 CA--C 1.586 2.339 0 N-CA-C 115.188 1.551 . . . . 71.120000000000005 115.188 167.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 25.1 Cg_exo -63.47 -53.66 1.32 Allowed 'Trans proline' 0 C--N 1.412 3.875 0 CA-C-N 123.329 2.225 . . . . 51.229999999999997 114.072 -163.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.36 159.64 84.0 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 114.904 -1.044 . . . . 74.420000000000002 111.685 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.79 -26.35 32.51 Favored 'Trans proline' 0 CA--C 1.554 1.511 0 C-N-CA 122.193 1.929 . . . . 63.43 111.044 162.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -98.87 31.98 2.78 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 124.44 1.096 . . . . 74.409999999999997 109.612 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 2.6 p -61.05 -20.8 62.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.405 1.082 . . . . 74.030000000000001 112.767 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -54.76 -38.27 67.01 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.176 0.99 . . . . 74.409999999999997 110.693 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.25 -23.89 74.82 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 115.06 -0.973 . . . . 74.219999999999999 112.781 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.476 ' O ' HG12 ' A' ' 18' ' ' VAL . 34.6 t -89.24 -43.47 10.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.492 1.117 . . . . 75.230000000000004 109.968 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 42.2 t -71.79 -52.02 19.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.151 -1.386 . . . . 64.019999999999996 111.455 -171.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.462 HD21 ' HB3' ' A' ' 22' ' ' PRO . 4.4 mp -73.0 9.89 1.06 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 115.583 1.697 . . . . 71.200000000000003 115.583 -173.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 15' ' ' CYS . 13.9 p -91.14 -12.56 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 118.875 0.761 . . . . 61.229999999999997 109.442 170.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.523 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 27.6 pt20 -152.86 2.4 0.31 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.344 0.657 . . . . 71.439999999999998 112.028 -167.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.523 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 1.4 m -147.03 156.66 43.2 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.607 0.763 . . . . 72.230000000000004 109.354 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.95 149.9 77.49 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.241 0.616 . . . . 73.140000000000001 110.819 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.462 ' HB3' HD21 ' A' ' 17' ' ' LEU . 13.2 Cg_endo -55.94 -23.2 41.81 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.525 2.817 . . . . 74.140000000000001 113.713 174.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -65.24 -38.71 91.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.955 0.502 . . . . 61.32 110.388 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.666 HG21 ' HB2' ' A' ' 2' ' ' CYS . 23.4 mm -75.1 -43.75 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.226 -0.657 . . . . 72.530000000000001 109.226 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.5 m -66.96 -28.41 68.25 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.158 0.983 . . . . 72.150000000000006 111.055 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.86 -28.3 68.86 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.563 0.745 . . . . 71.349999999999994 111.231 170.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.95 -35.71 38.34 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 116.221 -0.445 . . . . 75.140000000000001 112.133 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -82.52 -69.34 0.63 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.98 0.512 . . . . 71.040000000000006 110.296 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.5 m -64.68 -49.45 70.9 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.142 0.977 . . . . 74.010000000000005 112.096 -175.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.42 -12.6 83.63 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.52 -0.764 . . . . 23.399999999999999 112.968 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.1 -162.66 37.93 Favored Glycine 0 C--N 1.351 1.396 0 C-N-CA 123.117 0.389 . . . . 71.030000000000001 113.255 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 C--O 1.251 1.18 0 C-N-CA 123.586 0.755 . . . . 42.020000000000003 110.765 -176.762 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.456 ' HA ' HD12 ' A' ' 24' ' ' ILE . 29.9 t . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 108.934 -0.765 . . . . 63.130000000000003 108.934 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.698 ' HB2' HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER 59.4 -152.5 0.4 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.865 1.266 . . . . 61.299999999999997 109.71 -174.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.0 -5.46 73.4 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.527 -0.596 . . . . 75.120000000000005 112.306 166.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.3 m 64.88 18.54 11.52 Favored 'General case' 0 C--N 1.372 1.545 0 C-N-CA 124.721 1.208 . . . . 64.140000000000001 109.853 -171.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -102.82 -38.49 7.4 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.449 -1.315 . . . . 73.129999999999995 107.449 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.1 m -86.67 44.86 1.19 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.212 1.005 . . . . 73.230000000000004 111.707 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.433 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -122.6 33.11 0.22 Allowed Pre-proline 0 CA--C 1.576 1.973 0 N-CA-C 114.728 1.381 . . . . 64.5 114.728 165.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 35.3 Cg_exo -64.79 -61.05 0.11 Allowed 'Trans proline' 0 C--N 1.397 3.119 0 CA-C-N 122.675 1.991 . . . . 73.209999999999994 111.072 169.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -82.67 151.54 64.95 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-N 114.239 -1.346 . . . . 74.439999999999998 111.37 -170.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.5 -32.64 96.62 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.937 2.424 . . . . 65.200000000000003 110.67 162.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -94.61 70.0 3.53 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 122.44 1.114 . . . . 73.299999999999997 108.532 171.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.527 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 22.1 p -77.8 -15.26 59.22 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.366 -1.288 . . . . 71.439999999999998 112.803 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -48.5 -38.78 21.09 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.381 1.473 . . . . 55.409999999999997 112.885 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.83 -16.97 80.31 Favored Glycine 0 N--CA 1.476 1.315 0 CA-C-N 115.553 -0.749 . . . . 74.109999999999999 113.339 -172.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.435 ' O ' HG12 ' A' ' 18' ' ' VAL . 11.4 t -96.13 -51.75 4.29 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.166 0.984 . . . . 55.25 109.677 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 t -73.82 -45.3 52.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.685 -1.598 . . . . 54.210000000000001 112.715 -166.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.485 HD23 ' SG ' ' A' ' 25' ' ' CYS . 76.3 mt -59.15 -22.24 60.6 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.061 1.504 . . . . 73.25 115.061 -172.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 15' ' ' CYS . 7.6 p -78.52 -22.75 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 118.666 0.666 . . . . 33.200000000000003 111.184 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -133.85 1.0 3.27 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.03 0.932 . . . . 70.319999999999993 111.282 -170.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.1 m -149.09 167.65 25.31 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.479 1.112 . . . . 61.240000000000002 109.55 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.53 154.68 62.43 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.649 0.78 . . . . 50.130000000000003 110.492 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.32 -25.05 45.52 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.26 2.64 . . . . 53.310000000000002 112.856 167.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -57.37 -37.53 72.76 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.981 0.912 . . . . 73.129999999999995 111.137 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.698 HG21 ' HB2' ' A' ' 2' ' ' CYS . 43.3 mm -82.83 -49.41 16.93 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 C-N-CA 123.189 0.596 . . . . 70.120000000000005 110.341 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.485 ' SG ' HD23 ' A' ' 17' ' ' LEU . 11.4 m -64.26 -26.84 68.68 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.076 -0.966 . . . . 54.329999999999998 111.867 -171.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.78 -33.57 71.88 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.491 0.717 . . . . 64.430000000000007 111.76 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.51 -42.45 11.61 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 116.447 -0.342 . . . . 73.329999999999998 112.808 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -73.94 -34.23 64.23 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.868 0.467 . . . . 62.219999999999999 110.974 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 21.9 m -77.92 -78.76 0.13 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.249 0.62 . . . . 44.329999999999998 110.794 175.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.45 -48.44 0.06 OUTLIER Glycine 0 C--N 1.354 1.559 0 O-C-N 123.245 0.341 . . . . 44.020000000000003 112.911 -170.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.33 85.61 1.14 Allowed Glycine 0 C--N 1.341 0.85 0 C-N-CA 123.049 0.357 . . . . 60.530000000000001 113.034 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.5 m . . . . . 0 C--O 1.249 1.031 0 C-N-CA 124.336 1.054 . . . . 63.200000000000003 109.829 178.571 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.508 ' HB2' HD12 ' A' ' 24' ' ' ILE . 58.1 p . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 120.974 0.416 . . . . 74.340000000000003 110.056 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.765 ' HB2' HG21 ' A' ' 24' ' ' ILE . 9.3 t -134.93 -158.88 0.91 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 107.8 -1.185 . . . . 75.120000000000005 107.8 175.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.23 -11.41 67.05 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.363 -0.687 . . . . 53.229999999999997 112.958 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.4 m 68.94 6.23 5.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.998 1.319 . . . . 62.350000000000001 110.708 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -88.23 -45.47 10.05 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.291 1.037 . . . . 62.109999999999999 108.694 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 92.3 m -89.39 50.1 1.87 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.618 -1.174 . . . . 73.230000000000004 111.516 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.556 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -104.35 -15.27 0.16 Allowed Pre-proline 0 CA--C 1.577 2.011 0 N-CA-C 116.306 1.965 . . . . 61.439999999999998 116.306 167.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 14.0 Cg_exo -64.15 -49.47 3.71 Favored 'Trans proline' 0 C--N 1.407 3.644 0 CA-C-N 122.98 2.1 . . . . 71.209999999999994 113.342 -160.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -77.95 154.62 80.41 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 113.514 -1.676 . . . . 64.019999999999996 111.431 -166.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.17 -38.6 75.54 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.185 1.923 . . . . 62.149999999999999 110.425 174.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -100.56 82.42 2.45 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 107.358 -1.349 . . . . 61.229999999999997 107.358 167.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.533 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 23.6 p -73.48 -18.14 61.15 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.867 0.867 . . . . 62.149999999999999 111.778 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -48.5 -40.32 26.28 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 125.262 1.425 . . . . 73.530000000000001 112.354 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.3 -27.5 73.59 Favored Glycine 0 N--CA 1.478 1.441 0 CA-C-N 115.334 -0.848 . . . . 63.229999999999997 112.87 -172.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 12.7 t -90.66 -45.78 8.67 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.294 1.045 . . . . 75.329999999999998 110.107 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 11.4 t -74.75 -44.48 49.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.28 -1.782 . . . . 62.340000000000003 112.122 -166.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.405 HD23 ' SG ' ' A' ' 25' ' ' CYS . 72.7 mt -63.26 -15.99 58.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 115.019 1.488 . . . . 65.209999999999994 115.019 -173.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 15' ' ' CYS . 14.6 p -81.06 -10.81 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 118.706 0.684 . . . . 73.120000000000005 110.884 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -147.32 -3.81 0.55 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.377 0.671 . . . . 75.140000000000001 111.663 -169.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 8.2 m -145.61 162.87 36.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.115 0.966 . . . . 54.030000000000001 109.037 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.85 157.13 67.07 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.73 0.812 . . . . 64.010000000000005 111.399 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.84 -23.72 68.61 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.485 2.79 . . . . 54.32 113.066 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.4 p -65.17 -32.63 74.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.109 0.564 . . . . 75.109999999999999 110.643 173.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.765 HG21 ' HB2' ' A' ' 2' ' ' CYS . 14.6 mm -84.81 -49.04 16.18 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 121.175 0.512 . . . . 73.340000000000003 110.242 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.405 ' SG ' HD23 ' A' ' 17' ' ' LEU . 16.1 m -62.87 -28.1 69.8 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.837 -1.074 . . . . 73.299999999999997 111.235 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.25 -45.29 72.33 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.963 0.505 . . . . 64.109999999999999 111.004 169.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.13 -32.53 60.33 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.102 -0.954 . . . . 75.230000000000004 113.64 -175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -86.17 -28.7 23.76 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.896 0.478 . . . . 72.25 111.885 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.3 m -78.98 -70.07 0.53 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.615 0.366 . . . . 73.319999999999993 111.273 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.84 -53.64 0.02 OUTLIER Glycine 0 C--N 1.348 1.215 0 C-N-CA 121.743 -0.265 . . . . 52.240000000000002 113.552 -169.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.17 -66.86 1.79 Allowed Glycine 0 N--CA 1.47 0.908 0 N-CA-C 110.159 -1.176 . . . . 73.519999999999996 110.159 -169.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 CA--C 1.562 1.436 0 C-N-CA 125.736 1.614 . . . . 73.400000000000006 112.714 168.812 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.6 t . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.209 -0.293 . . . . 72.209999999999994 110.209 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.468 ' SG ' HG21 ' A' ' 24' ' ' ILE . 31.2 m -126.49 164.71 20.55 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.214 0.606 . . . . 60.399999999999999 109.887 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.04 12.2 58.52 Favored Glycine 0 N--CA 1.473 1.145 0 N-CA-C 116.81 1.484 . . . . 63.530000000000001 116.81 -161.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.2 p 58.1 15.43 3.24 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.105 1.362 . . . . 74.040000000000006 112.29 -172.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.63 -29.41 56.44 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 108.771 -0.826 . . . . 73.310000000000002 108.771 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 18.5 m -96.39 51.08 1.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.286 -0.87 . . . . 52.140000000000001 110.511 168.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.433 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -122.92 21.73 0.1 OUTLIER Pre-proline 0 CA--C 1.59 2.498 0 N-CA-C 115.071 1.508 . . . . 61.219999999999999 115.071 163.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 52.6 Cg_exo -58.32 -58.26 0.82 Allowed 'Trans proline' 0 C--N 1.409 3.751 0 CA-C-N 123.239 2.192 . . . . 74.409999999999997 113.115 174.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -80.1 154.65 75.0 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 114.845 -1.07 . . . . 64.439999999999998 111.193 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.26 -35.46 91.62 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.937 2.425 . . . . 75.439999999999998 110.655 168.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.44 75.41 5.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.003 -1.11 . . . . 63.43 108.003 167.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.547 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 20.7 p -68.22 -18.21 64.51 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.732 -1.122 . . . . 75.219999999999999 110.992 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -48.88 -36.69 17.67 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 125.411 1.484 . . . . 75.0 111.419 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.37 25.27 6.42 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-N 114.987 -1.006 . . . . 73.329999999999998 113.579 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.428 ' O ' HG12 ' A' ' 18' ' ' VAL . 20.0 t -143.5 -46.52 0.29 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.777 1.231 . . . . 73.329999999999998 108.649 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.2 t -78.02 -44.62 26.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.005 -1.907 . . . . 72.239999999999995 111.763 -170.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.2 mt -62.12 -12.59 20.33 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.974 1.472 . . . . 75.430000000000007 114.974 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 15' ' ' CYS . 11.4 p -82.22 -19.75 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 119.087 0.858 . . . . 74.099999999999994 110.584 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -142.08 5.26 1.69 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.046 0.938 . . . . 74.430000000000007 111.475 -169.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 48.4 m -146.49 172.05 14.13 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.751 1.22 . . . . 73.150000000000006 109.068 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.43 161.54 24.91 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 123.555 0.742 . . . . 52.009999999999998 110.871 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.04 -31.52 8.63 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 123.631 2.888 . . . . 51.119999999999997 114.61 169.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.8 m -56.42 -40.48 74.76 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.278 0.631 . . . . 62.439999999999998 111.505 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.468 HG21 ' SG ' ' A' ' 2' ' ' CYS . 47.6 mm -78.3 -55.73 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.603 -0.726 . . . . 72.040000000000006 110.089 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 m -63.88 -31.29 72.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.992 -1.003 . . . . 64.540000000000006 112.131 -170.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.82 -31.12 69.42 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.969 0.508 . . . . 74.430000000000007 112.012 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.45 -26.05 48.62 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.8 0.688 . . . . 51.450000000000003 112.561 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -91.2 -31.36 16.21 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.432 0.693 . . . . 70.310000000000002 111.015 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 18.6 m -80.82 -70.02 0.56 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.012 0.925 . . . . 70.329999999999998 111.935 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.35 34.96 0.39 Allowed Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.001 -1.0 . . . . 53.219999999999999 111.685 -167.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -92.93 -169.79 39.82 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 122.706 0.193 . . . . 75.239999999999995 112.631 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.7 p . . . . . 0 C--O 1.246 0.917 0 C-N-CA 123.801 0.84 . . . . 61.210000000000001 109.378 179.601 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.245 -0.65 . . . . 70.420000000000002 109.245 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.718 ' SG ' HG21 ' A' ' 24' ' ' ILE . 95.7 m 58.41 -157.41 0.31 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.051 0.94 . . . . 72.510000000000005 112.248 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.4 -6.51 77.67 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.266 -0.741 . . . . 61.43 113.966 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.0 p 60.0 15.98 5.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.475 1.51 . . . . 73.219999999999999 112.576 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -34.57 44.68 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.471 -0.786 . . . . 72.340000000000003 109.287 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 93.0 m -101.56 43.49 1.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.559 1.144 . . . . 70.340000000000003 110.727 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.535 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -95.89 -26.09 0.25 Allowed Pre-proline 0 CA--C 1.578 2.054 0 N-CA-C 115.826 1.787 . . . . 73.040000000000006 115.826 171.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 11.8 Cg_exo -65.8 -44.47 7.91 Favored 'Trans proline' 0 C--N 1.398 3.171 0 C-N-CA 122.161 1.907 . . . . 75.319999999999993 114.005 -157.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -83.34 157.0 65.83 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 114.109 -1.405 . . . . 72.120000000000005 111.983 -160.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.28 -27.61 63.81 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.214 1.943 . . . . 75.219999999999999 111.255 162.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -104.8 38.87 1.81 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.344 1.058 . . . . 72.129999999999995 109.224 174.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.5 p -64.92 -21.64 66.86 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.55 -0.719 . . . . 71.140000000000001 111.27 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -48.62 -38.78 21.85 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 125.242 1.417 . . . . 72.430000000000007 111.79 171.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.73 -14.47 79.86 Favored Glycine 0 N--CA 1.473 1.105 0 CA-C-N 115.04 -0.982 . . . . 72.349999999999994 113.104 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 20.5 t -99.43 -41.26 7.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.121 1.368 . . . . 74.540000000000006 110.151 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 9.9 t -81.03 -45.5 16.46 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 113.174 -1.83 . . . . 73.519999999999996 112.553 -168.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.6 -0.47 1.4 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.245 1.572 . . . . 71.129999999999995 115.245 -175.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -88.35 -23.46 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-N 119.176 0.898 . . . . 73.109999999999999 110.436 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -133.79 -3.42 2.9 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.161 0.985 . . . . 74.099999999999994 111.235 -169.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.507 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 63.2 m -144.14 170.18 16.45 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.643 0.777 . . . . 61.350000000000001 110.592 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.41 159.93 34.15 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.186 0.995 . . . . 71.340000000000003 110.795 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -48.12 -30.29 14.11 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 123.686 2.924 . . . . 51.439999999999998 114.161 168.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.2 m -60.91 -39.4 89.2 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.991 0.917 . . . . 62.240000000000002 111.395 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.718 HG21 ' SG ' ' A' ' 2' ' ' CYS . 51.1 mm -77.36 -53.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 C-N-CA 123.533 0.733 . . . . 73.299999999999997 109.82 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.7 m -62.76 -31.22 72.13 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.75 -1.114 . . . . 33.439999999999998 112.014 -173.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.6 -39.98 84.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.717 0.407 . . . . 65.150000000000006 110.572 172.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.64 -24.32 75.36 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.88 -0.6 . . . . 60.310000000000002 112.977 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.51 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . 81.7 m95 -97.14 -43.79 7.23 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.413 0.685 . . . . 74.329999999999998 111.665 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.5 m -71.4 -73.06 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.31 0.576 . . . . 52.109999999999999 110.864 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.06 100.69 0.15 Allowed Glycine 0 C--N 1.341 0.823 0 CA-C-N 114.998 -1.001 . . . . 62.210000000000001 111.315 -170.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.76 126.66 0.87 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.864 -0.495 . . . . 55.210000000000001 111.864 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.8 p . . . . . 0 CA--C 1.561 1.376 0 C-N-CA 124.275 1.03 . . . . 72.219999999999999 110.629 -177.134 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.421 -0.214 . . . . 75.409999999999997 110.421 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 50.1 m -82.95 161.02 21.94 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.815 0.446 . . . . 65.230000000000004 110.071 170.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.63 19.13 16.69 Favored Glycine 0 N--CA 1.47 0.905 0 CA-C-N 115.605 -0.725 . . . . 65.209999999999994 112.912 -174.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t 64.44 14.93 9.21 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.833 1.253 . . . . 74.209999999999994 110.791 -166.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -80.29 -33.14 37.93 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.372 -0.973 . . . . 72.209999999999994 108.372 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.403 ' SG ' ' NE2' ' A' ' 19' ' ' GLN . 91.3 m -99.6 46.93 0.96 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.626 -1.17 . . . . 70.329999999999998 110.964 173.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.541 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -112.74 -6.89 0.1 Allowed Pre-proline 0 CA--C 1.577 1.999 0 CA-C-O 116.409 -1.758 . . . . 24.210000000000001 115.565 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 39.1 Cg_exo -62.01 -50.69 4.63 Favored 'Trans proline' 0 C--N 1.408 3.692 0 CA-C-N 123.416 2.256 . . . . 73.409999999999997 113.176 -169.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -77.68 153.91 81.03 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 114.594 -1.185 . . . . 74.5 111.539 -170.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.47 -25.32 41.62 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.216 1.944 . . . . 61.149999999999999 110.658 164.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -104.26 45.84 0.94 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.014 1.326 . . . . 70.400000000000006 108.92 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.509 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 20.6 p -56.02 -19.79 14.13 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.499 1.12 . . . . 74.430000000000007 112.455 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.45 ' HZ2' ' HB2' ' A' ' 32' ' ' SER . 69.9 m95 -42.74 -39.51 2.47 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.096 1.758 . . . . 60.020000000000003 112.378 171.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.31 -22.09 76.12 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 115.413 -0.812 . . . . 72.409999999999997 113.616 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.469 ' O ' HG12 ' A' ' 18' ' ' VAL . 25.0 t -96.31 -46.21 6.51 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.25 1.024 . . . . 75.540000000000006 109.987 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -76.99 -47.35 21.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 113.424 -1.717 . . . . 72.319999999999993 112.734 -166.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.436 HD23 ' SG ' ' A' ' 25' ' ' CYS . 47.1 mt -61.46 -14.26 27.18 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.076 1.51 . . . . 62.409999999999997 115.076 -173.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 15' ' ' CYS . 14.0 p -74.93 -23.58 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 118.909 0.777 . . . . 74.129999999999995 110.952 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.403 ' NE2' ' SG ' ' A' ' 6' ' ' CYS . 21.4 pt20 -134.43 -18.54 1.96 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.139 0.976 . . . . 73.129999999999995 111.426 -167.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 66.8 m -128.55 170.9 12.65 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.243 1.017 . . . . 72.420000000000002 110.396 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.18 154.9 57.72 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.192 0.997 . . . . 74.209999999999994 110.8 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -49.48 -26.54 12.4 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.683 2.922 . . . . 74.319999999999993 114.304 168.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 m -61.98 -41.42 98.0 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.134 0.574 . . . . 55.25 111.174 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.04 -52.87 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 122.956 0.502 . . . . 54.030000000000001 110.28 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.436 ' SG ' HD23 ' A' ' 17' ' ' LEU . 4.0 m -62.0 -33.35 74.17 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.866 -1.061 . . . . 72.340000000000003 111.092 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.8 -36.77 77.43 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.603 0.761 . . . . 74.430000000000007 111.565 174.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.04 -41.53 22.13 Favored Glycine 0 C--N 1.351 1.364 0 O-C-N 123.91 0.756 . . . . 42.020000000000003 112.423 -174.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -77.93 -40.67 38.87 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.124 0.569 . . . . 63.399999999999999 111.863 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.8 m -67.35 -63.67 1.01 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.34 0.59 . . . . 72.329999999999998 110.542 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.08 -54.71 4.75 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 114.793 -1.094 . . . . 32.229999999999997 111.446 -167.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.51 103.73 0.46 Allowed Glycine 0 C--N 1.354 1.538 0 C-N-CA 123.562 0.601 . . . . 44.509999999999998 112.347 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.45 ' HB2' ' HZ2' ' A' ' 13' ' ' TRP . 38.7 t . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.023 -1.102 . . . . 72.530000000000001 108.023 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 110.12 -0.326 . . . . 71.019999999999996 110.12 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.765 ' HB2' HG21 ' A' ' 24' ' ' ILE . 6.2 t -154.07 -172.57 4.26 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.774 0.83 . . . . 25.420000000000002 108.931 178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.46 -18.71 65.77 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.796 -0.446 . . . . 73.329999999999998 112.567 173.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.8 m 69.54 8.6 6.84 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 124.777 1.231 . . . . 55.310000000000002 112.272 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -117.55 6.64 12.53 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.494 1.117 . . . . 73.140000000000001 110.437 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.5 m -113.66 31.88 6.2 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.131 0.972 . . . . 65.400000000000006 110.984 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.578 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -95.02 -20.88 0.23 Allowed Pre-proline 0 CA--C 1.58 2.103 0 N-CA-C 115.318 1.599 . . . . 64.450000000000003 115.318 166.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 9.6 Cg_exo -70.35 -47.27 0.78 Allowed 'Trans proline' 0 C--N 1.4 3.262 0 C-N-CA 122.448 2.098 . . . . 65.450000000000003 113.849 -162.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -70.62 159.64 84.39 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.591 -1.186 . . . . 74.319999999999993 112.164 -164.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.51 -29.62 44.43 Favored 'Trans proline' 0 C--N 1.368 1.572 0 C-N-CA 122.159 1.906 . . . . 61.229999999999997 111.352 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -109.22 31.77 5.47 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.644 1.178 . . . . 73.420000000000002 109.894 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.0 p -53.54 -21.39 6.36 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.189 1.396 . . . . 74.230000000000004 114.067 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.465 ' HE3' HD11 ' A' ' 17' ' ' LEU . 81.4 m95 -55.42 -38.31 68.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.439 1.096 . . . . 64.230000000000004 111.16 175.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.92 -21.08 78.14 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 114.984 -1.007 . . . . 54.450000000000003 112.542 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' O ' HG12 ' A' ' 18' ' ' VAL . 15.1 t -83.74 -45.06 13.78 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.112 0.965 . . . . 72.510000000000005 109.645 177.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.4 t -78.52 -55.72 4.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.98 -1.464 . . . . 74.420000000000002 111.776 -168.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.465 HD11 ' HE3' ' A' ' 13' ' ' TRP . 2.2 mp -62.0 -9.19 6.52 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 115.113 1.523 . . . . 72.439999999999998 115.113 -175.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 15' ' ' CYS . 11.1 p -80.28 -15.56 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 119.255 0.934 . . . . 64.439999999999998 109.919 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.611 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 26.5 pt20 -144.23 -4.8 0.79 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.875 0.87 . . . . 31.41 111.703 -170.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.611 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 3.9 m -139.77 170.32 16.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.666 0.787 . . . . 62.0 109.197 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.432 ' HB3' HG12 ' A' ' 24' ' ' ILE . . . -80.08 149.91 70.65 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 122.983 0.513 . . . . 73.209999999999994 111.236 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.437 ' HB3' HD21 ' A' ' 17' ' ' LEU . 9.3 Cg_endo -54.07 -27.25 44.99 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 123.364 2.709 . . . . 54.32 112.844 165.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.3 m -62.77 -39.62 94.76 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.599 0.76 . . . . 64.219999999999999 110.473 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.765 HG21 ' HB2' ' A' ' 2' ' ' CYS . 44.9 mm -73.29 -48.33 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 123.773 0.829 . . . . 70.450000000000003 110.0 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.4 m -64.05 -31.94 73.32 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.401 1.08 . . . . 74.409999999999997 111.54 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.58 -31.43 70.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.547 -0.751 . . . . 75.540000000000006 111.865 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.64 -32.87 26.29 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 116.381 -0.372 . . . . 25.210000000000001 112.937 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -80.73 -54.55 5.52 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.938 0.495 . . . . 71.310000000000002 111.338 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -79.19 -69.99 0.54 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.25 0.62 . . . . 62.200000000000003 112.527 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.57 102.57 0.35 Allowed Glycine 0 C--N 1.347 1.182 0 N-CA-C 112.02 -0.432 . . . . 63.140000000000001 112.02 -166.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.42 76.24 1.52 Allowed Glycine 0 C--N 1.346 1.104 0 C-N-CA 122.753 0.216 . . . . 34.439999999999998 112.592 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 C--O 1.251 1.136 0 C-N-CA 123.794 0.837 . . . . 62.420000000000002 109.244 -173.939 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.4 p . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.833 0.349 . . . . 62.340000000000003 111.148 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.748 ' HB2' HG21 ' A' ' 24' ' ' ILE . 2.0 t -94.18 -165.35 1.3 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.287 -1.005 . . . . 73.450000000000003 108.287 168.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.55 -17.64 79.75 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.392 -0.671 . . . . 52.0 112.457 170.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.1 t 71.07 29.68 2.87 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 124.808 1.243 . . . . 65.129999999999995 108.289 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -111.28 -31.27 7.12 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.278 -1.328 . . . . 72.150000000000006 109.94 -174.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 96.8 m -103.25 44.42 1.02 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.397 1.079 . . . . 73.230000000000004 112.435 -175.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.547 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -105.26 -10.47 0.12 Allowed Pre-proline 0 CA--C 1.589 2.445 0 N-CA-C 116.233 1.938 . . . . 72.030000000000001 116.233 167.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 16.3 Cg_exo -67.09 -50.67 0.97 Allowed 'Trans proline' 0 C--N 1.401 3.321 0 CA-C-N 123.752 2.376 . . . . 73.120000000000005 114.023 -167.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -80.72 162.33 60.68 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.627 -1.169 . . . . 75.239999999999995 112.602 -162.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.95 -17.09 28.95 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.534 2.156 . . . . 71.129999999999995 111.439 166.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -114.3 27.6 9.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.741 1.216 . . . . 74.299999999999997 110.249 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.9 p -62.48 -16.24 54.35 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.301 1.04 . . . . 75.310000000000002 112.779 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.43 ' HE3' HD11 ' A' ' 17' ' ' LEU . 89.2 m95 -53.76 -39.05 65.02 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.698 0.799 . . . . 72.109999999999999 110.818 173.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.36 -28.41 73.28 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 115.749 -0.66 . . . . 73.129999999999995 112.127 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.52 ' O ' HG12 ' A' ' 18' ' ' VAL . 34.3 t -80.94 -43.77 19.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.356 1.062 . . . . 75.219999999999999 109.742 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -70.32 -54.39 12.78 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.525 -1.216 . . . . 64.200000000000003 111.092 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 22' ' ' PRO . 2.1 mp -69.13 -2.64 10.77 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 115.17 1.544 . . . . 72.430000000000007 115.17 -174.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 15' ' ' CYS . 13.3 p -84.56 -16.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 119.408 1.003 . . . . 62.130000000000003 109.715 176.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -145.15 -3.07 0.77 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.55 0.74 . . . . 54.340000000000003 111.965 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.2 m -144.14 164.45 30.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.856 0.862 . . . . 70.109999999999999 109.531 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.63 154.7 73.7 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-N 115.894 -0.594 . . . . 65.519999999999996 110.515 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.479 ' HB3' HD21 ' A' ' 17' ' ' LEU . 18.3 Cg_endo -59.83 -19.53 54.83 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.957 2.438 . . . . 63.229999999999997 112.234 169.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -58.4 -38.59 77.67 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.905 0.882 . . . . 71.299999999999997 110.872 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.748 HG21 ' HB2' ' A' ' 2' ' ' CYS . 23.9 mm -84.59 -43.06 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.821 -0.627 . . . . 63.310000000000002 110.112 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 m -64.97 -30.5 71.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.238 1.015 . . . . 64.439999999999998 112.07 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.42 -24.4 65.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.991 0.516 . . . . 42.530000000000001 111.541 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.23 -45.49 8.82 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.133 -0.485 . . . . 71.439999999999998 112.138 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -77.48 -67.11 0.75 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.903 0.481 . . . . 73.409999999999997 110.906 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.1 m -69.66 -32.19 70.69 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.363 -0.835 . . . . 52.409999999999997 112.536 -173.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.18 -162.1 38.15 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 115.997 -0.547 . . . . 61.409999999999997 113.026 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.71 146.62 4.49 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.606 -0.597 . . . . 42.509999999999998 111.606 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 C--O 1.249 1.055 0 N-CA-C 108.795 -0.817 . . . . 74.019999999999996 108.795 -178.873 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.769 -0.456 . . . . 55.200000000000003 109.769 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 72.2 m -67.79 160.63 27.86 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.198 0.523 . . . . 71.439999999999998 111.086 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.81 19.78 32.6 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.282 -0.872 . . . . 33.450000000000003 113.866 -171.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.2 m 67.89 14.19 9.34 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.604 1.162 . . . . 64.230000000000004 111.193 -173.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.94 -20.37 20.07 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.409 1.083 . . . . 74.329999999999998 109.292 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 77.2 m -100.43 45.86 0.97 Allowed 'General case' 0 C--N 1.347 0.489 0 C-N-CA 124.382 1.073 . . . . 63.520000000000003 111.07 172.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.545 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -120.45 5.79 0.07 OUTLIER Pre-proline 0 CA--C 1.582 2.18 0 N-CA-C 115.657 1.725 . . . . 73.099999999999994 115.657 168.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 23.9 Cg_exo -65.55 -51.08 1.52 Allowed 'Trans proline' 0 C--N 1.406 3.589 0 CA-C-N 123.648 2.339 . . . . 72.030000000000001 112.415 -175.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -83.28 156.08 66.35 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 113.672 -1.604 . . . . 64.109999999999999 111.529 -167.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -60.9 -39.96 57.15 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.331 2.021 . . . . 72.319999999999993 110.252 166.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -92.76 75.33 4.94 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 108.411 -0.959 . . . . 70.439999999999998 108.411 170.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 15.9 p -73.24 -21.5 60.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.176 -0.92 . . . . 74.230000000000004 110.343 174.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -48.75 -37.86 20.09 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 125.351 1.46 . . . . 72.109999999999999 111.253 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.67 -36.52 92.47 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.0 -1.0 . . . . 61.399999999999999 112.006 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.9 t -80.87 -44.75 17.9 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.391 1.091 . . . . 61.130000000000003 110.439 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HA ' ' NE2' ' A' ' 19' ' ' GLN . 5.1 t -82.73 -54.11 5.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.282 -1.781 . . . . 74.510000000000005 112.029 -166.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.8 mt -55.99 -19.11 11.22 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.119 1.525 . . . . 45.43 115.119 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.52 -25.7 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 118.407 0.548 . . . . 72.030000000000001 111.324 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.431 ' NE2' ' HA ' ' A' ' 16' ' ' CYS . 2.9 pp0? -134.98 -0.72 2.75 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.75 0.82 . . . . 70.409999999999997 112.227 -175.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 74.2 m -136.47 175.88 9.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.265 1.026 . . . . 72.019999999999996 110.634 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.27 160.8 27.33 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.495 1.118 . . . . 62.340000000000003 110.188 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.6 -18.44 40.15 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 122.997 2.465 . . . . 65.519999999999996 113.504 173.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.9 p -60.79 -40.02 91.06 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.148 0.579 . . . . 65.340000000000003 110.635 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.7 mm -75.68 -56.03 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 123.307 0.643 . . . . 70.239999999999995 110.1 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.8 m -61.01 -29.07 69.49 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.74 -1.118 . . . . 64.5 112.573 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.37 -36.15 79.44 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.895 0.478 . . . . 43.530000000000001 111.659 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.13 -20.59 69.63 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.974 -0.557 . . . . 74.329999999999998 112.873 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -97.39 -35.21 10.76 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.311 0.644 . . . . 71.019999999999996 111.564 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.8 m -76.77 -69.89 0.49 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.137 0.575 . . . . 60.43 111.277 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.74 -64.03 0.03 OUTLIER Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.094 -0.803 . . . . 74.099999999999994 111.094 -173.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.34 175.18 44.97 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.303 -0.719 . . . . 44.399999999999999 111.303 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.251 1.151 0 C-N-CA 123.359 0.664 . . . . 44.100000000000001 109.615 179.067 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 109.683 -0.488 . . . . 71.200000000000003 109.683 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.491 ' HB2' HG21 ' A' ' 24' ' ' ILE . 4.0 t -72.45 170.29 14.61 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.083 0.553 . . . . 62.340000000000003 110.592 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.57 -0.72 75.44 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.712 -0.677 . . . . 73.329999999999998 112.884 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 m 64.05 18.63 11.34 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 124.296 1.038 . . . . 73.420000000000002 108.884 -161.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -74.32 -50.2 19.79 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 114.572 -1.195 . . . . 73.010000000000005 108.811 -165.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 64.4 m -106.2 50.33 0.78 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 113.795 -1.548 . . . . 73.310000000000002 110.858 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.538 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -89.62 -27.12 0.32 Allowed Pre-proline 0 CA--C 1.582 2.21 0 N-CA-C 115.199 1.555 . . . . 73.019999999999996 115.199 166.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 21.1 Cg_exo -64.37 -50.66 2.51 Favored 'Trans proline' 0 C--N 1.407 3.637 0 C-N-CA 122.862 2.374 . . . . 55.520000000000003 114.272 -161.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -72.45 158.81 86.82 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.765 0.826 . . . . 72.109999999999999 112.043 -167.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.41 -32.86 59.9 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.434 2.089 . . . . 62.039999999999999 110.616 163.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -95.68 32.7 1.78 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.96 1.304 . . . . 62.530000000000001 110.394 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -49.91 -32.49 14.79 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.417 1.487 . . . . 53.0 112.041 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -52.04 -40.66 61.45 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 124.719 1.207 . . . . 53.210000000000001 111.952 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.02 47.77 3.4 Favored Glycine 0 N--CA 1.478 1.434 0 CA-C-N 114.757 -1.11 . . . . 62.43 111.055 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 6.7 t -170.42 -46.44 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.055 1.342 . . . . 71.150000000000006 108.249 -169.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 41.2 t -79.56 -46.55 17.1 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 114.065 -1.425 . . . . 73.140000000000001 111.536 -170.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -76.3 15.44 0.59 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.491 1.293 . . . . 75.030000000000001 114.491 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 15' ' ' CYS . 8.1 p -97.13 -12.31 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-O 121.633 0.73 . . . . 64.329999999999998 109.725 168.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.62 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 25.9 pt20 -145.95 -3.68 0.67 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.695 0.798 . . . . 73.420000000000002 111.774 -170.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.62 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 0.8 OUTLIER -144.95 158.02 43.95 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 123.69 0.796 . . . . 61.109999999999999 108.96 -178.417 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.526 ' HB3' HG12 ' A' ' 24' ' ' ILE . . . -78.94 151.42 76.23 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.034 0.534 . . . . 51.210000000000001 110.722 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.16 -30.28 49.8 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.876 3.051 . . . . 44.329999999999998 113.281 172.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 m -63.57 -36.73 84.78 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.905 0.482 . . . . 74.420000000000002 110.776 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.526 HG12 ' HB3' ' A' ' 21' ' ' ALA . 12.1 mm -78.71 -48.35 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 109.212 -0.662 . . . . 74.329999999999998 109.212 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 m -61.69 -35.79 79.03 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.426 1.09 . . . . 75.510000000000005 111.326 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.72 -30.26 70.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.984 0.514 . . . . 64.329999999999998 111.574 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.75 -38.92 49.39 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.704 0.628 . . . . 74.129999999999995 112.071 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.491 ' HE1' HG22 ' A' ' 24' ' ' ILE . 60.0 m95 -75.96 -49.52 17.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.171 0.588 . . . . 75.140000000000001 110.831 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.08 -61.89 1.6 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.5 -0.773 . . . . 73.5 111.719 -175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.76 -9.8 20.19 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 114.264 0.466 . . . . 63.32 114.264 -170.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.99 -39.56 37.65 Favored Glycine 0 N--CA 1.47 0.964 0 CA-C-N 117.087 0.443 . . . . 73.430000000000007 112.998 -174.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 C--O 1.25 1.084 0 C-N-CA 123.806 0.842 . . . . 74.409999999999997 109.328 178.241 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.996 -0.372 . . . . 53.5 109.996 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.642 ' SG ' HG21 ' A' ' 24' ' ' ILE . 55.8 m -74.81 -176.62 2.94 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.206 0.603 . . . . 73.310000000000002 111.136 178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.49 -7.83 87.1 Favored Glycine 0 N--CA 1.468 0.809 0 CA-C-O 119.188 -0.785 . . . . 73.310000000000002 115.023 -165.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 m 70.34 6.09 5.63 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.016 1.327 . . . . 62.399999999999999 111.002 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.41 -34.2 63.2 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.219 1.008 . . . . 63.439999999999998 109.401 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.4 m -90.14 41.41 1.05 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.246 1.019 . . . . 73.439999999999998 111.277 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.484 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -126.53 26.72 0.13 Allowed Pre-proline 0 CA--C 1.58 2.103 0 N-CA-C 115.482 1.66 . . . . 72.319999999999993 115.482 172.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 13.0 Cg_exo -68.8 -54.47 0.27 Allowed 'Trans proline' 0 C--N 1.398 3.134 0 CA-C-N 122.746 2.016 . . . . 62.43 111.267 172.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -83.86 165.13 41.1 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 113.105 -1.861 . . . . 64.530000000000001 111.471 -164.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.33 -25.38 36.26 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.209 1.94 . . . . 74.239999999999995 110.494 160.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.95 45.09 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.445 1.498 . . . . 74.439999999999998 109.593 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 13.2 p -65.3 -23.7 67.09 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.041 0.536 . . . . 74.0 111.484 -176.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -49.85 -35.86 24.76 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 124.955 1.302 . . . . 74.409999999999997 110.981 173.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.54 41.62 3.06 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 114.65 -1.159 . . . . 40.420000000000002 112.5 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' O ' HG12 ' A' ' 18' ' ' VAL . 13.3 t -162.56 -51.15 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 125.117 1.367 . . . . 75.25 108.097 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.7 t -75.93 -44.64 39.18 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 113.624 -1.625 . . . . 64.409999999999997 111.578 -172.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 40.4 mt -61.83 -17.9 58.03 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.668 1.359 . . . . 71.310000000000002 114.668 -175.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 15' ' ' CYS . 11.9 p -79.89 -21.03 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.938 0.79 . . . . 63.520000000000003 110.447 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -140.34 8.73 2.24 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.792 0.837 . . . . 74.25 111.616 -170.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -150.86 173.47 14.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.3 1.04 . . . . 44.200000000000003 109.59 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.31 158.44 37.1 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.011 0.925 . . . . 63.030000000000001 109.959 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.73 -22.71 54.3 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.918 2.412 . . . . 73.409999999999997 112.947 171.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.5 m -63.81 -22.73 67.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.454 0.701 . . . . 71.019999999999996 111.826 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.642 HG21 ' SG ' ' A' ' 2' ' ' CYS . 43.9 mm -91.42 -53.05 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.155 0.582 . . . . 74.140000000000001 109.437 173.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.2 m -64.43 -28.36 69.62 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.789 -1.096 . . . . 52.009999999999998 113.156 -169.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.12 -32.85 72.53 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.27 0.628 . . . . 72.430000000000007 111.637 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.88 -0.94 74.03 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.885 -0.598 . . . . 62.140000000000001 112.62 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -105.67 -34.45 7.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.79 0.836 . . . . 73.430000000000007 110.562 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.0 m -77.21 -76.77 0.16 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.392 0.677 . . . . 72.409999999999997 111.029 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -148.36 53.74 0.52 Allowed Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.148 -0.478 . . . . 63.229999999999997 112.526 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.97 -50.64 10.36 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 111.097 -0.801 . . . . 52.420000000000002 111.097 173.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 CA--C 1.557 1.228 0 C-N-CA 124.787 1.235 . . . . 73.409999999999997 108.503 176.68 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.195 -0.298 . . . . 43.409999999999997 110.195 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.613 ' SG ' HG21 ' A' ' 24' ' ' ILE . 17.7 m 70.41 165.89 0.28 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.047 1.339 . . . . 71.319999999999993 110.637 -175.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.96 5.66 66.35 Favored Glycine 0 N--CA 1.472 1.074 0 CA-C-O 118.953 -0.915 . . . . 71.109999999999999 114.905 -168.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.6 p 54.68 20.7 3.07 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.103 1.361 . . . . 72.329999999999998 111.274 -169.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.12 -36.25 40.87 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.846 -1.07 . . . . 72.340000000000003 108.192 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.3 m -93.38 45.52 1.17 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.211 1.005 . . . . 41.420000000000002 111.476 171.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.549 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -116.94 7.38 0.08 OUTLIER Pre-proline 0 CA--C 1.582 2.181 0 N-CA-C 115.675 1.731 . . . . 71.239999999999995 115.675 167.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 24.5 Cg_exo -63.13 -48.96 5.43 Favored 'Trans proline' 0 C--N 1.409 3.744 0 CA-C-N 123.612 2.326 . . . . 65.209999999999994 112.261 -173.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -73.61 155.95 88.91 Favored Pre-proline 0 N--CA 1.439 -0.999 0 CA-C-N 113.187 -1.824 . . . . 44.329999999999998 111.927 -168.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.36 -37.79 79.4 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.199 1.933 . . . . 72.140000000000001 110.399 163.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -99.82 76.48 1.97 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.925 0.89 . . . . 75.450000000000003 108.79 170.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.503 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 19.7 p -69.34 -19.89 63.86 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.35 -0.841 . . . . 62.240000000000002 111.082 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -48.87 -37.18 18.85 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 125.38 1.472 . . . . 73.010000000000005 111.174 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.77 39.41 3.09 Favored Glycine 0 N--CA 1.474 1.167 0 CA-C-N 114.965 -1.016 . . . . 70.040000000000006 113.395 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.7 t -159.99 -48.65 0.05 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.958 1.303 . . . . 70.219999999999999 108.33 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 10.8 t -77.19 -42.01 39.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 112.952 -1.931 . . . . 62.030000000000001 112.041 -171.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.463 HD23 ' SG ' ' A' ' 25' ' ' CYS . 47.4 mt -64.34 -11.09 28.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.069 1.507 . . . . 73.400000000000006 115.069 -173.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.04 -26.3 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 118.857 0.753 . . . . 74.040000000000006 110.414 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -132.57 0.9 3.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.148 0.979 . . . . 74.209999999999994 111.598 -168.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 39.5 m -144.9 164.76 30.13 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.668 0.787 . . . . 73.219999999999999 109.889 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.7 155.41 65.25 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.581 0.752 . . . . 53.43 110.562 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.44 -23.85 15.14 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.271 2.648 . . . . 64.230000000000004 114.212 169.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 t -64.23 -44.62 91.28 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.079 0.552 . . . . 71.120000000000005 110.64 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.613 HG21 ' SG ' ' A' ' 2' ' ' CYS . 42.0 mm -68.04 -50.51 58.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 CA-C-O 121.283 0.564 . . . . 75.0 109.725 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.463 ' SG ' HD23 ' A' ' 17' ' ' LEU . 8.4 m -67.31 -27.54 67.25 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.95 -1.023 . . . . 42.119999999999997 111.657 -174.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.29 -25.27 67.56 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.717 0.407 . . . . 74.400000000000006 112.024 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.08 -19.68 56.93 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 112.259 -0.336 . . . . 52.439999999999998 112.259 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -99.83 -25.43 14.36 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.682 0.793 . . . . 75.209999999999994 111.361 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 17.6 m -94.14 -72.31 0.62 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.6 0.76 . . . . 73.530000000000001 110.455 175.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.97 163.21 16.38 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.361 -1.29 . . . . 71.140000000000001 111.658 -170.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -151.5 47.82 0.57 Allowed Glycine 0 N--CA 1.467 0.707 0 N-CA-C 111.38 -0.688 . . . . 63.450000000000003 111.38 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.2 t . . . . . 0 C--O 1.255 1.376 0 C-N-CA 124.055 0.942 . . . . 73.430000000000007 108.758 -177.571 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 110.362 -0.236 . . . . 75.549999999999997 110.362 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.779 ' HB2' HG21 ' A' ' 24' ' ' ILE . 18.5 t -166.06 178.79 6.15 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.223 1.009 . . . . 53.039999999999999 108.901 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.26 -11.52 51.82 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 119.155 -0.803 . . . . 64.450000000000003 113.325 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.6 p 51.67 22.63 1.68 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 125.334 1.453 . . . . 73.450000000000003 111.801 -171.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -94.76 -44.46 7.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.236 1.414 . . . . 75.439999999999998 108.469 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 67.4 m -94.5 47.95 1.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.166 -1.379 . . . . 75.25 111.475 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.56 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -109.07 7.18 0.08 OUTLIER Pre-proline 0 CA--C 1.584 2.259 0 N-CA-C 115.843 1.794 . . . . 73.319999999999993 115.843 166.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 16.9 Cg_exo -68.4 -57.02 0.16 Allowed 'Trans proline' 0 C--N 1.406 3.602 0 CA-C-N 123.904 2.43 . . . . 71.299999999999997 113.121 -174.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.06 164.28 62.35 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 114.455 -1.248 . . . . 71.409999999999997 111.968 -166.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.17 -29.18 27.11 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.251 1.967 . . . . 64.310000000000002 111.06 164.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.52 31.72 5.01 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.466 1.107 . . . . 43.409999999999997 110.098 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 p -60.31 -9.55 3.61 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.475 1.11 . . . . 72.219999999999999 113.544 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.479 ' HE3' HD11 ' A' ' 17' ' ' LEU . 83.4 m95 -49.33 -38.31 27.49 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.937 1.295 . . . . 72.239999999999995 111.595 169.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.38 48.41 3.77 Favored Glycine 0 N--CA 1.476 1.346 0 CA-C-N 115.213 -0.903 . . . . 72.409999999999997 111.679 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 7.3 t -168.76 -46.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.924 1.289 . . . . 64.510000000000005 108.556 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.44 ' HA ' ' NE2' ' A' ' 19' ' ' GLN . 41.2 t -73.12 -48.13 38.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.74 -1.573 . . . . 72.129999999999995 112.07 -173.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.479 HD11 ' HE3' ' A' ' 13' ' ' TRP . 5.7 mp -70.34 2.3 3.98 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.143 1.905 . . . . 52.009999999999998 116.143 -171.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.509 HG13 ' HG3' ' A' ' 19' ' ' GLN . 7.6 p -83.71 -29.48 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 118.667 0.667 . . . . 75.540000000000006 109.955 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.509 ' HG3' HG13 ' A' ' 18' ' ' VAL . 2.6 pp0? -132.69 6.01 4.0 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.07 0.948 . . . . 73.409999999999997 112.182 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 17' ' ' LEU . 2.6 m -142.78 161.8 37.15 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.04 -1.096 . . . . 71.010000000000005 108.04 172.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.24 157.79 53.11 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 122.97 0.508 . . . . 52.439999999999998 110.165 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HB3' HD21 ' A' ' 17' ' ' LEU . 19.2 Cg_endo -59.44 -22.53 66.45 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.05 2.5 . . . . 62.020000000000003 113.089 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.4 p -62.15 -38.89 90.71 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.429 0.692 . . . . 64.049999999999997 110.524 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.779 HG21 ' HB2' ' A' ' 2' ' ' CYS . 10.9 mm -81.83 -46.5 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.31 -0.859 . . . . 71.420000000000002 109.855 -177.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.4 m -64.96 -24.36 67.5 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.448 1.099 . . . . 75.450000000000003 111.233 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -31.76 73.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.106 0.562 . . . . 60.020000000000003 111.59 171.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.63 -45.68 21.76 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 116.401 -0.363 . . . . 62.140000000000001 112.241 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -73.17 -58.86 3.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.273 0.629 . . . . 71.25 111.158 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.3 m -74.18 -62.45 1.51 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.591 0.756 . . . . 52.109999999999999 112.42 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.55 -118.52 2.82 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-O 120.247 -0.196 . . . . 61.409999999999997 113.012 -170.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 144.13 95.18 0.2 Allowed Glycine 0 C--N 1.347 1.19 0 N-CA-C 110.678 -0.969 . . . . 30.52 110.678 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 CA--C 1.554 1.11 0 C-N-CA 123.543 0.737 . . . . 45.210000000000001 109.355 -174.352 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.632 -0.507 . . . . 70.510000000000005 109.632 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.747 ' SG ' HG21 ' A' ' 24' ' ' ILE . 58.4 m -92.08 179.81 5.48 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.114 0.566 . . . . 74.400000000000006 110.821 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.63 3.67 47.93 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 116.771 1.468 . . . . 53.130000000000003 116.771 -164.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m 68.63 1.36 2.98 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.464 1.106 . . . . 63.020000000000003 111.539 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.49 -18.38 45.33 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 123.522 0.729 . . . . 72.299999999999997 109.653 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 83.2 m -103.96 42.95 1.13 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.09 0.956 . . . . 72.150000000000006 110.945 172.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.532 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -110.7 -5.99 0.11 Allowed Pre-proline 0 CA--C 1.586 2.35 0 N-CA-C 115.597 1.702 . . . . 60.149999999999999 115.597 168.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 25.3 Cg_exo -63.82 -58.43 0.27 Allowed 'Trans proline' 0 C--N 1.405 3.531 0 CA-C-N 123.642 2.336 . . . . 74.519999999999996 113.634 -172.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -77.52 162.92 66.83 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 114.84 -1.073 . . . . 72.319999999999993 111.851 -170.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.38 -25.22 30.58 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.57 2.18 . . . . 72.319999999999993 110.411 160.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -93.25 23.54 4.37 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 125.312 1.445 . . . . 72.409999999999997 110.181 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 p -62.03 -17.74 58.32 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.719 1.207 . . . . 62.310000000000002 113.451 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -57.97 -33.37 68.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.094 0.957 . . . . 74.319999999999993 111.106 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.85 -34.02 88.78 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 115.6 -0.727 . . . . 74.450000000000003 112.105 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.469 ' O ' HG12 ' A' ' 18' ' ' VAL . 17.9 t -78.34 -47.65 17.27 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.641 1.176 . . . . 55.409999999999997 110.225 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.9 t -80.3 -45.26 18.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.855 -1.52 . . . . 72.439999999999998 112.033 -167.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.401 HD23 ' SG ' ' A' ' 25' ' ' CYS . 78.6 mt -65.66 -5.75 9.33 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.498 1.296 . . . . 71.510000000000005 114.498 -174.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 15' ' ' CYS . 9.1 p -87.67 -19.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.026 0.83 . . . . 74.219999999999999 110.571 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.415 ' HG3' ' SG ' ' A' ' 20' ' ' CYS . 27.0 pt20 -134.56 -2.66 2.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.076 0.951 . . . . 72.420000000000002 111.098 -170.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.415 ' SG ' ' HG3' ' A' ' 19' ' ' GLN . 37.4 m -143.27 171.11 14.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.574 0.75 . . . . 63.43 110.403 -175.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.82 155.33 41.75 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.736 0.815 . . . . 62.439999999999998 109.549 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.32 -16.41 28.41 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.826 2.351 . . . . 74.129999999999995 113.693 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 m -64.21 -36.76 85.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.617 0.367 . . . . 70.129999999999995 110.974 171.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.747 HG21 ' SG ' ' A' ' 2' ' ' CYS . 50.6 mm -75.98 -52.74 17.13 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 N-CA-C 109.051 -0.722 . . . . 74.519999999999996 109.051 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.401 ' SG ' HD23 ' A' ' 17' ' ' LEU . 21.1 m -65.17 -26.28 68.09 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.559 -1.201 . . . . 73.409999999999997 112.505 -170.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.2 -31.58 72.49 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.385 0.274 . . . . 62.329999999999998 111.171 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.91 -32.15 50.67 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 116.07 -0.514 . . . . 72.329999999999998 112.212 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -88.41 -37.47 15.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.199 0.6 . . . . 64.439999999999998 111.132 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.5 m -90.76 -80.26 0.34 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.29 0.636 . . . . 60.399999999999999 111.736 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.36 -84.32 0.06 OUTLIER Glycine 0 C--N 1.353 1.477 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 112.778 -167.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.98 155.99 18.48 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 112.223 -0.351 . . . . 60.420000000000002 112.223 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.7 t . . . . . 0 C--O 1.249 1.042 0 C-N-CA 123.958 0.903 . . . . 65.030000000000001 108.933 -178.667 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.646 0.26 . . . . 55.420000000000002 110.374 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.813 ' SG ' HG21 ' A' ' 24' ' ' ILE . 23.5 m -138.92 -166.86 2.1 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.266 0.626 . . . . 74.129999999999995 110.416 -173.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.83 -10.34 84.26 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-O 119.359 -0.69 . . . . 42.210000000000001 113.841 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.1 m 77.11 -12.77 1.02 Allowed 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.163 1.385 . . . . 62.409999999999997 112.176 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -94.89 19.16 10.61 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.956 0.884 . . . . 73.329999999999998 109.498 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 99.2 m -106.19 28.78 7.36 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.241 1.016 . . . . 73.140000000000001 110.25 166.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.542 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -103.78 -9.33 0.12 Allowed Pre-proline 0 CA--C 1.581 2.138 0 N-CA-C 116.337 1.977 . . . . 65.5 116.337 167.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 14.1 Cg_exo -67.58 -54.74 0.33 Allowed 'Trans proline' 0 C--N 1.405 3.54 0 CA-C-N 123.658 2.342 . . . . 72.540000000000006 112.926 -168.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -73.04 159.81 84.38 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 113.797 -1.547 . . . . 71.010000000000005 112.103 -166.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.77 -26.3 32.68 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.252 1.968 . . . . 70.129999999999995 110.633 162.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -99.17 27.67 4.96 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.436 1.495 . . . . 74.140000000000001 109.759 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 6.3 p -62.94 -17.79 62.31 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.411 1.084 . . . . 74.129999999999995 113.608 -176.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -54.47 -38.24 66.18 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.889 0.875 . . . . 75.209999999999994 110.339 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.06 -35.42 90.55 Favored Glycine 0 N--CA 1.469 0.848 0 CA-C-N 115.24 -0.891 . . . . 72.420000000000002 112.182 -176.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.47 ' O ' HG12 ' A' ' 18' ' ' VAL . 35.2 t -67.38 -51.82 47.45 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.016 0.912 . . . . 71.120000000000005 110.583 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 t -71.48 -54.5 10.39 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.792 -1.549 . . . . 43.100000000000001 111.629 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.417 HD23 ' SG ' ' A' ' 25' ' ' CYS . 68.6 mt -51.83 -27.22 11.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.373 1.62 . . . . 61.399999999999999 115.373 -175.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 15' ' ' CYS . 14.6 p -74.43 -14.09 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.395 0.617 . . . . 43.119999999999997 111.333 -174.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -146.96 3.68 0.82 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.574 0.75 . . . . 74.329999999999998 111.178 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.8 m -148.31 169.63 19.7 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.03 0.932 . . . . 52.229999999999997 109.863 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.28 157.84 50.02 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.528 0.731 . . . . 73.230000000000004 110.658 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.28 -22.56 5.85 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.424 2.75 . . . . 75.25 113.923 165.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 m -59.22 -44.87 92.28 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.579 0.752 . . . . 70.040000000000006 111.443 172.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.813 HG21 ' SG ' ' A' ' 2' ' ' CYS . 49.2 mm -74.61 -45.47 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.473 0.709 . . . . 74.219999999999999 110.018 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.417 ' SG ' HD23 ' A' ' 17' ' ' LEU . 11.1 m -64.85 -33.25 75.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.74 0.816 . . . . 54.310000000000002 111.163 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.55 -24.85 64.68 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.962 0.505 . . . . 64.319999999999993 110.945 173.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.56 -41.35 24.95 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.951 -0.46 . . . . 71.239999999999995 111.951 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -84.71 -59.91 2.22 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.052 0.541 . . . . 74.310000000000002 111.046 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.4 m -68.89 -51.17 42.91 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.001 0.52 . . . . 60.049999999999997 111.181 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.67 -45.33 17.87 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.708 -0.678 . . . . 73.109999999999999 112.731 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.65 -156.45 53.3 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-O 119.964 -0.353 . . . . 52.130000000000003 113.103 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.9 t . . . . . 0 C--O 1.252 1.192 0 N-CA-C 108.429 -0.952 . . . . 55.119999999999997 108.429 177.135 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.6 p . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 110.093 -0.336 . . . . 64.019999999999996 110.093 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.485 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 34.9 m -74.48 164.71 26.27 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.837 -0.431 . . . . 71.120000000000005 109.837 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.74 -63.28 2.77 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 116.274 -0.421 . . . . 71.519999999999996 112.274 173.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.1 p 160.44 -12.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.157 1.783 . . . . 74.019999999999996 109.275 -167.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.64 -20.5 62.72 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.787 0.835 . . . . 43.329999999999998 110.605 -177.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.8 m -91.42 52.04 2.01 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.734 0.778 . . . . 74.329999999999998 110.815 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.531 ' N ' ' HD3' ' A' ' 8' ' ' PRO . . . -130.01 13.25 0.05 OUTLIER Pre-proline 0 CA--C 1.575 1.909 0 N-CA-C 115.231 1.567 . . . . 53.0 115.231 169.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 7' ' ' ALA . 11.8 Cg_exo -68.05 -51.0 0.67 Allowed 'Trans proline' 0 C--N 1.407 3.635 0 CA-C-N 123.436 2.263 . . . . 73.340000000000003 111.275 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -81.82 151.05 67.04 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 113.508 -1.678 . . . . 74.430000000000007 110.74 -168.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.3 -32.09 81.83 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 121.914 1.743 . . . . 74.200000000000003 111.48 171.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -105.46 57.64 0.68 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.771 1.229 . . . . 72.430000000000007 108.932 175.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.559 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 18.7 p -58.94 -14.01 8.0 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.879 1.272 . . . . 72.530000000000001 113.345 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 61.3 m95 -48.8 -35.62 14.84 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.23 1.412 . . . . 63.340000000000003 111.65 173.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.13 -32.28 79.94 Favored Glycine 0 N--CA 1.475 1.244 0 CA-C-N 115.663 -0.699 . . . . 41.140000000000001 113.055 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.7 t -82.53 -44.51 15.82 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 122.397 1.094 . . . . 60.399999999999999 110.12 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.3 t -82.7 -60.23 2.25 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 112.948 -1.933 . . . . 72.010000000000005 111.758 -169.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.5 mt -52.34 -25.85 10.75 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.991 1.478 . . . . 74.319999999999993 114.991 -175.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.407 HG13 ' HG3' ' A' ' 19' ' ' GLN . 7.3 p -67.47 -22.4 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 CA-C-O 121.074 0.464 . . . . 74.209999999999994 111.1 -176.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.407 ' HG3' HG13 ' A' ' 18' ' ' VAL . 3.3 pp0? -140.63 -5.32 1.2 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.563 0.745 . . . . 71.340000000000003 112.683 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 2' ' ' CYS . 80.2 m -127.79 174.32 9.23 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.158 0.983 . . . . 61.149999999999999 110.295 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.44 157.7 46.9 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 124.832 1.253 . . . . 62.310000000000002 110.111 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.44 -17.56 41.46 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 123.366 2.711 . . . . 51.530000000000001 113.389 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.5 t -56.77 -42.68 79.83 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.329 0.651 . . . . 63.350000000000001 110.811 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mm -76.84 -48.53 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 115.937 -0.574 . . . . 74.209999999999994 110.036 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.2 m -64.73 -34.85 79.3 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.746 -1.115 . . . . 75.019999999999996 111.55 -174.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.44 -20.65 64.65 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.052 0.541 . . . . 71.530000000000001 111.425 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.48 -36.06 24.39 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.841 -0.504 . . . . 25.329999999999998 111.841 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -91.12 -41.85 10.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.355 0.662 . . . . 71.430000000000007 111.739 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.559 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 20.6 m -69.25 -71.84 0.21 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.43 0.633 . . . . 75.239999999999995 111.344 178.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.02 123.34 0.96 Allowed Glycine 0 C--N 1.34 0.804 0 CA-C-N 114.697 -1.138 . . . . 61.32 110.713 -169.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.79 -34.14 1.98 Allowed Glycine 0 N--CA 1.463 0.442 0 N-CA-C 110.985 -0.846 . . . . 43.219999999999999 110.985 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.6 m . . . . . 0 CA--C 1.56 1.33 0 C-N-CA 125.409 1.484 . . . . 73.310000000000002 111.266 176.04 . . . . . . . . 0 0 . 1 stop_ save_